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Heart valve disease is a tremendous national and global burden. Prosthetic 
replacement is essentially the only treatment for a critically damaged or malformed 
valve, and current aortic valve replacement options for pediatric patients are grimly 
inadequate. Tissue engineering has the potential to generate living heart valve 
replacements capable of growth and integration needed to treat children with valve 
disease. Over the last 15 years, researchers have developed and implemented novel 
synthetic polymers as scaffolds for engineered heart valves. Although much progress 
has been made, a persistent problem is the difficulty incorporating native-like 
heterogeneity and controlled remodeling into TEHV.  
 
The work presented here demonstrates a 3D bioprinting approach that generates 
complex 3D geometry tissue constructs using extrudable materials and encapsulated 
cells based on native aortic valve tissue heterogeneity. As a fabrication strategy 3D 
printing overcomes the limitations associated with classical heart valve tissue 
engineering assembly of scaffolds. To enable direct cell-hydrogel printing and thereby 
maximize geometric control within valve constructs, viability experiments were used to 
establish photoencapsulation fabrication parameters tolerated by cells. Photo-
crosslinking experiments demonstrate that contrary to numerous 2D cytotoxicity studies, 
in a 3D hydrogel culture environment and fabrication setting, Irgacure 2959 
photoinitiator can produce more viable encapsulated cells than VA086 photoinitiator in a 
 higher stiffness hydrogel. A dynamic conditioning system designed specifically for the 
culture of 3D bioprinted valves was 1st validated using porcine aortic heart valves. 
Photoencapsulation viability experiments and bioreactor validation studies presented in 
this work provide a range of fabrication and conditioning parameters, that were utilized 
for the fabrication and dynamic culture of 3D bioprinted hydrogel heart valves. Our 
studies indicate that the bioprinted valves can be produced with high viability 
encapsulated mesenchymal stem cells for the purposes of a TEHV or with primary 
aortic valve cells for the purpose of in vitro testing and mechanistic study.   
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CHAPTER 1 
PEDIATRIC VALVE DISEASE AND THE NEED FOR TISSUE ENGINEERED HEART 
VALVES 
 
Portions of this chapter were previously published in Advanced Drug Delivery Reviews 
(Butcher, Mahler et al. 2011) and in the book chapter entitled “Aortic Heart Valve Tissue 
Regeneration” (Duan, Hockaday et al. 2014) in Tissue and Organ Regeneration: 
Advances in Micro and Nanotechnology. 
 
1.1 Summary 
Valve related congenital heart defects are a serious clinical burden affecting 1/100 live 
births. Aortic valve replacement options for pediatric patients are grimly inadequate. Bio-
prosthetic fixed tissue valve prosthetics degrade in less than a few years in young, 
active patients.  Mechanical valve prosthetics, on the other hand, require lifelong 
anticoagulation therapy. Neither of these options have any potential for growth with the 
child.  Nearly 20% of children with prosthetic valves die within 10 years of aortic valve 
replacement and an additional 40% require repeat surgical operations. Tissue 
engineering has the potential to generate a living de novo valve replacement capable of 
growth and integration. Over the last 15 years, researchers have developed and 
implemented novel synthetic polymers as scaffolds for engineered heart valves. Though 
much progress has been made, a persistent problem is the difficulty in fabricating a 
complex-shaped valve with a relatively rigid root and compliant leaflets with a single 
material formulation.  The natural 3D anatomical geometry, non-uniform mechanical 
properties, and heterogeneous cellular composition of the aortic valve are important 
factors for its efficient function.  Recent advances in photo-polymerizable hydrogel 
technology enable the combination of tunable scaffold mechanical properties and cell-
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mediated degradation.  In addition, solid freeform fabrication (3D printing) technology 
has the capacity to generate complex 3D geometries with extrudable materials. 
 
1.2 Pediatric Valve Disease  
1.2.1 Congenital Heart Defects - Most Common and Lethal Birth Defects 
While the majority of patients with aortic valve disease in the United States are over the 
age of 65, approximately 1% of all live births in the U.S. suffer from congenital heart 
valve defects.  Congenital heart defects are the most common and lethal types of birth 
defects, causing 10–30% of preterm fetal demise in the US (Hoffman 1995; Hoffman 
and Kaplan 2002; Tanner, Sabrine et al. 2005).  The most common defects are 
malformations of the cardiac valves (Glen, Burns et al. 2004; McBride, Marengo et al. 
2005; Konstantinov, Karamlou et al. 2006; Owens, Gomez-Fifer et al. 2006; Ilbawi, 
Spicer et al. 2007).While often requiring heroic surgical intervention at birth, valve 
related congenital heart defects lead to pathological remodeling over time and 
premature valve failure. The underlying causes and malformative mechanisms for many 
human congenital disease conditions are not understood (Butcher, Mahler et al. 2011). 
Many studies have identified families for which a valve related congenital heart valve 
disease is heritable, while broader screens have suggested that only a small fraction of 
congenital heart defects can be explained by a specific genetic disorder. The least 
explored causes for congenital valve malformation are micro-environmental mechanical 
forces. Aortic valves develop and function under constantly changing mechanical 
loading conditions (Aikawa, Whittaker et al. 2006), which suggests that altered 
mechanical signaling could be an alternative causal mechanism for congenital valve 
malformations  (Colvee and Hurle 1983; Clark 1996; Kosaki, Mendoza et al. 1996). 
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1.2.2 Valve Disease in the Developing World Predominantly Impacts Children 
The vast majority of aortic valve disease patients in the developing world are children 
and young adults (Cohen, Malone et al. 2006; Zilla, Brink et al. 2008). This age group is 
critically important to sustaining economic development in a country. The global burden 
of heart valve disease is severely underappreciated. 80% of all cardiovascular disease 
cases occur in developing countries (Yusuf, Vaz et al. 2004), causing more than 19% of 
deaths. This is more than war and malaria combined (Ribeiro, Jacobsen et al. 2008).  In 
Western countries the populations  primarily suffers from aging related degenerative 
syndromes, but the population of the developing world suffers from non-ischemic 
cardiovascular pathologies characterized by fibrosis, inflammation, and immune 
reactions. The demographic most affected by valve disease in the developing world are 
children and young adults (Dajani and Taubert 1992; Mayosi 2007; Sani, Karaye et al. 
2007; Mocumbi, Ferreira et al. 2008).  In most of the developing world heart valve 
disease is the single largest cause of hospital admissions for children and young adults 
(Dajani and Taubert 1992). Recent epidemiological studies suggest that the incidence 
of valve disease in developing countries may be grossly underestimated (Marijon, Ou et 
al. 2007).  Numerous cases of valve related pathologies have been documented with no 
known cause. Infant mortality rates remain unacceptably high in developing countries, 
and the proportion of death due to CHD is over 15-fold higher than in the US (Rosano, 
Botto et al. 2000). These statistics indicate tremendous national and global burden of 
heart valve disease. 
 
Rheumatic Valve Disease 
Rheumatic valve disease is one example of a non-ischemic cardiovascular pathology, 
characterized by fibrosis, inflammation, and immune reactions. There are more than 15 
million documented cases and 282,000 deaths from rheumatic valve disease  worldwide 
each year, comparable to all cardiovascular related deaths in the US (Carapetis, Steer 
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et al. 2005). Rheumatic fever may develop after a non-treated throat infection by the 
gram-positive bacteria Streptococcus pyogenes in susceptible children and teenagers. 
Carditis (inflammation of the heart), which is the most serious rheumatic fever 
complication, occurs about 20 days after the infection in 40–50% of patients and can 
lead to valvular heart disease, heart failure, or death(Veinot 2006). Valve complications 
are the result of an autoimmune reaction induced by the molecular mimicry to human 
tissues of streptococcal M proteins and group A carbohydrate. The resulting valve 
pathologies include neovascularization, chronic inflammation, commissural fusion, 
thickening, calcification, and thickened and shortened chordae in the atrioventricular 
valves.  
 
1.3 Treatment of Valve Disease  
Heart valves, especially aortic valves, are critical for ensuring unidirectional blood flow 
through the heart.  90% of patients with severe aortic valve stenosis have a life 
expectancy of less than 10 years unless treated, and 50% of these patients with heart 
failure will die within 1 year (Carabello and Paulus 2009).  Prosthetic replacement is 
virtually the only clinical therapy for aortic valve disease. A small subset of patients 
undergo aortic valve repair (valvuloplasty), but this almost always involves replacing the 
leaflets and/or root with autologous or allogeneic tissue components(Cheng, Dagum et 
al. 2007).   
 
1.3.1 Valve Replacement 
Non-living prosthetics are the clinical standard for heart valve replacement. Living valve 
replacement of the aortic valve with the pulmonary valve in the Ross procedure is being 
explored and requires the replacement of the pulmonary valve with a non-living 
prosthetic. Non-living replacement valves can be divided into two classes: mechanical 
and bio-prosthetic/treated tissue.  
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Mechanical Prosthetic Valves  
Mechanical valves are composed of specialized metals and ceramics. They are 
manufactured in several forms but generally are built with pyrolytic carbon coated metal 
surfaces. These designs are structurally durable, but suffer from two limitations. First, 
they contain complex hinge geometries and components that must remain inside the 
flow zone of the outflow tract. This results in greater than physiological shear stresses 
that induce platelet lysis and protein aggregation on the mechanical valve surfaces. 
Despite 40 years of design iteration, no mechanical valve design has overcome this 
problem (Zilla, Brink et al. 2008). This requires that a patient with a mechanical valve 
prosthetic must manage treatment with anticoagulant drugs for the rest of their life. This 
is associated with severe occupational and lifestyle restrictions. Even with these 
treatments, mechanical prosthetic valve recipients suffer a 2–5% annually cumulative 
risk of serious bleeding events (hemorrhage, stroke, and infarction)(Grunkemeier, Li et 
al. 2000). 
 
Bio-prosthetic Valves  
Tissue valves include xenogenic (porcine and bovine) and allogenic (homograft) valves. 
These are manufactured either in a stented configuration, which contains a synthetic 
sewing ring and struts to support the leaflets, or in a stentless configuration that 
includes the entire root. These valves are not subject to the hemocompatibility concerns 
of mechanical valves and deliver more physiological hemodynamics, but instead risk 
structural degeneration because they contain no living cells. Numerous clinical studies 
have evaluated the efficacy of prosthetic valve replacements, but only a few have been 
comparative and randomized (Hammermeister, Sethi et al. 2000).  In general bio-
prosthetic and homograft valves are the conduit of choice for patients over the age of 
60–65 that are relatively physically inactive (Rahimtoola 2010). Mechanical valves, in 
contrast, are often chosen for patients with higher physical activity levels, those younger 
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than 60, and for those which blood thinner medication can be tolerated. If the prosthetic 
is properly chosen and sized to the patient, clinicians are pushing the age barrier for 
bio-prosthetic valves younger (because prostheses may be “exchanged” with less risk) 
and pushing the age barrier for mechanical valves older (because surgical morbidity is 
reduced). While bio-prosthetic results are acceptable for more sedentary older patients, 
it is unacceptable for more active, younger adults (Grunkemeier, Li et al. 1999). 
 
Pulmonary Autograft (The Ross Procedure)  
The pulmonary autograft, or Ross procedure has received the most attention as an 
alternative intervention strategy to non-living prosthetic valve replacement. This surgery 
replaces the diseased aortic valve with the patient's own pulmonary valve, leaving the 
far less demanding pulmonary position to be replaced with a bio-prosthetic valve. 
Clinical studies to date demonstrate that the Ross procedure is superior to homograft 
aortic valves in adults (El-Hamamsy, Eryigit et al. 2010). The fact that this now creates a 
two-valve problem has led some to question the utility of the procedure for some 
patients (Cameron and Vricella 2007).  
 
1.3.2. Grim Inadequacy of Valve Replacement for Pediatric Valve Disease 
 Unfortunately, aortic valve replacement options for pediatric patients are grimly 
inadequate. Bio-prosthetic valves exhibit exhibiting excellent hemocompatability and 
reasonable durability for patients over 65, but they degenerate and calcify within 5 years 
or faster in children (Schoen 2006). In infants and children, homograft tissue valves 
rapidly fail due to what appears to be an induced immune response(Rajani, Mee et al. 
1998). Meanwhile, mechanical valves are extremely durable, and are the only valves 
that are durable enough for children, but they necessitate lifelong anti-thrombotic 
medication that incurs a 5% annually cumulative risk of bleeding events (Vricella, 
Williams et al. 2005). Infants and young children requiring valve replacement are 
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especially difficult to treat because their conduits are extremely small (10–15 mm 
diameter), yet will grow substantially over time (5–10 mm in diameter). This therefore 
necessitates implantation of a much larger conduit than ideal and/or repeat operations 
to resize the prosthesis (Lupinetti, Warner et al. 1997; Alsoufi, Al-Halees et al. 2009). 
40% of growing children with prosthetic valves require repeat open-heart surgeries to 
resize the valve (Karamlou, Jang et al. 2005).  The pulmonary autograft, or Ross 
procedure, provides a living replacement for the aortic position while a prosthetic valve 
replaces the much less demanding pulmonary position (Ross 1967). While the autograft 
has been effective for adults in comparison to homografts (El-Hamamsy, Eryigit et al. 
2010), clinical results suggest that up to 40% of pulmonary autografts in children may 
dilate pathologically instead of grow (Koul, Lindholm et al. 2002; Frigiola, Varrica et al. 
2010), Consequently, a second prosthetic valve replacement is required.  
 
These limitations altogether indicate the need for valve replacements more suitable for 
growing children, and they also motivate the need to pursue tissue engineering 
strategies to create living aortic valves.  
 
1.4 Aortic and Pulmonary Valve Tissue Engineering 
Tissue engineering is the process by which de novo living tissue is fabricated to replace 
dysfunctional tissue.  A living cellular component enables the possibility for biological 
integration, adaptation, remodeling, and growth. Tissue engineering has great potential 
for real benefit for patients with aortic valve disease, particularly for children requiring 
valve growth and younger patients who cannot tolerate the debilitating side effects of 
current non-living prosthetics(Karamlou, Jang et al. 2005; Yacoub and Takkenberg 
2005).  This population is relatively small in Western nations, largely confined to 
congenital valve malformations underlying the disease (1-2% of all live births) (Roberts 
and Ko 2005; Hinton and Yutzey 2011). However, due to the prevalence of rheumatic 
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fever in the developing world, millions of young people could benefit from a tissue 
engineered conduit (Carapetis 2008; Zilla, Brink et al. 2008).  In many ways, the 
pulmonary autograft represents proof of principle for clinical effectiveness of tissue 
engineered aortic valves (TEHV) (Ross 1967; Koul, Lindholm et al. 2002; El-Hamamsy, 
Eryigit et al. 2010; Frigiola, Varrica et al. 2010), but since (1) it is not an aortic valve and 
(2) does not remove the need for a prosthetic valve replacement, a fabricated living 
valve is still needed. 
 
1.4.1 Design Criteria of a Tissue Engineered Heart Valve (TEHV) 
The basic characteristics of a replacement heart valve were expressed in 1962 by Dr. 
Dwight Harken and extended by Sacks and Schoen for tissue engineered valves 
(Sacks, Schoen et al. 2009): 1) it must be non-obstructive; 2) closure must be prompt 
and complete; 3) it must be non-thrombogenic and non-immunogenic; 4) it must 
accommodate the somatic growth of the recipient; and 5) it must last the lifetime of the 
patient. The fifth requirement means the valve must be durable enough to endure 
millions of load cycles and capable of ongoing remodeling. The natural engineering of 
the native aortic valve is ideal for its long-term function, which suggests key design 
criteria for a TEHV. We believe the most important criterion is to precisely mimic the 
natural anatomic 3D geometry, which is critical for enabling efficient conduit 
hemodynamics and coronary flow (Bellhouse, Bellhouse et al. 1968; Thubrikar, Bosher 
et al. 1979; Thubrikar, Nolan et al. 1980). A very close second is replicating the 
regionally heterogeneous tissue compliance of the root and cusp (Stephens, Durst et al. 
; Sauren, van Hout et al. 1983; Christie 1992; Billiar and Sacks 2000).  The cusps need 
to be sufficiently compliant so as to not impede blood ejection (risking stenosis) while 
the root wall needs to be sufficiently stiff to not pathologically dilate (risking aneurysm) 
(Sacks, Schoen et al. 2009).  While a prosthetic valve must function immediately upon 
implantation, it is also important not to replace diseased tissue with “disease prone” 
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tissue.  Secondary characteristics include mechanical strength (so that it won’t fail in 
elevated blood pressure), ease of biological functionalization (to encourage cell 
engraftment and differentiation), ease of reliable fabrication, cost, and the requirement 
for human tissue material components (Schoen 2008; Sacks, Schoen et al. 2009).  
Other design choices befall every TEHV strategy.  These include: whether they should 
be “off the shelf” or custom-made for each patient (implying storage and/or 
transportation logistics), first processed in vitro (e.g. to make stronger or better 
cellularized tissue) or implanted directly, what cell source to use, and whether design 
should be affected by demographics (age, gender, race) or “one size fits all”.  Some of 
these decisions will be more heavily influenced by market forces (e.g. what can be sold 
and/or reimbursed by insurance) than science, but in this review I focus only on the 
scientific aspects. 
 
1.4.2 Design Path for Tissue Engineered Heart Valves  
The current strategy for TEHV is to aim first for an engineered pulmonary replacement 
in concert with the Ross procedure before progressing to aortic valves.  The 
biomechanically weaker pulmonary valve is anatomically and micro-structurally similar 
to the aortic valve, which presents overlapping but more attainable benchmarks.  
Conduits are first evaluated in vitro for biological and biomechanical fidelity, often 
including in vitro hemodynamic simulation using bioreactors (Sutherland, Perry et al. 
2005; Flanagan, Sachweh et al. 2009; Gottlieb, Kunal et al. 2010; Ramaswamy, Gottlieb 
et al. 2010).  Next they are transferred to animal models for pre-clinical testing.  Novel 
biomaterials are implanted inside small animal models (rat, rabbit) to evaluate 
biocompatibility and calcification potential (Tedder, Liao et al. 2009; Wang, McGoron et 
al. 2010).  The sheep is the only FDA approved large animal model for heart valve 
replacement evaluation.  Sheep aged 10-100 weeks have quantitatively similar cardiac 
sizes and outputs as humans between 1 and 20 years old (Chanda, Kuribayashi et al. 
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1997; de Simone, Devereux et al. 1997), a high propensity for calcifying implanted 
tissue, but tolerate well invasive cardiothoracic surgery (Chanda, Kuribayashi et al. 
1997; Hong, Maish et al. 2000; Meuris, Ozaki et al. 2001; Meuris, Ozaki et al. 2003).  
Sheep however spontaneously endothelialize cardiovascular grafts, which may 
artificially improve performance because humans do not endothelialize grafts so readily 
(Ouyang, Salerno et al. 1998; Simon, Kasimir et al. 2003; Padera R Fi J r 2008).   The 
pig also has similar cardiac sizes and outputs, but poorly endothelializes grafts and 
tolerates poorly invasive surgery.  These features suggest pig to be a more human-like 
animal model for evaluating valves, but the technical challenges create too much risk for 
experimental variability and likelihood for prohibitive costs.  Once proven in the sheep, 
TEHV advance to human trials as pulmonary replacements in adult Ross procedures 
that don’t require growth.  Finally, growing children implantation studies would be 
conducted.  Due to the significant number of expensive steps involved for a relatively 
small affluent patient population, it is doubtful that industry will carry such a project 
forward without significant academic advancement and/or financial incentives 
(Administration October 2004). 
 
1.4.3 Tissue Engineered Heart Valve Approaches  
There are six main approaches for valve tissue engineering: decellularization of aortic 
valve scaffolds, shaping and seeding of scaffolds made of biodegradable polymers, 
shaping biological protein hydrogels that have encapsulated cells, hybrid or layered 
decellularized tissue/polymer scaffolds, in vivo   engineered valve shaped tissues, and 
3D printing of valves.  Each approach has advantages and limitations with respect to 
the above design criteria, which are summarized in Table 1.1.
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Table 1.1 Comparison of TEHV Approaches 
TEHV 
Type 
Ability to Mimic 
Native 
Geometry 
Fabrication Regional 
Heterogeneity 
Mechanical 
Strength of 
Tissue 
Secondary Reference 
Decell/Re
cell 
Excellent since 
the native 
tissue 
geometry is 
preserved 
 
 
 
 
Detergent Treatment 
 
Limited fabrication 
flexibility because the 
size and shape 
determined by 
existing porcine or 
human valve 
ECM 
heterogeneous 
structure 
remains 
 
Limited cellular 
heterogeneity  
Mechanical 
properties vary 
dependent on 
detergent 
protocol  
 
Change in 
mechanical 
properties more 
pronounced for 
enzyme than 
detergent 
treated. 
Less durable 
than native 
valve 
Slight Changes 
in transvalvular 
gradient, valve 
resistance, 
EOA, stroke 
work loss 
depending on 
detergent and 
enzyme used 
(Simon, Kasimir et al. 2003), 
(Rieder, Seebacher et al. 2005), 
(Liao, Joyce et al. 2008), (Bottio, 
Tarzia et al.), (Dohmen, 
Lembcke et al. 2002), (Miller, 
Edwards et al. 2006), (Sayk, Bos 
et al. 2005),  
(Erdbrugger, Konertz et al. 2006) 
Synthetic 
polymer 
Simplified 
Geometry 
(symmetric, 
sinuses) 
Injection Molding -  
easy to repeat the 
same shape 
 
Or 
 
Sutured by hand  
Homogeneous 
material 
Material stiffness 
is greater than 
native valve 
 
Burst strength 
decreases with 
degradation 
Progressive 
valve 
insufficiency 
 
Decreasing 
flexibility and 
motion of 
leaflets 
(Sutherland, Perry et al. 2005), 
(Gottlieb, Kunal et al.), 
(Ramaswamy, Gottlieb et al. 
2010) 
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Table 1.1 Continued 
TEHV 
Type 
Ability to Mimic 
Native 
Geometry 
Fabrication Regional 
Heterogeneity 
Mechanical 
Strength of 
Tissue 
Secondary Reference 
Biological 
polymer 
Simplified 
Geometry 
(symmetric, 
sinuses) 
Molding -  easy to 
repeat the same 
shape 
Homogeneous 
material 
Ultimate tensile 
strength and 
tensile modulus 
of the leaflets in 
the commissural 
direction were 
0.53 and 2.34 
MPa, 
Valve 
insufficiency 
observed 
 
Leaflet 
shortening/shri
nkage 
(Flanagan, Sachweh et al. 2009), 
(Ahmann, Weinbaum et al.), 
(Robinson, Johnson et al. 2007; 
Syedain, Bradee et al. 2013) 
In-vivo-
engineere
d 
Simplified 3D 
printed mold 
geometry 
(symmetric, 
sinuses) 
Molding, 
implantation, 
connective tissue 
capsule formation   
Single tissue 
type   
 
No valve cells 
Tensile strength 
less than native 
valve.  
 
Elastic modulus 
leaflets similar to 
radial direction in 
native valve 
Tissue formed 
thicker for 
larger molds. 
Molded cusps 
and sinuses. 
(Hayashida, Kanda et al. 2007), 
(Yamanami, Yahata et al. ; 
Nakayama, Takewa et al. 2014; 
Sumikura, Nakayama et al. 
2014) 
Layered 
/Hybrid/co
ated  
Excellent, but 
need to create 
a new mold for 
different 
implants 
Molding and suturing 
sinus w/ cusps into 
valve root 
 
Labor intensive, 
limit to how many 
different regions can 
be incorporated  
Layered 
heterogeneity, 
multiple 
material and 
cell types.   
Stiffer compared 
to native 
 (Tedder, Simionescu et al. 2010), 
(Stamm, Khosravi et al. 2004) 
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TEHV 
Type 
Ability to Mimic 
Native 
Geometry 
Fabrication Regional 
Heterogeneity 
Mechanical 
Strength of 
Tissue 
Secondary Reference 
3D 
Printing 
Excellent, able 
to replicate 
native 
geometry or 
simplified  
Low cost prototyping Leaflets can be 
printed with 
compliant, 
flexible 
materials while 
the root can be 
printed with 
stiffer materials 
Multiple cell 
types and 
materials can be 
printed into the 
structure 
 (Ballyns, Cohen et al. ; Cohen, 
Malone et al. 2006; Hockaday, 
Kang et al. 2012; Duan, 
Kapetanovic et al. 2014) 
Table 1.1 Continued 
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1.4.4 Decellularized Valves  
The best TEHV scaffold theoretically would be the native aortic valve itself since it 
contains all of the structural and mechanical heterogeneity required.  Since cells contain 
high lipid content in their membranes, valves can be washed and/or perfused with 
detergents to lyse and clear these cellular components.  In theory, all that would remain 
is a (relatively) undisturbed extracellular matrix structure.  Furthermore, removing cells 
may significantly reduce the immunogenicity of the tissue, raising the possibility that 
non-crosslinked xenogenic valve tissue could be used in humans.  Research over the 
past 15 years has focused on establishing optimized decellularization protocols(O'Brien, 
Goldstein et al. 1999; Simon, Kasimir et al. 2003; Schmidt, Stock et al. 2007).  These 
generally involve anionic, ionic, and/or hypotonic detergents (e.g. SDS, Triton-X, 
EDTA)(Rieder, Kasimir et al. 2004), enzymes (e.g.  trypsin)(Steinhoff, Stock et al. 
2000), and nucleases (DNase, RNase), but constituent doses and perfusion times can 
be varied (e.g. TRI-DOC and TRI-COL)(Rieder, Kasimir et al. 2004).  Results to date 
have identified the following insights.  First, Cusp tissue decellularizes much more 
readily than the root, likely because the root wall significantly thicker and more densely 
populated.  While decellularization largely preserves the matrix ultrastructure, collagen 
crimp patterns, fiber distributions, and glycosaminoglyan profiles can be changed(Naso, 
Gandaglia et al.).  This results in altered biomechanical function, but can be either stiffer 
or more compliant depending on the protocol applied (Liao, Joyce et al. 2008) (Bottio, 
Tarzia et al.).  This creates a difficult balance in completely removing cells while 
preserving tissue biomechanics.  Any remnant cellular debris elicits a strong immune 
response and provide nucleation sites for calcification(Naso, Gandaglia et al.) (Simon, 
Kasimir et al. 2003). While post-decellularization crosslinking of the tissue via 
glutaraldehyde can reduce this immunogenicity, it is not completely prevented and even 
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completely decellularized xenogenic matrix constituents may induce an immune 
response (Rieder, Seebacher et al. 2005).  Decellularized valves have advanced the 
furthest clinically of all TEHV approaches. Sheep pulmonary implantation studies 
demonstrated decellularized allografts can function long-term and upon explant appear 
to be repopulated in as little as 3 months (Erdbrugger, Konertz et al. 2006).   
 
The Synergraft valve by Cryolife is a decellularized pulmonary valve homograft that has 
been implanted in humans.  Adult clinical trials have been very encouraging, showing 
that this valve functions comparable to homografts (Konuma, Devaney et al. 2009).  
Explanted valves however showed minimal in vivo    recellularization (Sayk, Bos et al. 
2005; Miller, Edwards et al. 2006), questioning the ability of these conduits to remodel.  
This approach unfortunately proved disastrous in children, as rapid and massive 
inflammatory reactions caused deaths in 3 out of 4 patients (Simon, Kasimir et al. 
2003).  More recent strategies have focused on recellularizing these decellularized 
scaffolds to improve long-term biointegration (the “Decell-Recell” approach).  Scaffolds 
are either coated with bioactive substances to encourage repopulation in vivo   (Tedder, 
Liao et al. 2009), or populated with autologous cells in vitro before implantation 
(Dohmen, Lembcke et al. 2002; Tedder, Simionescu et al. 2010).  Precoating with 
adhesive proteins (Hayman, Pierschbacher et al. 1985; Seeger and Klingman 1985; 
Burdick and Anseth 2002) or cell surface antibodies (Ye, Zhao et al. 2009) have shown 
enhanced cellularization in vitro and in animals.  More recently, less stringent chemical 
crosslinking agents and porosity modulating protocols have been developed to enhance 
recellularization and matrix integrity following decellularization (Sierad, Simionescu et al. 
; Tedder, Liao et al. 2009).  While encouraging, a major limitation with the decell or 
decell-recell approach is that it still requires an human valve as starting material, which 
are of limited supply (Jashari, Goffin et al. 2010). 
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1.4.5 Biodegradable Synthetic Polymer TEHV 
A widely applied tissue engineering strategy has been to fabricate de novo scaffolds 
using synthetic biodegradable polymers.  These have the advantages of limitless 
supply, broad tailoring of material synthesis and characterization, large variety, ease of 
shaping, and compatibility with many manufacturing processes (stereolithography, 
injection molding).  The vast majority are organic solvent based acidic polymers that 
degrade by hydrolysis (e.g. PGA, PGLA, PLLA, P4HB, PHA) (Sodian, Hoerstrup et al. 
2000; Schmidt, Stock et al. 2007; Ramaswamy, Gottlieb et al. 2010).  Mechanical 
strength and rigidity will therefore decrease over time. While degradation can be 
prescribed somewhat through polymer blends, it results in an uncontrolled “race” 
between cell mediated tissue synthesis and material erosion.  Scaffolds can be shaped 
(by hand or with molds) into valved conduits, but cells cannot be seeded until after all 
cytotoxic solvents are removed (Gottlieb, Kunal et al. ; Sodian, Hoerstrup et al. 2000).  
An additional concern is that the end products from the degrading acidic polymers 
change local pH, causing undesired cell death and differentiation (Gunatillake and 
Adhikari 2003).   
 
Biodegradable polymer TEHV have been iterated over the past 20 years by John Mayer 
and his protégés (Shinoka, Ma et al. 1996; Sodian, Sperling et al. 1999; Sodian, 
Hoerstrup et al. 2000; Sutherland, Perry et al. 2005). Early valve conduits were 
fabricated with multiple biodegradable materials (Shinoka, Ma et al. 1996; Sodian, 
Sperling et al. 1999). The porosity, degradation time, and cell-polymer interaction were 
different between the materials. One of the materials, a non-porous 
polyhydroxyalkanoate (PHO) film was ill suited to use in the scaffold composite,  and 
this led to lack of tissue ingrowth as well as scar tissue formation is some areas 
(Sodian, Sperling et al. 1999). As a result the group shifted to using single material 
porous scaffolds (Sodian, Hoerstrup et al. 2000). In their longest animal trial to date, 
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composite biodegradable polymer components were constructed into valves with 
sinuses, seeded with mesenchymal stem cells, cultured for 4 weeks, and then 
implanted into a sheep model for up to 20 weeks (Sutherland, Perry et al. 2005). In vivo   
monitoring showed leaflet coaptation, and explanted valves showed near-native 
trilaminar matrix striation with both endothelial-like and interstitial-like cell phenotypes.  
Persistent elevated transvalvular pressure gradients suggest the cusps are yet too stiff. 
More recently, Hoerstrup and colleagues have expanded the capabilities of 
biodegradable polymer TEHV by creating a transapical delivery system and identifying 
new cell sources (Schmidt, Achermann et al. 2008; Schmidt, Dijkman et al. 2010).  
Amniotic fluid derived cells were isolated beads and differentiated and then used for the 
fabrication of valve leaflets. Sodian et al explored the use of human umbilical cord-
derived progenitor cells for tissue-engineering valves (Sodian, Schaefermeier et al. 
2010). Public and private tissue banks (more than 30 in the US and on 6 continents) 
store amniotic fluid derived cells and umbilical cord blood cells (Verter Copyright 2000 - 
2010 ). The rational of the tissue banking is to use the cells in stem cell transplantation 
treatments or as an autologous cell source for possible treatments of disease.   
 
1.4.6 Biological Protein Based TEHV  
Unlike biodegradable polymers, biological protein based scaffolds are inherently 
biocompatible and degrade though enzymolysis, which enables cell-controlled tissue 
remodeling.  The most commonly employed proteins are type I collagen and fibrin.  The 
former spontaneously forms a fiber network at neutral pH, while polymerization of the 
latter is controlled by thrombin analogs(Flanagan, Sachweh et al. 2009).  In-vitro studies 
have demonstrated that almost all mesenchymal cells including VIC thrive within and 
rapidly compact these protein hydrogels (Ahmann, Weinbaum et al. ; Butcher and 
Nerem 2004; O'Cearbhaill, Murphy et al. 2010).  Most biological hydrogels are created 
at less than 10% of native densities, resulting in significantly weaker matrices.  Denser 
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protein scaffolds can achieve greater mechanical strength but have limited cell 
infiltration.  Completely biological TEHV have been created using fibrin and collagen 
hydrogels created 3D molds with exaggerated shapes to ensure desired final geometry.  
In vitro studies show these tissues do remodel and strengthen, achieving anisotropic 
fiber structures similar to native valves, although much weaker (Robinson, Johnson et 
al. 2007).  In a first sheep implant study, fibrinogen encapsulating autologous arterial 
cells was injection molded into valve shapes, mechanically conditioned in vitro for 28 
days before 3 month implantation (Flanagan, Sachweh et al. 2009). Explanted valves 
showed almost no cusp tissue, suggesting severe tissue contraction.  Prediction of 
remodeling and strengthening is therefore a key requirement for the success of the 
biological protein based TEHV (Ahmann, Weinbaum et al.).  Furthermore, these results 
suggest that we do not yet know how the body interprets an engineered fibrin scaffold 
that resembles wound-like granulation matrix.  Likewise, until a safe recombinant 
human or xenogenic collagen supply can be obtained, it is unlikely that a collagen 
based valve will be possible in the near future. 
 
1.4.7 In-vivo-engineered TEHV   
In-vivo tissue engineering involves co-opting the natural foreign body response to 
synthesize autologous tissue around an implant material.  The initial proof of concept 
was established by Campell and colleagues, who created blood vessels by inserting 
silicone tubing into peritoneal cavity of dogs (Chue, Campbell et al. 2004).  They found 
elastin-rich medial wall architecture with mesothelial-derived endothelial-like and 
smooth muscle-like cell phentoypes.  This strategy was recently extended to valved 
conduits (Yamanami, Yahata et al. ; Hayashida, Kanda et al. 2007).  A silicone and 
polyurethane mold was implanted into the dorsal subcutaneous space of a rabbit. 
Connective tissue formed around the valve shaped mold and leaflets were cut into the 
tissue after removal from the rabbit. The in-vivo-engineered valve was tested in an in 
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vitro flow loading circuit and opening and closure of the leaflets without regurgitation 
was observed. Tensile strength of the tissue was less than the native valve, but the 
modulus matched the modulus of the native valve leaflets stressed in the radial direction 
(Yamanami, Yahata et al.). Yamanami and colleagues recently established proof of 
principle of this approach in a beagle model  (Yamanami, Yahata et al. 2010).  An 
anatomical mold assembly implanted in the dorsal subcutaneous space developed 
native-like geometry and burst strength.  Echocardiographic follow up over 84 days 
showed effective cusp kinematics.  Explanted valves contained endothelial and medial 
cells, supporting biointegration.  Recently  additional work demonstrated ‘biovalves” in a 
pulse duplicator system and in a goat animal model (Nakayama, Takewa et al. 2014; 
Sumikura, Nakayama et al. 2014).  Using a 3D printed mold that provided the construct 
with valve sinuses of native size and control of cusp aperture Nakayama et al created 
entirely autologous valves (no additional polymer scaffold) that were predominately 
fibrous collagen. They found that the connective tissue formed around the mold even 
prior to implantation had heterogeneous mechanical properties between the leaflet and 
the root, and they suspect that capsule contraction around the different parts of the 
mold is responsible. Although biaxial mechanics and the physiological strain behavior of 
the material has yet to be evaluated, the maximum elastic modulus properties of these 
engineered tissues match (leaflet) or surpass (root) native tissue. The in-vivo-
engineered valves were evaluated before and after implantation in an apico-aortic 
bypass. In apico-aortic bypass, a conduit is inserted into the apex of the heart so that 
part of the outflow of the left ventricle goes through the native aortic valve and part goes 
through a bypass engineered valve. Under these hemodynamic conditions Nakayama 
et al found minimal stenosis and regurgitation of the in-vivo-engineered TEHV after 1 
month. Histological evaluation of remodeling in the valves indicates that cell ingrowth is 
minimal and suggests slight thinning of the leaflet and root tissue.   Population of cells 
within the root and leaflet will affect long term remodeling and this could present a 
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challenge for this particular TEHV strategy. Earlier studies of in-vivo-engineered TEHV 
did find some cell ingrowth into these tissues although it appears much less in the 
leaflet compared to the root. Additionally there was evidence of differentiation/distinct 
cell phenotype between the cells populating the root and leaflet structures. However, 
the low cellularity indicates that these valves may be more useful for adult implantation 
rather than  pediatric valve replacement. Higher levels of cellularity and remodeling  
may be required to enable growth and functional development of valve tissue. It is 
suspected that during development cardiac tissue adapts to changing mechanical loads  
and that cells populating the valve activate and remodel matrix as needed to deal with 
increasing hemodynamic demand(Aikawa, Whittaker et al. 2006). Fetal and pediatric 
valve tissue has much higher cell density and the cells are more proliferative and 
activated than in adult valves.  More study will be needed to determine if a nearly 
quiescent valve dominated by a single ECM component will function long term in the 
adult and if it can adapt with a growing child. 
 
1.4.8 Hybrid TEHV Manufacturing Strategies   
Several TEHV strategies have combined features from the aforementioned categories 
for enhanced control of the fabrication process.  Several examples are presented.  
Tedder and colleagues recently created a composite TEHV using stem cell seeded 
accellular starter matrices adhered with a biological adhesive and vacuum pressed into 
a valve shape (Tedder, Simionescu et al. 2010).  This strategy approaches a completely 
biological valve, but is very labor intensive.  Motor controlled electrospinning has also 
been used to create TEHV with prescribed polymer fiber architectures (Courtney, Sacks 
et al. 2006). Cells can also be co-sprayed into the fiber mesh (Stankus, Guan et al. 
2006). The root and cusps however must be made separately and recombined 
(Sutherland, Perry et al. 2005). One failure mode for a TEHV is leaflet tissue contraction 
and subsequent valve insufficiency.  The progressive contraction of the leaflet tissue is 
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attributed to cell driven remodeling by populating cells, and one strategy to address this 
mode of failure is to remove transplanted cells from the TEHV(Dijkman, Driessen-Mol et 
al. 2012; Syedain, Bradee et al. 2013; Syedain, Meier et al. 2013)). The hypothesis is 
that decellularizing the TEHV of contractile phenotypes (which were needed for the 
production of the tissue) and then recellularization the TEHV with non-contractile 
phenotypes will eliminate contraction of the leaflets (Syedain, Meier et al. 2013).  
Syedain et al has combined a biological polymer hydrogel molding technique with a 
decellularization strategy. They harness the cell remodeling and collagen production 
capabilities of encapsulated dermal fibroblasts in a fibrin hydrogel molded into a valve 
shape. They have demonstrated that fibroblasts reorganize and deposit addition matrix 
so that the resultant tissue is mechanically robust enough to be decellularized and 
function short term under simulated in-vitro pulmonary conditions (Syedain, Bradee et 
al. 2013; Syedain, Meier et al. 2013).  Dijkman et al has used a similar strategy except 
they used a non-woven polymeric mesh shaped into leaflets held into a stented ring 
seeded with vascular derived (vein) myofibroblasts (Dijkman, Driessen-Mol et al. 2012). 
Both Dijkman et al and Syedain et al have reseeded their valves with bone marrow 
mesenchymal stem cells. This strategy has yet to be evaluated in-vivo long term.  
Possible challenges that this TEHV strategy may face are related to the growth and the 
deliberate/intended engineering of the TEHV as quiescent and/or minimally populated 
with cells in order to preserve the geometry and prevent tissue contraction. The strategy 
depends on cell repopulation of the decellularized tissue with a non-contractile cell type. 
Recellularization been convincingly demonstrated at the surface of the tissues and into 
the interior of leaflets tissue with bone marrow mesenchymal stem cells which appear to 
be less contractile than the fibroblasts(Dijkman, Driessen-Mol et al. 2012; Syedain, 
Bradee et al. 2013). However, although the contractile effects may not be as 
immediately apparent, MSC are functionally capable of remodeling and contraction of 
ECM proteins particularly collagen (Awad, Butler et al. 2000; Nirmalanandhan, Levy et 
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al. 2006) and the valve leaflets may still contract long term. Contraction of collagen 
structure is dependent on both cell density and the matrix density(Nirmalanandhan, 
Levy et al. 2006), and controlling distribution and density of cells within in the tissue can 
be difficult using an outside-in seeding technique and it can depend on cell type 
(Colazzo, Sarathchandra et al. 2011). Additionally if these decell-recell strategies do 
successfully produce quiescent valve tissue, they may be suitable only for short term 
adult valve replacement and may be inappropriate for the adaptive and growing needs 
of pediatrics.  The native pediatric valve remodels in response to changing 
hemodynamic loads(Aikawa, Whittaker et al. 2006) and the adult  aortic valve responds 
to the cyclic stresses of normal cardiac function through constant synthesis and renewal 
of the valve interstitial ECM(Schneider and Deck 1981). This is part of what gives native 
valve tissue its durability. It has also been shown that cell activity is different depending 
on the location within the valve, and region differences in ECM synthesis may be critical 
for balanced tissue maintenance (Merryman, Youn et al. 2006). 
 
Direct 3D tissue printing is a rapid prototyping technique where three dimensional 
structures are generated by extruding sequential layers of materials according to 
computer aided design (CAD) files (Cohen, Malone et al. 2006; Ballyns, Gleghorn et al. 
2008; Ballyns and Bonassar 2009). Rapid prototyping has been used previously to 
create anatomical molds from which to create TEHV scaffolds (Sodian, Loebe et al. 
2002; Nakayama, Takewa et al. 2014).   More recently, entire valved conduits were 3D 
printed at 100% using poly (ethylene glycol) diacrylate (PEG-DA) and layer by layer 
photo-crosslinking with ultraviolet light (Filho AL 2009).  Using multiple deposition 
syringes with different biomaterial formulations, it is possible to deposit valve and root 
specific microenvironments while maintaining anatomical geometry (Hockaday, Kang et 
al. 2012; Duan, Hockaday et al. 2013; Duan, Kapetanovic et al. 2014).   
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1.4.9 Cell Sources for TEHV 
The success of TEHV strategies depend on effective remodeling and maintenance by 
resident cells. Early studies demonstrated that allogenic cell sources cause an acute 
inflammatory response even in the presence of immunosuppressant treatment 
(Shinoka, Breuer et al. 1995). Subsequent strategies have focused on autologous 
differentiated cells and stem cells as sources for populating TEHV.  Marker expression 
studies indicate that VIC exhibit phenotypes that are similar between the four valves 
(aortic, pulmonary, mitral, and tricuspid), but have significantly different expression 
profiles compared to other sources (arterial smooth muscle, vein, skin, pericardium) 
(Messier, Bass et al. 1994; Taylor, Allen et al. 2000; Maish, Hoffman-Kim et al. 2003; 
Taylor, Batten et al. 2003). Maish et al proposed tricuspid valve biopsy as a method for 
obtaining autologous VIC and VEC for and aortic TEHV, and their supporting study in 
sheep demonstrated that tricuspid valve cells could be isolated, cultured, and the 
tricuspid valve could remain functional (Maish, Hoffman-Kim et al. 2003). Unfortunately, 
the risk of operative morbidity or damage to the tricuspid valve has dampened the 
acceptance of the procedure. VIC phenotype appears to fall between vascular smooth 
muscle cells and skin fibroblasts, and both of these cell types have been explored as 
potential TEHV cell sources (Shinoka, Breuer et al. 1995; Hoffman-Kim, Maish et al. 
2005). In engineered leaflets vascular smooth muscle cells isolated from veins and 
arteries performed better than dermal fibroblasts (Shinoka, ShumTim et al. 1997). 
 
Autologous stem cells are being explored as a source of cells for TEHV, to see if they 
can be differentiated to duplicate the phenotype and function of native valve cells. 
Studies using in vitro bioreactors and implantation into an animal model have shown 
that bone marrow derived and circulating progenitors have the capacity to form both 
endothelilal-like and interstitial-like cells when seeded on valve scaffolds (Perry, 
Kaushal et al. 2003; Sutherland, Perry et al. 2005; Ramaswamy, Gottlieb et al. 2010; 
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Sales, Mettler et al. 2010).  Additionally, preliminary experiments with adipose derived 
mesenchymal stem cells (ADSC) indicate they could be suitable for TEHV (Colazzo, 
Chester et al. 2010; Colazzo, Sarathchandra et al. 2011). ADSC can be isolated in 
comparatively high numbers, can form endothelial-like cells (Colazzo, Chester et al. 
2010), and have been shown in a partial tissue bioreactor study to have the ability to 
synthesize and process valve ECM components and are responsive to mechanical 
stress (Colazzo, Sarathchandra et al. 2011). Hoerstrup and colleagues have developed 
protocols and have carried out feasibility studies for several stem cell sources unique for 
pediatric applications. These cell sources include amniotic fluid, placenta, umbilical cord 
blood, and chorionic villi (Schmidt, Breymann et al. 2004; Schmidt, Mol et al. 2006; 
Schmidt, Mol et al. 2006; Schmidt, Achermann et al. 2008; Schmidt, Dijkman et al. 
2010). Autologous pediatric stem cells could be procured prenatally or perinatally and 
used to fabricate a TEHV or stored in a cell bank for future use (Weber, Zeisberger et 
al. 2011; Weber, Emmert et al. 2012). There is already some existing infrastructure for 
tissue banking with public and private tissue banks that store amniotic fluid derived cells 
and umbilical cord blood cells (Verter Copyright 2000 - 2010 ).  More research is 
necessary to determine if stem cell sources can adequately mimic native valve 
phenotypes and if they maintain that phenotype long term. Stem cell multi-lineage 
potential and plasticity may require that the biomaterials and the culture conditions be 
optimized for valve cell differentiation. A recent study highlights this, as stem cells can 
shift towards cartilage and osteogenic lineages which could predispose TEHV to 
calcification (Emani, Mayer et al. 2011). 
 
1.5 Need for Improved Remodeling and Heterogeneity in TEHV  
Classical TEHV strategies have made two key discoveries. First, in-vivo dynamic culture 
prior to implantation improves the performance of the tissue engineered valve. Second, 
autologous stem cells can differentiate into both endotheilial-like and interstitial-like cell 
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phenotypes (Shinoka, Ma et al. 1996; Hoerstrup, Sodian et al. 2000; Stock, Nagashima 
et al. 2000; Sutherland, Perry et al. 2005; Schmidt, Mol et al. 2006; Sales, Mettler et al. 
2010). However, the persistent problem for synthetic polymeric TEHV is that the 
material has been too stiff for the leaflets or the leaflets have stiffened over time 
resulting in stenotic function. For autologous biological polymeric valves, tissue 
contraction of the leaflets resulted in valve insufficiency. These classical TEHV 
strategies are limited by their fabrication strategy and materials. Using one material 
means that the even superficial regional mechanical differences, such as compliant 
leaflets and the stiff root, are neglected and the microenvironment limits heterogeneous 
differentiation of seeded cells. In native aortic valve there are four main structures of the 
valve (Figure 1.1A). The relatively stiff root to which the leaflets are attached connects 
to the aorta.  Three thin flexible leaftlets open completely when blood is ejected from the 
ventricle, and close to keep blood from flowing back into the ventricle. The three sinuses 
are pocket/parachutes structures shaped out of the root and leaftlets.  Vortexices form 
in these sinuses so that the leaflets efficiently close.  The coronary ostia which lead to 
the coronary arteries provide oxygenated blood to the heart.  In native valve tissue 
within each of the four main structures there is a heterogeneous distribution of 
mechanical properties, cell phenotypes, and extracellular matrix (ECM) proteins and 
fiber structure (Butcher, Mahler et al. 2011) (Figure 1.1D). For instance, the leaflets 
have a layered structure, with the fibrosa, spongiosa, and ventricularis having different 
flexure and stiffness properties (Courtney, Sacks et al. 2006). The heterogeneity and 
asymmetric shape of the valve  affects its ability distribute load, and as a result the 
strain response of the valve to load during the different phases of cardiac cycle is non-
uniform (Dagum, Green et al. 1999) (Figure 1.1C) . The root is populated by contractile 
smooth muscle cells, while the leaflets contain fibroblastic “interstitial” cells (Butcher, 
Mahler et al. 2011) (Figure 1.1B). The phenotype of these cells is highly sensitive to 
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  Figure 1.1.1 Aortic valve complex structure and function. 
A) The heart’s aortic valve has a layered fiber and multi-cellular structure within the 
root and leaflets. It also has a complex shape important for hemodynamic function. 
(B) AVIC, ASSMC, and VEC cells drive regional cellular response to load. (C)The 
root and cusps undergo dynamic anisotropic deformation with each heartbeat. 
(Dagum, Green et al. 1999)(D) Role of elastin and collagen microstructure in 
mediating valve cusp deformation(Schoen 1997). (Figure modified from (Sutherland, 
Perry et al. 2005; Butcher, Mahler et al. 2011)). 
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 intrinsic microenvironment cues and extrinsic mechanical stimulation (Butcher and 
Nerem 2004; Butcher, Penrod et al. 2004; Butcher and Nerem 2006). A tissue 
engineered heart valve will require this balanced heterogeneity in order to have 
sufficient durability and healthy remodeling upon implantation. 
 
The field has been shifting focus towards hybrid TEHV strategies which have focused 
on mimicking complex shape and heterogeneity (Sutherland, Perry et al. 2005; Stankus, 
Guan et al. 2006; Tedder, Simionescu et al. 2010) (Figure 1.2). While these studies are 
promising, molding and/or shaping/suturing/gluing scaffolds by hand has fundamental 
limits. For the field of TEHV to move forward  fabrication strategies need to be identified 
to incorporate heterogeneity, better control scaffold remodeling, and better control 
differentiation of seeded cells within TEHVs. 
 
1.6 Organization of the Dissertation  
The objective of this work is to develop a strategy to fabricate and condition multiple 
material heart valve scaffolds with fine geometric control and internal heterogeneity to 
guide scaffold remodeling and differentiation of 3D printed cells.   
 
In Chapter 2, 3D printing enabled advances and remaining unaddressed needs in in soft 
tissue engineering are reviewed    
 
In Chapter 3, a study is presented that demonstrates 3D printing and photo-crosslinking 
hydrogels can be used to rapidly fabricate anatomical scaffolds exhibiting mechanical 
heterogeneity and cytocompatibility. This manufacturing process was demonstrated with 
PEG-DA and a Fab@HomeTM printing platform, but the findings indicate that this 
method could be adapted for use with other photocrosslinkable polymers. The findings 
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Figure 1.2 .2 Recent hybrid TEHV strategies to achieve improved anatomical and 
microstructural heterogeneity.  
(A) Biomatrix/polymer composite valve synthesized by impregnating biodegradable 
poly(hydroxybutrate) into decellularized porcine aortic valve. (B) Tissue engineered 
semilunar heart valve synthesized using polyglycolic acid (PGA) and poly-l-lactic acid 
(PLLA) fiber. (C) Valve constructs generated by molding collagen layers that were 
assembled by bio-adhesive. (D) Valve conduit created by implanting a mold that 
encapsulates the tissue in vivo. (E) Fibrin-based valve with autologous cells. (F) 
Heterogeneous PEG-DA scaffold valves fabricated via 3D tissue printing. (Review 
figure from (Butcher, Mahler et al. 2011).  
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 presented in this chapter are encouraging steps toward improved valve scaffold 
designs for both adult and pediatric valve disease. 
 
In Chapter 4, a study is presented that explores variables associated with photo-
crosslinking hydrogels and their effects on viability for a 3D printable MEGEL:PEGDA 
3350 mixture containing valve cells or mesenchymal stem cells. Contrary to numerous 
2D cytotoxicity studies, the findings presented in this chapter indicate that in a 3D 
hydrogel culture environment and fabrication setting, Irgacure 2959 can produce more 
viable encapsulated cells than VA086 in a higher stiffness hydrogel.   Intracellular 
oxidative stress was not significantly greater in hydrogel conditions of more Irgacure 
2959 photoinitiator radicals. Normalized oxidative stress ratios suggest that increasing 
VA086 radicals induced higher intracellular oxidative stress. These findings 
demonstrate that suppression of intracellular oxidative stress using catalase 
pretreatment does not disrupt hydrogel crosslinking but it does not rescue cell viability 
from photoinitiator damage. 
 
In Chapter 5, methods to generate geometries exhibiting heterogeneous distribution of 
printable materials and living cells throughout a fabricated shape are presented. These 
algorithms provide a tool for 3D printing heterogeneous, anatomically relevant tissue 
engineered constructs.  Using the first algorithm demonstrated, the target print image is 
generated through processing any image into printable vector format.  A second 
algorithm that generates spatially heterogeneous gradients with multiple materials in 
arbitrary directions in 2D and 3D is presented. Finally a combination algorithm that 
separates intrinsic tissue heterogeneity present in medical imaging scans of anatomical 
tissue into printable format files is described. The fabrication of the files generated by 
these algorithms was demonstrated using the Fab@HomeTM platform by printing 
heterogeneous hydrogel scaffolds.  We also present a method to quantify the fidelity of 
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heterogeneous layers, and to quantify the degree of cell mixing and blending of different 
materials within the layer.  
 
In Chapter 6,   a brief review of heart valve bioreactors is presented. 
 
In Chapter 7, a dynamic conditioning system specifically for the culture of 3D bioprinted 
and ex-vivo native tissue heart valves is presented.  The custom water driven 
diaphragm-type bioreactor was engineered with a conditioning chamber specifically 
designed for ultrasound monitoring of valve root wall and leaflet motion and tissue 
strain. The parameters of the flexible control and water driven flow loop system can be 
scaled or throttled to enable dynamic culture of aortic and pulmonary valves at adult or 
pediatric stroke volume and flow rates. Additionally the system can be scaled for parallel 
conditioning in multiple reactor chambers containing individual valves. Physiological 
systolic and diastolic loading conditions can be achieved or diastolic only loading 
conditions can be induced with the control setup.  The results presented in this chapter 
will enable exploration into the optimal conditions and loading regimes needed to drive 
remodeling and tissue development in 3D printed hydrogel valves. 3D bioprinted heart 
valves composed of methacrylated gelatin, methacrylated hyaluronic acid, and PEGDA 
were cultured up to 14 days under static and dynamic conditions to validate the system 
and to induce remodeling in bioprinted valves.  
 
In Chapter 8, concluding summaries and future recommendations are presented.   
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CHAPTER 2 
APPLICATIONS OF 3D PRINTING TO ENGINEERING SOFT AND 
HETEROGENEOUS TISSUES 
 
2.1 3D Printing Fabrication Systems 
3D printing is a technology that is finding application in the automotive, aviation, 
manufacturing, jewelry, do-it yourself, food, and medical industries.  The beginnings of 
the technology were in 1976 with the invention of the inkjet printer and then in 1984 with 
the invention of stereolithography (SLA) to create solid three dimensional objects from 
digital information. The application of 3D printing to tissue engineering (TE) within the 
last two decades has been heavily exploratory – investigators testing the limits and 
utility of new and modified 3D printers, using new materials and schemes to incorporate 
living cells, and applying the technology to mimic different tissue systems for 
regenerative medicine, modeling, and diagnostics.    
 
3D printing, solid freeform fabrication (SFF), and additive manufacturing are general 
terms to describe techniques that build three dimensional objects in layers through 
sequential delivery of energy and/or material (Billiet, Vandenhaute et al. 2012). 3D 
printing is being explored for tissue engineering due to the flexibility, ease of patient 
specific geometry, and multiple material control.  
 
In this chapter, recent progress and remaining unaddressed needs for utilizing 3D 
printing for engineering replacement and regenerative tissues, and engineering support 
devices for in vitro culture and loading of engineered tissue are reviewed.   
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2.1.1 3D printing to create living tissue - encapsulation and direct cell printing vs 
post fabrication cell seeding of scaffolds 
The challenge of tissue engineering is characterizing and then translating understanding 
of native tissue and cell biology into an application format to engineer models that 
recapitulate organ and tissue function. Towards this goal, investigators are working on 
multiple fronts to identify biological mechanisms, evaluating and inventing new 
materials, and improving fabrication and culture technologies. With numerous studies 
indicating that cell-cell interactions and cell-material interactions in the 3D 
microenvironment in native tissue is fundamentally different than in 2D (Muller, 
Davenport et al. 2009; Bellis, Bernabe et al. 2013; Chitcholtan, Asselin et al. 2013), the 
emphasis and how cell biology is investigated is shifting from 2D culture models to 3D 
culture models (Lund, Yener et al. 2009; Baker and Chen 2012; Santos, Hernandez et 
al. 2012). 3D printing is of interest as a tool, both because it enables mechanistic and 
biological investigation in 3D at multiple scales from cell (Lee, Moon et al. 2008; 
Torgersen, Ovsianikov et al. 2012) to tissue (Chang, Boland et al. 2011; Fedorovich, 
Alblas et al. 2011); but, also because it could translate into a means for fabricating living 
tissue at a scale suitable for clinical use (Koch, Deiwick et al. 2012; Luangphakdy, 
Walker et al. 2013).  Two strategies feature prominently in TE for how to mimic native 
tissue – the first is to use a 3D biomaterial scaffold to mimic extracellular matrix as a 
necessary guide and support template for cells, the second is to position cells and allow 
them to self-organize through cell-cell interactions and to create their own matrix 
(Leong, Cheah et al. 2003; Norotte, Marga et al. 2009; Marga, Jakab et al. 2012). The 
strategy selection, scaffold or scaffold-free, and the tissue-target influences the choice 
of 3D printing fabrication process and the materials.  
 
Specific requirements for tissue engineering constructs will change depending on the 
tissue target and the intended application, but there are four critical categories to 
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consider - 1) biological requirements, 2) mechanical requirements, 3) transport 
requirements, and 4) geometric requirements (Butscher, Bohner et al. 2011; Billiet, 
Vandenhaute et al. 2012; Derby 2012).  For example, a tissue engineered heart valve 
intended for implantation might need an active population of remodeling interstitial-like 
cells that function with the endothelial cells to maintain valve function. A tissue 
engineered heart valve would also be required to function mechanically the moment it is 
implanted; however  transport is less of a problem for heart valves compared to other 
tissues because the valves are in contact with circulating blood in the heart, and the 
valve has a complex non-self-supporting geometry  (Butcher, Simmons et al. 2008; 
Gandaglia, Bagno et al. 2011; Hockaday, Kang et al. 2012). 
 
Materials that are compatible for a specific 3D printer may not fit the needs for 
engineering a specific tissue or strategy. In direct cell printing or in bioprinting, cells are 
incorporated into the tissue engineered construct during the printing process, and in the 
process they are exposed to the fabrication conditions. Determining the effect of the 
fabrication conditions during 3D printing on deposited cells – mixing (Cohen, Lo et al. 
2011), extrusion (Kang, Hockaday et al. 2013), light exposure on cell integrity (Cui, 
Breitenkamp et al. 2012), viability, function, and differentiation capability– is a critical 
step for 3D printing. Different cell types have different responses to fabrication 
conditions, including sensitivity to photoinitiator (Williams, Malik et al. 2005). By contrast 
in a strategy where only the scaffold is 3D printed and then cell seeded post-fabrication, 
the fabrication conditions do not have to be cell permissive as long as the end result 
scaffold is. This allows a wider range of scaffold materials and printing processes, but it 
also depends on cell infiltration and integration from the surface of the scaffold in which 
limits control over cell spatial organization within the engineered tissue.  
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2.1.2 3D Printing devices to grow engineered tissue: 3D printing in molds and 
support structures/devices for culture and mechanical loading  
Both indirect and direct rapid prototyping methods have been used for tissue 
engineering (Ballyns, Cohen et al. 2010). For indirect rapid prototyping, the scaffold 
and/or cells are processed out of a rapid prototyping mold (Tan, Chua et al. 2013) and 
for direct rapid prototyping the scaffold and/or cells are directly processed by the rapid 
prototyping machine (Yeong, Chua et al. 2004).  Indirect rapid prototyping has been 
used to make high fidelity injection molds of patient-specific anatomy for tissue 
engineered constructs (Ballyns, Gleghorn et al. 2008; Wilson, van Blitterswijk et al. 
2011). Another utilization of 3D printing is to produce support devices for culture and 
mechanical loading of the engineered tissue. Many tissue engineering strategies 
depend on an in vitro culture phase in order to control cell phenotype, to promote 
extracellular matrix (ECM) deposition, and to strengthen the tissue prior to implantation. 
To mimic physiologic loading conditions, which may be nearly as complex as the native 
tissue, support structures/devices that mimic proximal or impacting tissues have 
recently been built using 3D printing.  Ballyns et al created an in vitro knee bioreactor to 
dynamically load TE-menisci with patient specific geometry during culture (Ballyns and 
Bonassar 2011). A similar loaded organ culture device was made for intervertebral 
disks, but the parts were machined (Haglund, Moir et al. 2011). Several authors have 
discussed the unaddressed need for more 3D printable materials, usually in the context 
for direct fabrication of the engineered tissue; but, more materials for fabricating support 
and culture devices, screened for biocompatibility and long term contact with culture 
media, would help advance bioreactor technology.  
 
2.2 Recent progress in TE for soft tissue  
For soft tissue TE 3D printing has been utilized for developing tissue engineered skin, 
cartilage, myocardium, heart valves, blood vessels and vasculature, scaffolds for brain 
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injury and neural sheets. 3D printing because of its multi-material capability and 
geometric control, has enabled direct rapid prototyping of multi-level and multi-cell type 
structure into engineered soft tissue, been used to demonstrate the potential for in-situ 
printing into non-uniform wounds, and has been used in strategies that have advanced 
to in-vivo animal models and clinical trials.  
 
2.2.1Skin tissue engineering: Advances in multi-level structure, in-situ printing 
into contoured wounds, in vivo   animal model  
Skin is the largest organ in the body, it provides critical barrier functions, and it is 
densely innervated to perceive and discern between pain, temperature and touch 
(Groeber, Holeiter et al. 2011). Treatment of burns is an area of need where TE could 
be beneficial as the gold standard for deep burns- autologous split-thickness skin grafts 
can be of limited use for patients who have few unburned areas left on their body 
(Boettcher-Haberzeth, Biedermann et al. 2010). The ultimate goal for tissue engineered 
skin is a construct featuring both the epidermis and dermis that improves healing quality 
and avoids scar formation  (MacNeil and 2007 2007). Skin is a complex 3D tissue, with 
several cell types arranged/organized within distinct microenvironments for specific 
functions (Michael, Sorg et al. 2013). This complexity is what has motivated the use of 
3D printing for tissue engineering skin, for control of heterogeneity, pattern, and cell 
density. 
  
Both nozzle-based and printer-based 3D printing approaches have been used for skin 
tissue engineering. In one example study, Koch et al used a laser based direct-write 
printing technique to print fibroblasts and keratinocytes into 3D cell-hydrogel structures 
(Koch, Deiwick et al. 2012).  Although Koch et al. demonstrated using red and green 
labeled cells that they could fabricate more complex geometry grid-layered patterns, 
they specifically focused their study on tissue formation and intercellular junctions within 
 46 
 
the tissue constructs and used a simplified geometry. In a subsequent in vivo   study the 
3D printed bi-layer skin equivalents were implanted into full thickness wounds in the 
dorsal skin fold of mice for 11 days (Michael, Sorg et al. 2013). The printed skin 
implants form a tissue similar to native skin and appear to integrate into the wound 
accompanied by capillary and blood vessel formation in the matriderm layer.  However, 
native skin characteristic rete ridge structures are absent in the TE skin, during 
remodeling the TE skin thinned, and vascularization of the TE skin was incomplete.  
Michael et al anticipates that rete ridge structures could be printed in and that adding 
endothelial cells into the printed constructs will improve vascularization based on work 
showing endothelial cells in combination with fibroblasts and/or keratinocytes in 
biomaterial scaffolds or decellulized dermis form capillary like tubules in the dermis 
(Black, Hudon et al. 1999; Schechner, Crane et al. 2003).  
 
Using a nozzle-based 3D printing system to print collagen, gelatin, and fibroblasts, Lee 
et al demonstrated that cells and micro channels could be printed into cellularized 
scaffolds and that cell viability was improved with perfusion (Lee, Lee et al. 2010). The 
gelatin was used as a sacrificial material to form channels in the collagen. In a study by 
the same group, TE skin with stratified keratinocytes and fibroblasts was 3D printed into 
a contoured wound model using a nozzle-based 3D printer and nebulized mist of 
crosslinking agent (Lee, Debasitis et al. 2009). A collagen layer was deposited, partially 
crosslinked with mist, cells were deposited into the collagen layer, additional crosslinker 
was applied, and then the next layer was deposited. This nebulized crosslinker 
approach enabled print and build on a non-uniform surface without a bath or supporting 
frame. 
 
These TE skin studies have demonstrated the ability to control cell density, spatial 
distribution of multiple materials and cell types, and geometric complexity with 3D 
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printing. Additionally, TE skin has reached the in vivo   animal model stage. Key 
advances include creation of densely cellularized tissue with cell-cell junctions, multi-
cellularity with keratinocyte and fibroblast layers which may be critical for the ability to 
recruit vasculature and for ECM production (compared to acellular controls or single cell 
type TE skin studies), incorporation of perfusion channels to augment capillary self-
assembly and/or invasion from surrounding tissue, and filling of a non-level wound 
model which indicates feasibility for in situ treatment of burn wounds.  
 
A critical feature of the laser induced forward transfer printing technique for laser 
assisted bioprinting is that it is not yet automated and is dependent on coating and 
loading of glass slides. By contrast, nozzle based printing system used by Lee et al is a 
semi-automated system that allows for fast switching of materials (Lee, Debasitis et al. 
2009; Lee, Lee et al. 2010).  However, even with a non-automated process, Koch et al 
demonstrated spatial capabilities of this type of 3D printing higher than what were 
immediately needed for the biological/mechanistic investigation for which they used a 
simplified structure (Koch, Deiwick et al. 2012; Michael, Sorg et al. 2013) that was 
subsequently used in an in vivo   mouse study. Printing studies assessing the 
capabilities of a given 3D printer in terms of viability/impact on cells and geometry are 
generally followed by biological/mechanistic investigations of biomaterial and cell 
combinations and geometries. Identifying to what degree and which aspects of a native 
tissue to mimic for TE, is an iterative process based on what works in vitro and then in 
vivo  . TE skin studies have already demonstrated that 3D printing enable multi-material 
and multi-cell spatial control, but the next step with the technology is to incorporate 
additional complexity with additional cell types into TE skin, such as peripheral nerve 
cells, Schwann cells, melanocytes, and endothelial cells.  
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2.2.2 Cartilage tissue engineering – advances in ear, intervertebral disc, and 
meniscus TE and hybrid technologies for engineering cartilage  
3D printing has been used extensively for cartilage tissue engineering. While direct cell-
scaffold 3D printing has been used for cartilage TE to demonstrate that multiple regions 
of mechanical properties and/or cells can be deposited within cartilage structures, 
indirect rapid prototyping of tissue using 3D printed molds for tissue-injection molding 
has been used to create implants that have progressed to in vivo   animal testing. Load 
bearing and non-load bearing tissue engineered cartilage has been fabricated into 
specific structures including the ear auricle and knee menisci using 3D printing.  
 
Ear TE and non-load bearing cartilage  
The ear is a complex structure with several different tissue types within it. At the most 
basic level it contains skin, bone, cartilage, and nerve tissue. The pinna or auricle of the 
outer ear collects sound and directs it to the outer ear canal and is composed of 
cartilage and skin, and the ear drum aka tympanic membrane vibrates when sound 
waves reach it. The Eustachian tube connects the middle ear to the back of the nose 
and it equalizes pressure between the inner ear and the outside (Ciorba and Martini 
2006; Swarts, Alper et al. 2013). The three tiny bones of the ossicular chain - the 
hammer, then anvil, and the stirrup - transfer vibrations from the ear drum to the 
cochlea. The cochlea is a spiral shaped, fluid filled inner ear structure lined with cilia 
that move when vibrated and cause a nerve impulse to form. Investigators are 
interested in applying TE for replacement/treatment of several of these tissues/parts 
including: the tympanic membrane (Teh, Marano et al. 2013); the inner ear cells 
(Devarajan, Forrest et al. 2013); the Eustachian tube (Kanemaru, Umeda et al. 2013); 
the ossicular chain (D'Alessandro, Danti et al. 2012) and the auricular cartilage (Liu, 
Zhang et al. 2010; Mannoor, Jiang et al. 2013; Nimeskern, Martinez Avila et al. 2013; 
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Nimeskern, van Osch et al. 2013; Reiffel, Kafka et al. 2013; Sterodimas and de Faria 
2013; Xue, Feng et al. 2013). 
 
Both direct and indirect rapid prototyping 3D printing techniques have been used for ear 
TE, primarily to engineer auricular cartilage. Microtia is a congenital deformity where the 
auricle of the ear is underdeveloped. The gold standard treatment is to sculpt 
autologous costal cartilage from the anterior ends of the ribs into the shape of the 
auricle, and implant it under the periauricular skin (Reiffel, Kafka et al. 2013). However, 
limitations to this treatment include limited donor site supply, donor site morbidity, 
inherent difficulty in sculpting an anatomically accurate patient specific auricular shape, 
and auricular cartilage differs biomechanically from costal cartilage. While auricular 
cartilage is not load bearing in the same sense that joint cartilage is, it is elastic and 
experiences tension, bending, and compression.  
 
Auricle-TE has moved from merely coating a frame scaffold shaped like an ear to 
engineering underlying cartilage. To create an auricle frame coated with skin cells, Cai 
et al used FDM to print acrylonitrile butadiene styrene (ABS) plastic shaped like the ear 
auricle, coated it with fibronectin, seeded fibroblasts onto the structure, and then after 
two weeks of static culture seeded keratinocytes on top of the fibroblasts (Cai, Azangwe 
et al. 2005). Studies focused on TE cartilage for the ear have used both direct rapid 
prototyping 3D printing of cartilage (Mannoor, Jiang et al. 2013) and indirect rapid 
prototyping 3D printing of molds for cartilage (Liu, Zhang et al. 2010; Reiffel, Kafka et al. 
2013). Mannoor et al 3D printed bionic ears using an extrusion nozzle-based 
Fab@Home printer, using alginate and chondrocytes for the auricle and silver 
nanoparticle infused silicone to form cochlea-shaped electrodes (Mannoor, Jiang et al. 
2013). After the TE-auricle/Ag-cochlea was cultured in-vitro for up to 10 weeks, the 
chondrocytes were viable throughout the auricle and in contact with the Ag-cochlea and 
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the histology staining of the tissue was consistent with the development of new 
cartilage. They also performed an electrical and sound test to demonstrate that the 
bionic ears could hear/listen. For indirect fabrication, Reiffel et al used 3D printed 7-part 
molds to mold patent-specific auricle TE-cartilage using collagen and bovine auricular 
chondrocytes (Reiffel, Kafka et al. 2013). They found that auricle constructs implanted 
into the subcutaneous pockets of rats for up to 3 months showed significant differences 
between cellular constructs and acellular constructs. Cellular constructs demonstrated 
marked cartilage deposition and elastin content, while the acellular constructs only 
showed invasion of mononuclear cells and capsule formation around the constructs. 
  
One critical consideration for fabrication strategy is sufficiency and necessity. Reiffel et 
al found that treatment of the cartilage and the auricle structure as a single 
material/structure produced excellent in-vivo results, and the tissue injection molding 
strategy is generally less demanding in terms of material used to make the TE-construct 
(for example viscosity appropriate for deposition or speed of crosslinking for layer build 
and working time) compared to direct cell-scaffold 3D printing (Reiffel, Kafka et al. 
2013).  For the outer ear tissue, injection molds may be the extent of the need for 3D 
printing. However, while indirect rapid prototyping may prove sufficient for creation of 
effective TE auricles, the level of complexity needed for the inner and middle ear 
structures may require direct 3D printing (Mannoor, Jiang et al. 2013).   
 
Meniscus 
The meniscus is a load bearing cartilage structure in the knee. For meniscus injury, the 
most common treatment is partial or total removal of the injured tissue.  Investigators 
have been pursuing TE strategies to repair or ‘patch’ defects and tears in the meniscus, 
treatment with growth factors to stimulate growth and healing, and whole TE-menisci for 
replacement (Haddad, Pakravan et al. 2013). Clinical use of cadaveric menisci is 
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problematic due to scarcity of donor tissue, risk of disease transmission, and difficulties 
in matching native joint anatomical shape. The size and the shape of the native 
meniscus are critical for distribution of pressure across the joint. Both indirect and direct 
rapid protoytyping 3D printing has been used for meniscus tissue engineering. 3D 
printing has enabled advances in whole meniscus tissue engineering for replicating the 
characteristic meniscus shape.  
 
Cohen et al directly printed menisci constructs in alginate with chondrocytes and 
demonstrated 1 week viability and sterility using the Fab@Home extrusion nozzle-
based system (Cohen, Malone et al. 2006). Ballyns et al having used MRI and FDM in 
ABS to generate a 3D printed mold of a knee meniscus, used tissue-injection molding to 
make TE-cartilage menisci constructs that retained their shape throughout 8 weeks of 
static culture, showed viability throughout, but did not achieve the mechanics or ECM 
content of native menisci (Ballyns, Gleghorn et al. 2008). In a subsequent study, Ballyns 
et al investigated the effects of dynamic loading during in-vitro culture using platens 
designed to replicate anatomic loading that were 3D printed in ABS plastic (Ballyns and 
Bonassar 2011). They also evaluated shape fidelity for directly 3D printed alginate 
hydrogel menisci compared to injection molded menisci for uCT and MRI generated 
geometries (Ballyns, Cohen et al. 2010). Less deviation from the target geometry was 
observed for injection molding compared to 3D printing using the Fab@Home, and it 
could be argued that if a single starting composition is used for a tissue construct, such 
as the meniscus, indirect fabrication is a more practical strategy. However, optimized 
printing and handling of different materials for a given 3D printing system can improve 
the quality and fidelity of printed constructs (Cohen, Lo et al. 2011; Kang, Hockaday et 
al. 2013). 
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2.2.3 Cardiovascular tissue engineering 
Cardiovascular disease is the leading cause of death worldwide (Yusuf, Reddy et al. 
2001; Labarthe and Dunbar 2012). Cardiovascular tissue is a critical target for tissue 
engineering and regenerative medicine. 3D printing has been used in strategies to 
create engineered tissue for myocardium repair/regeneration, heart valve replacement, 
and blood vessels.  
 
Myocardium 
The central pathology for congestive heart failure, the loss of cardiomyocytes and the 
subsequent loss of myocardial contractile function is unaddressed by current clinical 
strategies (Zimmermann, Schneiderbanger et al. 2002). When injury or ischemia 
occurs, the heart forms scar tissue rather than regenerating cardiomyocytes. Using cell 
transplantation therapy with direct cell injection has shown improved ventricular function 
in injured hearts (Gaetani, Barile et al. 2009). The strategy for a tissue engineered 
myocardium patch is to increase the efficiency of cell delivery, provide mechanical 
support to the diseased myocardium, and provide appropriate microenvironment to 
transplanted cells.  
 
Gaetani et al used an extrusion based 3D printer, the BioScaffolder system, to print 
RGD-modified alginate hydrogel and encapsulated human fetal cardiomyocyte 
progenitor cells into porous patches (Gaetani, Doevendans et al. 2012). They showed 
that human fetal cardiomyocyte progenitor cell viability could be maintained if a pore 
structure was incorporated into the patch, and the printing and static culture conditions 
did not block the proliferation rate of encapsulated cells or change the cardiac 
commitment of the cells. This study demonstrated the utility of controlling the internal 
pore structure for TE-myocadium patches. They also anticipated that additional cell 
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types and multi-cellular could be implemented into the patches, because injection cell 
therapies found that non-cardiomyocyte also improved ventricular function. 
 
Heart Valves 
Heart valves ensure one way blood flow through the cardiovascular system. Critically 
diseased or defective heart valves require replacement, and tissue engineering has the 
potential to address the limitations of non-living prosthetics and to grow, remodel, and 
integrate with the patient, which is of particular relevance to pediatrics (Butcher, Mahler 
et al. 2011). Direct rapid prototyping 3D printing is being explored for aortic heart valve 
tissue engineering due to the complex 3D geometry and heterogeneity that is critical for 
valve function (Hockaday, Kang et al. 2012; Duan, Hockaday et al. 2013). 3D printed 
tissue engineered heart valves have multiple cells and material properties directly 
incorporated into TE constructs in addition to complex anatomical shape and have 
progressed to in vitro static culture.  
 
Hockaday et al used an extrusion nozzle-based Fab@Home 3D printer to fabricate 
aortic valve shaped polyethylene-glycol diacrylate (PEG-DA)/alginate scaffolds with two 
different mechanical properties in the leaflets and root structures and then post 
fabrication seeded aortic valve interstitial cells into them (Hockaday, Kang et al. 2012). 
A high degree of scaffold shape fidelity was achieved although it was affected by 
hydrogel swelling, and cells when seeded onto the scaffold had cell viability. However, 
cell infiltration into the scaffold was minimal and only a single cell type was used. In a 
subsequent study, Duan et al directly 3D printed aortic smooth muscle cells and valve 
interstitial cells into the valve root and leaflet using a gelatin and alginate hydrogel 
combination (Duan, Hockaday et al. 2013). Cellularized valve constructs were cultured 
up to 7 days and expressed regional valve markers. 
 
 54 
 
Blood Vessels and Microvasculature 3D Printing 
Large blood vessels, branched vessel networks within organs, and microvasculature are 
TE targets. Large blood vessels have been engineered with some success using a self-
assembly strategy by rolling and fusing cell sheets into tube structures and then 
conditioning in a bioreactor prior to implantation.  This strategy of engineering vascular 
grafts has reached clinical testing (L'Heureux, Paquet et al. 1998; McAllister, 
Maruszewski et al. 2009). 3D printing has been explored for more complex geometries 
than these simple tube structures. 3D extrusion printing, both cell-laden hydrogel direct 
printing and scaffold-free cell aggregate printing, has been used to print tubular and/or 
branched vessel structures that have been cultured in vitro (Norotte, Marga et al. 2009; 
Skardal, Zhang et al. 2010; Xu, Chai et al. 2012). 
 
A critical need for tissue engineering thick tissues and full scale organs. is engineering a 
functional vasculature into the tissue for transport of nutrients, oxygen, and waste 
products. 3D printing has enabled significant progress towards filling the need for 
complex branching and variable vessel size within a network that all lies within another 
tissue.  Cui et al used a modified HP Deskjet 500 thermal inkjet printer to fabricate grid-
like TE-microvasculature structures (Cui and Boland 2009). Human microvascular 
endothelial cells were mixed with thrombin and calcium ions and loaded into inkjet 
cartridges and then deposited drop by drop into a layer of fibrinogen, to form cellularized 
fibrin grid structures.  The cells proliferated and formed a confluent lining inside the 
fibrin channel after 21 days in vitro culture. The integrity of the vasculature was tested 
using red fluorescently tagged dextran molecules.  After 14 days culture red dye could 
leak through the endothelial cells, but by 21 days dextran could be excluded from the 
printed structures due to improvement in the endothelial cell lining. 
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Miller et al used 3D printing for a 3D sacrificial molding technique to generate a network 
of TE microvasculature within a monolithic tissue (Miller, Stevens et al. 2012). Using a 
thermal extrusion and drawing 3D printer a rigid open lattice of carbohydrate glass 
filaments was printed, the filament structure was coated with poly(D-lactide-co-
glycolide), and then a suspension of cells and precursor was poured to encapsulate the 
lattice and crosslinked. The coating on the filament structure enabled dissolved 
carbohydrates of the glass to flow out of the channels not through the bulk of the TE 
construct. Critical advancements for this technology included getting the glass to have 
appropriate mechanical and temperature handling, but also to be transparent and 
compatible with photopolymerization. Miller et al demonstrated the technology with 
cellularized agarose, alginate, PEG, fibrin, and Matrigel tissue constructs. With this 3D 
printing strategy it is possible to make multilayered vascular network structures within 
the interior of a tissue, control variation in filament/vessel size, and create perfusible 
gradients. Endothelial cells were seeded/perfused into the channels of tissue constructs 
after the glass filaments were dissolved and removed, and they formed a continuous 
lumen during culture.  Additionally, single and multicellular sprouts formed from 
patterned vasculature into the surrounding gel/cells. A significant part of Miller et al’s 
study demonstrated that the microvasculature enabled preservation of viability and 
function for densely seeded tissues, and they tested up to 40 million cells/ml in their 
constructs (native tissue approximately 10-500 million cells/ml). This is significant for 
engineering any tissue that is vascularized, and Miller et al demonstrated the 
carbohydrate glass printing technology with liver and kidney cells, both critical soft 
tissue engineering targets. While strategies for engineering functional vascular networks 
could advance TE for tissue engineered skin and thin myocardial patches, for high 
density and higher order complex tissues such as liver and kidney inherent 
vascularization is probably essential.   
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2.2.4 3D printing for Higher Order Complex Tissue  
Characterization of the biology, function, and organization of tissues and resident cells 
is incomplete and ongoing for even seemingly simple tissue systems. However, the 
challenges for tissue engineering become compounded as tissue complexity and multi-
functionality increase. 3D printing has been applied to engineering higher order complex 
tissues ultimately for the purpose of regenerative medicine, and it has also been used to 
better understand cell-material interactions and tissue development. 3D printing has 
enabled advances in liver tissue engineering, neural tissue engineering, heterogeneous 
soft and hard tissues, and mechanistic studies.    
 
Liver 3D Printing Advances 
Acute and chronic liver failure is major problem in human health and due to the limited 
number of donors, low survival rate after transplantation, and high cost of liver 
transplantation operations liver tissue engineering is a significant target for regenerative 
medicine (Wang, Yan et al. 2007). On the spectrum of tissue within the body, the liver is 
an ambitious engineering target. The liver is an intricate tissue with multiple functions 
including biosynthesis, biotransformation, and excretion. It has complex branched 
vasculature and bile ductular systems in addition to a variety of cell types, matrices, and 
regulatory factors. 3D printing has enabled some advances in liver tissue engineering 
by identifying some fabrication and construct conditions affecting hepatocyte viability. 
Investigators have found that 3D structure is important to hepatocyte stability. Wang et 
al 3D printed gelatin and hepatocytes into porous stacked grid structures using an 
extrusion based printer, where the temperature-based solidification of gelatin enabled 
for build of a many layered structure (38 layers) which could be post-fabrication 
crosslinked with glutaraldehyde to stabilize the structure (Wang, Yan et al. 2006). Wang 
et al found that hepatocytes survive within 3D matrix structures but die when the 
structures break down. Although the hepatocyte constructs had high viability for more 
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than 2 months, monitoring enzyme activity indicated that necrosis was occurring in 
constructs during the whole culture period. The study demonstrated that some liver 
specific functions, albumin and urea synthesis, were maintained by the hepatocytes in 
these printed constructs.  
 
Neural 3D Printing Advances 
3D printing has been applied for peripheral nerve repair TE, tissue engineered neural 
sheets, scaffold strategies to help with traumatic brain injury, and testing nervous 
system cell-material interactions. Advances in scaffold-free printing where a support cell 
is used to make Schwann cell aggregates printable has enabled functional neuron 
bridging that has advanced to in vivo   testing. In vitro studies have shown that neurons 
can retain their electrophysiological characteristics after printing, and multicellular and 
multi-material constructs can be printed out of astrocytes and neurons with a high 
degree of spatial control.  
 
Scaffold-free printing with cell aggregates using an extrusion based printer has been 
used to make TE grafts designed to bridge severed nerves, which have progressed to in 
vivo   animal model testing. Initially Schwann cell-only constructs were attempted, 
however Marga et al found that Schwann cells had insufficient cell-cell adhesion to 
make printable bio-ink/cell aggregates (Marga, Jakab et al. 2012).  An addition of 
different cell type can be used to modulate the scaffold-free bio-inks. Bone marrow 
derived mesenchymal stem cells were sufficiently cell-cell adhesive to be printable, had 
previously been shown to transdifferentiate into Schwann cells, and had previously 
been used to support nerve regeneration, so Marga et al combined Schwann cells with 
bone marrow derived stem cells to form cell aggregates which were printed into 
multichannel tube structures. After 7 days in vitro culture the multichannel construct was 
implanted as a nerve graft to bridge the sciatic nerve in rats, and after 3 weeks 40% of 
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the axons present in the sciatic nerve stump had reached the other side through the 
graft. Scaffold extrusion based 3D printing has been used to fabricate gelatin and 
hyaluronan into 3D open channel scaffolds without cells as a temporary support for 
brain trauma injury which have been implanted into rats (Zhang, Yan et al. 2007). 
 
Direct cell and scaffold printing has also been used for neural TE. Xu et al. used inkjet 
printing to print thrombin/CaCl2/cells into fibrinogen to form 3D neural sheet constructs 
(Xu, Gregory et al. 2006). Rat primary embryonic hippocampal and cortical neurons 
were printed into patterns and 3D fibrin/cell structures using a thermal nozzle inkjet 
printing process and then evaluated the functionality of printed cells using 
immunostaining and a patch clamp setup. The results supported that in addition to 
tolerating inkjet printing fabrication conditions (90% viability), neurons could maintain 
their neuronal phenotype and were able to regrow both axonal and dendridic processes 
after printing and could retain their electrophysiological properties. The speed of the 
inkjet printing technique may be a critical condition to avoid detrimental neuron 
response to heat shock and the effects of shear stress by the nozzles.  
 
Lee et al used the same nozzle-based 3D printer and nebulized mist crosslinking 
strategy they used for skin printing and applied it to neural TE (Lee, Pinckney et al. 
2009). Neurons and astrocytes were directly printed into single layer and multi-layer 
collagen constructs with cross and ring geometries. Single cell type and multi-cell type 
constructs were printed during the study and cultured in vitro for up to 15 days. They 
demonstrated that a high degree of spatial control within the constructs could be 
obtained and that neurons and astrocytes had similar viability between control and 
printed cells. They also observed that adjusting printed cell density could improve 
connectivity and growth and neurite outgrowth was dependent on collagen gel 
concentration. The same printing technology was used to print cells from a neonatal 
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derived cerebellum cell line into a composite collagen and vascular endothelial growth 
factor (VEGF) releasing fibrin construct (Lee, Polio et al. 2010). The study demonstrated 
that multiple hydrogel types (pH sensitive and enzymatically crosslinked) could be 
printed into constructs for neural TE, and VEGF releasing fibrin promoted migration and 
proliferation of cerebellum cells encapsulated in adjacent collagen regions. Findings 
from 3D printed in vitro models and the testing of materials and cells under simplified or 
controlled conditions have contributed to the knowledge base of TE. The advantage of 
doing in vitro studies with 3D printing is that the results have the potential to be directly 
applicable because of the pairing of basic science with the means of fabrication. 
 
Heterogeneous Tissue Engineering  
3D printing technologies are capable of printing multiple cell types and materials into TE 
scaffolds, but only a few strategies have advanced to evaluating the consequences of 
heterogeneity and multi-cellularity in vivo  . Recent work by Fedorovich et al has 
focused on evaluation of heterogeneous, multi-cell type functionality and 
development/differentiation within printed TE constructs in vitro and in vivo  .  They have 
printed  bone and cartilage combination constructs and implanted into mice ultimately 
intended for treatment of osteochondral defects (Fedorovich, Schuurman et al. 2012). 
Another separate study has implanted printed bone and blood vessel combination 
constructs to enable functional blood supply for engineered bone (Fedorovich, Wijnberg 
et al. 2011). For these studies a Bioscaffolder pneumatic dispensing printer system was 
used in a direct cell and scaffold fabrication strategy to extrude cell-laden hydrogels into 
chessboard structures and into multilayered tube-within-cube structures that were 
crosslinked post fabrication in calcium chloride solution. 
 
For osteochondral constructs, bone marrow derived mesenchymal stem cells and 
osteoinductive biphasic calcium phosphate particles were mixed into one alginate 
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solution and articular chondrocytes were mixed into another alginate solution and 
printed into constructs with different alginate/cell regions. For osteo-endothelial 
constructs, both matrigel and alginate solutions were used to print bone marrow derived 
mesenchymal stem cells and endothelial progenitor cells.  
 
These studies demonstrated that heterogeneous printing resulted in heterogeneous 
tissue formation during in vivo   culture.  ECM produced by the cells corresponded to 
the deposited cell type, and the scaffold mixture or hydrogel type could be used to direct 
and influence matrix production of encapsulated cells. Depending on the encapsulating 
scaffold material, cells maintained the original printed organization or migrated out of 
the pattern to different degrees.  New blood vessel formation and ingrowth was enabled 
by the presence of endothelial progenitor cells. While the scaffolds printed by 
Fedorovich (Fedorovich, Schuurman et al. 2012) are centimeter scale tissue constructs, 
the indications of a formation/recruitment of functional vascular network and blood 
supply is promising for the possibility of larger scale constructs.  
  
3D Printing Mechanistic Studies and Tools for Engineering Complexity into Soft Tissue 
Wang et al highlights obstacles hindering progress in bioartificial liver manufacturing 
using rapid prototyping technologies in terms of biological, biomaterial, and engineering 
challenges (Wang, Yan et al. 2007). Some of these obstacles/challenges are not unique 
to liver TE, but are challenges for the entire field of tissue engineering. One question 
that Wang et al raises is how can different time scales for maturation of different tissues 
and cell types be accommodated to ensure all cell types are functional? Depending on 
the fabrication and culture strategy, cell induction during in vitro culture, cell induction 
prior to assembly/printing, signals and mechanics directly incorporated into the matrix, 
or sequential release of signaling and growth factors may be necessary to engineer 
functional complex tissues.  
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There have been significant advances in hydrogel biomaterials research that could 
enable a high degree of control within the 3D matrix. Tibbet and Anseth describe these 
as technologies for 4D biology - 3D cell laden matrices that change or can be controlled 
over time (Tibbitt and Anseth 2012). Photodegradable/photoreleasible attachment 
peptides (Kloxin, Tibbitt et al. 2010), photocontrolled nanoparticles for triggered release 
of proteins (Azagarsamy, Alge et al. 2012), photodegradable mechanics and on 
demand pendant functionality release (Kloxin, Kasko et al. 2009), two photon 
immobilization of growth factors within hydrogels (Wylie, Ahsan et al. 2011), and mRNA 
transfection of mesenchymal stem cells prior to encapsulation in hydrogels (Mariner, 
Johannesen et al. 2012) are examples of tools that could be used with 3D printing to 
control the timing of development and maturation of 3D printed tissues with high spatial 
precision. Some of the fabrication strategies used to demonstrate these biomaterial 
technologies such as μSLA and 2-photon polymerization have already been used for 3D 
printing fabrication of tissue constructs (example cartilage) (Lee, Kang et al. 2008; Lee, 
Rhie et al. 2008) and for mechanistic studies to test how geometry and  
microenvironment direct cell morphogenisis or regeneration (Kloxin, Lewis et al. 2012). 
While the application of 3D printing to complex higher order tissue has been limited, as 
the knowledge base of biological mechanism and the number of possible materials 
compatible with 3D printing fabrication expand, tissue-level scale engineering of these 
types of tissue becomes more feasible.  
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CHAPTER 3 
RAPID 3D PRINTING OF ANATOMICALLY ACCURATE AND MECHANICALLY 
HETEROGENEOUS AORTIC VALVE HYDROGEL SCAFFOLDS 
 
This chapter was published in Biofabrication (Hockaday, Kang et al. 2012).  
3.1 Abstract 
The aortic valve exhibits complex three-dimensional (3D) anatomy and heterogeneity 
essential for long-term efficient biomechanical function. These are, however, 
challenging to mimic in de novo engineered living tissue valve strategies. We present a 
novel simultaneous 3D-printing/photo-crosslinking technique for rapidly engineering 
complex, heterogeneous aortic valve scaffolds. Native anatomic and axisymmetric 
aortic valve geometries (root wall and tri-leaflets) with 12 to 22 mm inner diameters (ID) 
were 3D printed with poly-ethylene glycol-diacrylate (PEG-DA) hydrogels (700 or 8000 
MW) supplemented with alginate. 3D printing geometric accuracy was quantified and 
compared using CT. Porcine aortic valve interstitial cells (PAVIC) seeded scaffolds 
were cultured for up to 21 days. Results showed that blended PEG-DA scaffolds could 
achieve over 10-fold range in elastic modulus (5.3±0.9 to 74.6±1.5 kPa). 3D printing 
times for valve conduits with mechanically contrasting hydrogels were optimized to 14 to 
45 minutes, increasing linearly with conduit diameter. Larger printed valves had greater 
shape fidelity (93.3±2.6, 85.1±2.0, and 73.3±5.2% for 22, 17, and 12 mm ID porcine 
valves; 89.1±4.0, 84.1±5.6, and 66.6±5.2% for simplified valves). PAVIC seeded 
scaffolds maintained near 100% viability over 21 days. These results demonstrate that 
3D hydrogel printing with controlled photo-crosslinking can rapidly fabricate anatomical 
heterogeneous valve conduits that support cell engraftment. 
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3.1 Introduction  
Aortic valve disease (AVD) is a serious and increasing clinical burden that affects 
patients at all stages and walks of life. In particular, congenital heart valve defects, 
which affect 1-2% of all live births in the United States, predispose the valve to 
premature failure and can be fatal if left untreated (Hoffman and Kaplan 2002). AVD is 
most commonly treated with surgical replacement of the defective valve. Tissue 
engineering has the potential to address current limitations of non-living prosthetics and 
donor supply shortage of allografts by providing living tissues that can grow, remodel, 
and integrate with the patient (Butcher, Mahler et al. 2011).  
 
A major criterion for a tissue engineered heart valve is that the engineered valve must 
mimic the physiological function of the native valve. Several studies highlight that the 
natural geometry of the root, cusps, and sinus wall is critical for enabling efficient 
hemodynamics and coronary flow (Bellhouse, Bellhouse et al. 1968; Vesely 2000). 
Geometry is also important for tissue durability, where the intrinsic asymmetry of the 
root prevents cusp deterioration by minimizing the transvalvular pressure and stress on 
the cusps (Dagum, Green et al. 1999). In addition to geometry, spatial and mechanical 
heterogeneity is also critical for function. During the majority of their in vivo   strain 
range (<20%), valve leaflets are very extensible and compliant, which permits rapid and 
efficient opening (modulus ~54 kPa aortic leaflet radial direction and the pulmonary 
leaflets are less stiff (Mavrilas and Missirlis 1991; Christie and Barratt-Boyes 1995)). 
The sinus root wall however is significantly more rigid (aortic root modulus ~ 140-180 
kPa and pulmonary root modulus ~50-85 kPa (Matthews, Azadani et al. 2010; Butcher, 
Mahler et al. 2011; Azadani, Chitsaz et al. 2012)), which helps maintain an open lumen 
under demanding hemodynamic loads (Sacks, Schoen et al. 2009).  Tissue engineers 
have fabricated mechanically heterogeneous tissues, but specific benchmarks for valve 
engineering are unmet. An improved tissue engineering fabrication strategy should 1) 
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effectively replicate native valve geometry and 2) effectively replicate regional 
mechanical heterogeneity. 
 
Traditional de novo valve scaffold engineering involves manually shaping valve root and 
leaflet geometries out of polymer scaffold and seeding them with cells. A number of 
synthetic (poly-glycolic acid, polylactic acid, poly-4-hydroxybutyrate, 
polyhydroxyalkanoate) (Sodian, Hoerstrup et al. 2000; Sutherland, Perry et al. 2005; 
Balguid, Mol et al. 2009; Gottlieb, Kunal et al. 2010; Ramaswamy, Gottlieb et al. 2010; 
Sales, Mettler et al. 2010; Schmidt, Dijkman et al. 2010; Sodian, Schaefermeier et al. 
2010; Eckert, Mikulis et al. 2011; van Geemen, Driessen-Mol et al. 2012) and biological 
polymeric (collagen I, fibrin) (Neidert and Tranquillo 2006; Robinson, Johnson et al. 
2007; Flanagan, Sachweh et al. 2009) scaffolds have been created, mechanically 
conditioned in vitro, and tested in animal models. In the longest such trial to date (8 
months within a growing sheep model), engineered valves (leaflet + conduit) were still 
functional but mildly stenotic, suggesting that the leaflets lacked sufficient compliance 
(Sutherland, Perry et al. 2005). While the exact cause is unknown, forming the root and 
leaflets with the same scaffold material mesh may have created root walls that are too 
compliant and/or cusps that are too stiff, both of which are characteristics of valve 
pathology (Butcher, Simmons et al. 2008). Incorporation of heterogeneity into tissue 
engineered valves with different root versus leaflet materials has been achieved, but 
this required the different parts to be fabricated sequentially and then joined with 
sutures manually (Shinoka, Ma et al. 1996; Sodian, Sperling et al. 1999). 
 
 Automated manufacturing technology has the potential to fabricate tissue-engineered 
scaffolds more rapidly with higher anatomical precision. Stereolithographic 3D printing 
and extrusion based 3D printing have both been used to fabricate scaffolds on the scale 
of heart valves.  Schaefermeier et al. used stereolithography to fabricate a silicone 
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aortic valve replica based on X-ray computed tomography (CT) scans and then used 
the replica to mold a PGA valve scaffold (Sodian, Loebe et al. 2002; Schaefermeier, 
Szymanski et al. 2009). Extrusion based 3D printing has been employed to engineer 
hard tissue scaffolds such as knee menisci and intervertebral disks complete with 
encapsulated cells (Cohen, Malone et al. 2006; Ballyns, Cohen et al. 2010). This 
process can rapidly recreate 3D computer aided design (CAD) models by slicing them 
into layers and building the layers upward using deposition tools that can extrude a wide 
range of materials. Adapting 3D printing technology to fabricate soft tissue heart valve 
scaffolds, however, requires overcoming the additional challenges of 1) adapting highly 
extensible elastomeric cell-friendly materials for 3D printing, and 2) printing complex soft 
tissues with overhanging structures and both internal and external geometric features.  
 
Hydrogels can be designed to mimic mechanical and biological properties of soft tissue, 
and can be controlled for direct 3D printing. By modifying polymer precursors hydrogels 
can have tunable mechanics, provide attachment and signals to cells,  have custom 
degradability, and be modified to allow for photo and chemical crosslinking (Benton, 
Fairbanks et al. 2009; Huebsch, Arany et al. 2010; Kloxin, Kloxin et al. 2010; Pedron, 
Kasko et al. 2010; Chandler, Berglund et al. 2011; Hutson, Nichol et al. 2011). The 
technology exists to rapidly 3D print clinically sized, geometrically complex constructs 
with hydrogels (Arcaute, Mann et al. 2006; Ballyns, Cohen et al. 2010; Fedorovich, 
Schuurman et al. 2012), but it has not been utilized for engineering heart valves. 3D 
printing clinically sized tissues (>10 mm) with high anatomical precision has been 
primarily demonstrated for hard tissues such as bone and cartilage (Hollister 2005; 
Ballyns, Cohen et al. 2010; Cipitria, Lange et al. 2012). Clinically sized soft tissues are a 
small minority of the 3D printing literature, dominated by vascular conduits and networks 
that don’t exhibit external geometric complexity or non-self-supporting geometries 
(Skardal, Zhang et al. 2010; Xu, Chai et al. 2012).  Micro-scale 3D printed tissues have 
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been fabricated with very fine precision using hydrogels, but have been  limited to 
tissues  ~5 mm tall or less (Liu and Bhatia 2002; Chan, Zorlutuna et al. 2010; Gauvin, 
Chen et al. 2012).  This leads us to investigate utility of extrusion based 3D hydrogel 
printing for enabling rapid soft tissue hydrogel fabrication at clinically necessary sizes 
(>10 mm) with high spatial precision.   
 
In this study, we implemented an on-board photo-crosslinking system to enable 
simultaneous 3D extrusion printing and curing of hydrogels in complex aortic valve 
geometries. We additionally compare 3D printed geometry accuracy for native and 
axisymmetric valve anatomy using micro-CT. Cell viability and spreading of PAVIC 
cultured on 3D printed scaffolds were assessed over 21 days. 
 
3.2 Materials and Methods  
3.2.1 Base hydrogel formulation 
Poly(ethylene glycol)-diacrylate (PEG-DA) was used as the base polymer precursor for 
this study. Many tissue engineering applications have used PEG-DA as a scaffold 
component because it is a biocompatible, photo-crosslinkable elastomer whose 
mechanical properties can be easily modified (Peyton, Raub et al. 2006; Guo and Chu 
2007). 700 and 8000MW PEG-DA precursors were chosen for this study because their 
differences in molecular weight have been shown by others to correlate with hydrogel 
stiffness (Hahn, McHale et al. 2007; Huebsch, Arany et al. 2010; Browning, Wilems et 
al. 2011; Hutson, Nichol et al. 2011). PEG-DA undergoes slow hydrolytic degradation in 
vivo  , and it can also be functionalized and combined with other precursors to 
encourage cell attachment (Peyton, Raub et al. 2006; Hutson, Nichol et al. 2011; 
Browning and Cosgriff-Hernandez 2012). Several studies employing stereolithography 
printing have demonstrated that photopolymerizing layered hydrogels using ultraviolet 
(UV) irradiation can yield 3D structures (Dhariwala, Hunt et al. 2004; Arcaute, Mann et 
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al. 2006; Chan, Zorlutuna et al. 2010).  These features support the use of PEG-DA as 
base polymer precursor for 3D printing of valve scaffolds.  
 
The base hydrogel solution used in this study consisted of phosphate buffered saline 
(PBS), photoinitiator, and PEG-DA. Photoinitiator (Irgacure 2959; Ciba Specialty 
Chemicals, Tarrytown, NJ) was first dissolved in PBS at 60oC. After cooling the solution 
to room temperature, 700 MW (Sigma Aldrich, St. Louis, MO) and/or 8000 MW PEG-DA 
(synthesized by the authors (Guo and Chu 2005)) were dissolved into the solution.  
 
3.2.2 Mechanical testing of base hydrogel blends 
We examined the degree of biomechanical tunability in PEG-DA hydrogels by 
performing uniaxial ring tensile tests (Seliktar, Black et al. 2000; Seliktar, Nerem et al. 
2001). Hydrogel precursor solutions were prepared by dissolving 0.1-0.2% w/v 
photoinitiator and 0-20:0-10% 700:8000 MW PEG-DA in PBS, where amount of 
photoinitiator was directly proportional to increasing PEG-DA concentration (to maintain 
1% w/w precursor to polymer). For the extremes, 10% w/v 8000 MW and 20% w/v 700 
MW PEG-DA hydrogels were optimal for handling (room temperature solubility and 
resulting robust gels). Precursor solutions were crosslinked at 365 nm UV light at 245 
mW/cm2 inside 4-well plates for 10 minutes (EN280L lamp; Spectroline, Westbury, NY). 
Rings were created from crosslinked hydrogel cylinders with an 8-mm biopsy punch and 
then secured in a vertical orientation between two hook fixtures within a PBS bath on 
the testing platform (EnduraTec 3200; Bose Electroforce, Eden Prairie, MN). Samples 
were loaded quasi-statically at 0.02mm/sec until failure (strain rate is  0.005/sec). 
 
3.2.3 3D printing system and hydrogel modification 
Detailed specifications and mechanics of the open-source Fab@HomeTM Model 1 
extrusion based 3D printing (robocasting) can be found at www.fabathome.org and in 
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our previous studies (Cohen, Malone et al. 2006; Malone and Lipson 2007). For this 
study, the printing platform was modified to carry three syringes. In addition, we built a 
UV-LED crosslinking module, in which four LEDs were arranged in a 2 x 2 formation 
and mounted directly on the syringe carriage (crosslinking energy at the printing surface 
was 16.5 mW/cm2/LED, (Nichia America Corporation, Wixom, MI) (Figure 3.1(A)). For 
sterile printing, an autoclavable bag attached with a UV transparent film with access 
ports for the nozzles was autoclaved. The bag was then mounted below the syringe 
carriage inside a laminar hood, and the precursor solutions were printed through the 
access ports while the UV-LED crosslinked the printed solutions through the film.  
 
Un-modified soluble alginate (LF10/60, FMC BioPolymer, Drammen, Norway) was 
mixed into PEG-DA precursor formulations to temporarily increase viscosity during the 
printing extrusion process. While 2% w/v alginate mixed in PBS is sufficiently viscous to 
be extrudable (Cohen, Malone et al. 2006), pilot studies found that PEG-DA 
dramatically increased the solubility of alginate. We found adding 10-15% w/v alginate 
to a PEG-DA solution achieves suitable extrusion viscosity. In addition, PEG-DA 
extrusion was sensitive to the salt concentration of the buffer in a MW dependent 
manner. Precursor solutions made with 1x PBS and only 700 MW PEG-DA could not be 
printed due to phase separation, but this was overcome by changing the salt 
concentration (13.7 mM NaCl) but maintaining normal pH. 
 
3.2.4 Measuring crosslinking time of hydrogels 
The crosslinking time required of the printed precursor solutions need to match each 
other in order to fabricate heterogeneous hydrogel layers. Therefore, we investigated  
  
 75 
 
 
 
  
Figure 3.1-3 3D Printer setup and valve geometry modeling.  
 
Portions of the material presented in chapter 3 were published in a scientific 
journal in the August 2012 issue of Biofabrication (Hockaday, Kang et al. 2012).  
I have received permission from the publishers to reprint this information in 
this document.  
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aortic valve hydrogel scaffolds 
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(A) Syringe tools were loaded with different hydrogels, and UV-LED array integrated 
into the deposition tools crosslinked hydrogels during printing. Sterile scaffolds were 
generated by printing inside an autoclaved bag that was mount d on the printer
stage inside a laminar hood. (B) Axisymmetric valve STL file with the root and leaflet
in the closed position was designed in Solidworks. (C) A fixed porcine aortic valve 
underwent micro-CT scan, and (D) the leaflet and root regions were thresholded 
based on tissue density. (E) The thresholded regions were reconstructed into 
printable STL geometries, (F) and the printing software sliced the geometries into 
layers and generated extrusion paths for each layer (red: contour, green: fill-in 
paths). Scale bar = 1 cm. 
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how crosslinking time was controlled by molecular weight PEG-DA and varying 
photoinitiator concentration. Hydrogel precursor solution containing 10-15% w/v alginate 
and 0.2-2.0% w/v Irgacure was first injected into 4-8 mm diameter, 1-mm thick disc 
molds made with either 700 MW or 8000 MW PEG-DA. The solutions were then 
exposed to 365 nm UV light from the crosslinking module. Minimum crosslinking time 
was defined as the point when the hydrogel gel transitioned from liquid to solid. This 
was the point where the hydrogel disc did not flow after the mold was removed, did not 
flow in response to gentle compression with a spatula, and held its shape upon being 
transferred into PBS (did not dissolve).  
 
3.2.5. Valve geometry design 
Two aortic valve models were created for printing. The first model, an axi-symmetric 
aortic valve geometry including the sinus and leaflets (kind gift of Dr. Reetu Sing), was 
generated in SolidWorks (Waltham, MA) as shown in Figure 3.1(B). For the second 
model, a porcine aortic valve conduit obtained fresh at slaughter (Shirk Meats, Himrod, 
NY) was fixed in formalin (Figure 3.1(C)) and scanned with the leaflets in a partially 
open position via micro-CT at 100 m voxel size, 80 keV, 30 mA, 800 angles, 30 ms 
exposure time, 30 gain, and 20 offset (eXplore CT120; GE Healthcare, United 
Kingdom). The root and leaflet regions in the resulting DICOM scans were segmented 
via intensity thresholds (Figure 3.1(D)) and rendered into 3D geometries in stereo-
lithography format of Standard Tessellated Language (STL) files (Mimics 12.0; 
Materialise, Leuven, Belgium) (Figure 3.1(E)). A separate temporary scaffold to support 
the ostia lumens was generated by Boolean subtraction. 
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3.2.6. Heterogeneous valve printing 
Based on the mechanical testing crosslinking test results (Figure 3.2), we established a 
biomechanically stiff PEG-DA formulation (20%:0% 700:8000 MW) to comprise the 
aortic root wall and a compliant and extensible hydrogel for the leaflets formulation 
(5%:7.5% 700:8000 MW). Using these ratios, stiff hydrogel (13.7 mM NaCl, 1% w/v 
photoinitiator, 20:0% PEG-DA, 12.5% w/v alginate) and compliant hydrogel (PBS, 1% 
w/v photoinitiator, 5:7.5% w/v PEG-DA, 15.0% w/v alginate) precursor solutions were 
prepared. 1% photoinitiator concentration was chosen since it enabled both hydrogel 
formulations to crosslink rapidly in about 30-60 seconds, which was comparable to the 
print time of each layer.  
 
Precursor solutions were loaded into the deposition syringes fitted with 0.83 mm inner 
diameter nozzles. After importing the STL geometries, the software generated print 
paths at 0.6-0.7 mm path height and 0.8-0.9 mm path width (Figure 3.1(F)) for all 
geometries. The aortic root was printed with the stiff hydrogel while the leaflet was 
printed with the compliant PEG-DA hydrogel at 0.6 and 0.4 ml/min and traversing rate of 
6 and 3 mm/s, respectively. The UV crosslinking array attached on the carriage 
crosslinked the printed hydrogel paths as they were extruded at 16.5 mW/cm2 during 
fabrication (Figure 3.2(E)). To print the support geometry for the overhanging ostia and 
leaflets, a third syringe was loaded with a non-photo-crosslinking alginate-gelatin 
solution. The temporary support structure printed with this formulation was able to 
support itself without crosslinking due to the high viscosity of the solution, but was easily 
removed by rinsing in aqueous buffer. To assess size dependent accuracy and volume, 
scalability, valve scaffolds were printed at 100, 50, and 18% of the original model. 
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 (A) Stress-strain profile, and (B) elastic modulus of hydrogels with 20:0, 15:2.5, 
5:7.5, and 0:10% 700:8000 MW PEG-DA hydrogels (n = 3). Non-matching letters are 
statistically different (p < 0.05). (C) Crosslinking time of 700 and 8000 MW PEG-DA 
hydrogels with varying photoinitiator concentrations (n ≥ 5). 
Figure 3.2 -4 Uniaxial tensile testing and crosslinking time testing of PEG-DA 
hydrogels. 
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3.2.7 Shape fidelity evaluation of aortic valve scaffolds 
Shape fidelity was assessed quantitatively using micro-CT. Valve conduits were printed 
using 20% w/v 700 MW PEG-DA hydrogel (13.7 mM NaCl, 1% w/v photoinitiator, 12.5% 
w/v alginate). Conduits were scanned directly after printing via micro-CT. To test how 
swelling affects geometry, they were also hydrated in PBS overnight and scanned. 
Resulting scans were then reconstructed into STL geometries using MicroView (GE 
Healthcare). Surface deviations between printed and native STL models were quantified 
through autoregistration and heat maps in Geomagics Qualify (v9.0; Research Triangle, 
NC;(Ballyns, Cohen et al. 2010). We chose ±10% in diameter as the tolerance threshold 
for valve fabrication since greater than 10% diameter mismatch in non-living prosthetic 
valves has been shown to impair hemodynamic function (Pibarot and Dumesnil 2006). 
 
Assessing the internal geometric fidelity was impossible with surface heat maps.  
Therefore, slice-by-slice comparison of each printed layer was also performed. Micro-
CT generated virtual slices of the printed scaffolds were compared to the corresponding 
image-derived layers of the original valve STL files in the XY-plane (Figure 3.2(D)). The 
two slices were overlapped and compared using Boolean operations. For a given slice, 
regions printed outside the target print area were designated overprint error, and 
regions that were not printed within the target area were designated underprint error. 
 
3.2.8 Cell viability and spreading  
Porcine aortic valve interstitial cells (PAVIC) were employed as model cell source to 
investigate valve scaffold biocompatibility because VIC are the main cell type that 
populates valve leaflets (Butcher, Simmons et al. 2008). PAVIC were isolated via 
collagenase digestion as previously described (Butcher, Penrod et al. 2004) and 
cultured with Dulbecco’s Modified Eagle’s Medium (DMEM; Invitrogen, Carlsbad, CA) 
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supplemented with 10% fetal bovine serum (FBS; Invitrogen) and 1% 
penicillin/streptomycin (PS; Invitrogen). Cells were used at passage 5-8. 
 
Sterile 12 mm diameter aortic valve conduits were printed with 700 MW PEG-DA 
hydrogel. Conduits were rinsed in PBS overnight to leach out the non-crosslinking 
alginate. They were then transferred to a 50 ml conical vial containing 20 x 106 PAVIC 
in 40 ml of culture media. After 24 hours of rotary seeding at 37oC, 5% CO2 (day 1), 
valve conduits were cultured in flasks for 7 and 21 days. Media was exchanged every 
48 hrs. Conduits were then stained with 4 mM calcein-AM and 2 mM ethidium 
homodimer (LIVE-DEAD, Invitrogen) for 30 min at 37oC and then rinsed with PBS. 
Conduits were cut with a razor blade and imaged using an epiflourescence 
stereomicroscope (SteREO Discovery.V20; Zeiss, Germany). 
 
Since PEG-DA is virtually non-adhesive and non-adsorptive in its unmodified form 
(Hutson, Nichol et al. 2011), we tested whether collagen fibrillized within the PEG-DA 
hydrogels could provide enhanced cell activity. Collagen I was extracted from rat tail 
tendons (Pel-Freez Biologicals, Rogers, AR) and dissolved in sterile 0.1% acetic acid 
for 24 hrs prior to hydrogel preparation as previously described (Bowles, Williams et al. 
2010). Low concentrations of collagen (0.1 or 0.5 mg/ml) were mixed in 3x DMEM 
containing 10% FBS, and 0.1M NaOH was added to neutralize pH. This solution and 
PEG-DA hydrogel precursor solutions were kept on ice until they were combined. The 
combined solution was photo-crosslinked in disc molds and then incubated at 37oC for 
30 minutes to allow the collagen monomers to fibrillize. Ultrastructure of completely 
crosslinked PEG-DA hydrogels with and without collagen and/or alginate leaching prior 
to seeding was analyzed via scanning electron microscopy (SEM). Fully hydrated 
hydrogels were flash frozen, lyophilized, mounted on aluminum SEM stubs, and imaged 
(Leo 1550 FESEM Cornell Center for Materials Research, Ithaca, NY; (Benton, 
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DeForest et al. 2009).  Image J was used to analyze mean pore area for each 
representative image. Hydrogel discs were then rinsed and surface-seeded with 0.5 x 
106 PAVIC/ml. Cell circularity (index of cell spreading) was quantified using ImageJ.  
 
3.2.9 Statistical analysis 
Mechanical testing was conducted with n = 3 rings per formulation. Crosslinking tests 
were conducted with n ≥ 5 disks per condition. Fidelity and viability assessment was 
performed with n = 3-4 printed valve scaffolds. Measurements were indicated as mean 
and standard deviation unless noted otherwise. Statistical comparisons were made 
using 1-way analysis of variance (ANOVA) followed by Tukey modified t-tests. P<0.05 
denoted significance. For SEM pore area analysis statistical comparisons were made 
using 2-way ANOVA with Tukey post-test, p < 0.05. 2-way factors are gel MW and 
treatment (unrinsed, rinsed, collagen). 
 
3.3. Results 
3.3.1 Mechanical properties of hydrogels  
Mixing of 700 and 8000 MW PEG-DA resulted in elastomeric hydrogels with a broad 
range of mechanical properties. In general, hydrogels became stiffer and less extensible 
as the proportion of 700 MW PEG-DA increased (Figure 3.2(A, B)). 0:10% w/v 
(700:8000 MW) hydrogels exhibited very extensible, nearly linear elastic behavior with 
modulus of 5.3 ± 0.9 kPa through a strain of 1.6 ± 0.1. 20:0% w/v hydrogels, on the 
other hand, exhibited nonlinear tensile stress-strain behavior, with an approximately 13-
fold greater modulus at 74.6 ± 1.5 kPa through a strain of 0.50 ± 0.15. Intermediate 
ratios between these extremes created stress-strain responses between the individual 
polymer extremes (Figure 3.2(A)). As examples, 5:7.5% w/v hydrogels exhibited 
modulus of 12.7 ± 1.6 kPa though a strain of 2.0 ± 0.5, and 15:2.5% w/v hydrogels 
exhibited modulus of 42.5 ± 1.0 kPa through a strain of 0.94 ± 0.01. Modulus between 
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5:7.5% and 0:10% w/v did not vary significantly. Collectively, these results show that 
PEG-DA hydrogels exhibit nonlinear elastic mechanics that can be tuned through 
polymer mass and molecular weight ratio.  
 
3.3.2 Effect of photoinitiator concentration on hydrogel crosslinking time 
PEG-DA hydrogel crosslinking time decreased exponentially with increasing 
concentrations of Irgacure (Figure 3.2(C)). 700 MW PEG-DA hydrogels crosslinked 5-10 
fold faster than 8000 MW hydrogels at the same Irgacure concentration, likely because 
of the increased availability of polymer chains and active end groups. At 0.2% w/v 
Irgacure, 700 MW hydrogels crosslinked in 98 ± 3 s, but 8000 MW hydrogels 
crosslinked at 1140 ± 60 s. At 2% w/v Irgacure, 700 MW hydrogels took only 17 ± 1 s to 
crosslink, and 8000MW hydrogels took just 78 ± 8 s. These results demonstrate that 
hydrogel crosslinking time can be tuned with photoinitiator concentration, and they 
further suggest that balancing photoinitiator concentration for each base material can 
maintain overall crosslinking kinetics. 
 
3.3.3 Rapid printing of heterogeneous and scaled valve scaffolds 
Crosslinking the hydrogel during fabrication enabled the two different hydrogels 
formulations to fuse and integrate with each other and between printed layers. Printed 
valve conduits retained biomechanical heterogeneity, where the leaflets extended and 
bent easily while the root remained relatively rigid (Figure 3.3(B, E). Both anatomic and 
axially symmetric valve scaffolds were successfully printed at 100%, 50%, and 18% of 
the original model volume. The valve conduits had inner diameters (ID) of 22, 17, and 
12 mm (Figure 3.3(C, F)) and heights of 25, 20, and 14 mm, respectively. Gross 
anatomical features such as ostia, commissures, and sinuses were present at all sizes. 
The 12 mm ID valve conduits were fabricated in 14 minutes, the 17 mm in 30 minutes, 
and the 22 mm in 45 minutes. Together, these results support that 3D printing strategy  
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Figure 3.3- 5 Printing heterogeneous valve and scaled valve constructs.  
(A) Porcine aortic valve model was (B) printed, where root was formed with 700 MW 
PEG-DA hydrogel while the leaflets were formed with 700/8000 MW PEG-DA 
hydrogels. Key features such as the coronary ostium and sinuses were present (C) 
Scaffolds were printed with 700 MW PEG-DA at different scale for fidelity analysis, 
where the inner diameters (ID) were 22, 17, and 12 mm. (D) Axisymmetric valve 
model was (E) printed with two blends of hydrogels (F) and at 22, 17, and 12 mm ID. 
Scale bar = 1 cm. 
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can rapidly generate mechanically heterogeneous, anatomically complex valve 
conduits. 
 
3.3.4 Shape fidelity 
We further characterized their shape fidelity using surface deviation analysis through 
micro-CT imaging. For the 22, 17, and 12 mm ID image-derived, hydrated valve 
scaffolds, 93.3 ± 2.6, 85.1 ± 2.0, and 73.3 ± 5.2% of the points laid within the ±10% 
diameter threshold respectively (Figure 3.4(A, C)). For the axial symmetric hydrated 
valve scaffolds, 89.1 ± 4.0, 84.1 ± 5.6, and 66.6 ± 5.2% of the points were within ±10% 
threshold (Figure 3.4(B, C)). These results indicate that the 3D printing strategy 
generates scaffolds with high geometric precision, but accuracy decreased somewhat 
with reduced size. For the image-derived valve scaffolds, overprint error (points lying 
beyond +10% threshold) predominated the underprint error (points beyond -10%  
threshold, error proportion over:under was 89.0:11.0%, 90.0:10.0%, and 82.3:17.7%, for 
22, 17, and 12 mm ID, respectively) throughout the root and leaflet (Figure 3.4(D) solid 
bars). Overprint error also predominated over the underprint error in the axially 
symmetric valve scaffolds (88.2:11.8, 92.7:7.3, and 94.4:5.6%, for 22, 17, and 12 mm ID 
in over:under ratio, respectively) (Figure 3.4(D) striped bars).  
 
Slice-by-slice analysis to assess the internal geometic fidelity indicated that overlapping 
area percentage decreased as the size of the image-derived valve scaffolds decreased 
(81.7 ± 1.9 to 61.9 ± 4.3% from 22 to 12 mm ID) (Figure 3.5(A)). Total overprint and 
underprint area percentage between fully hydrated and scaffolds scanned immediately 
after printing was not significantly different, but the error locations were different. Non-
hydrated scaffolds contained overprinted regions on the inner walls, but hydrated valve 
scaffolds were underprinted on the inner walls and overprinted on the outer walls  
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(A) Heat maps and average % frequency histograms representing surface deviations 
between printed porcine scaffold vs. model geometries and (B) printed simplified 
scaffolds vs. model geometries. Printed valve constructs were fully hydrated in PBS 
(equilibrium swollen). Warmer colors indicate positive deviation while cooler colors 
indicate negative deviation in millimeters. % frequency histograms show the 
deviations that lie within ±10% tolerance (green), and outside the tolerance (blue and 
pink). ±10% tolerance is 2.2, 1.7, and 1.2 mm for the 22, 17 and 12 mm diameter 
scaffolds, respectively. (C) The percentage of surface points whose deviation falls 
within ±10% tolerance. This percentage decreases as scaffold size decreases. Bars 
of the same pattern with different letters are significantly different from each other, 
P<0.05 (D) The percentage of surface points whose deviation falls outside the ±10% 
tolerance that are above (pink) and below (blue). Scale bar = 1 cm. n = 2-4, p < 0.05.  
Figure 3.4 -6 Fidelity analysis of fully hydrated printed valve scaffold geometry 
compared to model geometry using CT-derived STL files.  
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 (A) Overlap, underprint, and overprint area percentage of each printed construct. S 
denotes constructs that were fully hydrated in PBS (swollen), and absence of an S 
means constructs were scanned directly after printing. Bars of the same color with 
different letters or symbols are significantly different from each other, P<0.05 (B) 
Representative images of Boolean analysis of valve sections at levels of base, mid-
sinus, and sino-tubule junction (STJ). CT image slices of a printed scaffold are 
compared to slices of the native geometry used to print the scaffold. Top row: 17 mm 
ID valve scaffold scanned immediately after printing. Bottom: Same scaffold that was 
later fully hydrated. Solid arrow: leaflets; hollow arrow: ostium. N=3-4, p < 0.05 
Figure 3.5-7 Slice-by-slice analysis comparing CT image slices of printed 
porcine valve scaffolds to model layers and assess internal geometric fidelity. 
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(Figure 3.5(B)). These results suggest that residual error in final shape is caused in part 
by outward but not inward swelling. 
 
3.3.5 Alginate removal and cell cytocompatibility of hydrogel scaffolds 
PEG-DA hydrogel structure appears to be modulated by molecular weight and type of 
additives (alginate and collagen I) (Figure 3.6). The SEM images show that PEG-DA 
precursor solution + 10% w/v alginate appears to form small pores, with alginate 
packing the structure (Figure 3.6 (A, B)). Alginate leached out of hydrogels rinsed in an 
aqueous buffer (nearly 100% within 24 hours according to weight), and this was 
confirmed with the SEM images where PEG-DA pore size appears to increase for 700 
and 8000 MW, respectively (Figure 3.6 (C, D)). We noticed that post-polymerization the 
alginate hydrogels were opaque and were opaque even after leaching, which suggests 
that a microscopic amount of alginate may persist. When PEG-DA precursor solutions 
with alginate were further mixed with neutralized collagen I before crosslinking (0.01% 
w/v collagen in total solution) and then alginate was leached out, the structures 
appeared more fibrous (Figure 3.6 (E, F)).  Image analysis of mean pore area for each 
representative SEM image (A) 6.1±1.0 um2 , (B) 14.0±2.8  um2, (C) 36.6±7.4  um2, (D) 
103.5±14.1 um2,  (E) 103.1 ± 21.3 um2, and (F) 154.8± 36 um2. The pore size was non-
uniform. Pores in A, B, and C were significantly different from D, E, and F.  
 
PAVIC seeded valve scaffolds contained cells across the entire surface of the conduits, 
and to a lesser degree within the root and leaflet interstitium (Figure 3.7 (A, B)). Cells 
were 91.3 ± 10.7% viable at day 1. At day 7 and 21 cells were 100% viable. For PAVIC 
cultured on disks, cell morphology was tested on the base hydrogel formulation and with 
0.1 or 0.5 mg/ml collagen I to the precursor solution (Figure 3.8). The mean circularity of 
PAVIC on 700 MW PEG-DA base gels decreased significantly over time (0.83 ± 0.03 to 
0.74 ± 0.01 between day 1 and 21) (Figure 3.8(A)). Meanwhile, PAVIC circularity in 
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Figure 3.6 - 8 Representative SEM imaging of hydrogels.  
Top row: 700 MW PEG-DA; bottom row: 8000 MW PEG-DA. (A, B) Images of PEG-
DA hydrogels that were made with alginate viscosity modifier in the precursor 
solution. (C, D) Rinsed PEG-DA hydrogels made with alginate viscosity modifier (E, 
F) Rinsed PEG-DA hydrogels made with the addition of 0.1 mg/ml collagen and 
alginate viscosity modifier to precursor solution.  Hollow arrows indicate fibrous 
material. Scale bar = 20 µm.  
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(A) Live PAVIC were visible in both the root (top) and leaflets (bottom) surface for 
day 1, 7, and 21 (scale bar = 2 mm). (B) Cells were also detected in the interstitium 
of the root and leaflet for up to 21 days (scale bar = 100 mm). 
Figure 3.7- 9 Live/Dead imaging of PAVIC cultured on 12 mm ID printed valve 
constructs.  
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(A) Circularity of PAVICs on 700 MW PEG-DA (control), + 0.1 mg/ml, and + 0.5 
mg/ml collagen at 1, 7, and 21 days of culture. (B) Circularity of PAVIC on 8000 MW 
PEG-DA hydrogels with and without collagen for up to 21 days. * indicates statistical 
difference with p < 0.05. 
Figure 3.8- 10 Morphology of PAVIC cultured on PEG-DA and collagen hydrogels 
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8000 MW PEG-DA hydrogels did not change significantly over time (0.80 ± 0.01, 0.80 ± 
0.01, and 0.79 ± 0.02 at day 1, 7, and 21, respectively) (Figure 3.8(B)). Circularity after 
addition of 0.1 or 0.5 mg/ml of type I collagen into either PEG-DA hydrogel did not 
change over time. These results indicated that PAVIC adhere and spread on the PEG-
DA hydrogel (with alginate removed) scaffold material, but that the addition of collagen 
at 0.1 or 0.5 mg/ml did not improve cell spreading. 
 
4. Discussion 
Replicating mechanical heterogeneity and geometry of the native tissue has been 
increasingly considered critical for engineering living de novo aortic heart valves. We 
developed and implemented a 3D printing strategy combining on-board UV photo-
crosslinking with mechanically tunable PEG-DA hydrogels to rapidly fabricate 
anatomically complex, mechanically heterogeneous valve scaffolds at different sizes. 
These scaffolds can be seeded with valve cells, which populated the surface and 
reached the interstitium and remained viable to at least 21 days. The relatively rapid 
printing times (14-45 minutes), with no requirement for further processing post-
fabrication (e.g. joining components), support that 3D printing is an efficient process for 
engineering anatomically precise soft tissue scaffolds.  
 
Matching patient-specific size is integral for proper valve function. An ongoing limitation 
of current valve prosthetics is that the prosthetics are often too big for pediatric and 
young patients. The smallest manufactured mechanical valve to date spans 17 mm (St. 
Jude Medical Mechanical Heart Valve; St. Jude Medical Inc., Minneapolis, MN). Smaller 
sized mechanical prosthetic valves have higher gradients and are effectively occluded 
more by the mechanical leaflets that lie in the flow field (Dasi, Simon et al. 2009). We 
were able to print valve conduit scaffolds spanning a range of clinically relevant sizes as 
small as 12 mm ID, which is approximately the size of a 6 month infant aortic valve, and 
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up to 22 mm ID valve, which is an adult size. We also demonstrated that multiple 
geometries, a simplified axial symmetric geometry and a medical imaging derived 
geometry, can be printed using this printing technique. The capability to incorporate 
direct sizing and patient derived geometry into valve scaffolds suggests that 3D printing 
could potentially alleviate the prosthetic sizing concern. It is important to note that this 
study focused on valve scaffold fabrication, and determination of function will require in 
vitro flow studies that are beyond the scope of this work.  
 
Assessing shape fidelity is important for tissue engineering. The common approach of 
visual inspection, mainly by identifying the presence of key features such as the 
coronary ostia and the sinuses (Sodian, Loebe et al. 2002), is helpful as a cursory 
screening process. However, it cannot pinpoint deviations or tolerances of scaffolds in 
detail required for scale-up manufacturing or complex patient specific applications. 
Calipers provide limited information on how to improve shape fidelity (Ballyns, Gleghorn 
et al. 2008), particularly for a complex shape such as a valve where leaflet and root 
tissue thickness may vary along their lengths. In this study, we used an image-based 
method to quantitatively assess print accuracy, which was as high as 93% that reduced 
somewhat as the inner diameter size decreased. This evaluation, which supplemented 
the visual inspections, provided a more comprehensive demonstration that the printed 
scaffolds exhibit geometric fidelity.  
 
Our shape fidelity analysis suggested steps that can be taken to improve print accuracy. 
The same print parameters that yielded high fidelity for 22 mm ID valves produced 
much more overprint for 12 mm ID valves, suggesting that the print paths were too wide 
for filling in smaller regions of the 12 mm ID valves without overprinting. Therefore, 
employing smaller extrusion rate and narrower nozzle diameters (to increase print 
resolution) would be a scaled approach for optimizing the printing. This adjustment 
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would have to be balanced with an accompanying increase in print time, but the time 
would still likely remain to be less than 45 minutes, which was the print time for the 22 
mm ID valve. The other step is to adjust for swelling. Compensating for swelling is 
important because hydrogels have characteristic equilibrium swelling ratio (Bryant and 
Anseth 2002; Ma and Elisseeff 2005). Since our scaffolds expanded outward but not 
inward, we suspect that surface tension on the inner walls prevented the scaffolds from 
swelling inward. Hydrogel scaffolds should therefore be printed thinner than the target 
size so that the expanded final state matches the native model. By analyzing the fidelity 
of the printing process layer by layer, we were also able to pinpoint anatomical features 
that were locally over- or underprinted. Therefore, the fidelity of the final printed shape 
can likely be improved by adjusting the initial print paths for each layer, but the specific 
changes will be dependent on the relative thicknesses of each polymer component, the 
curvature of the shape, and the kinetics of the extrusion process. 
   
Ultimately, tissue engineered heart valve scaffolds must be able to support cell 
adhesion and migration. The 3D printed scaffolds were populated at the surface and 
with high viability, indicating that the printing method and resulting material were not 
cytotoxic. Seeded scaffolds and disks were fed and rinsed with media every 48 hours, 
and it is possible that cells unable to attach or dying washed away from the valve 
scaffolds over time.   We expect that cell viability is conservatively maintained at the 
same levels as day 1. We measured a circularity of 0.7-0.8 for all conditions, which 
indicates that cells were in an elliptically spread configuration. Contrary to our 
expectations, the addition of collagen into the PEG-DA hydrogels did not promote 
further spreading. While our SEM images show a hydrogel structure that appears more 
fibrous upon the addition of collagen to the precursor solution, this addition did not 
significantly affect the cell behavior. What is interesting to note is that other studies 
indicate that PEG-DA is non-adsorptive (Rogers, Pagaduan et al. 2011) and alginate is 
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non-absorptive due to electrostatic repulsion (Rowley, Madlambayan et al. 1999). 
Additionally, alginate does not have groups that provide any means for mammalian cell 
attachment (Genes, Rowley et al. 2004), and PEG-DA alone is also reported to 
discourage cell attachment (Hutson, Nichol et al. 2011). We hypothesize that that a 
small amount of alginate must remain in the PEG-DA network and the combination 
roughens the scaffold surface to permit cell adhesion, similar to the microphase 
separation that is seen in multicomponent PEG-DA hydrogels (Zhang, Wang et al. 
2011).  
 
Controlling the mechanical heterogeneity between the root and leaflet has been a major 
focus in engineering valve scaffolds for ensuring proper hemodynamics and durability. 
We believe 3D printing can be advantageous for incorporating heterogeneity since it 
can establish relative differences between tissue regions using these synthetic materials 
with ease. The ability to rapidly fabricate scaffolds also provides a platform for studying 
how cells behave on heterogeneous environments, which is crucial to investigate since 
the modulus of the scaffold material can direct cell migration (Tayalia, Mendonca et al. 
2008), spreading (Kloxin, Kloxin et al. 2010), and differentiation (Engler, Sen et al. 2006; 
Kloxin, Kloxin et al. 2010). The modulus numbers in this study fall within the range of 
values demonstrated by other studies investigating the tunability of PEG-DA hydrogel 
tensile mechanical properties (Hahn, McHale et al. 2007; Hou, Schoener et al. 2010; 
Browning, Wilems et al. 2011). Our results overall suggest that PEG-DA hydrogels can 
partially recreate the mechanical properties of the aortic valve and pulmonary valve. At 
physiological tensile strains (0.01-0.20) and low strain rates, the moduli of PEG-DA 
hydrogels tested here (700 MW: ~75 kPa; 8000 MW: ~5 kPa) fall within range of 
modulus of native leaflet tissue in the radial direction (~54 kPa (Mavrilas and Missirlis 
1991)). However, they are softer than the aortic valve sinus tissue (~ 140-180 kPa 
(Matthews, Azadani et al. 2010; Butcher, Mahler et al. 2011; Azadani, Chitsaz et al. 
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2012)). The mechanical properties of the PEG-DA hydrogels more closely match 
pulmonary valve sinus tissue (~50-85 kPa) (Matthews, Azadani et al. 2010). With the 
clinical success of the Ross procedure, the pulmonary valve has been identified as a 
first target for tissue engineered heart valves (Butcher, Mahler et al. 2011), and 
duplicating those mechanics may be initially more relevant to the field. Additionally, it 
has been shown that cellularized PEG-DA hydrogels with the addition of moieties that 
allow for remodeling have improved mechanical properties with dynamic culture (Hahn, 
McHale et al. 2007). Therefore, this fabrication strategy for engineering valve conduits 
could be pursued further with the addition of a variety of moieties to PEG-DA hydrogels 
and dynamic conditioning.  
 
5. Conclusions 
This study demonstrated that 3D printing and photo-crosslinking hydrogels can rapidly 
fabricate anatomical scaffolds exhibiting mechanical heterogeneity and 
cytocompatibility. This manufacturing process was demonstrated with PEG-DA, but we 
believe this method could be adapted for use with other photo-crosslinkable polymers. 
Further work is necessary to complete the translation of this strategy to the clinic. 
Continued effort must be made to understanding how cells on constructs would remodel 
the scaffold in simulated hemodynamic conditions. Further investigation of multiple 
polymer blends to be incorporated into heterogeneous valve conduits would also be 
required to mimic the complete low and high magnitude strain behaviors of native valve 
tissues. Our findings herein are encouraging steps toward improved valve scaffold 
designs for both adult and pediatric valve disease. 
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CHAPTER 4 
PHOTO-ENCAPSULATION AND VIABILITY OPTIMIZATION OF VALVE CELLS AND 
MESENCHYMAL STEM CELL FOR DIRECT 3D PRINTING 
 
4.1 Summary 
This study further explores variables associated with photo-crosslinking hydrogels and 
relationships previously demonstrated or suspected by other investigators, for a 
printiable MEGEL:PEG-DA 3350 mixture containing valve cells or mesenchymal stem 
cells. Contrary to numerous 2D cytotoxicity studies, we demonstrate that in a 3D 
hydrogel culture environment and fabrication setting, Irgacure 2959 can produce more 
viable encapsulated cells than VA086 in a higher stiffness hydrogel.   Intracellular 
oxidative stress was not significantly greater in hydrogel conditions of more Irgacure 
2959 photoinitiator radicals. Normalized oxidative stress ratios suggest that increasing 
VA086 radicals induced higher Intracellular oxidative stress.   Suppression of 
intracellular oxidative stress using catalase pretreatment does not disrupt hydrogel 
crosslinking but it does not rescue cell viability.  
4.2 Introduction 
Numerous studies indicate that cell-cell interactions and cell-material interactions in the 
3D microenvironment in native tissue are fundamentally different than in 2D (Muller, 
Davenport et al. 2009; Bellis, Bernabe et al. 2013; Chitcholtan, Asselin et al. 2013).  As 
a result, the emphasis of how cell biology is investigated is shifting from 2D culture 
models to 3D culture models (Lund, Yener et al. 2009; Baker and Chen 2012; Santos, 
Hernandez et al. 2012). 3D printing is of interest as a tool both because it enables 
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mechanistic and biological investigation in 3D at multiple scales, such as at the cell level 
(Lee, Moon et al. 2008; Torgersen, Ovsianikov et al. 2012) and the tissue level (Chang, 
Boland et al. 2011; Fedorovich, Alblas et al. 2011)), and because it could translate into 
a means for fabricating living tissue at a scale suitable for clinical use (Koch, Deiwick et 
al. 2012; Luangphakdy, Walker et al. 2013). In our first study (described in Chapter 3) 
where we 3D printed hydrogel valve constructs, the hydrogel constructs were post-
fabrication seeded with PAVIC (Hockaday, Kang et al. 2012). We demonstrated that by 
using photo-crosslinking we could achieve a high degree of geometric control and 
shape fidelity. However, the cellularity of these constructs is limited to the surface of the 
scaffolds. In a subsequent study we directly printed cells into valve constructs but used 
a chemical/ionic crosslinker to solidify the hydrogel (Duan, Hockaday et al. 2013). We 
did not have the same level of geometric control with this crosslinking strategy. In order 
to fully utilize the geometric control of the Fab@HomeTM 3D printer to incorporate 
heterogeneity and to deposit multiple cell types throughout the valve construct, optimal 
conditions for direct cell printing and photo-crosslinking were investigated.  
 
In this study, poly-(ethylene glycol)diacrylate (PEG-DA) and methacrylated gelatin 
(MeGel) photo-crosslinkable hydrogel precursors (Benton, DeForest et al. 2009; 
Hutson, Nichol et al. 2011)  were combined with non-photo-crosslinking alginate to 
make a solution suitable for extrusion 3D printing. PEG-based hydrogels have been 
used to study heart valve interstitial cells response to mechanical properties in both 2D 
and encapusulate 3D in-vitro studies (Kloxin, Benton et al. 2010; Durst, Cuchiara et al. 
2011). This vast potential for mechanical and/or molecular customization, coupled with 
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their relatively low cost, suggests PEG-DA could be an ideal material component for 
clinically relevant scale 3D tissue printing. Gelatin is synthesized by partial breakdown 
of collagen, but it retains some bioactive features of collagen, particularly cell 
attachment/binding domains (Benton, DeForest et al. 2009). Gelatin can be modified for 
photo-crosslinking by incorporating double bond pendent groups on the gelatin chains, 
to make methacrylated gelatin. Methacrylated gelatin (MeGel) hydrogels are 
enzymatically degradable and have been used to encapsulate valve interstitial cells 
(Benton, DeForest et al. 2009), and with the addition of PEG-DA the degradation 
properties are modifiable (Hutson, Nichol et al. 2011). Irgacure 2959 and VA086 
photoinitiators have previously been used with live cells in 3D hydrogels (Rouillard, 
Berglund et al. 2010; Hutson, Nichol et al. 2011). Irgacure 2959 and VA086 were tested 
in this study for their ability to photo-crosslink MEGEL/PEG-DA precursor solution and 
for their effect on encapsulated cells.    
 
In a healthy cell of an aerobic organism reactive oxygen species (ROS) are produced at 
a controlled rate, but in  a cell subjected to oxidative stress there is an imbalance 
between production of ROS and the cell’s ability to scavenge and  manage them 
(Molecular Probes Handbook;(Abramov, Scorziello et al. 2007; Mallajosyula, Kaur et al. 
2008; Quintanilla, Matthews-Roberson et al. 2009; Wang, Su et al. 2009).  As a result 
oxidative stress and ROS can cause alterations in membrane lipids, proteins, and nuclei 
acids. The free radicals produced by Irgacure 2959 photo-initiation are membrane 
impermeable and are suspected to cause damage by lipid peroxidation (Lampe, Namba 
et al. 2009). Less is known about VA086 radicals, but as a photoinitiator it is considered 
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less cytotoxic than Irgacure 2959 (Chandler, Berglund et al. 2011; Rouillard, Berglund et 
al. 2011; Occhetta, Sadr et al. 2013). Fedorovich et al tested the effects of Irgacure 
2959 photo-initiation on bone marrow mesenchymal stem cells in both 2D and in 
encapsulating hydrogels. They found that cell viability, cell cycle, and cell proliferation 
are negatively affected by Irgacure 2959 photoinitiation/radicals and that DNA damage 
occurs inside the cell (indicated by positive staining of p53 binding protein 1). DNA 
damage in the nucleus suggests that oxidative stress may propagate into the cell.  In 
their 3D hydrogels, they observed significantly less DNA damage in the 3D conditions 
than in the 2D conditions (10% compared to 66% of cells) and at the concentrations and 
energies they used (0.05-0.1% w/v Irgacure, 6 mW/cm2) photo-polymerization in a 3D 
hydrogel precursor environment did not negatively influence cell survival or osteogenic 
differentiation (Fedorovich, Oudshoorn et al. 2009).  They also did not observe 
differences between Irgacure concentration conditions in 3D.  They conclude from this 
protective effect that in the 3D hydrogel environment that photoinitiator radicals 
preferentially react with target polymer precursors and that reactive species are 
therefore unavailable to damage cellular components. Roulliard et al working at a lower 
concentration of Irgacure 2959 (0.03% w/v) in alginate hydrogels observed that Irgacure 
2959 had a detrimental effect on chondrocyte viability (below 70%) (Rouillard, Berglund 
et al. 2011). The difference between these two studies (Irgacure effects viability in one, 
Irgacure does not affect viability in the other) suggests that the protective effect of a 3D 
hydrogel photo-crosslinking system could be related to the encapsulating hydrogel 
material (methcrylated alginate verses the methacrylated hyaluronic acid and 
methacrylated hyperbranched polyglycerol) or that the two cell types have different 
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sensitivities to the Irgacure radicals in photo-crosslinking conditions. Others have 
observed cell-specific differences in in response to photoinitiator radicals (Williams, 
Malik et al. 2005) and different amounts/expression of intracellular and membrane 
components can engender protection against oxidative stress (Manevich, Sweitzer et al. 
2002; Singh, Brocker et al. 2013).  Identifying what causes cell-type specific viability 
differences in hydrogels could lead to a strategy to combat photo-crosslinking damage 
in more sensitive cells. This would enable a broader use of photo-crosslinking in tissue 
engineering.  
 
 In this study we quantify the different viability response of valve interstitial cells, valve 
smooth muscle cells, and adipose derived mesenchymal stem cells to photo-
crosslinking encapsulation conditions in Methacrylated Gelatin/PEG-DA hydrogels with 
Irgacure 2959 and VA086 photoinitiators. To investigate the role intracellular oxidative 
stress in cell-specific vulnerability to photo-crosslinking conditions, encapsulated cells 
were loaded with DCF, a general oxidative stress indicator, prior to encapsulation. We 
also tested catalase treatment for its ability to rescue photo-encapsulated cells from 
photoinitiator induced damage.   
4.3 Materials and Methods 
4.3.1 Synthesis of Polymer Precursors 
Methacrylated gelatin (MEGEL) was synthesized as previously described (Nichol, 
Koshy et al. 2010; Duan, Hockaday et al. 2013; Duan, Kapetanovic et al. 2014). Brieﬂy, 
gelatin from bovine skin (Sigma) was dissolved at 10% w/v into distilled water at 40 C 
and then methacrylic anhydride (MA, Sigma) (1:5 v/v to gelatin solution) was added 
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drop by drop under stirred conditions at 40 C for 1 hour.  Polyethylene glycol diacrylate 
molecular weight 3350 was synthesized as previously described (PEG-DA 3350) 
(Cruise, Scharp et al. 1998; Guo, Chu et al. 2005).  Poly(ethylene glycol) (PEG, Sigma) 
was dissolved in benzene (1.5 mmol of PEG in 150 ml of benzene) and heated to 45 °C 
with continuous stirring until completely dissolved. The solution was cooled to room 
temperature and triethylamine was added at 8 fold molar concentration (based on PEG 
diol end groups) to the PEG solution (12 mmol). Acryloyl choride (Sigma) at eightfold 
molar excess concentration was weighed out then diluted using benzene (1:40 acryloyl 
chloride to benzene) and added drop wise to the PEG solution through a drop funnel 
under an ice bath. The mixture was stirred overnight, and then the reaction stopped. 
The insoluble triethylamine was removed by filtration. PEG-DA was precipitated from 
the solution by the addition of petroleum ester (Sigma). The PEG-DA precipitate was 
collected using a funnel, re-dissolved in 20 ml of benzene, and again precipitated by 
adding petroleum ester. The precipitation process was repeated several times. 
 
After synthesis the MEGEL and PEG-DA products were dissolved in distilled water and 
transferred and sealed into dialysis tubing with a molecular weight cut off of 1000 Da. 
The polymers were dialyzed against distilled water for 5-7 days in 5 gallon containers 
with frequent water changes. The polymer product was then frozen at -20C and then 
lyophilized.  Lyophilized polymers were stored at -20°C. 
4.3.2 Preparation of Sterile Polymer Precursor Solution 
Polymer precursor solution was prepared the same way for mechanical comparisons 
and for cell encapsulation for viability assessment and printing.  Polymer solutions were 
prepared in a biosafety cabinet. Hydrogel precursor solutions were made 20% w/v 
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polymer to solution, MEGEL:PEG-DA 3350 1:1. Polymer precursors were weighed out 
dry and then sterilized for 1 hour using germicidal UV and then transferred into sterile 
50-ml conical tubes. Photoinitiators 2,2'-Azobis[2-methyl-N-(2-
hydroxyethyl)propionamide] (VA-086, Wako Chemicals)  and 2-hydroxy-1(4-
(hydroxyethox)pheny)-2-methyl-1-propanone (Irgacure 2959, BASF Corporation, 
Newport, DE) were weighed out and dissolved in 70% ethanol  to make stock solutions 
of 0.1g VA086/ml of ethanol solution and 0.015g Irgacure/ml of ethanol solution which 
were then sterile filtered (Chandler, Berglund et al. 2011; Rouillard, Berglund et al. 
2011). Stock solutions were stored at room temperature and used within 1 week.  
Photoinitiator stock solution was added to sterilized polymers to give a final 
concentration of 0.25-1.0% w/v VA086 or 0.025-0.1% w/v Irgacure. The remaining 
solution volume was valve cell culture media.   Polymer precursors, photoinitiator 
solution, and media were combined in conical tube, the tube cap was wrapped with 
parafilm, and the tube placed into water bath at 37°C to dissolve.  
4.3.3 Light Meter Measurements and Light Sources for Photo-crosslinking 
365 nm UV light intensity was measured at different distances from several light 
sources with a UVX Radiometer UVP and sensor model UVX-36 Serial Number E 
23832. The meter reached its maximum at 20  mW/cm2 so the distance from the sensor 
and the intensity was measured and then a power fit to the data was used to extrapolate 
the intensity at the printing surface for the higher intensity light sources.   
 
Three light sources were measured - a lamp, a low power LED array, and a high power 
LED array. The lamp used was a Spectroline Lamp 365nm EN280L with a single bulb. 
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The 365nm LED arrays were built to mount on the syringe carriage. The low power LED 
array, previously used for printing valve scaffolds [Biofabrication 2012], was built with 4 
NCSU033A  LEDs (Nichia America Corporation, Wixom, MI). Note: NCSU033A LEDs 
have since been discontinued and the equivalent is NCSU033B LEDs. The circuit was 
built with 50 Ω, 33 Ω, or 25 Ω limiting resistances per LED (calculated 248 mA, 375 mA, 
and  496 mA forward current per LED and radiant flux at LED 154 mW, 233 mW, and 
307mW for each limiting resistance). The high power LED array, was built with 4 
NC4U133A LEDs (Nichia) and 60 Ω limiting resistances (calculated 350 mA forward 
current per LED and radiant flux 868 mW). An ice water cooled copper heatsink was 
built into the high powered LED array to keep the LEDs cool.  
4.3.4 Mechanical Testing of Hydrogel Disks 
Mechanical properties of crosslinked hydrogels were tested to determine working 
ranges for fabrication. Hydrogel precursor solution was crosslinked into disks and rinsed 
for mechanical testing and swelling tests. Precursor solution was pipetted into a syringe, 
7.5% w/v Protanal LF 10/60 sodium alginate (alginate, FMC Biopolymer now changed 
name to FMC Health and Nutrition) was added as a viscosity modifier and stirred in with 
a spatula. The syringe stopper was reinserted, the bubbles squeezed out, and the 
viscous precursor solution was mixed back and forth between two syringes connected 
by a Luer adapter to fully homogenize. The solution was extruded into silicon rubber 8 
mm diameter disk molds in a petri dish and leveled with a coverslip (coverslip used to 
scrape excess off). The solution filled molds were positioned under either the lamp (2.7 
cm from source) or high power LED array mounted on the printer syringe carriage (at 
print surface 1.2 cm from source) and crosslinked for 3, 5, and 7 min minutes. The 
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gaskets were peeled off the petri dish, and 1X phosphate buffered saline (PBS, VWR 
International, Radnor PA) was added to the petri dish with the crosslinked hydrogel 
disks. The hydrogels in PBS were placed on rocker/rotator at room temperature, and 
PBS was exchanged after 1 hour and 24 hours to rinse out the alginate viscosity 
modifier. Disks were mechanically tested or evaluated in swelling tests.   
 
Uniaxial confined compression testing was performed on hydrated and rinsed disks 
within 48 hours on a mechanical testing platform (EnduraTec 3200; Bose Electroforce, 
Eden Prairie, MN). Samples were ramp loaded quasi-statically at 0.01mm/sec to 30% 
strain.  Modulus (E5to15) was calculated from the 5 to 15% strain portion of the stress 
strain curve. Sample size was n=3 to n=14.  The Student’s t-test was applied to the data 
set.  
 
PBS hydrated and rinsed disks were weighed to determine the equilibrium swollen 
mass, then lyophilized for 48 hours, and then weighed to obtain the dry polymer mass 
for each sample. The hydrogel swelling ratio based on mass was calculated (Baier 
Leach, Bivens et al. 2003) with the relationship: 
                    
                                
                    
 
 Sample size was n=5 to n=8.  
4.3.5 Heart Valve and Mesenchymal Cell Culture  
Direct cell printing encapsulation conditions were tested with both primary aortic valve 
cells and adipose derived mesenchymal stem cells (ADMSC). Valve interstitial cells 
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(VIC) are the main cell type that populates valve leaflets (Butcher, Simmons et al. 2008) 
and valve sinus smooth muscle cells (SSMC) populate the root wall of the valve. 
Primary valve cells have been used to study mechanistic and remodeling behavior as 
well as to establish tissue engineering targets (Stephens, Durst et al. 2011; Gould, Chin 
et al. 2012; Duan, Hockaday et al. 2013; Gould and Anseth 2013).  Heart valves are 
non-sacrificial, and for the purposes of tissue engineering a heart valve a cell source 
other than primary valve cells is needed. A recent study profiled ECM gene expression 
of  ADMSC and VICs in response to strain. They found that the two cell types have the 
capacity to synthesize and remodel the surrounding matrix and the two cell types have 
comparable response to mechanical stimulus (Latif, Sarathchandra et al. 2007; 
Colazzo, Sarathchandra et al. 2011).  ADMSC can be differentiated towards osteogenic, 
adipogenic, myogenic, chondrogenic, neurogenic, endothelial, and smooth muscle cell 
lineages (Colazzo, Chester et al. 2010; Wang, Yin et al. 2010). ADMSC have 
demonstrated similar phenotypic  and functional characteristics to bone marrow 
mesenchymal stem cells (BMMSC), which are more established in the literature, but 
ADMSC isolation is less invasive (Bunnell, Flaat et al. 2008); (Colazzo, Chester et al. 
2010).  In addition, adipose tissue is present in infants, children, and adults (Kuzawa 
1998). These characteristics suggest ADMSC are a potentially feasible cell source for 
TEHV that could be applicable to all three age groups.   
 
Porcine aortic valve interstitial cells (PAVIC) were isolated via collagenase digestion as 
previously described (Butcher and Nerem 2004; Butcher, Penrod et al. 2004; Richards, 
El-Hamamsy et al. 2013). PAVIC were cultured with Dulbecco’s Modified Eagle’s 
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Medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum 
(FBS; Invitrogen) and 1% penicillin/streptomycin (PS; Invitrogen). Cells were fed every 
2-3 days and were used at passage number 4-8.  
 
Human aortic valve interstitial cells (HAVIC) and human aortic sinus smooth muscle 
cells (HASSMC) were isolated from the aortic valve of the donor heart of a 12-year old 
patient undergoing cardiac transplant for a myocardial contractility mutation that is not 
present in valves (Duan, Kapetanovic et al. 2014).  Human cells were isolated using the 
same procedure as previously used for porcine cells (Butcher and Nerem 2004), except 
that the collagenase used to digest the endothelial cell denuded leaflet and root tissue 
was made with MCDB 131 medium (Sigma) instead of DMEM and the HASSMC were 
isolated from biopsy punches taken below the sinotubule junction. The valve leaflets 
were inspected and contained no calcific deposits or thickened lesions. Tissue was 
procured with consent as approved by the Institutional Review Board of Weill-Cornell 
Medical College in New York City. Cells were cultured in MCDB131 medium 
supplemented with 10% FBS, 1% PS, 0.25 µg/L recombinant human fibroblast growth 
factor basic (rhFGF-2; Invitrogen) and 5 µg/L recombinant human epidermal growth 
factor (rhEGF; Invitrogen). Cells were fed every 2-3 days and used at passage number 
4-8. 
 
Cryopreserved HADMSC were purchased (Cat #:PT-5006, Lot#0F4505) Lonza, 
Walkersville). HADMSC were isolated from a 52 year old female donor and 
cryopreserved December 6, 2010.  Greater than 90% of the cells were positive for 
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CD13, CD29, CD44, CD73, CD90, CD105, and CD166. Less than 5% of cells were 
positive for CD14, CD31, and CD45.   (Note: According to the certificate of analysis for 
HADMSC 23 hour doubling time).  HADMSC were thawed and cultured using 
Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (F12:DMEM, Invitrogen) 
supplemented with 10% FBS, 1% PS. HADMSC were passaged at just sub-confluent 
(~90%) and fed every 3-4 days. Cells were used at passage number 4-8.  
 
PAVIC, HAVIC, HASSMC, and HADMSC were expanded and maintained in flasks with 
DMEM, MCDB 131, MCDB 131, and F12/DMEM media respectively.   
4.3.6 Encapsulation and Handling for Disk Experiments and In vitro Culture 
To test how variations in photoinitiator type, photoinitiator concentration, and intensity of 
UV light exposure effect printed cells, cells were encapsulated in precursor solution, 
extruded into disk molds, and crosslinked with either lamp or the high power LED array. 
For encapsulation studies porcine cells were cultured in DMEM, and all human cells 
were cultured in MCDB131 media.  Cells were rinsed with PBS, trypsinized from flasks 
that were 80-95% confluent, trypsin was inactivated with supplemented media, and cells 
were counted. Cells were spun down into a pellet (1000 RPM, 5 min). Cells were 
suspend in a small amount of media and then resuspended in warmed 37°C precursor 
solution so that the concentration was 2.5 million cells/ml of precursor solution. 
Precursor solution was pipetted into syringes connected by Luer adapter with the 
stopper/piston removed from one side. 7.5% w/v alginate powder was added and stirred 
in with a sterile spatula.  The syringe piston was reinserted, the bubbles squeezed out, 
and the viscous precursor solution was mixed back and forth between the two syringes 
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to fully homogenize. Syringes were kept in the incubator at 37°C until ready to crosslink 
to keep precursor gel warm.  If the solution is allowed to cool, the MEGEL component 
solidifies and the photo-crosslinking does not work or is only partial. The Luer adapter 
was detached and the syringe was used to extrude precursor gel into 8 mm diameter, 1- 
mm thick gasket molds in a petri dish. The gel was leveled with a sterile coverslip. Filled 
molds were positioned under the lamp or HLED array and were exposed to UV light for 
5 minutes.  20 ml of media was applied to submerge, hydrate, and loosen the hydrogel 
disks and the gasket was peeled/removed before the petri dish was placed in the 
incubator.  After 1 hour incubation in the media, the hydrogel disks were transferred to 
6-well plates containing fresh media. Plates were placed on a rocker in a walk in 
incubator set at 37°C and 5% CO2. Media was exchanged after 24 hrs and then 
hydrogels were fed every 48 hours   
4.3.7 LIVE/DEAD Staining 
Encapsulated cells were stained with LIVE/DEAD Viability and Cytotoxicity Kit 
(Invitrogen) to determine viability of cells after 1 day, 3 day, 4 day, and 7 day culture. 
Green fluorescent calcein-AM (LIVE) staining indicates intracellular esterase activity 
and red fluorescent ethidium homodimer-1 (DEAD) indicates loss of plasma membrane 
integrity.  Dye working solution was prepared at a concentration of 4 μM DEAD and 2 
μM LIVE in PBS warmed to 37°C.  Media was aspirated from wells containing gel disks 
and dye working solution was applied directly to gels. Working solution submerged gels 
were incubated for 30 minutes at 37°C. Dye solution was aspirated and gels were 
rinsed with warmed PBS. PBS was aspirated and warmed culture media was added to 
wells.  LIVE/DEAD stained disks were imaged using an epiflourescence 
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stereomicroscope (SteREO Discovery.V20; Zeiss, Germany). 3-4 disks per condition 
were imaged and 3 images per sample were averaged. Images for analysis were taken 
using the 1X objective and 150X magnification and analyzed using Image J. 
4.3.8 Metabolic Activity Assessment  
3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide; thiazolyl blue (MTT, 
Sigma-Aldrich) was used to assess metabolic activity of encapsulated cells after 1 day, 
3 day, 4 day, and 7 day culture (Duan, Wang et al. 2010). MTT is yellow in solution and 
then is converted to a dark blue water insoluble MTT formazan by mitochondrial 
dehydrogenase of living metabolically active cells (Carmichael, DeGraff et al. 1987). 
Cells that are actively proliferating have an increased metabolic activity while cells that 
have been exposed to toxins will have decreased metabolic activity.  MTT assay does 
not distinguish between cytostatic (growth inhibitory) and cytocidal (lethal) effects of a 
treatment. Hydrogel disks seeded with encapsulated cells were cultured for 1, 3, 4, and 
7 days and then stained with MTT.  MTT solution was prepared at a concentration of 5 
mg MTT powder/ml in PBS and sterile filtered before use.  Cultured disks were rinsed 
with PBS and transferred to a 24-well plate with each well containing 1 ml of media. 
1/10 media volume of MTT solution (0.1 ml) was added to each well and incubated for 4 
hours at 37°C. Disks were transferred to a 48 well plate containing 500 μl of dimethyl 
sulfoxide (DMSO, Sigma-Aldrich) per well and pulverized using forceps to break up the 
gel and completely dissolve the formazan. 100 μl aliquots of solution were pipetted into 
a 96-well plate and the absorbance of the solution was analyzed using a multi-detection 
microplate reader (BioTek Synergy HT) at 570 nm.  3-4 disks per condition were 
analyzed.  
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4.3.9 Doubling Time Assay  
Sensitivity to photoinitiator conditions and degree of oxidative damage can depend on 
cell type and proliferation rate (Williams, Malik et al. 2005).  Growth kinetics were 
assessed for all 4 cell types: PAVIC, HAVIC, HASSMC, and HADMSC (Williams, Malik 
et al. 2005). Cells were plated at an initial cell density of 2500 cells/cm2 in 24-well plates 
and cell medium (MCDB for human, DMEM for porcine). Media was changed every 
other day and cells were trypsinized from 4 individual wells per cell every other day for 
10 days and counted with a hemocytometer.  The number of cells for each day for each 
cell type was calculated as a mean of the 4 wells.  Population doubling times (PD) were 
calculated by dividing the length of log phase of growth by the results of the equation 
P=3.32(log10N1-log10N0). N1=number of cells at end of log phase, N0=number of cells at 
beginning of log phase, P= number of population doublings.  
4.3.10 General Oxidative Stress  
Cells were labeled with a general oxidative stress indicator and exposed to photo-
encapsulation  conditions to determine if oxidative stress could explain viability 
differences between human cell types and conditions. Two chloromethyl derivative dyes 
were used to investigate oxidative stress in encapsulated and printed cells: 5-(and-6)-
chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester CM-H2DCFDA 
(DCF, Invitrogen) and CellTracker Red CMTPX (CTR, Invitrogen). DCF was used to 
indicate general oxidative stress in encapsulated cells. CTR was used to tag all cells 
being encapsulated to determine what fraction of cells were fluorescing positive for 
oxidative stress with DCF.  DCF passively diffuses into a cell where its acetate groups 
are cleaved by intracellular esterases and its thiol-reactive group reacts with intracellular 
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glutathione and thiols (Kirkland and Franklin 2001; Kirkland, Saavedra et al. 2007). 
Oxidation of this product results in a fluorescent adduct that is trapped inside the cell. 
DCF is oxidized by cellular hydrogen peroxide, hydroxyl radicals, and radicals 
downstream from hydrogen peroxide. DCF is itself insensitive to oxidation by 
superoxide (O2
-) (Kirkland and Franklin 2001) or singlet molecular oxygen (O2*) (Bilski, 
Belanger et al. 2002), but it can be considered an indirect indicator of these. It reacts 
with the downstream products of O2* reaction with cellular substrates that produce 
peroxy products and peroxyl radicals, and it reacts with the hydrogen peroxide 
produced by dismutation of O2
- (Kirkland and Franklin 2001; Bilski, Belanger et al. 
2002).  CTR passes freely through the cell membrane where upon it is converted into 
cell membrane impermeant fluorescent dye which is retained for several days and 
multiple cell divisions.  Celltracker Red does not require enzymatic cleavage to be 
fluorescent.  
For oxidative stress studies, cells were pre-loaded with DCF and CTR prior to 
encapsulation. After cells were trypsinized and spun down, cells were suspended in 
DCF/CTR working solution at a concentration of 0.5 million cells/ml of working solution. 
Working solution concentration was 10 μM DCF and 7 μM CTR in Hank’s Balanced Salt 
Solution (HBSS, Gibco Invitrogen(Johnson 2010)). DCF working solution concentration 
and incubation time was previously described (except in media instead of 
HBSS)(Kirkland, Saavedra et al. 2007). Cells were incubated in working solution for 20 
minutes at 37°C, spun down (1000 RPM, 5min), rinsed and re-suspended with HBSS, 
spun down, and then encapsulated in polymer precursor solution made with either 0.1% 
w/v Irgacure or 1.0% VA086 (same encapsulation procedure at above).  Precursor 
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solution was mixed with alginate, extruded into disks, and exposed to UV light using the 
lamp or the high powered LED array for 5 minutes. MCDB media was applied to 
hydrogel disks to hydrate and loosen from the petri dish and gaskets.  1 ml of HBSS 
was pipetted into each well of a black bottom 48 well plate and the hydrogel disks were 
transferred into the wells.  Cell suspension controls of loaded cells suspended in HBSS 
were also pipetted into wells. The plate was scanned immediately on the plate reader 
for fluorescence intensity of DCF using an area scan of each well (Ex/Em 485/528).   
 
Hydrogel disks were transferred back into media and incubated at 37°C and imaged 
using confocal laser scanning microscopy (25X H2O objective, LSM 710, Carl Zeiss).  
n=4 for all conditions.  Images were evaluated using image J. Number of red fluorescent 
cells (cell tracker) and green fluorescent cells (DCF) were counted and then percent of 
cells experiencing oxidative stress was calculated (DCF cell count/Cell tracker cell count 
*100) . 
4.3.11 Catalase Treatment of Cells 
Cells were treated with catalase prior to encapsulation to determine if oxidative stress 
could explain viability differences between cell types and conditions and if reduction in 
oxidative stress could improve viability in encapsulated conditions.  Cells were 
incubated in catalase isolated from bovine liver (Sigma-Aldrich) solution 1000 units/ml of 
HBSS. This dosage is in the range of what has previously been used with live cells 
(Hela cells, smooth muscle cells)(Sakata, Miyamoto et al. 1998; Sakai, Liu et al. 2013) 
Catalase is an enzyme that catalyzes the decomposition of hydrogen peroxide into 
water and oxygen. For testing the effect of catalase on oxidative stress, catalase was 
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added to the DCF/CTR/HBSS working solution and incubated with cells for 20 minutes 
prior to encapsulation.  Samples were assessed using the plate reader and confocal 
imaging.  For testing the effect of catalase on day 3 viability, cells were incubated in 
catalase/HBBS solution for 20 minutes prior to encapsulation.  
 
Oxidative stress ratio was calculated from the average of relative fluorescence values of 
HBSS treated cell laden hydrogels relative fluorescence divided by catalase treated cell 
laden hydrogels relative fluorescence of a given photoinitiator and light source 
condition.  
                       
                                     
                                          
 
 
As a cell suspension control, cells DCF and cell tracker loaded and resuspended were 
then benchtop incubated in media while the hydrogel disks were printed and photo-
crosslinked.  The cells were then spun down and then suspended in HBSS.  Relative 
fluorescence data was collected using the plate reader and then the HBSS suspended 
cells were imaged with the confocal microscope.  
4.3.12 Statistics 
JMP PRO was used to make statistical comparisons. The Student’s t-test was applied 
to the data sets. Standard error of the mean was calculated and is displayed on graphs. 
Fit least squares regression analysis was done on the day 3 lamp viability results to 
compare slopes.  
  
 119 
 
4.4 Results 
4.4.1 Range of Light Intensities for Photo-crosslinking During Printing 
Strategies for photo-crosslinking include both crosslinking during the fabrication, directly 
after material is extruded from the syringe tips (example: mounted LEDs configuration 
shown in Figure 4.1A, 1D), or crosslinking post fabrication of the whole scaffold 
(example: bench top lamp configuration shown in Figure 4.1B). It is important to 
consider that the energy delivery is not constant with a mounted light source that photo-
crosslinks material as it is being printed. There is a range of light intensity on the 
extruded hydrogel during the course of printing since the distance between the light 
source and construct changes. During the course of printing the syringes trace out the 
print paths and the stage moves up and down when it initiates a new path, and as the 
scaffold builds up in layers the stage moves down.  In this printing platform the minimum 
crosslinking time and light exposure required to solidify a hydrogel are critical variables 
that set the fabrication time of a construct as well as determines the feasibility of using a 
particular polymer combination for direct bio-printing of cells. Light sources were first 
characterized to establish working ranges in subsequent experiments that cells will 
tolerate for printing. The 365 nm light intensity of the low power LEDs (Figure 4.1A), 
previously used in a 4 LED array to print  PEG-DA hydrogel aortic valve constructs 
(Hockaday, Kang et al. 2012), fell between the Spectroline lamp (Figure 4.1B) and the 
high powered LED array (Figure 4.1C, Figure 4.1E, Table 4.1). The array circuit 
resistance is used to set the forward current through each LED and thus the radiant flux. 
The measured and extrapolated intensity at the printing surface with a single low power 
LED (the other 3 LEDs were masked for the measurement) increases as the resistance   
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(A) Low Power 4 Nichia LED Array (NCSU033A  LEDs Biofabrication 2012) (B) 
Spectroline Lamp 365 nm EN280L single bulb, 2.0 mW/cm2 (C) Underside view of 
High Powered 4 LED Array and circulation heat sink, 136mW/cm2, 60 Ohm 
resistance per LED, Nichia 365 nmUV LED NC4U133A (D) Side view of High 
Powered LED array at printing distance with tip in contact with printing surface. (E) 
Intensity measured with radiometer. Power fit data and extrapolated to generate 
intensity estimates at print surface (Table 4.1). Plotted are the intensity vs distance 
for the light meter sensor centered under the high powered LED array mounted on 
the syringe carriage (C 4 HLED), sensor under the right syringe tip  (RT 4 HLED) , 
sensor under the left syringe tip  (LT 4 HLED), sensor under single high power LED 
(HLED), sensor under single low power LED with resistance set at 25 Ohms (LLED 
25 Ohm), under single low power LED with resistance set at 33 Ohms (LLED 33 
Ohm ), single low power LED with resistance set at 55 Ohms (LLED 55  Ohm ), and 
sensor under the Spectroline lamp.  
 
Figure 4.1-Error!  No text of specified s tyle in document.11 UV light intensity vs distance for different sources used for 
crosslinking printed hydrogels.  
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Table 4.1-2 Extrapolation of light source measurements and intensity at printing and 
crosslinking surface. 
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decreases (Table 4.1).  The high power LED array was positioned on the carriage so 
that the LED array was centered between the two syringe tips. On the Model 1 
Fab@Home printer, the syringe tips are 29 mm apart, and the intensity at the center 
between the two tips was 136m W/cm2. At 14.5 mm off center, where the right or left 
syringe tip make contact with the printing stage, the intensity is roughly 2/3 that of 
centered intensity.  The lowest and highest intensities tested were used for the 
subsequent photo-crosslinking experiments (2 mW/cm2 and 136 mW/cm2).  
 
4.4.2 Mechanical Testing Photo-crosslinked Hydrogel Disks 
Modulus (E5to15) and swelling ratio of photo-crosslinked MEGEL:PEG-DA hydrogels 
were affected by the photointitator type (Figure 4.2), the photoinitiator concentration, the 
light source intensity, and exposure time (Figure 4.3). Hydrogels could be tuned to three 
significantly different moduli. For this study a hydrogel was considered crosslinked when 
it could be transferred into media or PBS and it did not dissolve at either room 
temperature or 37°C.  Properties of the polymer precursor solution; viscosity; 
temperature sensitivity; polymer concentration and availability of double bonds; 
photoinitiator  concentration; photoinitiator efficiency in producing free radicals; and  
type of free radical produced  can all effect the minimum crosslinking time if the 
precursor solution crosslinks at all, and can also effect the resulting mechanical 
properties (Hockaday, Kang et al. 2012).  A single polymer combination and 
concentration was used in this study to keep the availability of double bonds, the 
density, and the viscosity of the solution constant. The solutions were kept as close to 
37°C as possible during handling and staging.  The MEGEL:PEG-DA solutions will 
solidify  as the temperature drops from 37°C to room temperature (25°C) because of the 
gelatin component. If the solution is allowed to cool, it will not photo-crosslink and the 
gel will dissolve when transferred into PBS or Media.    
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Figure 4.2 -12 Concentration and intensity study of mechanical properties of 
crosslinked hydrogels.  
(A) Young’s modulus of hydrogels made with variable photoinitiator type and 
concentration and light source during crosslinking. All the precursor solutions in 
these conditions were photocrosslinked under either the lamp or high LED array 
(HLED) for 5 minutes.  p< 0.05 non-matching letters, testing effect of photoinitiator 
type and concentration and light power, Student’s t-test and  standard error of the 
mean used. (B) Stress verses strain for hydrogels in A. 
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(A) Young's Modulus of hydrogels made with variable crosslinking time. Standard 
error of the mean, p< 0.05 non-matching letters, testing effect of photoinitiator type 
and crosslinking time. (B) Stress verses strain for hydrogels in A. 
 
Figure 4.3-13 Time study of mechanical properties of crosslinked hydrogels.  
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E5to15 of hydrogels made with VA086 and photo-crosslinked for 5 minutes with the low 
intensity light source (2 mW/cm2) was not significantly affected by increasing the 
photoinitiator concentration except below a certain photoinitiator concentration, a robust 
gel did not form (Figure 4.2-12A) (For 0.5,0.75,1.0% w/v E5to15  was 19.3±2.7,  20.0±3.9, 
and 21.3±2.7 kPa respectively, NSD). Only a small fraction of hydrogel disk batches 
made with 0.25% w/v VA086 did not dissolve when transferred into PBS or media.  
Crosslinking for 0.5% w/v VA086 was inconsistent, but almost 100% for 0.75% w/v 
VA086. E5to15 of hydrogels made with Irgacure 2959, and photo-crosslinked for 5 min 
with the low intensity light source (2 mW/cm2), was affected by increasing the 
photoinitiator concentration (For 0.025,0.05,0.075,0.1% w/v E5to15  22.8±3.1, 37.1±4.8, 
42.0±8.2, 40.9±4.1 kPa respectively, but only 0.1 and 0.025% w/v were significantly 
different).  Increasing the light intensity that precursor solution was exposed to for 5 
minutes of crosslinking (centered under high powered LED 136 mW/cm2) significantly 
increased the E5to15 for hydrogels made with both photoinitiator types. For 1.0% w/v 
VA086 gels increasing the light source intensity increased the E5to15 from 21.3±2.7 kPa 
to 45.7±5.2 kPa. For 0.1% w/v Irgacure gels increasing the light source intensity 
increased the E5to15 from 40.9±4.1 kPa to 120.7±10.2 kPa. E5to15 of hydrogels made with 
VA086 and Irgacure, and photo-crosslinked with the low intensity light source (2 
mW/cm2) were affected by the amount of exposure time. For hydrogels made with 
0.05% w/v Irgacure and photo-crosslinked at 3, 5, 7 min during the timing experiment, 
E5to15 was 17.4±2.2, 20.3±7.8, and 24.1±2.6 kPa (Figure 4.3). For hydrogels made 
during the timing experiment made with 0.5% w/v VA086 photo-crosslinked at 3, 5, 7 
min, E5to15 was 4.2±1.0, 5.1±1.8, 16.6±1.5 kPa respectively. During hydrogel 
 127 
 
compression the stress response to strain is non-linear (Figure 4.2B and 3B), and 
changing the photoinitiator and light source intensity produces hydrogels that fall into 3 
different stiffness. 
 
Hydrogel swelling ratio was affected by both the light intensity used for crosslinking and 
the photoinitiator concentration (Figure 4.4A).  1.0% w/v VA086 hydrogels and 0.1% w/v 
Irgacure hydrogels photo-crosslinked for 5 min were significantly less swollen when 
crosslinked at the higher intensity. SR was 19.9±0.3 (2 mW/cm
2 ) compared to 10.5±0.4 
(136mW/cm2 ) for VA086 hydrogels, and SR was13.2±1.2 (2 mW/cm2 ) compared to 
10.2±0.7 (136mW/cm2 ).  However, for the low photoinitiator Irgacure hydrogels (0.025% 
w/v), increasing the intensity of light source did not significantly affect the swelling ratio, 
26.3±1.8 at 2 mW/cm2, compared to 24.0±1.1 at 136 mW/cm2.  Increasing the 
photoinitiator concentration affected the swelling ratio for both VA086 hydrogels and 
Irgacure hydrogels. In general decreasing swelling ratio indicates increased levels of 
crosslinking (Leach and Schmidt 2005), and increased modulus indicates increased 
levels of crosslinking. Plotting the modulus against the swelling ratio (Figure 4.4B) 
confirms the trend that as swelling ratio decreases the modulus increases.  
 
These results indicate that there are saturation points in the polymer precursor solution 
terms of the photoinitiator ranges being tested. The modulus data suggests that once a 
certain point is reached there are diminishing returns for increasing photoinitiator 
concentration when using a particular light source. Increasing the light intensity to  
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Figure 4.4-14  Swelling properties of crosslinked hydrogels.  
 
(A) Weight based swelling ratio (swollen weight divided by dry weight) of crosslinked 
hydrogels made with variable photoinitiator type and concentration and light source 
during crosslinking.  p< 0.05 non-matching letters, testing effect of photoinitiator type 
and concentration and light power, standard error of the mean shown by error bars. 
(B) Young’s modulus verses swelling ratio of hydrogels. (VA086 1.0 Lamp, VA086 1.0 
HLED, Irgacure 0.1 lamp, Irgacure 0.1 HLED). Standard error of the mean shown by 
error bars. 
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136mW/cm2 does increase the stiffness of the gel for each photoinitiator, but 
VA086 hydrogel modulus does not reach the magnitude of Irgacure hydrogel 
modulus. 
4.4.3 Encapsulated Valve and Mesenchymal Cell Viability 
Encapsulated valve cells had significantly less viability and rounded morphology 
compared to mesenchymal stem cells in photo-crosslinked MEGEL:PEG-DA hydrogels.   
 HADMSC, HAVIC, and HASSMC survival were all affected by photoinitiator 
concentration in the photo-crosslinked hydrogels (Figure 4.5A).  Irgacure has a more 
detrimental effect on encapsulated cells than VA086 concentrations tested. HADMSC 
encapsulated viability in Irgacure hydrogels prepared with 0.05% w/v was significantly 
higher than both 0.075 and 0.1 % w/v (89.7±1.9 compared to 83.4±1.5 and 78.9±1.1 
%live cells). VA086 hydrogels HADMSC cultured to day 4 had no significant difference 
in viability with photoinitiator concentration (percent live for 0.05, 0.075, and 0.1 % w/v 
was 93.4±0.8, 92.5±1.6, and 90.9±0.9).  HAVIC encapsulated viability in hydrogels 
prepared with 0.05% w/v Irgacure was significantly higher than 0.075% w/v (66.4±2.3 
compared to 57.7±0.6). VA086 hydrogels HAVIC cultured to day 3 had no significant 
difference in viability with photoinitiator concentration (percent live was 0.05, 0.075, and 
0.1 % w/v, 92.7±0.9, 92.1±2.0, and 86.0±3.3). HASSMC encapsulated viability in 
hydrogels prepared with Irgacure did not follow the same trend as HADMSC and HAVIC 
(0.05, 0.075, and 0.1% w/v hydrogels had 61.2±1.6, 61.7±2.4, and 67.2±1.1 percent 
viability at day 3 culture). In VA086 hydrogels HASSMC cultured to day 3 had a 
significant decreasing trend in viability with increasing photoinitiator concentration  
(percent live was 0.05, 0.075, and 0.1 % w/v, 94.8±0.4, 81.2±3.3, and 71.1±2.0). In   
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Figure 4.5-15 (A) Viability of encapsulated HADMSC, HAVIC, HASSMC stained at 
day 3 of culture.  
Percentage of live of cells encapsulated in hydrogel discs and cultured for 3-4days. 
Gels made with increasing Irgacure 2959 and VA086 concentration. Standard error 
of the mean used.*p<0.05  within groups (effect  of cell type),  #   p<0.05  between 
groups (effect of photoinitiator concentration)   Lamp 2 mW/cm2 crosslinking.  
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Figure 4.5-16 (B) Circularity of viable encapsulated HADMSC, HAVIC, HASSMC 
stained at day 3 of culture. 
Circularity of live of cells encapsulated in hydrogel discs and cultured or 3-4 days. 
Increasing Irgacure 2959 and VA086 concentration. 1 is a perfect circle. Standard 
error of the mean used, p<0.05 within groups (effect of cell type), # p<0.05 between 
groups (effect of photoinitiator concentration). 
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hydrogels prepared with Irgacure HADMSC viability is higher than both HAVIC and 
HASSMC. At 0.1 % w/v viability is significantly different between HADMSC, HAVIC, and 
HASSMC. In hydrogels prepared with VA086 at 0.5% w/v there is no significant 
difference in viability between the 3 cell types. Increasing the VA086 concentration 
caused the percentage of live HASSMC to decrease but did not affect the HADMSC 
and HAVIC viability which remained the same.  
 
ANCOVA (analysis of covariance) for the day 3&4 viability data trends: 
Least squares fit  of the Irgacure concentration and cell type interaction data with the 
JMP full factorial macro showed the HASSMC/IRG slope was significantly different from 
the HAVIC and HADMSC slopes (p<0.0005). HADMSC/IRG and HAVIC/IRG slopes 
were not different (p=0.4498) and ANCOVA showed that the groups are significantly 
different (least square mean HADMSC 83.99±1.20 and HAVIC 60.99±1.20). The least 
squares fit of the data from testing the VA086 concentration and cell type interaction 
showed the HASSMC/VA086 slope was significantly different from the HAVIC and 
HADMSC slopes (p<0.0001) but the HADMSC/IRG and HAVIC/IRG slopes were not 
different (p=0.2386). ANCOVA showed that the groups are not significantly different 
(least squares means HADMSC 92.24±1.00 and HAVIC 90.13±1.04). 
4.4.4 Encapsulated Valve and Mesenchymal Cell Morphology 
Encapsulated HADMSC had significantly more spread morphology compared to HAVIC 
and HASSMC at all photoinitiator concentrations tested, at day 3 and 4 (Figure 4.5B) 
and day 1 and day 7 of culture (Figures 4.6 - 4.11) . HADMSC cultured in Irgacure and 
VA086 hydrogels cultured to day 3 and day 4 did not have any significant difference in 
circularity with increasing photoinitiator concentration For 0.05, 0.075, 0.1% w/v  
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Figure 4.6-17 Viability in HAVIC/Irgacure hydrogels.  
(A) Representative images of Live/Dead stained  HAVIC gels  crosslinked at 2 
mW/cm2 after up to Day 7 culture. (B) Percentage of live HAVIC encapsulated in 
hydrogel discs and then stained at 1, 3, 7days  culture time.  Increasing Irgacure 
concentration. SEM, *p<0.05  within groups (effect  of photoinitiator concentration), 
#p<0.05 between groups (effect of day in culture). 
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Figure 4.7-18 (A) Viability in HAVIC/VA086 hydrogels.  
Representative images of Live/Dead stained HAVIC gels crosslinked at 2 mW/cm2 
after up to Day 7 culture. 
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Figure 4.7-19 (B) and (C) Viability in HAVIC/VA086 hydrogels.  
(B) Percentage of live HAVIC encapsulated in hydrogel discs and then stained at 1, 
3, and 7 day culture time.  Increasing VA086 concentration. (C) MTT plate reader 
absorbance of HAVIC encapsulated in hydrogel discs and then stained at 1, 3, and 7 
day culture time at two VA086 concentrations. SEM, *p<0.05 within groups (effect of 
photoinitiator concentration), #p<0.05  between groups (effect of day in culture). 
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Representative images of Live/Dead stained HASSMC gels crosslinked at 2 mW/cm2 
after up to Day 7 culture. 
Figure 4.8 20 (A) Viability in HASSMC/Irgacure hydrogels. 
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(B) Percentage of live HASSMC encapsulated in hydrogel discs and then stained at 
1, 3, and 7 day culture time.  Increasing Irgacure concentration. (C) MTT plate reader 
absorbance of HASSMC encapsulated in Irgacure hydrogel discs and then stained at 
1,3, and 7 day culture time for increasing Irgacure concentrations. SEM, *p<0.05 
within groups (effect of photoinitiator concentration), # p<0.05 between groups (effect 
of day in culture). 
 
Figure 4.8 21(B) and (C)  
Figure 4.8-(B) and (C) Viability in HASSMC/Irgacure hydrogels. 
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Figure 4.9-22  (A) Viability in HASSMC/VA086 hydrogels.  
Images of Live/Dead stained HASSMC gels crosslinked at 2 mW/cm2 after up to Day 
7 culture.  
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Figure 4.9-23  (B) and (C) Viability in HASSMC/VA086 hydrogels.  
(B) Percentage of live HASSMC encapsulated in hydrogel discs and then stained at 
1, 3, 7 day  culture time.  Increasing VA086 concentration. (C) MTT plate reader 
absorbance of HASSMC encapsulated in VA086 hydrogel discs and then stained at 
1, 3, 7 day  culture time for increasing VA086 concentrations. SEM, *p<0.05 within 
groups (effect  of photoinitiator concentration), #p<0.05  between groups (effect of 
day in culture). 
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Figure 4.10-24 (A) Viability in HADMSC/Irgacure hydrogel.  
 Representative images of Live/Dead stained HADMSC gels crosslinked at 2 mW/cm
2 
after up to Day 7 culture.  
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Figure 4.10-25 (B) and (C) Viability in HADMSC/Irgacure hydrogel.  
 (B) Percentage of live HADMSC encapsulated in hydrogel discs and then stained at 
1, 3, and 7 day culture time.  Increasing Irgacure concentration. (C) MTT plate reader 
absorbance of HADMSC encapsulated in Irgacure hydrogel discs and then stained at 
1,3, and 7 day  culture time for increasing Irgacure concentrations. SEM, *p<0.05 
within groups (effect of photoinitiator concentration), #p<0.05  between groups (effect 
of day in culture).  
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Figure 4.11-26  (A) Viability in HADMSC/VA086 hydrogel.  
Representative images of Live/Dead stained HADMSC gels crosslinked at 2 mW/cm2 
after up to Day 7 culture.  
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Figure 4.11-27  (B) and (C) Viability in HADMSC/VA086 hydrogel.  
(B) Percentage of live HADMSC encapsulated in hydrogel discs and then stained at 
1, 3, and 7 day culture time.  Increasing VA086 concentration. (C) MTT plate reader 
absorbance of HADMSC encapsulated in VA086 hydrogel discs and then stained at 
1, 3, and 7 day  culture time for increasing VA086 concentrations. SEM, *p<0.05 
within groups (effect of photoinitiator concentration), #p<0.05 between groups (effect 
of day in culture). 
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Irgacure, the circularity was 0.45±0.02, 0.54±0.04, 0.52±0.02 respectively. For 0.5, 0.75, 
1.0% w/v VA086, the circularity was 0.53±0.03, 0.47±0.03, 0.49±0.01 NS respectively 
(Figure 4.5B).  HAVIC cultured in Irgacure and VA086 hydrogels cultured to day 3 
became more rounded (increase in circularity) with increasing photoinitiator 
concentration. For 0.05, 0.075, 0.1% w/v Irgacure, the circularity was 0.66±0.03, 
0.76±0.01, 0.78±0.01 respectively. For 0.5, 0.75, 1.0% w/v VA086, the circularity was 
0.64±0.02, 0.70±0.03, 0.71±0.02 respectively.   HASSMC cultured in Irgacure hydrogels 
cultured to day 3 had no significant difference in circularity with the photoinitiator 
concentrations tested. For 0.05, 0.075, 0.1% w/v Irgacure, the circularity was 0.67±0.01, 
0.71±0.03, 0.71±0.01, NS respectively. (Figure 4.5B). HASSMC cultured in VA086 
hydrogels cultured to day 4 became more rounded with increasing photoinitiator 
concentration (0.5, 0.75, 1.0% w/v VA086 circularity was 0.63±0.01, 0.69±0.01, 
0.71±0.01 respectively). 
ANCOVA (analysis of covariance) for the day 3&4 circularity data trends:  
Least squares of the Irgacure concentration and cell type interaction circularity data with 
the JMP full factorial macro showed the HASSMC/IRG, HAVIC/IRG, and HADMSC/IRG 
slopes were not significantly different (p=0.3300). Subsequent ANCOVA and Student’s-t 
test indicated that HADMSC were significantly different from HASSMC and HAVIC 
which were not different from each other (least squares means 0.51±0.01, 0.69±0.01, 
0.73±0.01 respectively). Least squares fit of the VA086 concentration and cell type 
interaction circularity data showed the HADMSC/IRG slope was significantly different 
from the HASSMC/IRG and HAVIC/IRG slopes (p=0.0081) and the HASSMC/IRG and 
HAVIC/IRG slopes were not different from each other (p=0.6083). Subsequent 
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ANCOVA and Student’s t-test of the HAVIC and HASSMC data, indicated no significant 
difference (least squares means 0.68±0.01, 0.68±0.01 respectively). 
4.4.5 Cell Viability at Day 1, 3, 4, and 7 Culture 
Over the course of 7 days of culture, in general the viability of encapsulated HAVIC and 
HASSMC decreased the longer hydrogel disks made with Irgacure were cultured, while 
the percentage of live HADMSC was maintained (Figure 4.6, 4.8, and 4.10).  In general 
HAVIC, HASSMC, HADMSC viability is maintained in hydrogels prepared with VA086 
(Figure 4.7, 4.9, and 4.11). HAVIC viability was less in Irgacure hydrogels compared to 
VA086 hydrogels, and photoinitiator concentration affected the viability over time 
(Figure 4.6 and 4.7). HAVIC percent viability in lower Irgacure hydrogels (0.05 % w/v) 
had a dip in viability on day 3 (day 1, 3, and 7 viability 79.1±0.1, 66.4±2.3, 74.1±1.56 
respectively, Figure 4.6B). Viability of encapsulated HAVIC decreased with increasing 
day in culture for hydrogels made with higher Irgacure concentration (0.075% w/v: day 
1, 3, and 7 viability 75.1±2.0, 57.7±0.6, 43.9±1.9 respectively; 0.1% w/v: day 1, 3, and 7 
viability 65.8±2.6, 58.8±3.4, 50.6±5.6 respectively; Figure 4.6B)). Least squares fit 
analysis in JMP indicated the slopes are significantly different. HAVIC viability in 0.5 and 
0.75% w/v VA086 hydrogels was not significantly different between day 1, 3, and 7 of 
culture or between photoinitiator concentrations (0.5% w/v: day 1, 3, and 7 viability 
91.0±1.5, 92.7±0.9, 91.0±1.7 respectively; 0.75% w/v: day 1, 3, and 7 viability 90.6±1.3, 
92.2±2.0, 94.1±0.8; Figure 4.7B respectively).  Percentage of live encapsulated HAVIC 
in in 1.0% w/v VA086 hydrogels initially was lower than in 0.5 and 0.75% w/v VA086 
hydrogels but it increased  with time in culture (1.0% w/v: day 1, 3, and 7 viability 
84.3±2.7, 86.0±3.3, 91.8±1.9 respectively). 
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HASSMC viability was less in Irgacure hydrogels compared to VA086 hydrogels.  
Photoinitiator concentration affected the viability over time for Irgacure and VA086 
hydrogels (Figure 4.8 and 4.9). 
 
HASSMC viability decreased in Irgacure hydrogels as the time in culture increased 
(0.05% w/v: day 1, 3, and 7 viability 89.7±1.1, 61.3±1.6, 61.3±0.8 respectively; 0.075% 
w/v: day 1, 3, and 7 viability 79.9±1.2, 61.7±2.4, 53.7±0.1 respectively; 0.1% w/v: day 1, 
3, and 7 viability 85.1±1.0, 67.2±1.1, 56.3±4.6 respectively; Figure 4.8B). The 
encapsulated cells follow the same decreasing viability trend for all three Irgacure 
concentrations. Least squares fit analysis in JMP indicated the slopes are not 
significantly different.  There were significant differences in viability between 
photoinitiator concentrations at day 1,3, and 7. HASSMC viability decreased in VA086 
hydrogels as the day in culture increased only in the highest photoinitiator concentration 
(1.0%, Figure 4.9B, day 1, 3, and 7 viability 81.1±1.6, 71.1±2.0, 69.6±1.2 respectively) 
and for the lower photoinitiator concentrations (0.5 and 0.75% w/v) the viability was not 
significantly different between the different days (0. 5% w/v: day 1, 3, and 7 viability 
93.2±0.6, 94.8±0.4, 89.7±2.3; 0.75% w/v respectively; day 1, 3, and 7 viability 89.0±1.2, 
81.2±3.3, 82.8±4.5 respectively). For day 1, 4, and 7 culture times, percent viability 
decreased with increasing photoinitiator concentration 
 
HADMSC viability did not vary significantly between days for 1,3, and 7 day culture for 
Irgacure hydrogels except for one condition (Figure 4.10B; 0.05% w/v: day 1, 3, and 7 
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viability 93.6±0.4, 89.7±1.9, 89.3±1.5;0.075% w/v respectively; day 1, 3, and 7 viability 
89.5±2.2, 83.4±1.5, 91.2±2.1 respectively; 0.1% w/v: day 1, 3, and 7 viability 83.9±1.7, 
88.9±1.1, 81.2±2.5 respectively). In the 0.075% Irgacure hydrogel the viability of 
HADMSC was less on day 3 than on day 1 and day 7.  There were significant viability 
differences between photoinitiator concentration conditions. On day 1 and 7 0.05% w/v 
and 0.075% w/v had higher viability than 0.1% w/v hydrogels. On day 3 HADMSC 
viability was significantly different between 0.05% w/v hydrogels and the 0.075 and 
0.1% Irgacure hydrogels. Percent viability for HADMSC in VA086 hydrogels was not 
significantly different between day 1, 4, and 7 of culture or between photoinitiator 
concentrations (Figure 4.11B; 0.5% w/v: day 1, 4, and 7 viability 91.1±1.1, 93.4±0.8, 
90.7±2.4; 0.75% w/v respectively; day 1, 4 viability 93.8±0.9, 92.5±1.6 respectively; 
1.0% w/v: day 1, 4 viability 92.4±1.2, 90.9±0.9 respectively).   
 
These results indicate that compared to VA086, Irgacure by weight has a more 
detrimental effect on cell viability for both primary valve cells and adipose derived stem 
cells. As time in culture increases, viability of HASSMC and HAVIC decreases. As time 
in culture increases the viability of HADMSC is generally maintained except at the 
highest Irgacure concentration where it also decreases.   
4.4.6 Metabolic Activity of Encapsulated Cells in 3D Culture  
MTT absorbance decreased with increasing time in culture for HASSMC and HADMSC 
in Irgacure hydrogels (Figure 4.8C,4.10C). In VA086 hydrogels, MTT absorbance 
decreased with increasing day in culture for HAVIC and HASSMC and increased with 
increasing time in culture for HADMSC.  MTT absorbance of HAVIC hydrogels was 
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significantly different between 0.75 and 1.0% w/v VA086 conditions at day 1 and day 3 
(Figure 4.7C; 0.75% w/v: day 1, 4, and 7 absorbance 0.180±0.012, 0.123±0.12, 
0.107±0.007 respectively; 1.0% w/v: day 1, 4 absorbance 0.220±0.015, 0.185±0.016, 
0.129±0.014 respectively). MTT absorbance of HASSMC Irgacure hydrogels decreased 
with increasing time in culture, and only at day 1 of culture was there a significant 
difference between photoinitiator concentrations (Figure 4.8C, 0.05% w/v: day 1, 3, and 
7 absorbance 0.335±0.014, 0.267±0.026, 0.150±0.009 respectively; 0.075% w/v: day 1, 
3, and 7 absorbance 0.273±0.006, 0.235±0.024, 0.150±0.009 respectively; 0.1% w/v: 
day 1, 3, and 7 absorbance 0.324±0.008, 0.202±0.009, 0.169±0.010 respectively). MTT 
absorbance of HASSMC VA086 hydrogels decreased with increasing time in culture 
(Figure 4.9C). At day 1 of culture photoinitiator condition 0.75% w/v had greater MTT 
abosrbance than 0.5 which was greater than 1.0% w/v conditions (0.5, 0.75, and 1.0% 
w/v:0.253±0.016, 0.339±0.009, 0.181±0.007 respectively), at day 4 of culture 
photoinitiator conditions 0.5% w/v and 0.75w/v% MTT absorbance were higher than 
1.0% w/v  condition  (0.5, 0.75, and 1.0% w/v:0.214±0.005, 0.216±0.005, 0.153±0.005 
respectively), and at day 7 of culture photoinitiator condition 0.75% w/v had a higher 
MTT absorbance than both 0.5% w/v and 1.0% w/v conditions (0.5, 0.75, and 1.0% 
w/v:0.133±0.007, 0.181±0.008, 0.128±0.006 respectively).  
 
MTT absorbance of HADMSC Irgacure samples decreased with increasing time in 
culture (Figure 4.10C). At day 1 of culture MTT absorbance decreased with increasing 
Irgacure concentration (0.05, 0.075, and 0.1% w/v:0.244±0.014, 0.224±0.012, 
0.170±0.006 respectively), at day 3 of culture absorbance was higher for the 0.05 
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condition than 0.075 and 0.1 conditions (0.05, 0.075, and 0.1% w/v:0.209±0.012, 
0.169±0.010, 0.184±0.005 respectively), and at day 7 in culture MTT absorbance 
decreases with increasing Irgacure concentration (0.05, 0.075, and 0.1% 
w/v:0.156±0.017, 0.142±0.007, 0.102±0.003 respectively). MTT absorbance of 
HADMSC VA086 samples increased with increasing time in culture (Figure 4.11C). At 
day 1 0.5% w/v condition, MTT absorbance was higher than 0.75 and 1.0 %  w/v 
conditions (0.5, 0.75, and 1.0% w/v:0.191±0.005, 0.174±0.003, 0.172±0.003 
respectively), at day 4 of culture MTT absorbance decreased with increasing VA086 
photoinitiator concentration (0.5, 0.75, and 1.0% w/v:0.308±0.011, 0.222±0.013, 
0.182±0.005 respectively), at day 7 of culture MTT absorbance decreased with 
increasing VA086 photoinitiator concentration (0.5, 0.75, and 1.0% w/v:0.245±0.011, 
0.232±0.010, 0.216±0.011 respectively).  
 
These results indicate that over the course of 7 days the metabolism of the cell laded 
hydrogel decreases in all but the HADMSC populated VA086 hydrogels. Hydrogel and 
cell erosion was observed for the low concentration VA086 hydrogels which could affect 
MTT results.  
4.4.7 Doubling Time Compared to 3D Survival 
Williams et al found that rapidly proliferating cells had higher sensitivity to photoinitiator 
toxicity (Williams, Malik et al. 2005)  and hypothesized that cell doubling time could be a 
predictor of survival during photo-encapsulation  in hydrogels.  To test if doubling time 
could predict/explain cell type survival in photo-crosslinked hydrogels, 2D proliferation 
was assessed.   In addition to the HAVIC, HASSMC, and HADMSC a 4th cell type was 
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included for the 2D doubling time test. Porcine Aortic Valve Interstitial Cells (PAVIC) are 
known in the lab for being robust in 2D culture and are often utilized as a model cell 
type due to the similarity between the porcine and human cardiovascular systems 
(Swindle, Makin et al. 2012). HAVIC 2D doubling time on tissue culture plastic was 
significantly slower than the PAVIC and HADMSC doubling time (Figure 4.12A) (HAVIC, 
HASSMC, HADMSC, PAVIC doubling times 65.5±6.4, 46.3±2.4 hrs, 37.7±4.2 hrs, and 
33.2±1.8 respectively).  HADMSC tolerated encapsulation and photo-crosslinking 
conditions the best and PAVIC tolerated the conditions the least (Figure 4.12B). Human 
valve cell viability fell between the two extremes and the percentage of cells alive in the 
hydrogels prepared with 0.05%% w/v and 0.1% w/v Irgacure and photo-crosslinked with 
the lamp for 5 minutes after 3 and 4 days culture was not significantly different between 
HAVIC and HASSMC or between the two Irgacure concentrations (HAVIC 0.05% w/v: 
65.8±2.6 %live; HAVIC 0.1% w/v: 58.8±3.3 %live; HASSMC 0.05% w/v: 61.3±1.6 %live; 
HASSMC 0.1% w/v: 67.2±1.1 %live).  HADMSC viability was significantly higher than all 
the other cell types and was sensitive to Irgacure concentration (HADMSC 0.05% w/v: 
89.7±1.9 %live; HADMSC 0.1% w/v: 78.9±1.1 %live).  PAVIC viability was significantly 
lower than all the other cell types and was also sensitive to Irgacure concentration 
(PAVIC 0.05% w/v: 46.0±9.7 %live; PAVIC 0.1% w/v: 38.9±4.2 %live).   The PAVIC 
sensitivity to encapsulation conditions was also observed in VA086 hydrogels (Figure 
4.12C). The percentage of PAVIC alive in the hydrogels prepared with 0.5% VA086 and 
photo-crosslinked with the lamp for 5 minutes after 3 and 4 days of culture was 
significantly less than it was for the other 3 cell types (PAVIC 0.5% w/v: 62.7±6.8 %live; 
HADMSC 0.5% w/v: 93.4±0.8 %live ; HAVIC 0.5% w/v: 92.7±0.9 %live, HASSMC 0.5% 
w/v: 94.8±0.3).  
3D viability did not appear to correlate with 2D doubling time for either Irgacure or 
VA086 hydrogels (Figure 4.12 D and E).  HADMSC and PAVIC have similar doubling 
time, but have the most pronounced survival differences in 3D.  
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(A) 2D doubling time of 4 different cell types. p<0.05 non-matching letters. (B) 
Live/dead viability of 4 different cell types encapsulated in Irgacure gels made with 
two photoinitiator concentrations cultured to day 3 and 4. p<0.05 non-matching 
letters. (C) Live/dead viability of 4 different cell types encapsulated in VA086 gels. 
Standard error of the mean was used. #p<0.05. (D) Viability verses 2D doubling time 
plot for 0.05% w/v Irgacure hydrogels. (E) Viability verses 2D doubling time plot for 
0.5% w/v VA086 hydrogels.  
 
Figure 4.12-28 Cell type 2D doubling time and 3D hydrogel viability. 
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4.4.8 Percentage of Encapsulated Cells Experiencing General Oxidative Stress 
(DCF) with and without Catalase Treatment 
Hydrogels prepared at the highest photoinitiator concentrations tested in this study, 
Irgacure 0.1% w/v and VA086 1.0% w/v,  had the most pronounced  differences in 
encapsulated cell viability  between cell-type (Figure 4.5).  DCF fluorescence indicates 
that general oxidative stress was induced in HADMSC, HAVIC, and HASSMC by these 
encapsulation conditions (Figure 4.13). In a given condition not all cells fluoresced 
green (positive for oxidative stress) and to the same degree and intensity (Figure 4.13 -
4.17). Figure 4.18 summarizes the percentage of cells with positive DCF fluorescence 
and the relative DCF fluorescence intensity of encapsulated cells. The graph y-axes of 
4.18A and 4.18C are percent of encapsulated cells that are DCF positive. Figure 4.18B 
and 4.18D graph y-axes are the relative fluorescence of DCF in encapsulated cells. 
Magnitude for B and D axes is different to include the range of the HLED/VA086 
condition. (The HLED/VA086 condition fluorescence signal is more intense due to the 
higher buoyancy of the hydrogels, which is explained in more detail in the HLED 
section). 
Lamp Tests  
For cells treated with HBSS control solution prior to encapsulation and then lamp photo-
crosslinking for 5 minutes there was no significant percentage difference of cells 
showing oxidative stress between cell types in each photoinitiator condition (Figure 
4.18A) (Irgacure 0.1% w/v: HADMSC 58.82±7.31, HAVIC 58.18±11.66, HASSMC 
72.38±6.68; VA086: HADMSC 41.59±12.28, HAVIC 39.46.18±10.86, HASSMC 
38.27±8.69 ).  Between photoinitiator types only HASSMC had a significantly different   
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(A) HAVIC  (B) HASSMC (C) HADMSC. Green is the DCF indicating oxidative stress 
and red is cell tracker red staining the cytoplasm.  
 
Figure 4.13-29 Representative images of encapsulated DCF/CTR labeled HBSS and 
catalase treated cells taken directly after crosslinking of hydrogel. 
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Figure 4.14-30 Representative images of HBSS and catalase treated cells labeled 
with DCF/DTR suspended in HBSS and benchtop incubated during 
encapsulation handling.   
(A) HAVIC  (B) HASSMC (C) HADMSC. Green is the DCF indicating oxidative stress 
and red is cell tracker red staining the cytoplasm.  
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Figure 4.15-31 Split channels of representative images of  encapsulated DCF/DTR 
labeled HAVIC  taken directly after crosslinking of hydrogel.  
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Figure 4.16-32  Split channels of representative images of encapsulated DCF/DTR 
labeled  HASSMC cells taken directly after crosslinking of hydrogel. 
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Figure 4.17-33 Split channels of representative images of encapsulated DCF/DTR 
labeled HADMSC cells taken directly after crosslinking of hydrogel. 
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Figure 4.18-34  Oxidative stress differences between cell type: HAVIC, HASSMC, 
and HADMSC treated with catalase or HBSS (control) before encapsulation and 
light exposure.  
 (A)  Percent of encapsulated cells that are DCF positive and experiencing general 
oxidative stress after photo-crosslinking with lamp. Non matching letters p<0.05   
testing between groups (effect of photoinitiator and treatment), *p<0.05 testing within 
groups (effect of cell type). (B) Relative fluorescence of general oxidative stress 
indicator in encapsulated HAVIC, HASSMC, and HADMSC samples crosslinked with 
lamp.  Non matching letters p<0.05 testing between groups (effect of photoinitiator 
and treatment), *p<0.05 testing within groups (effect of cell type). All error bars are 
standard error of the mean. (C)  Percent of encapsulated cells DCF positive after 
photo-crosslinking with high powered LED. Non matching letters p<0.05  testing 
between groups (effect of photoinitiator and treatment), *p<0.05 testing within groups 
(effect of cell type.(D) Relative fluorescence of general oxidative stress indicator in  
encapsulated HAVIC, HASSMC, and HADMSC samples crosslinked with high power 
LED.  Non matching letters p<0.05 testing between groups (effect of photoinitiator 
and treatment), *p<0.05 testing within groups (effect of cell type).  
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percentage of cells showing oxidative stress between Irgacure and VA086 hydrogels, 
and Irgacure induced a higher percentage (Figure 4.18A) (Irgacure 0.1% w/v: 
72.38±6.68; VA086: HASSMC 38.27±8.69).  Catalase decreased the percentage of 
cells displaying an oxidative stress response in all 3 cell types. For cells treated with 
catalase solution prior to encapsulation and then lamp photo-crosslinking for 5 minutes 
there was no significant percentage difference of cells showing oxidative stress between 
cell types in each photoinitiator condition (Irgacure 0.1% w/v: HADMSC 3.80±1.80,  
HAVIC 0.82±0.82, HASSMC 7.18±3.45; VA086: HADMSC 0.0±0.0, HAVIC 3.24±2.50, 
HASSMC 0.78±0.78).  Between photoinitiator types only catalase treated HADMSC had 
a significantly different percentage of cells showing oxidative stress between Irgacure 
and VA086 hydrogels, and Irgacure induced a higher percentage (Irgacure 0.1% w/v: 
34.10±10.88, VA086 0.5% w/v: 0.0±0.0).  
 
HLED Test  
Additionally, the effect of increasing the photo-crosslinking light intensity was tested.   
Within cell type, the percent of cells experiencing oxidative stress induced by the high 
power LED array compared to the lamp was not significantly different (Figure 4.19, 
Figure  4.20, and Figure  4.21 showing lamp and LED comparisons). For cells treated 
with HBSS control solution prior to encapsulation and then HLED array photo-
crosslinking for 5 minutes there was a significant percentage difference of cells showing 
oxidative stress between cell types in each photoinitiator condition (Figure 4.18C). In 
0.1% Irgacure hydrogels HASSMC had a higher percentage of cells experiencing 
oxidative stress than both HAVIC and HADMSC (HADMSC 51.79±6.93, HAVIC 
53.76±5.82, HASSMC 79.86±6.68) and in 1.0% VA086 hydrogels HAVIC had a higher 
percentage of cells experiencing oxidative stress than HASSMC (HADMSC 29.27±4.82, 
HAVIC 50.98±9.45, HASSMC 25.47±6.27).  Between photoinitiator types the 
percentage of HASSMC and HADMSC displaying oxidative stress was higher in  
 160 
 
Percent of HADMSC experiencing general oxidative stress after photo-crosslinking. 
Non matching letters p<0.05 testing between groups (effect of photoinitiator and 
treatment, *p<0.05 testing within groups (effect of light source). No significant 
difference within groups (no effect of light source). (B)  Relative fluorescence of 
general oxidative stress indicator in encapsulated HADMSC samples.  Non matching 
letters p<0.05 testing between groups (effect of photoinitiator and treatment), *p<0.05 
testing within groups (effect of light source). (C) Percent live treated and 
encapsulated HADMSC after 3 days culture. Non matching letters and #p<0.05  
testing between groups (effect of photoinitiator and treatment ), *p<0.05 testing within 
groups (effect of light source ). (D) Circularity of HADMSC after 3 days culture. 
#p<0.05 testing between groups (effect of photoinitiator and treatment), *p<0.05 
testing within groups (effect of light source). All error bars are standard error of the 
mean.  
 
Figure 4.19-35 Oxidative stress and effect of catalase loading for HADMSC as a 
function of light source intensity.  
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Figure 4.20-36 (A) Viability and circularity of HBSS treated control cells verses 
encapsulating hydrogel modulus.   
Percent Live/Dead at day 3 verses modulus (calculated between 5 and 15% strain). 
Each cell type and data from both photoinitiators linear fit (red HAVIC line, green 
HASSMC line, blue HADMSC line). All cell types and data from both photoinitiator 
linear fit (black line).  
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Figure 4.20-37 (B) Viability and circularity of HBSS treated control cells verses 
encapsulating hydrogel modulus.   
Circularity of live cells at day 3 verses modulus Each cell type and data from both 
photoinitiators linear fit (red HAVIC line, green HASSMC line, blue HADMSC line). All 
cell types and data from both photoinitiator linear fit  (black line). 
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Figure 4.21-38(A) Viability and morphology verses percentage of cells 
experiencing oxidative stress for catalase treated and HBSS controls cells in 
Irgacure and VA086 encapsulation conditions. 
Percent Live/Dead at day 3 verses percent of cells positively stained oxidative stress 
after crosslinking of treated cells.  
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Figure 4.21-39 (B) Viability and morphology verses percentage of cells 
experiencing oxidative stress  for catalase treated and HBSS controls cells in 
Irgacure and VA086 encapsulation conditions. 
Circularity of live cells at day 3 verses percent of cells positively stained for oxidative 
stress verses. Each cell type and data from both photoinitiators and light sources 
linear fit (red HAVIC line, green HASSMC line, blue HADMSC line). All cell types and 
data from both photoinitiator types and light sources linear fit (black line). 
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Irgacure compared to VA086 hydrogels, but there was no significant difference for 
HAVIC.  Catalase decreased the percentage of cells displaying an oxidative stress 
response in all 3 cell types (Irgacure 0.1% w/v: HADMSC 8.46±1.94, HAVIC 2.06±1.41, 
HASSMC 3.90±0.93; VA086 1.0% w/v: HADMSC 0.0±0.0, HAVIC 1.14±1.14, HASSMC 
2.50±2.50). For cells treated with catalase solution prior to encapsulation and then 
HLED array photo-crosslinking for 5 minutes between cell types in each photoinitiator 
condition only HADMSC when compared to HAVIC in Irgacure hydrogel had a 
significantly higher percentage of cells showing oxidative stress.  Between photoinitiator 
types none of the catalase treated cell types had a significantly different percentage of 
cells showing oxidative stress between Irgacure and VA086 hydrogels.  
 
These results indicate that catalase treatment prior to encapsulation dramatically 
decreases the number of cells experiencing intracellular general oxidative stress. The 
percentage of cells positive for oxidative stress is higher for Irgacure 0.1% w/v 
conditions compared to VA086 1.0% w/v conditions between photoinitiator types for 
HASSMC at the lower light intensity and for HASSMC and HADMSC at the greater light 
intensity. Between cell types, percentage of cells experiencing oxidative stress are 
evident at the higher light intensity, where HASSMC experience more oxidative stress 
compared to HAVIC and HADMSC in Irgacure hydrogels and HAVIC experience more 
oxidative stress compared to HASSMC and HADMSC in VA086 hydrogels.   
 
4.4.9 Relative Fluorescence of Hydrogels Loaded with DCF Tagged Cells  
The plate reader was used to get a quantitative measurement of the relative 
fluorescence of an entire encapsulated cell-hydrogel disk. Relative fluorescence was 
measured directly after photo-crosslinking.   From the confocal images it is possible to 
see that in a given condition not all cells fluoresced green (positive for oxidative stress) 
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and to the same degree and intensity (Figure 4.13 and Figure 4.14). The plate reader 
area scan of the entire gel was performed to quantitatively capture the intensity 
differences of the positively stained cells.  
Lamp Tests 
For cells treated with HBSS control solution prior to encapsulation and then lamp photo-
crosslinking for 5 minutes there were significant differences in oxidative stress 
fluorescence (DCF)  between cell types in each photoinitiator condition (Figure 4.18B). 
HADMSC hydrogels were significantly less fluorescent than HAVIC and HASSMC 
(Irgacure 0.1% w/v: HADMSC 38.96±2.39, HAVIC 73.85±7.24, HASSMC 135.88±14.79; 
VA086 1.0% w/v: HADMSC 52.90±2.08, HAVIC 91.40±7.09, HASSMC 86.29±2.67).  
Between photoinitiator types HAVIC and HADMSC hydrogels had significantly different 
oxidative stress fluorescence between Irgacure and VA086 hydrogels. HAVIC VA086 
hydrogels had higher fluorescence than Irgacure hydrogels, and HADMSC VA086 
hydrogels had higher fluorescence than Irgacure hydrogels. Catalase decreased the 
relative fluorescence oxidative stress response in all 3 cell types. For cells treated with 
catalase solution prior to encapsulation and then lamp photo-crosslinking for 5 minutes 
there were significant differences of relative fluorescence between cell types in each 
photoinitiator condition (Irgacure 0.1% w/v: HADMSC 17.92±1.03, HAVIC 12.75±0.39, 
HASSMC 14.65±0.16; VA086 1.0% w/v: HADMSC 17.27±0.27, HAVIC 15.50±0.19, 
HASSMC 16.42±0.66). Interestingly, in the catalase condition the HADMSC hydrogels 
have higher relative fluorescence than the valve cells.  Between photoinitiator types 
there was no significant difference in relative fluorescence oxidative stress between 
Irgacure and VA086 hydrogels. 
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HLED  Tests  
In general increasing the photo-crosslinking light intensity increased the relative 
fluorescence of cell-hydrogels in VA086 conditions and not Irgacure conditions.   There 
was not a significant difference in Irgacure hydrogel fluorescence between the high 
power LED array compared to the lamp, with the sole exception of catalase treated 
HASSMC (Figure  4.22B). The relative fluorescence measurement induced by the high 
power LED array compared to the lamp was significantly higher in all VA086 conditions 
Figure 4.18D, Figure 4.19B, Figure  4.22B and Figure  4.23B, showing lamp and HLED 
comparisons) (HLED VA086 1.0% w/v: HADMSC 375.90±80.21, HAVIC 
495.42±113.35, HASSMC 1007.81±182.18). However, the relative fluorescence signal 
for the VA086 cell-hydrogels may be artificially high.  The VA086 photoinitiator foams 
the hydrogel during photo-crosslinking, and it is dramatic/pronounced in the HLED array 
crosslinked hydrogels. The oxidative stress measurements were taken quickly after 
photo-crosslinking (within 1 hour with the peeling, media rinse, and transfer of disks into 
HBSS filled black-bottom well plates steps), and the gels likely did not have sufficient 
time to equilibrate with the surrounding solution. The HLED/VA086 cell-hydrogel disks 
were noticeably more buoyant than the other conditions in the well plates. The read 
height setting on the multi-plate reader is the same for all the wells, and the top-read 
scan would place the floating gels closer to the excitation light source and the detector 
(Figure  4.24A).  Therefore the relative fluorescence measurements of the VA086/HLED 
conditions should not be compared to the VA086/Lamp, Irgacure/Lamp, and 
Irgacure/HLED conditions.  Treatments and cell type within the VA086/HLED condition 
can be compared for this experiment.  For cells treated with HBSS control solution prior 
to encapsulation and then HLED array photo-crosslinking for 5 minutes there were  
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(A) Percent of HASSMC experiencing general oxidative stress after photo-
crosslinking. Non matching letters p<0.05 testing between groups (effect of 
photoinitiator and treatment, *p<0.05 testing within groups (effect of light source). No 
significant difference within groups (no effect of light source). (B)  Relative 
fluorescence of general oxidative stress indicator in encapsulated HASSMC samples.  
Non matching letters p<0.05 testing between groups (effect of photoinitiator and 
treatment), *p<0.05 testing within groups (effect of light source). (C) Percent live   
treated and encapsulated HASSMC after 3 days culture. Non matching letters and # 
p<0.05 testing between groups (effect of photoinitiator and treatment), *p<0.05 
testing within groups (effect of light source). (D) Circularity of HASSMC after 3 days 
culture. #p<0.05 testing between groups (effect of photoinitiator and treatment), 
*p<0.05 testing within groups (effect of light source). All error bars are standard error 
of the mean.  
 
Figure 4.22-40 Oxidative stress and effect of catalase loading for HASSMC as a 
function of light source intensity. 
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Figure 4.23-41 Oxidative stress and effect of catalase loading for HAVIC as a 
function of light source intensity. 
(A)  Percent of HAVIC experiencing general oxidative stress after photo-crosslinking. 
Non matching letters p<0.05 testing between groups (effect of photoinitiator and 
treatment), *p<0.05 testing within groups (effect of light source). No significant 
difference within groups (no effect of light source). (B)  Relative fluorescence of 
general oxidative stress indicator in encapsulated HAVIC samples.  Non matching 
letters p<0.05 testing between groups (effect of photoinitiator and treatment), *p<0.05 
testing within groups (effect of light source). (C) Percent live treated and 
encapsulated HAVIC after 3 days culture. Non matching letters   and #p<0.05  testing 
between groups (effect of photoinitiator and treatment), *p<0.05 testing within groups 
(effect of light source). (D) Circularity of HAVIC after 3 days culture. # p<0.05  testing 
between groups (effect of photoinitiator and treatment), *p<0.05 testing within groups 
(effect of light source). All error bars are standard error of the mean.  
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Figure 4.24-42 Linear fit of percent of encapsulated cells experiencing general 
oxidative stress verses relative fluorescence of general oxidative stress 
indicator in encapsulated cell-hydrogels. 
(A) Diagram of how foaming in VA086 hydrogels crosslinked with HLED array would 
cause higher signal in the multi-well plate reader set on top read. (B) Linear fit of 
percentage of cells displaying oxidative stress in confocal images verses relative 
fluorescence of cell-hydrogel disks for all 24 conditions. 3 cell types, 2 light sources, 
2 cell treatments (HBSS and Catalase), 2 photoinitiator conditions. All error bars are 
standard error of the mean. (C) Excluding HLED/VA086 data and refit percentage of 
cells displaying oxidative stress in confocal images verses relative fluorescence of 
cell-hydrogel disk. 
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significant differences in oxidative stress fluorescence (DCF) between cell types in each 
photoinitiator condition (Figure 4.18D) (Irgacure 0.1% w/v: HADMSC 40.24±2.45,  
HAVIC 78.00±9.05, HASSMC 135.88±14.79; VA086 1.0% w/v: HADMSC 
375.90±80.21, HAVIC 495.42±113.35, HASSMC 1007.81±182.18). HADMSC hydrogels 
were less fluorescent than HAVIC and HASSMC, and HASSMC hydrogels were more 
fluorescent than HAVIC.   Catalase decreased the relative fluorescence oxidative stress 
(response in all 3 cell types (Irgacure 0.1% w/v: HADMSC 40.24±2.45, HAVIC 
78.00±9.05, HASSMC 135.88±14.79; VA086 1.0% w/v: HADMSC 375.90±80.21, 
HAVIC 495.42±113.35, HASSMC 1007.81±182.18). For cells treated with catalase 
solution prior to encapsulation and then HLED array photo-crosslinking for 5 minutes 
there were significant differences of relative fluorescence between cell types in the 
Irgacure condition (Figure 4.18D). In the Irgacure catalase condition the HAVIC 
hydrogels have lower relative fluorescence than the HASSMC and the HADMSC.   
 
When percent of encapsulated cells experiencing general oxidative stress were plotted 
against relative fluorescence of general oxidative stress indicator in encapsulated cell-
hydrogels for all cell types and conditions there was very little correlation R2=0.0097 
(Figure  4.24B). However, when the HLED VA086 condition was excluded the 
percentage of cells experiencing general oxidative stress and the intensity of the 
oxidative stress correlate, R2=0.7581.   
 
These results indicate that there are differences in oxidative stress between cell type, 
and in general oxidative stress is greater in HASSMC and HAVIC compared to 
HADMSC in 3D hydrogel photo-crosslinking conditions. These results indicate the 
VA086 1.0% w/v condition induces a higher degrees of oxidative stress in HAVIC and 
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HADMSC than the Irgacure 0.1% w/v condition (2 mW/cm2 crosslinking).  These results 
indicate that catalase treatment prior to encapsulation dramatically decreases 
intracellular general oxidative stress.  
4.4.10 Cell Suspension Relative DCF Fluorescence After Bench Top Incubation 
HAVIC, HASSMC, and HADMSC experience oxidative stress after the handling steps 
prior to encapsulation and bench top incubation (Figure  4.25). Cells tagged with DCF 
dye and cell tracker dye that were subjected to HBSS and catalase treatment and all the 
same handling and spin down steps as encapsulated cells but were not encapsulated 
experienced oxidative stress detectable by both confocal microscopy (Figure 4.14, 
Figure  4.25A) and the plate reader (Figure  4.25B).  The percentage of cells stained 
positive for oxidative stress in these suspension controls was not significantly different 
between cell types (HAVIC 78.8±2.8, HASSMC 73.2±4.2, HADMSC 84.9±4.8). Catalase 
decreased the percentage of cells fluorescing positive for oxidative stress more in the 
HAVIC and HASSMC than in the HADMSC (HAVIC 13.4±4.2, HASSMC 17.1±4.1, 
HADMSC 68.9±9.8).  DCF relative fluorescence was significantly different between cell 
types for the HBSS conditions. Fluorescence intensity was highest in HASSMC 
(104.1±19.1), then the HAVIC (71.9±8.0), and then the HADMSC (38.1±7.1). Treatment 
with catalase reduced the fluorescence to the same intensity as the no cell hydrogel and 
HBSS controls (HAVIC 6.91±0.28, HASSMC 10.4±0.5, HADMSC 14.1±3.4, No cell 
hydrogel 9.35±0.34, HBSS 10.4±1.4)  
4.4.11 Effect of Catalase Treatment on Cell Viability and Morphology 
Catalase treatment did not improve 3 day encapsulated cell viability. 
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(A)  Percent of encapsulated cells experiencing general oxidative stress  after HBSS 
and catalase treatment and bench top incubation. Non matching letters p<0.05  
(effect of cell type and treatment ). (B) Relative fluorescence of general oxidative 
stress indicator in cells experiencing general oxidative stress after HBSS and 
catalase treatment and bench top incubation and no cell controls.  Non matching 
letters p<0.05 (effect of cell type and treatment ). All error bars are standard error of 
the mean. 
Figure 4.25-43  General oxidative stress cell suspension controls for HAVIC, 
HASSMC, HADMSC. 
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Lamp Tests  
Catalase treatment had a detrimental effect on HASSMC 3 day encapsulated viability, a 
beneficial effect on HAVIC in VA086 hydrogels, and a detrimental effect on HADMSC in 
Irgacure hydrogels (Figure  4.26 and  4.27A).  Cells treated with HBSS control solution 
compared to catalase treated cells prior to encapsulation and then lamp photo-
crosslinking for 5 minutes had a significantly  higher percentage of live cells for 
HASSMC in both photoinitiator conditions  (Irgacure: 60.7±1.8 compared to 
41.3±3.0%live, VA086: 74.4±2.9 compared to 43.7±1.4 %live). Catalase treatment of 
HAVIC did not significantly affect encapsulated viability in Irgacure gels crosslinked with 
the lamp (NS, Irgacure: 34.2±5.9 for HBSS compared to 49.2±2.4 %live for catalase 
treated). Catalase treatment of HAVIC improved encapsulated viability in VA086 gels 
crosslinked with lamp (VA086: 23.4±3.5 for HBSS compared to 46.1±1.8 %live for 
catalase treated). Catalase treatment did not affect HADMSC viability in VA086 
hydrogels and it was detrimental in Irgacure hydrogels crosslinked with the lamp light 
source (Irgacure: 92.8±1.7 compared to 62.0±2.5 %live, VA086: 83.6±4.8 compared to 
93.7±0.9 %live). In all HBSS conditions HADMSC and HASSMC viability is greater than 
HAVIC viability, but with catalase treatment HAVIC viability is greater than HASSMC.  
  
Circularity increased and morphology became less spread for HASSMC in both Irgacure 
and VA086 hydrogels with catalase treatment (Figure  4.27B; Irgacure: HBSS 
0.559±0.018 compared to catalase treated 0.661±0.009; VA086: 0.554±0.033 
compared to 0.742±0.011). HAVIC circularity remained the same in Irgacure hydrogels 
and increased in VA086 hydrogels with the application of catalase treatment (Irgacure: 
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Figure 4.26-44 Representative images of Day 3 encapsulated,  HBSS and catalase 
treated cells stained with Live/Dead. 
(A) HAVIC,  (B) HASSMC(C) HADMSC. 
 
 (A) HAVIC (B) HASSMC ( )  
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Figure 4.27- 45  Effect of catalase loading on cell viability and circularity.   
Differences between cell type. HAVIC, HASSMC, and HADMSC treated with 
catalase or HBSS (control) before encapsulation and light exposure. (A) Percentage 
of live of cells encapsulated in hydrogel discs and cultured for 3 day after photo-
crosslinking with lamp (B) Circularity of live of cells encapsulated in hydrogel discs 
and cultured for 3 days after photo-crosslinking with lamp. (C) Percentage of live 
cells encapsulated in hydrogel discs and cultured for 3 day after photo-crosslinking 
with high powered LED. (D) Circularity of live of cells encapsulated in hydrogel discs 
and cultured for 3 days after photo-crosslinking with high powered LED. Non 
matching letters and #p<0.05 testing between groups (effect of photoinitiator and 
treatment), *p<0.05 testing within groups (effect of cell type). 
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HBSS 0.686±0.013 compared to catalase treated 0.650±0.020; VA086: 0.787±0.17 
compared to 0.699±0.019).   HADMSC circularity remained the same in Irgacure and 
VA086 hydrogels with the application of catalase treatment (not significantly different; 
Irgacure: HBSS 0.609±0.042 compared to catalase treated 0.574±0.037; VA086: 
0.532±0.010 compared to 0.568±0.030).  
  
HLED Tests  
For cells treated with HBSS control solution prior to encapsulation and then HLED array 
photo-crosslinking for 5 minutes there were significant differences in live/dead viability 
between cell types in each photoinitiator condition. HADMSC hydrogels had higher 
viability compared to HAVIC and HASSMC (Figure  4.27C) and generally followed the 
trend HADMSC > HASSMC > HAVIC.   For cells treated with catalase solution prior to 
encapsulation and then HLED array photo-crosslinking for 5 minutes there were 
significant differences in each photoinitiator condition (Figure  4.27C). In hydrogels 
prepared with Irgacure catalase treatment decreased HASSMC and HADMSC viability 
in Irgacure hydrogels and did not affect HAVIC viability (HASSMC: in HBSS 44.8±5.7 
compared to catalase 24.4±3.8 percent live; HADMSC: in HBSS 85.2±1.4 compared to 
catalase 59.2±2.5 percent live; and HAVIC: in HBSS 38.5±3.9 compared to catalase 
41.3±3.0 percent live).  In hydrogels prepared with VA086, catalase treatment 
decreased HASSMC viability, but did not affect HADMSC or HAVIC viability (HASSMC: 
in HBSS 45.1±4.6 compared to catalase 25.0±12.8 %live; HADMSC: in HBSS 76.5±6.1 
compared to catalase 80.0±4.9 %live; and HAVIC: in HBSS 7.44±1.2 compared to 
catalase 15.8±1.3 %live). 
 
Circularity remained the same with catalase treatment for encapsulated HASSMC in 
both Irgacure and VA086 hydrogels crosslinked with HLED array (Figure 4.27D, 
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Irgacure: HBSS 0.697±0.032 compared to catalase treated 0.728±0.015; VA086:  HBSS 
0.759±0.021 compared to catalase treated 0.751±0.028). HAVIC circularity remained 
the same in Irgacure hydrogels and VA086 hydrogels with the application of catalase 
treatment (Irgacure: HBSS 0.657±0.063 compared to catalase treated 0.779±0.029; 
VA086:  HBSS 0.759±0.021 compared to catalase treated 0.751±0.029). HADMSC 
circularity decreased in Irgacure hydrogels with the application of catalase treatment 
and circularity remained the same in VA086 hydrogels with the application of catalase 
treatment (Irgacure: HBSS 0.767±0.013 compared to catalase treated 0.678±0.013; 
VA086:  HBSS 0.726±0.014 compared to catalase treated 0.735±0.008). 
4.4.12 Light Source Intensity Comparisons 
Increasing the light source intensity from 2 mW/cm2 to 136mW/cm2 has a detrimental 
effect on encapsulated cell viability in VA086 hydrogels for HAVIC, HASSMC, and 
HADMSC (Figure 4.19C, Figure 4.22C, and Figure  4.23C show the pair comparisons).  
The reduction in viability for 1.0% w/v VA086 hydrogels crosslinked with 2 mW/cm2 and 
136mW/cm2 was HAVIC: 23.4±3.4 to 7.43±1.2, HASSMC: 74.4±2.9, to 45.1±4.6 
HADMSC: 83.5±4.8 to 76.5±6.1 percent viability, which corresponded to a mechanical 
bump of19.3±2.8, 45.6±5.2 kPa. 
 
The light source intensity does not significantly affect encapsulated HAVIC or HADMSC 
viability in Irgacure hydrogels (Figure 4.19C and Figure  4.23C). However, increasing 
light source intensity has a detrimental effect on encapsulated HASSMC viability in 
Irgacure hydrogels (Figure  4.22C). The percent viability for 0.1% w/v Irgacure 
hydrogels crosslinked with 2 mW/cm2 to 136mW/cm2 was HAVIC: 49.2±2.4 to 41.3±3.0 
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NSD, HASSMC: 62.0±1.8, to 44.8±5.7, HADMSC: 92.7±1.7 to 85.2±1.4 NSD 
corresponded to a mechanical bump of 40.9±4.1, 120.7±10.2 kPa. 
 
Increasing light source intensity increases encapsulated HADMSC circularity in VA086 
and Irgacure hydrogels (Figure 4.19D, shows the pair comparisons). The effect of light 
source intensity on encapsulated HAVIC and HASSMC follows a less regular pattern 
(Figure  4.23D and Figure 4.22D). In Irgacure hydrogels, increasing light source 
intensity increases both HAVIC and HASSMC circularity, but not significantly in the 
HASSMC catalase treated condition. In VA086 hydrogels, increasing light source 
intensity decreases the HAVIC circularity in the HBSS condition but decreases the 
HAVIC circularity in the catalase treated condition.  In VA086 hydrogels increasing light 
source intensity decreases the HASSMC circularity in the HBSS condition, but the 
circularity in the catalase treated condition remained the same (Figure  4.22D). 
4.4.13 Effect of Handling Buffer and Incubation on Encapsulated Cell Viability 
There were differences in viability that resulted from using the oxidative stress assay 
encapsulation protocol compared to the standard encapsulation protocol (HBSS verses 
PBS) (Figure 4.28 compares HBSS data to Figure 4.5 PBS data). HBSS was used 
instead of PBS for the oxidative stress experiments for the handling buffer and a 20 
minute incubation time with the DCF and cell tracker working solution. The addition into 
the encapsulation protocol of a 20 minute incubation in HBSS significantly decreases 
HAVIC viability in Irgacure and VA086 hydrogels (Figure 4.28A; Irgacure: PBS 58.8±3.4 
vs HBSS 34.2±5.9; VA086: PBS 86.0±3.2 vs HBSS 23.4±3.5). The addition of the 20 
minute incubation in HBSS it is not detrimental to the HADMSC (Figure 4.28C, Irgacure:  
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Percentage of live (A) HAVIC (B), HASSMC(C) HADMSC. Handled in either PBS or 
HBSS and then encapsulated in hydrogel discs and cultured for 3 day after photo-
crosslinking with lamp for 5minutes. Non-matching letters and # p<0.05 testing 
between groups (effect of photoinitiator and handling buffer) . Note: Handling time for 
HBSS was longer as there was a 20 minute incubation for the oxidative stress 
experiments.  
 
Figure 4.28-46  Handling buffer and extended incubation effect on 3 day viability.   
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PBS 78.9±1.1 vs HBSS 92.8±1.7; VA086: PBS 90.8±0.9 vs HBSS 83.5±4.8), and it 
affects HASSMC only in Irgacure hydrogels (Figure 4.28B Irgacure: PBS 78.9±1.1 vs 
HBSS 92.8±1.7; VA086: PBS 90.8±0.9 vs HBSS 83.5±4.8).  
4.4.14 Linear Regression Analysis of Viability, Circularity, Oxidative Stress, 
Modulus 
The viability of HBSS treated encapsulated cells was plotted against E5to15  and a linear 
fit applied to data from each cell type and then to the entire data set (Figure  4.20A). For 
HAVIC, HASSMC, and HADMSC data the linear fit R2 values were 0.278, 0.520, and 
0.002 respectively. For the combined data set the linear fit R2 value was 0.0008.   
HASSMC viability shows decrease with increasing hydrogel stiffness, but for HADMSC 
we find no relationship between the viability and the hydrogel stiffness. Independent of 
cell type, we find no relationship between viability and hydrogel stiffness.   
 
The circularity of HBSS treated encapsulated cells was plotted against E5to15 and a 
linear fit applied to data from each cell type and then to the entire data set (Figure 
4.20B). For HAVIC, HASSMC, and HADMSC data the linear fit R2 values were 0.001, 
0.255, and 0.672 respectively. For the combined data set the linear fit R2 value was 
0.226.   Cells become more round with increasing hydrogel stiffness, but in the 
conditions tested this appears not to be true for HAVIC. Low HAVIC viability may be 
affecting this measurement.  
 
The viability of HBSS and catalase treated encapsulated cells was plotted against 
percent cells positive for oxidative stress and a linear fit applied to data from each cell 
type and then to the entire data set (Figure  4.21A). For HAVIC, HASSMC, and 
HADMSC data, the linear fit R2 values were 0.142, 0.319, and 0.207 respectively. For 
the combined data set the linear fit R2 value was 0.009.   Weak relationships show 
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HADMSC and HASSMC viability increase with increasing percentage of cells 
experiencing oxidative stress. Also, HAVIC viability decreases with increasing oxidative 
stress (weakly). However, independent of cell type the linear regression shows there is 
no relationship between the percentage of live cells verses percentage of cells 
experiencing oxidative stress. 
 
The circularity of HBSS and catalase treated encapsulated cells was plotted against 
percent cells positive for oxidative stress and a linear fit applied to data from each cell 
type and then to the entire data set (Figure  4.21B). For HAVIC, HASSMC, and 
HADMSC data the linear fit R2 values were 0.028, 0.321, and 0.006 respectively. For 
the combined data set the linear fit R2 value was 0.046.  HASSMC circularity appears to 
decrease with increasing oxidative stress. Independent of cell type the linear regression 
shows there is not a relationship between circularity and percentage of cells positive for 
oxidative stress.  
 
The percentage of HBSS treated and encapsulated cells positive for oxidative stress 
was plotted against E5to15 and a linear fit applied to data from each cell type and then to 
the entire data set (Figure 4.29). For HAVIC, HASSMC, and HADMSC data the linear fit 
R2 values were 0.218, 0.424, and 0.092 respectively. For the combined data set the 
linear fit R2 value was 0.211.  
 Percentage of cells experiencing oxidative stress correlates weakly with E5to15 
independent of cell type and the percentage of cells experiencing oxidative stress 
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Figure 4.29-47 Percentage of cells stained positive for oxidative stress verses 
modulus for HBSS control cells in Irgacure and VA086 encapsulation 
conditions. 
 Percent of cells positively stained for oxidative stress after crosslinking of treated 
cells. Each cell type and data from both photoinitiators and light sources linear fit (red 
HAVIC line, green HASSMC line, blue HADMSC line) All cell types and data from 
both photoinitiator types and light sources linear fit  (black line). 
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increases with hydrogel stiffness. Percentage of cells experiencing oxidative stress 
correlates more strongly with E5to15 for HASSMC than for HAVIC and HADMSC. 
 
Percentage of live cells at day 3 in culture that had been treated with HBSS and 
catalase and encapsulated was plotted against oxidative stress relative fluorescence 
and a linear fit applied to data from each cell type and then to the entire data set (Figure 
4.30A). The HLED/VA086 condition was excluded for this plot.  For HAVIC, HASSMC, 
and HADMSC data the linear fit R2 values were 0.7423, 0.2923, and 0.2179 
respectively. For the combined data set the linear fit R2 value was 0.0102.  Reduction of 
oxidative stress does not improve the viability of HADMSC and HASSMC, in fact for 
those cell types percentage of live cells appears to increase as oxidative stress ratio 
increases for individual cell types. HAVIC viability decreases as oxidative stress 
increases. Independent of cell type, percentage of live cells is not related to oxidative 
stress intensity when both HBSS and catalase treatments are considered.  
 
When just the HBSS treated cells are considered, and percentage of live cells at day 3 
in culture was plotted against oxidative stress relative fluorescence and a linear fit 
applied to data from each cell type and then to the entire data set (Figure 4.30B), there 
is a stronger correlation between cell viability and oxidative stress.  The HLED/VA086 
condition was excluded for this plot.  For HAVIC, HASSMC, and HADMSC data the 
linear fit R2 values were 0.7605, 0.9048, and 0.4943 respectively. For the combined 
data set the linear fit R2 value was 0.4049.   
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Live/dead viability verses oxidative stress relative fluorescence for HBSS and 
catalase treated cells conditions. Each cell type treated with HBSS and catalase data 
from 3 encapsulation conditions (lamp Irgacure and VA086, and HLED Irgacure) 
linear fit (red HAVIC line, green HASSMC line, blue HADMSC line). Data from all 
HBBS and catalase treated cells in 3 conditions linear fit (black line). 
 
Figure 4.30-48 (A) Viability verses relative fluorescence excluding VA086/HLED 
condition. 
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Figure 4.30-49 (B) Viability verses relative fluorescence excluding VA086/HLED 
condition. 
Live/dead viability verses relative fluorescence of HBSS and catalase treated cells. in 
encapsulation conditions. Each cell type treated with HBSS and data from both 
photoinitiator conditions and light source conditions linear fit (red HAVIC line, green 
HASSMC line, blue HADMSC line). Data from all HBBS treated cells in 4 conditions 
linear fit (black line). 
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For the HBSS conditions HAVIC, HASSMC, and HADMSC viability decreases as 
oxidative stress relative fluorescence increases for all three cell types and independent 
of cell type.  
 
Oxidative stress ratio was plotted to normalize the artificially high HLED/VA086 relative 
DCF fluorescence values. The oxidative stress ratio was the ratio of the HBSS control 
DCF fluorescence average divided by the catalase treated DCF fluorescence average 
for a given photo-crosslinking condition and cell type. The incorporation of the 
HLED/VA086 data using the oxidative stress ratio produces fits that generally follow the 
same trends seen with the relative fluorescence data of the other three conditions. 
Oxidative stress ratio was calculated for 3D conditions and bench top incubation cell 
suspensions (Figure 4.31A). Oxidative stress ratio is higher for nearly all HAVIC and 
HASSMC conditions than for HADMSC (HLED/IRG, HLED/VA086, Lamp/IRG, 
Lamp/VA086, and Bench top for HAVIC:6.40, 5.79, 7.21, 5.9,10.41; HASSMC:8.37, 
6.49, 12.97,5.25,10.01; HADMSC:2.17,2.17,4.98,3.06,2.70 respectively).   
 
Percentage of live cells that had been treated with HBSS and encapsulated at day 3 
was plotted against oxidative stress ratio and a linear fit applied to data from each cell 
type and then to the entire data set (Figure 4.31B). For HAVIC, HASSMC, and 
HADMSC data the linear fit R2 values were 0.490, 0.651, and 0.775 respectively. For 
the combined data set the linear fit R2 value was 0.355. For the combined data set a 
natural log fit was better than a linear fit, and the R2 value was 0.504.    The percentage 
of live cells decreases as oxidative stress ratio increases for individual cell types and 
independent of cell type.  
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Figure 4.31-50  (A) Oxidative stress ratio for HBSS treated cells. 
 Oxidative stress ratio for HBSS treated cells for 4 encapsulation conditions and the 
bench top incubated cell suspension.  
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Figure 4.31-52  (B) Viability verses oxidative stress ratio for HBSS treated cells. 
 Live/dead viability verses relative fluorescence of HBSS and catalase treated cells. In 
encapsulation conditions. Each cell type treated with HBSS and data from both 
photoinitiator conditions and light source conditions linear fit (red HAVIC line, 
green1HASSMC line, blue HADMSC line). Data from all HBBS treated cells in 4 
conditions linear fit (black line). 
 
i r  . .51 (B) Viability verses oxidative stress ratio for HBSS treated cells. 
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The percentage of HBSS treated and encapsulated cells positive for oxidative stress 
was plotted against E5to15 (excluding the VA086 HLED condition) and a linear fit applied 
to data from each cell type and then to the entire data set (Figure 4.32A). For HAVIC, 
HASSMC, and HADMSC data the linear fit R2 values were 0.229, 0.999, and 0.361 
respectively. For the combined data set the linear fit R2 value was 0.027.  Relative 
fluorescence correlates with modulus to some degree for each cell type; but, the relative 
fluorescence decreases with increasing stiffness for HAVIC and HADMSC while the 
relative fluorescence increases with increasing hydrogel stiffness for HASSMC. 
Independent of cell type, there is not a relationship between relative fluorescence 
oxidative stress and E5to15. 
 
The oxidative stress ratio was plotted against E5to15 (excluding the VA086 HLED 
condition) and a linear fit applied to data from each cell type and then to the entire data 
set (Figure 4.32B). For HAVIC, HASSMC, and HADMSC data the linear fit R2 values 
were 0.871, 0.960, and 0.442 respectively. For the combined data set the linear fit R2 
value was 0.041.  Oxidative stress ratio is related to with modulus for each cell type. 
Oxidative stress ratio increases with stiffness for HAVIC and HASSMC while the 
oxidative stress ratio slightly decreases with increasing hydrogel stiffness for HADMSC.  
Independent of cell type, linear regression shows there is not a relationship between 
oxidative stress ratio and hydrogel stiffness. 
 
These studies with DCF indicate that general oxidative stress is higher in 
photocrosslinking conditions that induce lower cell viability. Elimination of that oxidative  
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Relative fluorescence intensity of oxidative stress verses modulus.  
 
Figure 4.32-53 (A) Relative fluorescence intensity of oxidative stress verses 
modulus for HBSS control cells in encapsulation conditions, excluding HLED 
VA086 condition. 
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Figure 4.32-54 (B) Relative fluorescence intensity of oxidative stress verses 
modulus for HBSS control cells in encapsulation conditions, excluding HLED 
VA086 condition. 
Ratio of HBSS to catalase treated cells relative fluorescence verses modulus. Each 
cell type and data from lamp crosslinked Irgacure and VA086 conditions and HLED 
array crosslinked Irgacure conditions (red HAVIC line, green HASSMC line, and blue 
HADMSC line). Data from 3 conditions and 3 cell types with linear fit (black line). 
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stress does not increase cell viability, which suggests that intracellular oxidative stress 
is not a primary mode or symptom of damage caused by photocrosslinking conditions. 
 
4.5 Discussion 
MEGEL and PEG-DA 3350 when combined with alginate viscosity modifier and either 
Irgacure 2959 or VA086 photoinitiator and maintained at 37°C is a 3D printable and 
photo-crosslinkable precursor mixture that was used for encapsulated bioprinting/direct 
extrusion cell printing. A range of photoinitiator concentrations, 0.05 to 0.1% w/v 
Irgacure and 0.5 to 1.0% w/v VA086, and light source intensities, 2 mW/cm2 to 
136mW/cm2 at printing surface, produced crosslinked hydrogels that were robust 
enough for handling and culture for at least 1 week with encapsulated cells.  Hydrogel 
stiffness and swelling ratio were tunable using photoinitiator type, photoinitiator 
concentration, UV light source intensity, and UV exposure time. The range of 
encapsulation conditions (photoinitiator concentrations, light source intensities, and 
hydrogel mechanical properties) tested were tolerated to different degrees by HADMSC, 
HAVIC, HASSMC, and PAVIC.  The viability of encapsulated HADMSC was always 
higher than the other three cell types, except at the lowest concentration of VA086 and 
the lowest light intensity tested where HAVIC and HASSMC viability was the same as 
HADMSC.  Other groups have observed cell specific sensitivity to photoinitiator toxicity 
and different toxicity of various photoinitiators (Atsumi, Murata et al. 1998; Bryant, 
Nuttelman et al. 2000; Williams, Malik et al. 2005; Rouillard, Berglund et al. 2011; 
Occhetta, Sadr et al. 2013). Williams et al tested 6 different cell lines and found cell-
specific sensitivities to Irgacure 2959 radical toxicity, and demonstrated that cell 
proliferation rate in 2D could predict vulnerability to free radical damage in 3D. However, 
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in the present study 2D doubling time for HADMSC, HAVIC, HASSMC, and PAVIC did 
not correlate with viability in 3D.  
Many studies using photo-crosslinking systems have attributed encapsulated cell death 
to free radical damage. Our results indicate that photoinitiator radicals contribute to cell 
death in our printed hydrogels. Increasing the concentration of active photoinitiator 
radicals in the encapsulation conditions decreased cell viability (tested by increasing the 
photoinitiator concentration or by increasing the light source intensity). We found that 
HAVIC and HASSMC experience more general oxidative stress than HADMSC when 
encapsulated in photo-crosslinked hydrogels. Viability decreases as the intensity of 
oxidative stress experienced (measured by DCF relative fluorescence) increases in 
untreated photocrosslinking conditions, and this relationship exists independent of cell 
type and for each cell type. Atsumi et al found that more radical oxygen species were 
produced in submandibular-duct cells exposed to a more cytotoxic photoinitiator 
(Atsumi, Murata et al. 1998).  In 2D culture they also found that reactive oxygen induced 
in cells was dependent on irradiation time and concentration of photoinitiator, and that 
the photocytotoxicity could be suppressed with a free radical scavenger hydroquinone.  
Lampe et al found that in 2D culture lactic acid could be added to the environment to 
scavenge free radicals produced by Irgacure 2959 and improved cell viability (Lampe, 
Namba et al. 2009). There have also been more elaborate strategies/inventions to 
mitigate oxidative damage in to cells in photo-crosslinking systems. Singh et al has 
developed protective nanospheres encapsulating catalase and superoxide dismutase 
and has tested them in 2D on keratinocytes (Singh, Singh et al. 2013) . Shin et al added 
1.5nm graphene oxide sheets to cell encapsulating methacrylated gelatin hydrogels and 
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observed a protective effect from UV damage and improvement of viability, but also 
found that the graphene oxide reduced crosslinking efficiency (Shin, Aghaei-Ghareh-
Bolagh et al. 2013).   A treatment or additive to precursor solutions that prevents or 
mitigates damage to cells during photocrosslinking would broaden the application of 3D 
printing so that it could be used for sensitive cell types. However, interference with the 
hydrogel crosslinking, such as in the case of graphene oxide (Shin, Aghaei-Ghareh-
Bolagh et al. 2013) or ascorbic acid  (Sabnis, Rahimi et al. 2009), makes some radical-
sink treatments strategies unsuitable for 3D printing. In the present study we 
investigated catalase pretreatment of cells prior to encapsulation as a strategy to reduce 
oxidative stress experienced by the cells without interfering with the crosslinking of the 
polymer precursor solution.  
 
Treatment of HAVIC, HASSMC, and HADMSC prior to encapsulation with catalase 
almost eliminated general intracellular oxidative stress and hydrogels were still able to 
solidify/crosslink. However, this treatment with catalase did not rescue encapsulated cell 
viability. Catalase treatment gave a slight benefit to HAVIC encapsulated viability, and it 
reduced or did not affect HADMSC and HASSMC viability in the photo-encapsulation  
conditions tested. The dosage of catalase may be need to be optimized, and its 
possible normal cell functions utilizing free radicals were suppressed as the intracellular 
redox state  impacts several signaling pathways and functions (Lampe, Namba et al. 
2009) which could account for the reduction in viability. Another possible explanation is 
that while the catalase successfully reduced the intracellular oxidative stress in terms of 
hydrogen peroxide pathway, other types of oxidative stress that were not examined in 
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this study could be causing critical damage and the outer cell membrane in particular is 
still vulnerable to attack. Radicals produced by Irgacure are membrane impermeable 
and are suspected to cause damage by lipid peroxidation (Bryant, Nuttelman et al. 
2000; Williams, Malik et al. 2005; Lampe, Namba et al. 2009). Less is known about the 
progression of VA086 radicals, but as an azo initiator it may also cause lipid 
peroxidation. In this study the fluorescence indicator of oxidative stress DCF is oxidized 
by cellular hydrogen peroxide, hydroxyl radicals, and radicals downstream from 
hydrogen peroxide. DCF is itself insensitive to oxidation by superoxide (O2
-) (Kirkland 
and Franklin 2001) or singlet molecular oxygen (O2*) (Bilski, Belanger et al. 2002), but it 
can be considered an indirect indicator of these. It reacts with the downstream products 
of O2* reaction with cellular substrates that produce peroxy products and peroxyl 
radicals, and it reacts with the hydrogen peroxide produced by dismutation of O2
- 
(Kirkland and Franklin 2001; Bilski, Belanger et al. 2002).  Catalase catalyzes the 
decomposition of hydrogen peroxide into water and oxygen.  If lipid peroxidation is 
occurring at the outer membrane of the cells, unless that oxidation propagates into the 
interior of the cell, our diagnostic and rescue strategy misses the critical mechanism of 
damage. 
 
Compared to VA086, Irgacure by weight has a more detrimental effect on cell viability 
for both primary valve cells and adipose derived stem cells.  We investigated a range of 
photoinitiator concentrations that can produce similar mechanical property 
MEGEL/PEG-DA hydrogels using both Irgacure and VA086, the implication being that 
modulus and swelling ratio are proportional to the degree of crosslinking.  Rouillard et al 
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found that Irgacure 2959 was a more cytotoxic photoinitiator than VA086 by testing 
chondrocytes in both 2D and 3D culture and that Irgacure crosslinks hydrogels at weight 
fractions 10 times lower than VA086 (Rouillard, Berglund et al. 2011). They found that in 
methacrylated alginate hydrogels the aggregate modulus when prepared with 0.03% 
w/v Irgacure was not significantly different from those prepared with 0.3% w/v VA086 
after 5 minutes of UV exposure time at 2 μW/cm2 365 nm light intensity, but the viability 
was below 70% Irgacure hydrogel and greater than 90% in VA086 hydrogels after 48 
hours in culture. Chandler et al found that to get comparable modulus of RGD modified 
methacrylated alginate, 7.5 times more VA086 needed to be used (0.04% w/v Irgacure 
compared to 0.3% w/v VA086),  and that the corresponding viability of preadipocytes 
(3T3-L1 cells) in 2D culture treated with these concentrations was 2% and 82% 
(Chandler, Berglund et al. 2011).   The modulus of our MEGEL/PEG-DA hydrogel 
crosslinked with the 2 mW/cm2 light source becomes significantly different between 
Irgacure and VA086 hydrogels at a slightly higher concentration ratio than the 1 to 10 
that Rouillard et al observed. To get comparable modulus in the methacrylated gelatin 
hydrogels a ratio of 1 to 15 was needed (0.05% w/v Irgacure compared to 0.75% w/v 
VA086). This could be related to the viscosity of our precursor solution and the possible 
interference of the non-crosslinking alginate viscosity modifier or the polymer precursor 
type and weight ratio. At this comparable modulus, the viability of the three cell types at 
day 3 is HADMSC: Irgacure 89.7±1.9 and VA086 92.5±1.6; HAVIC: Irg 66.4±2.3 and 
VA086 92.1±2.0; and HASSMC: Irgacure 61.2±1.6 and VA086 81.2±3.3. Additionally, in 
terms of modulus we observed that for a given light intensity there appears to be a 
saturation point for the photoinitiator concentration. Additional photoinitiator after that 
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point does not significantly increase the stiffness. Increasing the light intensity does 
increase the stiffness of the gel for each photoinitiator. However, by crosslinking VA086 
hydrogel (1.0% w/v) at the higher light source, the modulus only increases to the 
modulus level of low intensity light Irgacure hydrogel modulus. In 1.0% VA086 precursor 
solution increasing the exposing light intensity from 2 mW/cm2 and 136 mW/cm2 caused 
the encapsulated viability to drop 16% for HAVIC, 29% for HASSMC, and 7% for 
HADMSC while there was a 26 kPa increase in modulus. For Irgacure hydrogels 
increasing the light intensity from 2 mW/cm2 and 136 mW/cm2 did not induce a 
significant drop in viability for HAVIC and HADMSC but induced a 18% drop in 
HASSMC percent viability while the hydrogel experienced a 80 kPa increase in 
modulus.  
 
2D culture and treatment with a photoinitiator is commonly used as a screening tool to 
evaluate the feasibility of using that photoinitiator with a particular cell type in a photo-
crosslinking hydrogel (Bryant, Nuttelman et al. 2000; Chandler, Berglund et al. 2011; 
Occhetta, Sadr et al. 2013). Exposure to a photoinitiator in 2D has been described as a 
worst case scenario for cells, where the maximum amount of free radical damage by the 
photoinitiator can occur (Williams, Malik et al. 2005).  Occhetta et al used 30 times more 
VA086 compared to Irgacure 2959 (1.5% w/v compared to 0.05% w/v) to get 
comparable viability between the two photoinitiator types  in their 2D tests with human 
umbilical vein endothelial cells (HUVEC) and bone marrow stromal cells (BMSC) prior to 
encapsulating in a MEGEL and PEG-DA hydrogel. The rate  radicals are produced in 
solution depends on the concentration of the photoinitiator, the molar extinction 
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coefficient/absorptivity of the photoinitiator at a particular wavelength, the activation 
energy of the photoinitiator, the intensity of light, and the time of exposure to light 
(Bryant, Nuttelman et al. 2000). In a 3D hydrogel or encapsulating precursor solution, 
the radicals have more possible propagation and termination targets (Figure 4.33).  
 
Polymer double bonds are the intended target, but competing targets in the precursor 
solution are the cells and any impurities or additives such as the alginate viscosity 
modifier.  A higher extinction coefficient increases the rate of initiation at a given light 
intensity, and the molar extinction coefficient of Irgacure 2959 in water is 6.7 mol-1cm-1 
(at 365 nm) (Bryant, Nuttelman et al. 2000) and the molar extinction coefficient of 
VA086  is 30 mol-1cm-1 (at 375 nm) (Wako Chemicals Technical Information). While the 
number of VA086 radicals produced in a given solution/lightsource combination was not 
quantified in 2D for this study, by increasing the light intensity we effectively increased 
the number of VA086 radicals in the hydrogel precursor solution (an over saturated 
VA086 initiator concentration). The effective radical concentration of VA086, and its 
efficiency in chain initiation for polymerization reaction in our hydrogel appears to be 
much less than Irgacure. Increasing the number of effective VA086 radicals, as 
evidenced by the increase in mechanical properties, decreased the viability of 
encapsulated cells. The effective cell damage of the VA086 radicals is not the same as 
Irgacure, but with the increase in light source intensity, we found we could get higher or 
equivalent viability in Irgacure hydrogels of much stiffer mechanical properties than the 
VA086 hydrogels.  Bryant et al characterized photoinitiator solutions to do viability  
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Figure 4.33-55 Schematic of precursor and crosslinked hydrogel environment. 
 
In the precursor solution upon exposure to the UV light free radicals are produced 
from the photoinitiator. The initiation reaction and the number of radicals it produces 
depends on concentration of photoinitiator, the intensity of light, and how long the 
light exposure is. Radical production also depends on the molar extinction coefficient 
and the activation energy of the photoinitiator.  The free radicals can interact with 
multiple targets in a 3D hydrogel system. Additionally solution properties like 
temperature and viscosity can affect the rate of these reactions.  
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testing with the matched number of radicals produced by different photoinitiators 
(Bryant, Nuttelman et al. 2000). If this type of matched free radical number study was 
done on VA086 and Irgacure in conjunction with 3D crosslinking studies in different 
materials a more quantitative and generally applicable guide to photoinitiator selection 
could be defined.  
 
Previously, studies have compared VA086 and Irgacure in terms of pair effects.  For 
example mechanical effectiveness of photoinitiator is generally 10 to 1 and effective cell 
damage is 30 to 1 for Irgacure to VA086.  In this study we observe a cell damage to 
mechanical gain ratio (Table 4.2). This ratio of cell damage to mechanical gain indicates 
that VA086 is actually a more detrimental photoinitiator in a hydrogel system because 
so much more of it is needed. However, it should be noted that we only calculate this 
damage ratio between two radical conditions for the two photoinitiators in one 
precursor combination for the 3 cell types. This was useful in demonstrating cell-type 
dependent sensitivity and that VA086 when compared to Irgacure in specific 3D 
conditions can produce a less crosslinked hydrogel with equivalent or greater 
detrimental effects on cell viability. More characterization and perhaps more sensitive 
mechanical characterization is needed to determine if this relationship between 
damage/mechanics is the same at higher and lower photoinitiator concentration and 
light intensity combinations. At the lower concentration initiator and light intensity 
VA086 does produce higher viability hydrogels than Irgacure. This suggests that 
hydrogel stiffness and cell viability slopes with increasing number of free radicals are 
different for the two photoinitiators. Additionally the mechanics/damage relationship of  
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Table 4.2 3 Damage to mechanics ratio. Decrease in cell viability corresponding to 
a jump in photoinitiator radicals induced by increasing the light intensity was divided 
by the increase in mechanical properties to give a  damage to mechanical gain ratio.  
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photocrosslinking conditions could be established for other polymer precursor materials 
and cell combinations. Mironi-Harpaz et al also observed the importance of crosslinking 
efficiency verses cytotoxicity in PEGDA and PEG-fibrinogen hydrogels when evaluating 
different photoinitiators (Mironi-Harpaz, Wang et al. 2012). Mironi-Harpaz et al compare 
4 different photoinitiators (including Irgacure 2959) for their effects on shear modulus 
and crosslinking time and found that only Irgacure 2959 and I184 initiators could 
achieve high chondrocyte viability and suitably efficient photocrosslinking during the 
photopolymerization reactions (Mironi-Harpaz, Wang et al. 2012). Mironi-Harpaz et al 
look at the photocrosslinking kinetics with the exposure time to achieve comparable 
mechanics and the subsequent viability. By contrast the present study increased 
photoinitiator to achieve comparable mechanics and the subsequent viability. Different 
polymer precursors and weight ratios also have different crosslinking efficiencies with a 
given radical photoinitiator (Hockaday, Kang et al. 2012). Fully understanding the 
mechanics and cell damage induced by a photoinitiator in a particular material, perhaps 
in a standard set of characterizing tests so this information can be compared, could 
better guide printing of multi-material and multicellular constructs to mimic complex 
living tissue. 
 
Nearly every 3D bio-printing study uses a custom material and fabrication strategy for 
the needs of the particular cell being used and the type of tissue being developed which 
has led to some degree of custom characterization.  On the whole 3D bio-printing 
technology with its many different platforms currently involves a great deal of 
troubleshooting as investigators are rapidly eliminating non-working procedures and 
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refining encapsulation protocols with different materials. As researchers contribute to a 
growing body of knowledge and identify a growing number of printable material 
combinations, eventually common overlap will occur and comparable 
material/fabrication characterization could enable broader application of 3D printing.  
Precisely controlling crosslinking kinetics during fabrication and the resultant hydrogel 
mechanics will determine inductive properties of engineered tissues. Stiffness is just 
one micro-environmental property of a hydrogel that can affect the behavior of the 
resident cells and the subsequent tissue development. This is particularly important tto 
tissue engineering strategies where stiffness is being used to drive cell behavior and 
differentiation (Engler, Sen et al. 2006; Chandler, Berglund et al. 2011; Park, Chu et al. 
2011; Duan, Hockaday et al. 2013).  
 
Additionally the mechanism of cell death and primary mode of cell damage in 3D 
hydrogels still needs to be identified and mitigated. We observed an increase in the 
calculated oxidative stress ratio with higher intensity light, and we observed that VA086 
produced a higher intracellular oxidative stress ratio than Irgacure. These ratios are the 
divided averages of the different conditions to see the normalized high powered LED 
and VA086 condition and were not compared statistically.  When just the relative 
oxidative fluorescence values and percentage of cells experiencing oxidative stress are 
considered, between conditions with more photoinitiator radicals (in Irgacure conditions 
since the VA086 data has to be excluded in this comparison), there is not a significant 
difference in intracellular oxidative stress. This indicates that Irgacure radicals are not 
causing intracellular oxidative stress. Cells did experience oxidative stress during the 
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handling of the cells for printing aside from the photo-encapsulation. While this may 
affect viability, HASSMC, which experienced the most oxidative stress also had the 
poorest response to the rescue attempt using treatment of catalase prior to 
encapsulation. This supports the conclusion that intracellular oxidative stress is not the 
main driver of cell death in our photo-crosslinking hydrogel system. Identifying where 
photoinitiator radicals (both VA086 and Irgacure radicals) are targeting and causing the 
most damage to cells could lead to a better rescue strategy and higher viability in photo-
encapsulation  fabrication techniques.   
 
Engineering protection from a reaction oxygen species has been done in a 3D gels 
system, although it was for protection against external ROS attack as opposed to ROS 
produced as a byproduct of the fabrication of the hydrogel. Hume et al demonstrated 
that they could effectively protect PEG-DA encapsulated pancreatic cells from ROS 
external attack by incorporating a super oxide dismutase mimetic into the hydrogel 
itself(Hume and Anseth 2011).  As a continuation of the study presented here, lipid 
peroxidation should be specifically stained for and compared between for VA086 and 
Irgacure 2959 photoinitiators. We suspect that a strategy to protect the cell membrane 
during the photo encapsulation process would significantly improve cell viability.  
 
In our study we also tested longer term viability and metabolism in our hydrogels.  As 
time in culture increases, the percent viability of HASSMC and HAVIC decreases in 
Irgacure photo-crosslinked hydrogels.  Over the course of 7 days the metabolism of 
these tissue constructs decreases in all but the HADMSC populated VA086 hydrogels.  
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Additional variables characteristic of 3D culture, not examined here, may be affecting 
the viability of HADMSC, HASSMC, and HAVIC. For example the contribution of binding 
domains and density/presentation of these domains was not varied here and in the 
hydrogel used may actually be sub-optimal for valve interstitial cell culture.  More 
bioactive and softer hydrogel photo-encapsulation (0.03% w/v Irgacure) have resulted in 
PAVIC viability closer to 80%.  Studied here is one polymer mixture for printing, 
however, different polymer formulations may require more or less photoinitiator and 
more or less intense light source to enable fabrication of stable tissue engineered 
constructs (Hockaday, Kang et al. 2012).  
4.6 Conclusion 
This study further explores variables associated with photo-crosslinking hydrogels, 
relationships previously demonstrated or suspected by other investigators, for a 
MEGEL:PEG-DA 3350 mixture containing valve cells or mesenchymal stem cells. 
Contrary to numerous 2D cytotoxicity studies, we have demonstrated that when 
considered in a 3D hydrogel culture environment and fabrication setting, Irgacure 2959 
rather than VA086 can produced more viable encapsulated cells.  Intracellular oxidative 
stress was not significantly greater in hydrogel conditions of more Irgacure 2959 
photoinitiator radicals. Normalized oxidative stress ratios suggest that increasing VA086 
radicals induced higher Intracellular oxidative stress.   Suppression of intracellular 
oxidative stress using catalase pretreatment does not disrupt hydrogel crosslinking but it 
does not rescue cell viability.  
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4.7 Future Directions 
 
Characterization to establish fabrication conditions that optimize cell viability and 
hydrogel solidification and to fully appreciate the consequences of these conditions on 
subsequent tissue is useful within the field of bioprinting and tissue engineering as a 
whole. The effects of fabrication conditions on other markers of functional health in the 
cells should be evaluated – such as cell differentiation, gene expression, extracellular 
matrix deposition following photocrosslinking. Identifying the primary mode of cell 
damage in photocrosslinking conditions and the radical sinking and protective effects of 
different polymers could lead to a means to improve cell viability.   Two recommended 
future studies would be to (1) identify hydrogel material specific differences in ability to 
capture photoinitiator radicals and (2) test for lipid peroxidation and then pursue 
membrane targeted rescue strategies.  
 
VA086 and Irgacure have different crosslinking efficiencies in the same solution and 
have different crosslinking efficiencies depending on the polymers in the precursor 
solution (Rouillard, Berglund et al. 2010; Chandler, Berglund et al. 2011). Encapuslated 
cell viability can be different using the same photoinitiator concentration using the same 
cell type but with different precursors in the solution. HAVIC photoencapsulated in 
methacrylated gelatin/methcrylated hyaluronic acid hydrogels have a viability over 90% 
at day 3 and day 7 when prepared with precursor solutions containing 0.05%w/v 
Irgacure 2959 that are exposed to 2 mW/cm2 365nm light  (Duan, Kapetanovic et al. 
2014) but in MEGEL/PEGDA for the same crosslinking conditions the viability was 
below 80%. In the precursor solutions there are competing reactions in terms of radical 
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targeting of polymer double bonds verses targeting of cells, and these reactions may 
not be equal. Some materials used in hydrogels are even cited for their antixodidant 
properties such as hyaluronan(Farnsworth, Bensard et al. 2012). While cells may prefer 
one hydrogel material over another for reasons such as availability of binding sites or 
network structure, there may also be a contribution of the material’s ability to sink 
radicals away from the cells.  To characterize multiple materials for the purposes of 3D 
bioprinting it would be useful to establish crosslinking and cell damage trends induced 
by a quantified number of photoinitiator radicals to generate standardized cell damage 
to mechanical gain ratios.  
  
Lipid peroxidation is a major suspected mechanism of cell damage by Irgacure 2959 
radicals. Testing of chondrocytes indicate that Irgacure 2959 in photocrosslinking 
conditions induced lipid peroxidation (Farnsworth, Bensard et al. 2012).  Lipid 
peroxidation modifies the membranes and generates aldehydes, which unlike free 
radicals aldehydes are relatively long lived and unlike Irgacure radicals can diffuse from 
their site of origin in the lipid bilayer to react with intracellular targets(Balasubramanian, 
Bevers et al. 2001).  To test for lipid peroxidation and pursue membrane targeted 
rescue strategies using membrane associated antioxidants, I recommend pretreatment 
of the cells with either melatonin or vitamin E prior to photoencapsulation and using 
diphenyl-1-pyrenoylphosphine (DPPP) and annexin V binding to screen for lipid 
peroxidation.    
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Melatonin could be explored as a pretreatment of cells prior to photoencapsulation to 
potentially reduce damage induced by photoinitiator radicals. Melatonin is an antioxidant 
that neutralizes directly several free radicals including superoxide anion, hydrogen 
peroxide, hydroxyl radical, singlet oxygen, peroxinitite anion, nitric oxide, hypochlorous 
acid (Sokolovic, Djordjevic et al. 2013). Melatonin incorporates itself into the head-group 
region of the phospholipid bilayer where it reacts with radicals as an antioxidant 
defense, and it has been shown to stimulate production of intracellular antioxidants such 
as catalase(Col, Dinler et al. 2010; Drolle, Kucerka et al. 2013).  In addition melatonin 
alters the biophysical properties of the membrane.   Studies indicate that melatonin 
causes bilayer thinning, it introduces disorder into the membrane, and it increases 
membrane fluidity which could affect propagation of lipid peroxidation reactions (Drolle, 
Kucerka et al. 2013). Melatonin treatment of cells has previously been demonstrated to 
decrease the amount of cell membrane damage lipid peroxidation caused by UV-B light 
exposure and microwaves and to increase cell viability under these conditions(Ryoo, 
Suh et al. 2001; Sokolovic, Djordjevic et al. 2013).  However, the anti-oxidative 
properties of melatonin depend on the cell type and the concentration of melatonin 
used, and prolonged incubation of cells in melatonin could cause damage to the cells 
(Krokosz, Grebowski et al. 2013). For a future photoencapsulation study a dose-
melatonin study would need to be included for the different cell types.   
 
The Vitamin E analog Trolox could be explored as a pretreatment of cells prior to 
photoencapsulation to potentially reduce or repair damage induced by photoinitiator 
radicals. Vitamin E is an antioxidant that prevents lipid peroxidation (Manevich, Sweitzer 
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et al. 2002), and in erythrocytes membrane lysis induced by oxidative stress is 
prevented by vitamin E supplements (Howard, McNeil et al. 2011). α-tocopherol, the 
most common form of vitamin E, is lipid soluble and it partitions into the hydrophobic 
core of the plasma membrane bilayer. Upon incorporation of α-tocopherol in to the 
membrane, membrane fluidity increases at surface and decreases in interior. The 
chromanol-head group of α-tocopherol binds to the head group of phospholipids which 
limits their mobility within the membrane. α-tocopherol (most common form of vitamin E) 
promoted plasma membrane repair and resealing after mechanical damage or laser 
induced injury. Trolox a biologically active analog of vitamin E (less understood 
biophysical mechanism of membrane association) has been used to promote 
membrane repair after short pre-incubation with cells. Trolox quickly associates with the 
cell membrane (after less than 15 minute incubation) while α-tocopherol needs 24 hours 
or longer depending on the concentration to promote repair. Cells could be pre-treated 
with Trolox prior to photoencapsulation. 
 
‘Rescue’ attempt experiments in VA086 and Irgacure photocrosslinking conditions 
should be performed with a live/dead viability assay for day 1 and day 3 time points in 
combination with a lipid peroxidation and membrane characterization. In a study with 
neuronal cells, vitamin E added at the same time as a toxins that cause lipid 
peroxidation, prevented lipid peroxidation did not prevent cell death (Slotkin and Seidler 
2010). A toxin can have multiple mechanisms of cytotoxicity and cell damage. If lipid 
peroxidation oxidative stress is occurring in photoencapsulated cells to different degrees 
based on photoinitiator type and cell type, a functional test is needed to see if this is a 
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driving cause of observed differences in cell death.  Running the day 1 and day 3 
encapsulated viability study following treatment with melatonin or Trolox will help 
indicate if this is a mode of cell damage worth mitigating for the purposes of 3D 
bioprinting.  
 
For our purposes either DPPP or BODIPY® 581⁄591 C11 could potentially work to 
quantify lipid peroxidation. DPPP is a probe used in live cells that localizes in cell 
membranes and becomes fluorescent in response to lipid peroxidation (Takahashi, 
Shibata et al. 2001; Manevich, Sweitzer et al. 2002) and BODIPY® 581⁄591 C11 and 
lipid peroxidation kit (C10445, Invitrogen). C11-BODIPY581/591 is a fluorescent fatty 
acid analog that upon free-radical induced oxidation shifts from red to green (Drummen, 
van Liebergen et al. 2002; Johnson 2010).  In its reduced state C11-BODIPY581/591 
has an excitation maxima at 581 and emission maxima at 591 nm and upon free radial-
induced oxidation the probe shifts the excitation and emission to 488/510 nm. C11-
BODIPY581/591 does preferentially labels mitochondrial membranes (a factor of 11-15 
less in the plasma-membrane) (Drummen, van Liebergen et al. 2002). To assess 
membrane disruption caused by phospholipid peroxidation an annexin V binding assay 
can be used (Manevich, Sweitzer et al. 2002).  Annexin V is a Ca2+ dependent 
phospholipid-binding protein that has a high affinity for negatively charged 
phospholipids (van Engeland, Nieland et al. 1998). In normal viable cells the negatively 
charged phospholipid phosphatidylserine is on the cytoplasmic surface of the plasma 
membrane.  In the intermediate stages of apoptosis phosphatidylserine is translocated 
from the inner to the outer part of the membrane and the membrane integrity is still 
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maintained (van Engeland, Nieland et al. 1998; Johnson 2010). Modification of the 
membrane where negative charged moieties are introduced promotes annexin V 
binding, and it has been shown that the amine-reactive aldehydes produced by lipid 
peroxidation can react  with aminolipids to produced negatively charged adducts that 
bind annexin V (Balasubramanian, Bevers et al. 2001). Imaging for both lipid 
peroxidation and testing for annexin V binding of cells in photocrosslinking conditions 
could assess damage to cell membranes.  
 
If treatments of the cells with antioxidants that associate with the membrane do not 
improve photoencapsulated cell viability, alternative strategies could be pursued. 
Studies have demonstrated a protective shell of pericellular matrix improves cell viability 
in photocrosslinking conditions (Villanueva, Bishop et al. 2009; Farnsworth, Bensard et 
al. 2012), transfection to over express protective membrane antioxidants can combat 
membrane targeted oxidative stress (Manevich, Sweitzer et al. 2002), and antioxidant 
enzymes can be stimulated/recruited to the plasma membrane to counteract lipid 
peroxidation (Hagmann, Kuczkowski et al. 2014).  Identifying the primary mode of 
damage and then mitigating it for different cell types in hydrogel photoencapsulation 
would greatly expand the application of 3D printing technology, and this could 
potentially be done with antioxidant strategies targeting the membrane, modification of 
the membrane, or encasing the cells in a protective layer. 
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CHAPTER 5 
ARBITRARY AND ANATOMICALLY BASED CONTROL OF INTERNAL 
HETEROGENEITY OF 3D PRINTED TISSUES  
 
5.1 Summary 
In this study we present methods to generate geometries exhibiting heterogeneous 
distribution of printable materials throughout a fabricated shape. These algorithms 
provide a tool for 3D printing of heterogeneous, anatomically relevant tissue engineered 
constructs.  Using the first algorithm demonstrated, the target print image is generated 
through processing any image into printable vector format.  We present a second 
algorithm that generates spatially heterogeneous gradients with multiple materials in 
arbitrary directions in 2D and 3D. We then present a combination algorithm that 
separates intrinsic tissue heterogeneity present in medical imaging scans of anatomical 
tissue into printable format files. The fabrication of these files was demonstrated using 
the Fab@HomeTM platform by printing heterogeneous hydrogel scaffolds.  We also 
present a method to quantify the fidelity of heterogeneous layers, and to quantify the 
blending of different materials that were printed.  
 
5.2 Introduction 
Heterogeneity is a critical functional characteristic of many living tissues. One of the 
primary drivers for exploration into 3D printing as a method for tissue engineering is the 
cellular, mechanical, and biochemical heterogeneity present in native tissue that cannot 
be replicated with traditional fabrication strategies like injection molding and 
shaping/suturing/gluing scaffolds by hand.   3D extrusion bioprinting enables a high 
level of geometric control and direct deposition of cells within tissue constructs (Skardal, 
Zhang et al. 2010; Fedorovich, Wijnberg et al. 2011; Schuurman, Khristov et al. 2011; 
Tirella, Vozzi et al. 2011; Fedorovich, Schuurman et al. 2012; Mannoor, Jiang et al. 
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2013; Ahn, Lee et al. 2014; Pati, Jang et al. 2014). A few strategies have advanced to 
evaluating the consequences of heterogeneity and multi-cellularity in vivo   (Fedorovich, 
Wijnberg et al. 2011; Fedorovich, Schuurman et al. 2012). These studies have 
demonstrated that heterogeneous printing resulted in heterogeneous tissue formation 
during in vivo   culture.  ECM produced by the cells corresponded to the deposited cell 
type, and the scaffold mixture or hydrogel type could be used to direct and influence 
matrix production of encapsulated cells. Depending on the encapsulating scaffold 
material, cells maintained the original printed organization or migrated out of the pattern 
to different degrees.   
 
Fab@HomeTM is an open source extrusion based 3D printing platform that has recently 
been used to print heterogeneous tissue constructs. Materials that have been 
demonstrated with the platform for direct cell encapsulation and printing are 
methcrylated gelatin/methcrylated hyaluronic acid (Duan, Kapetanovic et al. 2014), four-
armed PEG/hyaluronic acid/gelatin derivatives (Skardal, Zhang et al. 2010; Skardal, 
Zhang et al. 2010), alginate (Mannoor, Jiang et al. 2013),  gelatin/alginate (Duan, 
Hockaday et al. 2013), and hydroxyapatite loaded gelatin/alginate (Wust, Godla et al. 
2014). The primary file type used with the Fab@HomeTM is a CAD drawing in Standard 
Tessellation Language (STL) format.  This only contains the shell information of a 
shape, and the printer automatically plots and prints the outline of the shape and fills the 
layer with a single material.  Interlocking and multiple STL files and similar files can be 
printed simultaneously to create multiple blocks of material in a single structure (Cohen, 
Malone et al. 2006; Hockaday, Kang et al. 2012; Duan, Kapetanovic et al. 2014). 
However, the Fab@HomeTM has a second file format called a vector file.  It is possible 
to control the information and material deposition within regional blocks with the vector 
printing.   
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In this study we develop and test algorithms designed to generate geometries exhibiting 
heterogeneous distribution of printable materials throughout a fabricated shape by 
utilizing the vector file format. Poly-(ethylene glycol)diacrylate (PEG-DA) and 
methacrylated gelatin (MeGel) photo-crosslinkable hydrogel precursors (Benton, 
DeForest et al. 2009; Hutson, Nichol et al. 2011)  were combined with non-photo-
crosslinking alginate to make a solution suitable for cell encapsulation and extrusion 3D 
printing. We previously demonstrated PEG-DA as a base polymer precursor for 
extrusion 3D printing of valve scaffolds (Hockaday, Kang et al. 2012).The potential for 
mechanical and/or molecular customization, coupled with their relatively low cost and 
biocompatibility, suggests PEG-DA could be an ideal material component for clinically 
relevant scale 3D tissue printing (Kloxin, Benton et al. 2010; Durst, Cuchiara et al. 
2011); (Gunn, Turner et al. 2005; Peyton, Raub et al. 2006; Guo and Chu 2007).  
Gelatin is synthesized by partial breakdown of collagen, but it retains some bioactive 
features of collagen, particularly cell attachment/binding domains (Benton, DeForest et 
al. 2009). Gelatin can be modified for photo-crosslinking by incorporating double bond 
pendent groups on the gelatin chains to make methacrylated gelatin. Methacrylated 
gelatin (MeGel) hydrogels. MEGel hydrogels are enzymatically degradable and have 
been used to encapsulate valve interstitial cells (Benton, DeForest et al. 2009), and with 
the addition of PEG-DA the degradation properties are modifiable (Hutson, Nichol et al. 
2011). These materials were 3D printed with and without encapsulated human adipose 
derived mesenchymal stem cells (HADMSC) using the Fab@HomeTM printer to test 
arbitrary and image derived  vector geometries to achieve material heterogeneity.  
 
5.3 Materials and Methods 
5.3.1 Fab@HomeTM 3D Printing Platform and Vector File Format 
A model 1 Fab@HomeTM printer was used for testing geometries and fabricating 
hydrogel scaffolds. Detailed specifications and mechanics of the open-source 
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Fab@HomeTM Model 1 extrusion based 3D printing platform can be found at 
www.fabathome.org and in previous studies (Cohen, Malone et al. 2006; Malone 2007).  
Vector files can also be formatted into Fab files for printing in the Model 2 printer, but 
the model 1 was used for all data presented here. To enable heterogeneous printing we 
utilize a format in the Fab@HomeTM called vector printing. In vector printing format, the 
user defines lines to be printed for a given layer using pairs of points. The start and end 
point are grouped with each other (Figure 5.1A).  For a given layer the z coordinates are 
usually the same throughout the layer. When the vector file is uploaded to printer, the 
pair of coordinates is recognized and system will extrude material starting at the first 
point and ending at the second (Figure 5.1B). In contrast, when the user loads a file in 
Standard Tessellation Language (STL) format, which only contains the shell information 
of the shape, the printer automatically plots and prints the outline of a shape and fills the 
layer with a single material.  Interlocking and multiple STL files and similar files can be 
printed simultaneously to create multiple blocks of material in a single structure (Cohen, 
Malone et al. 2006; Hockaday, Kang et al. 2012; Duan, Kapetanovic et al. 2014). 
However, with the vector printing it is possible to control the information and material 
deposition within those blocks.   
 
5.3.2 Materials for Printing 
Silicone sealant was used as a testing material to check and troubleshoot printed 
geometries (GE Silicone Sealant  II, Lowes Ithaca NY).  Poly(ethylene glycol)-diacrylate 
(PEG-DA) and Methacrylated Gelatin (MEGEL) were used as the base polymer 
precursors for this study. PEG-DA700 hydrogel was used for test geometries when no 
cell encapsulation was needed for the experiment, and PEG-DA3350 in combination 
with MEGEL was used for direct cell bioprinting and photo-encapsulation  of cells.  2-
hydroxy-1(4-(hydroxyethox)pheny)-2-methyl-1-propanone (Irgacure 2959, BASF 
Corporation, Newport, DE) which has previously been used with live cells in 3D 
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hydrogels was used as the photoinitiator (Rouillard, Berglund et al. 2010; Hutson, Nichol 
et al. 2011). Un-modified soluble alginate (LF10/60, FMC BioPolymer, Drammen, 
Norway) was mixed into polymer precursor solutions to temporarily increase viscosity 
during the printing extrusion process (Hockaday, Kang et al. 2012; Kang, Hockaday et 
al. 2013).  
 
5.3.3 Precursor Solution Preparation for Printing without Cells 
For hydrogel printing without cells, the precursor solution consisted of 13.7 mM NaCl 
solution,1.0%w/v photoinitiator, and 20%w/v PEG-DA 700MW.  Red and blue food dye 
was added to precursor solutions for contrast and imaging heterogeneous scaffolds.  
 
5.3.4 Polymer Synthesis and Solution Preparation for Cell Encapsulation  
In this study poly-(ethylene glycol)diacrylate molecular weight 3350 (PEG-DA3350) and 
methacrylated gelatin (MeGel) photo-crosslinkable hydrogel precursors (Benton, 
DeForest et al. 2009; Hutson, Nichol et al. 2011)  were combined with non-photo-
crosslinking alginate to make a solution suitable for cell encapsulation and extrusion 3D 
printing.  
 
Synthesis 
Methacrylated gelatin (MEGEL) was synthesized as previously described (Nichol, 
Koshy et al. 2010; Duan, Hockaday et al. 2013; Duan, Kapetanovic et al. 2014). Brieﬂy, 
gelatin from bovine skin (Sigma) was dissolved at 10% (w/v) into distilled water at 40 C 
and then methacrylic anhydride (MA, Sigma) (1:5 v/v to gelatin solution) was added 
drop by drop under stirred conditions at 40 C for 1 hr.  Polyethylene glycol diacrylate 
molecular weight 3350 was synthesized as previously described (PEG-DA 3350) 
(Cruise, Scharp et al. 1998; Guo, Chu et al. 2005).  Poly(ethylene glycol) (PEG, Sigma) 
was dissolved in benzene (1.5 mmol of PEG in 150ml of benzene) and heated to 45 °C 
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with continuous stirring until completely dissolved. The solution was cooled to room 
temperature and triethylamine was added at 8 fold molar concentration (based on PEG 
diol end groups) to the PEG solution (12mmol). Acryloyl choride (Sigma) at eightfold 
molar excess concentration was weighed out then diluted using benzene (1:40 acryloyl 
chloride to benzene) and added drop wise to the PEG solution through a drop funnel 
under an ice bath. The mixture was stirred overnight, and then the reaction stopped. 
The insoluble triethylamine was removed by filtration. PEG-DA was precipitated from 
the solution by the addition of petroleum ester (Sigma). The PEG-DA precipitate was 
collected using a funnel, re-dissolved in 20 ml of benzene, and precipitated again by 
adding petroleum ester. The precipitation process was repeated several times. After 
synthesis the MEGEL and PEG-DA products were dissolved in distilled water and 
transferred and sealed into dialysis tubing with a molecular weight cut off of 1000 Da. 
The polymers were dialyzed against distilled water for 5-7 days in 5 gallon containers 
with frequent water changes. The polymer product was then frozen at -20C and then 
lyophilized.  Lyophilized polymers were stored at -20°C. 
 
Preparation of Sterile Polymer Precursor Solution  
Polymer solutions were prepared in a biosafety cabinet. Hydrogel precursor solutions 
were made 20%w/v polymer to solution, MEGEL:PEG-DA3350 1:1. Polymer precursors 
were weighed out dry and then sterilized for 1 hour using germicidal UV and then 
transferred into sterile 50 ml conical tubes. Irgacure 2959 was weighed out and 
dissolved in 70% ethanol  to make stock solutions of 0.1g VA086/ml of ethanol solution 
and 0.015 g Irgacure/ml of ethanol solution which were then sterile filtered (Chandler, 
Berglund et al. 2011; Rouillard, Berglund et al. 2011). Stock solutions were stored at 
room temperature and used within 1 week.  Photoinitiator stock solution was added to 
sterilized polymers to give a final concentration of 0.075%w/v Irgacure. The remaining 
solution volume was valve cell culture media.   Polymer precursors, photoinitiator 
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solution, and media were combined in conical tube, the tube cap was wrapped with 
parafilm, and the tube placed into water bath at 37°C to dissolve.  
 
5.3.5 Light Sources for Photo-crosslinking Printed Hydrogel Solutions 
For photo-crosslinking hydrogel constructs more than two layers. a low power 365 nm 
LED array built to mount on the syringe carriage, previously used for printing valve 
scaffolds [Biofabrication 2012], was built with 4  NCSU033B LEDs (Nichia America 
Corporation, Wixom, MI). The limiting resistance was set at 33 Ω per LED (calculated 
376 mA forward current per LED and radiant flux at the LED was 233 mW, and at the 
print surface per LED 18.5mW/cm2). A Spectroline Lamp 365nm EN280L with a single 
bulb was used for photo-crosslinking printed hydrogels containing cells at 2 mW/cm2 
(intensity at stage/plate surface).   
 
5.3.6 Adipose Derived Mesenchymal Cell Culture  
Direct cell encapsulation printing of heterogeneous scaffolds was demonstrated using 
adipose derived mesenchymal stem cells (ADMSC). ADMSC can be differentiated 
towards osteogenic, adipogenic, myogenic, chondrogenic, neurogenic, endothelial, and 
smooth muscle cell lineages (Colazzo, Chester et al. 2010; Wang, Yin et al. 2010). 
ADMSC have demonstrated similar phenotypic  and functional characteristics to bone 
marrow mesenchymal stem cells (BMMSC), which are more established in the 
literature, but ADMSC isolation is less invasive (Bunnell, Flaat et al. 2008); (Colazzo, 
Chester et al. 2010).  In addition, adipose tissue is present in infants, children, and 
adults (Kuzawa 1998). These characteristics suggest ADMSC are a potentially feasible 
cell source for tissue engineering replacement tissues that could be applicable to all 
three age groups.  Cryopreserved HADMSC were purchased (Cat #:PT-5006, 
Lot#0F4505, Lonza, Walkersville). HADMSC were isolated from a 52 year old female 
donor and cryopreserved December 6, 2010.  Greater than 90% of the cells were 
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positive for CD13, CD29, CD44, CD73, CD90, CD105, CD166. Less than 5% of cells 
were positive for CD14, CD31, and CD45. HADMSC were thawed and cultured using 
Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (F12:DMEM, Invitrogen) 
supplemented with 10% FBS, 1% PS. HADMSC were passaged at just sub-confluent 
(~90%) and fed every 3-4 days. Cells were used at passages 4-8. HADMSC were 
expanded and maintained in flasks with and F12/DMEM media.   
 
5.3.7 Cell Encapsulation and Handling for 3D Printing 
To test how cells were distributed throughout constructs when heterogeneous 
geometries were printed, cells were encapsulated in precursor solution, loaded into 
syringes, extruded into vector paths using the printer, and photo-crosslinked with the 
lamp at 2 mW/cm2 for 5 minutes. Cells were rinsed with PBS, trypsinized from flasks 
that were 80-95% confluent, trypsin was inactivated with supplemented media, and cells 
were counted. Cells were spun down into a pellet (1000 RPM, 5min) and then incubated 
in working solution of 7 μM Cell Tracker Red or Cell Tracker Green in PBS for 20 
minutes at 37°C, spun down (1000RPM, 5min), rinsed and re-suspended with PBS, 
spun down, and then encapsulated in prewarmed and dissolved MEGEL/PEG-DA3350 
precursor solution at a concentration of 2.5 million cells/ml. Precursor solution 
containing the suspended cells was pipetted into syringes connected by Luer adapter 
with the stopper/piston removed from one side. 7.5%w/v alginate powder was added 
and stirred in with a sterile spatula.  The syringe piston was reinserted, the bubbles 
squeezed out, and the viscous precursor solution was mixed back and forth between 
the two syringes to fully homogenize. Syringes were kept in the incubator at 37°C until 
ready to load into the printer syringe carriage.  If the solution is allowed to cool, the 
MEGEL component solidifies and the photo-crosslinking does not work or is only partial.  
The Luer adapter was detached from the mixing syringe and reattached to a printing 
syringe. The gel was transferred to a printing syringe. Heating coils were applied to the 
 225 
 
syringe barrels and tips to keep precursor gel warm. Wust et al previously demonstrated 
a heating setup with the Fab@HomeTM for gelatin/alginate printing (Wust, Godla et al. 
2014). Precursor solution was printed and then printed layers were exposed to UV lamp 
for 5 minutes.  20 ml of cell culture media was applied to submerge, hydrate, and loosen 
the hydrogel construct and was placed in the incubator.  After 1 hour incubation in the 
media, the hydrogel constructs were transferred to 6-well plates containing fresh media. 
Plates were placed on a rocker in a walk-in incubator set at 37°C and  5% CO2. Media 
was exchanged after 24 hr and then hydrogels were fed every 48 hours. After printing, 
HADMSC hydrogel constructs were cultured in MCDB131 medium supplemented with 
10% FBS, 1% PS, 0.25 µg/L recombinant human fibroblast growth factor basic (rhFGF-
2; Invitrogen) and 5 µg/L recombinant human epidermal growth factor (rhEGF; 
Invitrogen).     
 
5.3.8 First Algorithm: Conversion of Images to Printable Vectors 
Images can be converted into printable vector files using a custom algorithm. 
Photographs or images are converted into a 2D binary image (Figure 5.1C), and the 
algorithm identifies the different color regions and assigns materials.  Coordinate points 
are designated within each region or dithered and then connected to create printable 
vector files. Silicone sealant geometries were extruded by the printer to test patterns 
specified by the vectors (Figure 5.1C and 5.1D). Regular and irregular shapes are 
possible with this printing format.   
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Figure 5.1-56      Image defined heterogeneity - image based vector printing patterns 
in multiple materials. 
(A)  In the Fab@HomeTM vector printing format, the user defines lines to be printed. 
In the vector format, the start and end point are grouped with each other. (B)The 
printing platform recognizing this will observe this pair and will extrude material 
starting at the first point and ending at the second. (C) Images can be converted into 
printable files. In this example a photograph was converted to a 2D binary image, an 
algorithm identifies the different color regions and assigns materials. Coordinate 
points were designated within each region and then connected to create printable 
vector files. Silicone sealant was extruded by the printer into patterns specified by the 
vectors, right (C) and (D).  
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5.3.9 Second Algorithm: Application of Gradients within Shapes and Generation 
of Printable Vectors 
Functions are used to generate coordinate points within a shape assigned to different 
materials and those points are connected to vectors using a 2nd algorithm.  This can be 
used to define gradients of material within a desired shape (Figure 5.2).  Individual 
heterogeneous layers were printed with PEG-DA700 hydrogel solution mixed with red 
and green dye to visualize the pattern and to assess accuracy compared to the 
intended geometry (Figure 5.3A). Print parameters for the gradient print were: nozzle 
diameter 16G; deposition rate 0.004; path speed 7.5 mm/s; path width 1.0mm; and 
path height 0.8mm. Individual gradient layers were assessed directly after printing 
(uncrosslinked) to determine printer/pattern fidelity (Figure 5.3A and 5.3D). These layers 
when built up and photo-crosslinked to form a 3D gradient construct (Figure 5.3B) and 
were generated from a linear gradient function (Figure 5.3C). Hydrogel layers were 
imaged using an epiflourescence stereomicroscope (SteREO Discovery.V20; Zeiss, 
Germany). To assess fidelity the image of a target geometry and an image of a printed 
layer were appropriately scaled, overlapped, and compared in Matlab to calculate 
percent accuracy. This was done for circular and diagonal gradients to test the effect of 
pattern on accuracy.  
 
5.3.10 Region Dither Vector (RDV) Algorithm: Converting Tissue Heterogeneity 
into Vectors 
We developed an algorithm that combines the ideas of algorithm 1 an 2 to extract  
tissue heterogeneity  information from images (Figure 5.4). The more detailed process 
is summarized as a flowchart (Figure 5.5). The algorithm converts image slices, such as 
those from CT, into printer vector instructions. The object or tissue is first extracted from 
the image slices using a threshold defined by the user. The object is then separated into 
distinct materials using a dithering algorithm with the threshold defined  
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Functions can be applied within a shape to define gradients of material (A) Example 
of a linear gradient within a cube starting at one edge. Each layer is shown from left 
to right.  (B) Example of a linear diagonal gradient within a cube starting at one 
corner. (C) Example of a circular/cone gradient within a cube.   
 
Figure 5.2-57 Prescribed component heterogeneity - function generated 
geometries in Matlab and Excel. 
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Figure 5.3-58 Prescribed component heterogeneity - function generated 
geometries converted to vectors and fabricated in hydrogels. 
Functions can be applied within a shape to define gradients of material (A) Example 
of a linear gradient within a cube starting at one edge. Each layer is shown from left 
to right with the design of the layer shown above the printed hydrogel layer. Red and 
green dye was added to the hydrogel to visualize the pattern. (B) The layers shown 
in A were printed into a 3D photo-crosslinked hydrogel gradient structure.  (C) 
Function defining material distribution printed in A and B. (D) Fidelity and Pixel value 
for red and green dye labeled hydrogels. Image of target geometry and printed layer 
overlap and compared to calculate percent accuracy for circular and diagonal 
gradients.  
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Figure 5.4-59  Brief algorithm function schematic. The RDV algorithm combines two 
strategies for generating printable vector files.  
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Figure 5.5-60 RDV Algorithm. flowchart for fabricating  geometries exhibiting 
anisotropic heterogeneity based on prescribed images. 
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by the user. Since the printer has difficulty printing dots, all the holes and islands in the 
dithering results must be removed. This must be done with minimal distortion to the 
original shape. Lastly, the software outputs the printer instructions that will print the 
paths as defined by the dither results. More detail on the conversion of dithered points 
into vectors step (highlighted in red in the Figure 5.5 flowchart) is described in Figure 
5.6. 
 
The algorithm dithers images into coordinates/ or points associated with a material 
assignment. In the Figure 5.6 diagram, the dithered results or coordinate points are 
represented by red and blue boxes.   Once images are dithered into coordinates that 
would be printed in different materials, the software creates vector paths for fabricating 
the target model. A starting segment is first selected and then compared to the 
neighboring segment (Figure 5.6A). If the segments are assigned to the same material, 
a vector between the segments will be created. This process repeats until sufficient 
numbers of vector paths have been generated for fabricating the target geometry. 
Directional priority is incorporated into algorithm to maximize efficiency and minimize 
error. (Figure 5.6B). Without directionality a non-ideal scenario of converting dithered 
segments into vectors can occur (Figure 5.6 B1). When comparing the starting segment 
to the adjacent one, the software needs to understand which direction it should search 
for segments with matching materials. If no directionality is specified, the resulting 
vector paths can exhibit numerous directional changes. This requires more movement 
of the printer tools, which can lead to inefficient and inaccurate fabrication. In Figure 5.6. 
B1, the vectors continuously change in directions, which is non-ideal for fabrication.   
 
To enhance fabrication efficiency, we prioritize the direction that the program should 
search for matching coordinates (Figure 5.6B2). We first instruct the program to search  
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Figure 5.6-61 Flowchart summary and diagram for converting dithered paths into 
vectors paths.   
Once images are dithered into segments that would be printed in different materials, 
the software creates vector paths for fabricating the target model. (A) Starting 
coordinate is first selected and then compared to the neighboring coordinate. If the 
coordinates are assigned to the same material, a vector between the coordinates will 
be created. This process repeats until sufficient numbers of vector paths have been 
generated for fabricating the target geometry. (B) Directional priority is incorporated 
into algorithm to maximize efficiency and minimize error. (B1) Without directionality a 
non-ideal scenario of converting dithered coordinates into vectors can occur. (B2) By 
prioritizing the direction that the program should search for matching coordinates, 
smoother more continuous vector paths are created. 
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in the +x direction (Figure 5.6B2.1). The software compares the starting material 
coordinate to the adjacent one directly to the right, and if the materials match, a new 
vector path is created. This process continues until no more matching index can be 
found along the +x direction. The program then searches in the second direction (-y 
direction) (Figure 5.6B2.2), and vectors paths are created in the –y direction if matching 
material points are found. If there is no match, the software moves onto the next 
direction (–x direction) (Figure 5.6B2.3). Once all directions have been explored, the 
newly formed vectors along same directions are added to form continuous vector paths 
(Figure 5.6B2.4). A new material point that has not been processed is then selected as 
starting point, and the comparison process repeats until all coordinate points have been 
processed.  By prioritizing the direction that the program should search for matching 
coordinates, smoother more continuous vector paths are created. 
 
5.3.11 MicroCT and MRI Scanning of Aortic Valve Tissue  
A porcine aortic valve conduit obtained fresh at slaughter (Shirk Meats, Himrod, NY) 
was fixed in formalin and scanned with the leaflets in a partially open position via micro-
CT at 100 μm voxel size, 80 keV, 30 mA, 800 angles, 30 ms exposure time, 30 gain, 
and 20 offset (eXplore CT120; GE Healthcare, United Kingdom). For μCT the valve was 
positioned on a foam tray and scanned in air.  For the MRI scan the same valve was 
embedded in agarose. 1.5% agarose was added to deionized water, the solution heated 
until the agarose dissolved, the solution partially cooled, and then used to embed the 
valve tissue.  The MRI scan performed on the valve was type T1, resolution: of 0.2 mm 
x 0.2 mm with a slice thickness of 0.3 mm (Model: Signa HDxt, GE Medical Systems). 
MicroCT and MRI scans were processed using the RDV algorithm (Figure 5.7 and 
Figure 5.8). 
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  Figure 5.7- 62 User interface of RDV algorithm software written in Matlab. 
(A) A cylinder exhibiting a gradient applied through the image is dithered into 
vertexes. The top row represents the object with original data segmented out of the 
background for different planes (y verses x, z verses x, and z verses y), and the 
bottom row represents the dithering results. (B) Set of CT scans of a pig aortic heart 
valve, original data segmented out of background and then dithered into points at the 
resolution requested by the user for printing.  
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Figure 5.8-63 Interpretation of μCT and MRI intensity values for heterogeneous 
vector generation. 
(A) μCT (B) MRI scan images of a fixed porcine aortic valve were dithered and 
converted to printable formats. The valve base with leaflets is shown with different 
threshold (alpha) settings (left to right) to segment out the tissue region from the 
background.  Material distribution was arbitrarily set at 50:50 red and blue. For μCT 
the valve was scanned in air, and in MRI the valve was embedded in agarose.  
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Other parameters of the scan were: Series Description: 'SPGR 45deg nex=8, 0.2 x 0.2 x 
0.3' ;Repetition Time: 31.6550; EchoTime: 7.4200; Number Of Averages: 8; Imaging 
Frequency: 127.7133; Imaged Nucleus: '1H‘; Echo Number: 1; Magnetic Field Strength: 
3; Device Serial Number: '0000000COR373216‘; Software Version: '15\LX\MR Software 
release:15.0_M4A_0947.a‘; Protocol Name: 'SPGR 45deg nex=8,0.2 x 0.2‘; Receive 
Coil Name: 'HD WristCoil‘.  
 
5.3.12 Vector Printing MEGEL/PEG-DA Hydrogels  
Alternating line vector files were designed in Microsoft Excel as a simplified geometry to 
test heterogeneous path mixing and crosslinked scaffold fidelity. Previously assessment 
of fidelity and printing parameters has been done with single material 
constructs/scaffolds (Ballyns, Cohen et al. 2010; Hockaday, Kang et al. 2012; Kang, 
Hockaday et al. 2013). MEGEL/PEG-DA was used because of its cell compatibility and 
printability. We found that photo-crosslinking of hydrogel scaffolds bleaches food dye so 
a cellularized test was designed to assess fidelity after photo-crosslinking and pattern 
maintenance at time points in culture. (Refer back to Figure 5.3 for assessment of 
printed layers prior to photo-crosslinking or for non-photo-crosslinking hydrogels, and 
Figure 5.3.) Signs of color bleaching are visible in the base of the valve construct in 
Figure 5.9. The gelatin component in the hydrogel required the nickel chromium wire 
heating coils to be applied to the syringe barrel and tips to maintain temperature at 37°C 
during printing (Figure 5.10C). Without the heating coil the working time of the 
MEGEL/PEG-DA solution after it is removed from the water bath is very short, the 
viscosity will change as the solution cools (affecting deposition), and it will solidify in the 
syringes. 
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Figure 5.9-64  Image defined material heterogeneity in printed hydrogel valve 
constructs. 
(A)μCT image slices in MicroViewTM at base, mid sinus, and sinotubular junction of a 
porcine aortic heart valve (B) Defined tissue region and dithered material designation 
of valve slice generated in Yeh-Cheng algorithm.(C) Single heterogeneous valve 
layers printed in two different hydrogel solutions corresponding to μCT image slices. 
(D) 3D heterogeneous valve printed with hydrogel in stages. Left to right – initial 
printed layers, partially printed scaffold top view, final heterogeneous structure.    
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Figure 5.10-65  Setup for printing line pattern heterogeneous hydrogel constructs 
(A) Vector paths were generated and plotted in Microsoft Excel and then formatted 
into vector files for printing. (B) The paths were grouped into files, and the priority set 
in Fab@Home program based on which materials and paths we wanted to be printed 
1st. The first hydrogel precursor solution is used to trace out the border and the 1st set 
of lines (C), then the second material fills in the alternating lines (D) This repeats for 
4 scaffolds per print (E), and (F).  For this geometry a 0.625 path width, was used, 
and the printer syringes were loaded containing MEGEL/PEG-DA3350 0.075w/v% 
Irgacure (colorless here), and a solution of MEGEL/PEG-DA3350  0.75w/v% VA086 
(blue dye added) each with a 0.800 mm tip. Heating coils were attached to the 
syringes to maintain the hydrogel temperature at 37C and keep the gelatin 
component a liquid. 
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5.3.13 Quantifying Cell Distribution within Crosslinked Heterogeneous Hydrogel 
Constructs 
In order to use hydrogels for tissue engineering, and control the dimensions of 
fabricated constructs, we need to anticipate construct geometry, based on swelling and 
mixing introduced by the printer.  Pattern accuracy for individual scaffolds after photoen-
capsulation bioprinting and cell distribution within hydrogels was assessed using image 
J and fluorescent imaging.  HADSMC were tagged with either Cell Tracker Red or Cell 
Tracker Green dye and added to MEGEL/PEG-DA hydrogel precursor solution which 
was printed into a heterogeneous alternating line pattern scaffold. The construct was 
photo-crosslinked post-printing for 5 minutes at 2 mW/cm2. The encapsulation solution 
was made with 0.075%w/v Irgacure. The compressive modulus of this hydrogel when 
crosslinked is 42.0.3±8.2 kPa in the 5 to 15%strain range and the estimated weight 
based swelling ratio  of the hydogel is 13.7 (Chapter 4). The HADMSC/MEGEL/PEG-
DA3350 hydrogel constructs were cultured to 1, 2, and 3 days.  Hydrogel constructs 
were imaged using an epifluorescence stereomicroscope (SteREO Discovery.V20; 
Zeiss, Germany).  
 
A region count macro and the particle analysis function in Image J enables counting of 
cells in specific regions to analyze fluorescent images (Figure 5.11A). In image J the 
steps used to count the number of cells in printed regions to determine distribution 
were: 1st the image scale is set and the pixel/units are used to define the macro for an 
image taken at a particular magnification, 2nd the color channels are split for a given 
red/green stripe image, 3rd the dotted line tool is used to add a marker dot per each bin, 
4th the channel image is thresholded so that the cells (which should be bright/higher 
intensities) are clear from the background fluorescence (which is actually pretty high for 
the hydrogels), and then 5th the macro which has arbitrary user defined size bins is used 
with the analysis particles function to count cells within a size range. The dotted line  
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Figure 5.11-66 Cell distribution within crosslinked heterogeneous hydrogel 
constructs. 
Pattern accuracy for individual scaffolds after printing and cell distribution within 
hydrogels was assessed using image J and fluorescent imaging. HADSMC were 
tagged with either Cell Tracker red or Cell Tracker Green dye and added to 
MEGEL/PEG-DA hydrogel precursor solution printed into a heterogeneous 
alternating line pattern scaffold, and photo-crosslinked for 5 minutes at 2 mW/cm2 .(A) 
A simple region count macro and the particle analysis function in Image J enables 
counting of cells in specific regions. Color channels (red or green) were thresholded 
and bin/counted to generate histograms of %cell type per 100 μm wide column along 
the scaffold.  (B) Theoretical red and green cell distribution through scaffold 
depending on tip size and path width. Mixing at the edges of the extruded lines 
occurs if tip size is greater than path width. (C) Representative images of line 
scaffol1ds printed with red and green labeled HADSMC and (D) the percentage of 
red and green cells across the scaffold corresponding to the 25X image, Top to 
bottom, scaffold cultured for 1, 2, 3 days. Left to right printed scaffold at 10X, 25X 
(used for analysis), and histogram. If compared to a ‘no edge mixing model these 
scaffolds have 79%, 83%, 63% accuracy.  
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step is important so that every bin has at least one particle. This is subtracted out later. 
This is necessary so that empty bins (no cells counted) are reflected in the output data. 
The cell count data from image J (red and green in this case) is converted to a 
histogram of percentage of red and green per bin region of the scaffold. 25X images 
were analyzed in this study to generate histograms of %cell type per 100μm wide 
column along the scaffold. Theoretical red and green cell distribution through scaffold 
was estimated based on tip size, path width, and swelling of the hydrogel. The 
distribution of cells throughout the scaffold could also change depending on how well 
optimized the print parameters are (Kang, Hockaday et al. 2013).  Mixing at the edges 
of the extruded lines is anticipated if the actual path width/path space (based on tip size, 
deposition rate, print speed, distance to stage, and viscosity of solution) is greater than 
the path space of the geometry (Figure 5.11B and Figure 5.12A).  The theoretical 
distribution of cells through the scaffold was compared to the actual distribution of cells 
across the constructs to estimate the pattern fidelity of a given construct.  
 
5.4 Results 
5.4.1 Layer Fidelity of Prescribed Component Heterogeneity  
Heterogeneous gradients can be printed directly into hydrogel scaffolds and high 
pattern fidelity results regardless of 3D gradient (Figure 5.3D). A diagonal gradient and 
a circular gradient design when compared to the printed hydrogel layer have similar 
accuracy changes through the scaffold.  The average percent accuracy and standard 
deviation for the circular gradient layers decreased and then increased through the print 
(layer 1, 2, 3, 4, 5, 6, 7 percent accuracy was 97.36±0.62%, 96.21±0.63%,  
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Figure 5.12-67 Assessment of fabrication accuracy changes depending on path 
mixing during printing and the post-fabrication material properties of the 
hydrogel.   
(A) Boolean model of printed hydrogel lines for predicting optimal path space that 
yields uniform layer (Kang et al 20013). Q: half cross-sectional area of each line; R: 
void region between printed lines; S: overlapping region; T: rectangular region 
formed between the centers of the two lines. This model assumed that when lines 
are overlapped, the void region R is reduced by equal volume of the overlapping 
region S. Some path overlap is needed so that the discrete materials are contiguous, 
and the printed heterogeneous layer is sound.  (B) Distribution of cells across  day 1 
printed scaffold (Figure 11C1) and the optimal scaled theoretical distribution are 
compared to obtain a percent error estimate.(C) Optimization of % accuracy estimate 
for the day 1 scaffold (Figure 11C1), comparing the percent accuracy verses the path 
space scaling with and without edge overlap. (D) Diagram of printed construct 
undergoing isotropic swelling. (E) Diagram of mechanically heterogeneous hydrogel 
construct experiencing anisotropic deformation due to non-uniform material swelling.  
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94.04±2.34%, 80.61±1.42, 84.47±1.46, 90.35±1.02, 97.36±0.62). The average percent 
accuracy and standard deviation for the diagonal gradient layers decreased and then 
increased through the print (layer 1, 2,3, 4, 5, 6, 7 percent accuracy was 97.36±0.62%, 
96.95±0.78%, 89.25±1.01%, 80.79±1.49, 85.86±2.52, 93.06±0.55, 97.36±0.62).  
 
5.4.1 RDV Algorithm: Converting Tissue Heterogeneity into Vectors 
We used the RDV algorithm to process images into printable format through a user 
interface written in Matlab (Figure 5.7). This can be done for arbitrary shapes, such as a 
cylinder exhibiting a gradient applied through the image (Figure 5.7A)  or medical 
images such as CT scans of a porcine aortic heart valve (Figure 5.7B). In each image, 
the top row represents the object with the original data segmented out of the 
background, and the bottom row represents the dithering results. At this interface the 
user can set the ‘alpha’ channel to segment out the tissue region from the background 
and the user sets the material distribution throughout the tissue region. Images from 
both  μCT and MRI scans of an aortic valve were  processed with the RDV algorithm 
software (Figure 5.8A and 5.8B).  Tissue heterogeneity is detectable in both types of 
scans and can be converted to a dithered and printable format.  For the scans used in 
this study when comparing between leaflets and the aortic valve sinus wall the 
difference is more pronounced for μCT scans. When the scans are run through the RDV 
algorithm to create printable vectors the μCT scans give more distinction between the 
root and the leaflet.   
 
5.4.2 Printing of Heterogeneous Anatomical Geometry 
The utility of the RDV algorithm was demonstrated by fabricating a heterogeneous valve 
construct using two hydrogel precursor solutions based on the μCT scan (Figure 5.9).  
The algorithm effectively identifies regions of heterogeneity in the images, it isolates the 
anatomic shape from the background, it applies a heterogeneous material gradient 
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throughout the valve geometry based on the intensity values present in each image 
slice (Figure 5.9B), and then generated printable vectors from that information.  Each 
layer of the geometry when printed had discretized red and blue labeled hydrogel 
precursor solution throughout (Figure 5.9C). The heterogeneous layers were then 
deposited in 3D with simultaneous photocroslinking with the low power LED array, to 
form a hydrogel valve construct (Figure 5.9D).   
 
5.4.3 Cell Distribution within Crosslinked Heterogeneous Hydrogel Constructs 
HADMSC were printed into a linear stripe pattern with MeGel/PEG-DA hydrogels so that 
a different gel cell mixture alternates with the other. (Figure 5.11C). A heterogeneous 
pattern was present in the scaffolds at 3 days in culture. The histograms of percentage 
of red and green cells across the scaffold corresponding to the 25X image (Figure 
5.11D) show that the alternating pattern of cells is present at day 1, 2, and 3. To 
estimate fidelity it is possible to scale the theoretical distribution of cells within scaffold 
(Figure 5.12). If compared to a ‘no edge mixing‘ model with the path space expanded to 
0.8 these scaffolds have 78%, 83%, 63% accuracy.  
 
The scaffolds were compared to a ‘no edge mixing‘ model distribution with the path 
space expanded to 0.8 because the highest percent accuracy occurred at that scaling. 
The optimization data is shown for the day 1 scaffold (Figure 5.11C1), comparing the 
percent accuracy verses the path space scaling with and without edge overlap (Figure 
5.12D and 5.12C).  The printed scaffolds better matched the theoretical model with no 
edge mixing. While there is some edge mixing observed in the constructs Figure 5.11D) 
the cell distribution does not match a 0.1 mm overlap. The estimated path space upon 
printing was nearly matched between the extrusion strand of deposited precursor 
solution and the geometry (~0.6 to 0.625)  (Kang, Hockaday et al. 2013), so the degree 
of overlap should be minimal.  These constructs were removed from culture and 
 246 
 
imaged, and each construct was assessed for pattern fidelity.  Although it was not done 
for this study, one could make comparisons between days, tracking the construct and 
baseline print fidelity day by day for a given material combination and geometry 
determined.   
 
5.5 Discussion 
By combining the methods to print anatomical geometries and establish spatial and 
material gradients, we demonstrate the ability of 3D printing to fabricate truly 
heterogeneous tissue geometries. This capability is uniquely enabled by 3D printing and 
is not possible using molding or classical fabrication techniques. Researchers are 
rapidly expanding the capabilities of 3D printing, particularly in the area of engineering 
heterogeneity into tissue constructs (Fedorovich, Wijnberg et al. 2011; Fedorovich, 
Schuurman et al. 2012; Lee, Ahn et al. 2014; Pati, Jang et al. 2014; Wust, Godla et al. 
2014). There are an expanding number of materials and handling methods for 
heterogeneous printing(Lee, Ahn et al. 2014; Pati, Jang et al. 2014) and imaging 
advances in the realm of soft tissues and hydrogels(Feng, Taraban et al. 2011; Curtis, 
Zhang et al. 2012; Franquet, Avril et al. 2013; Kotecha, Klatt et al. 2013). These 
advances could be used in conjunction with our image processing and path generation 
RDV algorithm to enable better engineering of living tissues.  
 
In this study, tissue heterogeneity information was extracted from μCT and MRI images 
of an aortic heart valve and converted into printable format. The algorithm effectively 
identifies regions of heterogeneity in the images, it isolates the anatomic shape from the 
background, it applies a heterogeneous material gradient throughout the valve 
geometry based on the intensity values present in each image slice, and then it 
generates printable vectors from that information.  We demonstrate image-derived and 
arbitrary heterogeneous vector geometries by 3D printing of heterogeneous hydrogel 
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constructs both with dye labeled precursor solution and fluorescent labeled 
encapsulated cells.  3D printing or additive manufacturing strategies have previously 
generated computer aided design (CAD) files of tissues from CT and MRI and have 
used them to fabricate implants and tissue engineered constructs. CT imaging and 3D 
printing of hard tissues has dominated in this area, incorporating higher level structure 
to mimic cortical and trabecular bone(Schieker, Seitz et al. 2006; Tarafder, Balla et al. 
2013; Zhang, Jones et al. 2013). Soft tissue constructs have generally only used gross 
shape information from CT and MRI and variations in intensity and the information 
describing structural heterogeneity within the tissue is thresholded out/processed out 
(Ballyns, Gleghorn et al. 2008; Hockaday, Kang et al. 2012). Investigators have 
incorporated regional heterogeneity into vertebral disc, cartilage-bone, blood vessel-
bone, and ear cartilage-electronic combination constructs using 3D printing (Cohen, 
Malone et al. 2006; Fedorovich, Wijnberg et al. 2011; Schuurman, Khristov et al. 2011; 
Fedorovich, Schuurman et al. 2012; Mannoor, Jiang et al. 2013). 3D printed constructs 
have also demonstrated control of internal structure within a bulk shape, and 
investigators have designed geometries to mimic tissue microstructure, 
microvasculature, capillary branching structure, and distribution of more than one cell 
type (Bianchi, Rosi et al. 2007; Cui and Boland 2009; Lee, Debasitis et al. 2009; Lee, 
Pinckney et al. 2009; Lee, Lee et al. 2010; Lee, Polio et al. 2010; Tirella, Vozzi et al. 
2011; Gaetani, Doevendans et al. 2012; Koch, Deiwick et al. 2012; Marga, Jakab et al. 
2012; Miller, Stevens et al. 2012; Blais, Parenteau-Bareil et al. 2013; Michael, Sorg et 
al. 2013). In these efforts a variety of techniques have been developed to control and 
introduce heterogeneity of strength and stiffness, fiber structure, bioactivity, and 
differentiation inductive properties of the microenvironment into tissue engineered 
constructs. Our algorithm could be applied with these other techniques and potentially 
adapted with the functional-tissue-unit concept. This would enable anatomically derived 
macroscopic tissue shape and internal structure of functionally heterogeneous tissues.  
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While the hydrogel scaffolds shown here were cellularly and spatially heterogeneous, 
they were mechanically homogeneous (Figure 5.9 and 5.11). The precursor solutions in 
a given layer had the same polymer formulation and the same photoinitiator 
concentration and photo-crosslinking was used so that the light energy delivered was 
uniform.  The consequence of this is that the swelling of fabricated heterogeneous valve 
constructs and the HADMSC/hydrogel constructs is effectively isotropic (Figure 5.12D). 
The isotropic swelling makes it straight forward to demonstrate high fidelity per printed 
layer. Two types of heterogeneous layer fidelity analysis were demonstrated for a 
simplified geometry and with more complexly heterogeneous layers. Labeling hydrogel 
solution with dye or using cell tracking fluorescent labels enables assessment of print 
fidelity.  However, it is important to consider that when printing with hydrogels with 
dissimilar swelling ratios anisotropic swelling may occur (Figure 5.12E). A predictive 
model to assess shape fidelity and guide iterative engineering will need to take this into 
account (Figure 5.13). To completely account for hydrogel swelling in 3D 
heterogeneous scaffolds, depending on the complexity of the tissue to be engineered, a 
finite elemental analysis model may be needed.  
 
Additionally, non-uniform swelling may also induce stress in the structure.   In our 
previous work where we fabricated valve constructs using an STL valve geometry, we 
observe a significant effect of swelling on valve volumetric and layer specific shape 
fidelity using μCT (Hockaday, Kang et al. 2012).  Other studies indicate that assessment 
of whole tissue heterogeneous pattern fidelity post-fabrication and then post-remodeling 
using μCT or MRI could be possible.  Wust et al printed heterogeneous hydrogel 
scaffolds and found that by adding hydroxyapatite into their extrusion solution they 
could change the radiopacity of the material and the contrast for μCT in order to assess 
the heterogeneous pattern within the printed construct after swelling (Wust, Godla et al. 
2014).  However, one of the problems with CT is the inability to distinguish  
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In order to use hydrogels for tissue engineering, and control the dimensions of 
fabricated constructs, we need to anticipate construct geometry, based on swelling 
and mixing introduced by the printer. The user controls the fabrication settings 
associated with the printer, the file geometry, and the materials and cells being used. 
Under these fabrication conditions a construct of a specific fidelity will be produced. 
When using hydrogels, the actual geometry post-fabrication and equilibrium with 
culture medium may differ significantly from printer input geometry. Therefore the 
user needs to anticipate contribution of swelling and mixing. In the context of tissue 
engineering important future work is to study the contribution of cell remodeling.  
 
Figure 5.13-68 Diagram of heterogeneous material printing  scaffold shape fidelity 
and feedback. 
 250 
 
many soft tissues based on native contrast which are largely homogeneous in density  
(Wathen, Foje et al. 2013). For tissues where hydroxyapatite could introduce 
undesirable microenvironmental or differentiation characteristics (such as in heart 
valves where osteogenic differentiation is not ideal) MRI may be a better choice to 
assess heterogeneous pattern maintenance and remodeling.  Studies have 
demonstrated that MR can be used to detect remodeling and differentiation in 
engineered tissues and to detect differences in modulus between different hydrogels 
(Feng, Taraban et al. 2011; Curtis, Zhang et al. 2012; Kotecha, Klatt et al. 2013).  MR 
spectroscopy, imaging, and elastography could be used to analyze 3D printed hydrogel 
tissue remodeling and pattern maintenance in the entire structure.  
 
When the MRI and CT scans were run through the RDV algorithm to create printable 
vectors, we found that the μCT scans gave better distinction between the root and the 
leaflet. This is likely related to the fact that the μCT scans used here had a smaller slice 
thickness for the scan (0.1 μCT scans verses 0.3 for the MRI scan) and was a better 
match for the dither and fabrication settings in the algorithm, and not an indication of 
feasibility, suitability, or capability of the imaging modality for this application. We 
demonstrate that we can extract heterogeneity from both MRI and CT type images. 
However, identification of the physical or biological meaning of that information was not 
within the scope of this study. The intensity output of μCT is generally related to the 
material density and MRI image intensity  is related to water proton relaxation time 
within a magnetic field after a radiofrequency pulse, diffusion, and water density 
(Kotecha, Klatt et al. 2013).  Correlating image intensity values to fabricatable 
variables such as modulus or cell type is a critical next step in this research and for the 
application of this tissue heterogeneity algorithm. Ultimately μCT or MRI alone may be 
insufficient information to inform heterogeneous fabrication, and additional techniques 
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such as  μCT detectable immunostaining to obtain 3D visualization of cell and molecular 
patterning within tissues (Metscher and Muller 2011) may be needed.   
 
5.6 Conclusion 
The RDV algorithm presented in this study can be used to extract tissue heterogeneity 
and anatomic shape information from μCT and MRI images and convert those intensity 
values into a printable format for the scanned 3D tissue geometry. Image-derived and 
arbitrary heterogeneous vector geometries can be 3D printed into heterogeneous 
hydrogel constructs both with dye labeled precursor solution and fluorescent labeled 
encapsulated cells with high fidelity. This algorithm provides a tool for 3D printing 
heterogeneous, anatomically relevant tissue engineered constructs.   
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CHAPTER 6 
HEART VALVE BIOREACTORS FOR DYNAMIC CONDITIONING 
 
Portions of this chapter was published as a book chapter titled “Aortic Heart Valve 
Tissue Regeneration” in Tissue and Organ Regeneration: Advances in Micro and 
Nanotechnology (Duan, Hockaday et al. 2014). 
 
6.1 Introduction 
The classical tissue engineering concept is to fabricate a temporary scaffold that can 
support cell adhesion and signaling and eventually be remodeled into the patients’ own 
tissue. Heart valves are particularly challenging because the scaffold must function 
mechanically the moment it is implanted. The aortic valve is situated in one of the most 
demanding mechanical environments in the body (Butcher, Simmons et al. 2008). 
Tissue engineered heart valves have required dynamic in vitro conditioning in a 
bioreactor that simulates in vivo   flow conditions prior to implantation (Gandaglia, 
Bagno et al. 2011). To fulfill strenusous requirements of geometry, mechanical strength, 
and biological function in aortic valve tissue engineering, successful strategies must 
thus consider cell source, scaffold parameters, fabrication techniques, and bioreactor 
design. This chapter will briefly review the functional characteristics of dynamic culture 
systems.  
 
6.2 Heart valve tissue bioreactors 
Native heart valves develop and function under dynamic conditions. Bioreactors 
designed to mimic the physiological stress and hemodynamics heart valves experience 
are integral to tissue engineering strategies for heart valve regeneration. Numerous 
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studies have demonstrated that TEHVs cultured in bioreactors have improved ECM 
content and organization, mechanical properties, and function upon implantation 
compared to those that are statically cultured (Hoerstrup, Sodian et al. 2000; Flanagan, 
Cornelissen et al. 2007; Flanagan, Sachweh et al. 2009; Ramaswamy, Gottlieb et al. 
2010; Schmidt, Dijkman et al. 2010).  The magnitude and distribution of mechanical 
loading and flow changes during the cardiac cycle, and it changes during the course of 
heart valve development, as shown in Figure 6.1 and Table 6.1 (Brewer, Mentzer et al. 
1977; Dagum, Green et al. 1999; Aikawa, Whittaker et al. 2006).  Two main classes of 
bioreactors have been used for these studies: component bioreactors and whole organ 
bioreactors.  
 
6.2.1 Component bioreactors  
Component bioreactors are designed to apply a single specific mechanical stimuli to 
identify how and by what mechanism it effects cell differentiation and/or scaffold 
remodeling. Biomechanical components of the environment tested with specialized 
bioreactors include cyclic stretch, cyclic flexure, and oscillating shear stress and flow 
(Berry, Steen et al. 2010). Some of the major findings of these three types of partial 
tissue bioreactor studies are summarized in Table 6.2.  
 
To apply defined fluid shear stress to tissues and cell seeded scaffolds, different 
designs of a parallel plate flow chamber combined with a pump have been used. 
Butcher et al found that valve endothelial cells align perpendicular to flow while vascular 
endothelial cells align parallel to flow within 24 hours when steady, unidirectional shear 
stress (20 dynes/cm2) is applied (Butcher, Penrod et al. 2004). They also found that the 
signaling pathways mediating the alignment response was different between the two 
cell types (Butcher and Nerem 2006).   
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Figure 6.1 -69 Native valve loading and flow conditions change during cardiac 
cycle and as the valve develops.   
(A) In addition to the leaflets, the aortic root and sinuses deform during the cardiac 
cycle (Dagum, Green et al. 1999; Butcher, Mahler et al. 2011). (B) Changing 
mechanical forces during cardiac valve development are tied to matrix organization 
and cell activity. Modified from (Aikawa, Whittaker et al. 2006).  
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Table 6.1-4 Native valve loading and flow conditions change as the valve 
develops  
Age/Stage Aorta Blood 
Pressure 
Sys/Dias 
Pulmonary Artery 
Blood Pressure 
Sys/Dias 
Heart Rate [bpm] 
 Fetal  50/15 mmHg 50/15 mmHg 140-180 
Postnatal  70/40 mmHg 30/15 mmHg 100-160 
Toddler (2 years 
old) 
95-105/53-66mm 
Hg 
? 80-140 
Adult  120/80 mmHg 20/9 mmHg 60-80 
 (Dagum, Green et al. 1999; Aikawa, Whittaker et al. 2006; Kovacs, Berghold et 
al. 2009; Butcher, Mahler et al. 2011).  
 260 
 
Table 6.2-5 Miniaturized/partial tissue bioreactors 
Bioreactor types Cell/scaffold types 
Bioreactor features in specific 
study 
Mechanistic findings Ref. 
Flow Cell Monolayer (VEC) Steady, laminar, unidirectional 
shear stress  (20 dynes/cm
2
) 
Valve endothelial cells are distinct from 
vascular endothelial cells in behavior 
and signaling pathways.  
Valve endothelial cells align 
perpendicular to flow.  
(Butcher, Penrod 
et al. 2004) 
Flow VIC + VEC collagen slab 
construct 
Steady, laminar, unidirectional 
shear stress  (20 dynes/cm
2
) 
Valvular interstitial cells proliferate when 
not in communication with valvular 
endothelial cells.  
VIC ECM secretion is dependent on 
endothelial cells and on flow.  
(Butcher and 
Nerem 2006) 
Flow PGA fiber scaffold aortic 
myofibroblasts  
Flow rate 250-500ml/min Collagen synthesis increases in 
response to shear  
(Jockenhoevel, 
Zund et al. 2002) 
Stretch (Flexcell) Confluent VICs and MSC 
plated on collagen I 
coated membrane 
Flexible membrane culture 
surface stretched across posts 
by applied vacuum.  0.6 Hz; 
radial stretch 7, 10, 14, 20%  
VIC and MSC increase collagen 
synthesis  in response to cyclic stretch 
(Ku, Johnson et al. 
2006) 
Stretch (Flexcell) PGA fiber scaffold coated 
with P4HB seeded with 
human venous 
myofibroblasts with fibrin 
gel cell carrier 
Scaffold ends reinforced and 
attached to Flexcell well with 
silicone rubber. Intermittent 
straining at 4% 1Hz. 
Intermittent straining engineered tissues 
increased collagen production, crosslink 
density, collagen organization, and 
mechanical properties faster than 
constrained controls. Stronger tissues in 
shorter culture time. 
(Rubbens, Mol et 
al. 2009; Syedain 
and Tranquillo 
2009) 
Uniaxial Stretch 
(linear actuator)  
Aortic valve leaflet 
circumferential direction 
10%,15%, 20% strain at 1.167 
Hz (70 beats/min) 
10% cyclic stretch ‘normal’ maintains 
native matrix remodeling activity.  
Cell proliferation and apoptosis increase 
as cyclic stretch increases from normal 
to pathologic levels (15%, 20%). 
Increase in matrix remodeling enzyme 
activity and expression at elevated cyclic 
stretch (15, 20%).  
(Balachandran, 
Sucosky et al. 
2009) 
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Table 6.2 Continued 
Bioreactor types Cell/scaffold types 
Bioreactor features in specific 
study 
Mechanistic findings Ref. 
Stretch 
(linear actuator)  
Aortic valve leaflets 
circumferential direction 
Uniaxial tension delivered with 
actuating arm. Tissues threaded 
with stainless steel springs. 15% 
stretch, 1 Hz  
Cyclic stretch + biochemical factor 
TGFB1 increase contractile and 
biosynthetic proteins in VICs  
(Merryman, Lukoff 
et al. 2007) 
Stretch (biaxial) Mitral VIC or chordal cells 
seed in collagen gels 
10% strain, 1.167 Hz. Alternate 
stretch and relaxation every 24 
hrs. Collagen gel anchored by 
mesh holders.  
GAG secretion up regulated during 
cyclic stretch and down regulated during 
relaxation. VICs adapt to high cyclic 
strains indicated by proportion of GAG 
classes changing. For chordal cell 
constructs GAG classes remain 
consistent.   
(Gupta, 
Werdenberg et al. 
2008) 
Stretch (Biaxial and 
anisotropy) 
Aortic VIC seeded into 
collagen gels  
Equibiaxial and controlled 
anisotropic strain.  
Collagen gel anchored/formed in 
a compression spring.  
Increasing anisotropy of biaxial strain 
increases cell orientation and collagen 
fiber alignment along principal directions 
of strain.  Cells orient before fibers 
reorganize. Results suggest strain field 
anisotropy regulates VIC fibroblast 
phenotype, proliferation, apoptosis, and 
matrix organization. 
(Gould, Chin et al. 
2012) 
Flex 
(linear actuator) 
PGA vs PLLA scaffolds 
each coated with P4HB 
(No cells) 
Three point bending with 
controlled strain rate. 1Hz 
Decrease in stiffness both materials 
after 2, 3, 5 weeks of flexure. 
(Engelmayr, 
Hildebrand et al. 
2003) 
Flex (linear 
actuator) 
Ovine vascular smooth 
muscle cells seeded into 
PGA and PLLA scaffolds 
Three point bending, flexure 
angle  62%, 1 Hz. Multiple wells 
to hold rectangular specimens 
(isolated from each other) 
Cyclic flexure increased effective 
stiffness, collagen, vimentin expression 
of cell seeded scaffolds 
(Engelmayr, 
Rabkin et al. 2005) 
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Table 6.2 Continued 
Bioreactor types Cell/scaffold types 
Bioreactor features in specific 
study 
Mechanistic findings Ref. 
Flow + Stretch + 
Flex (Bending and 
stretch with a linear 
actuator, shear flow 
induced by a 
paddle wheel.) 
Bone marrow 
mesenchymalstem cells 
from juvenile sheep 
seeded into PGA and 
PLLA scaffolds  
Can study flex, stretch, flow each 
independently or coupled. 12 
rectangular scaffolds at once.  
Spiral metal binders threaded 
through ends of scaffolds. 0.012–
1.875 dynes/cm
2
. Up to 75% 
tensile strain. 
Cyclic flexure and laminar flow 
synergistically accelerate BMSC 
mediated tissue formation.  Collagen 
content and effective stiffness was 
higher for flex-flow conditions compared 
to flex and flow only conditions.  
Comparable collagen and effective 
stiffness for flex only conditions to SMC 
seeded scaffolds.  
(Engelmayr, Sales 
et al. 2006; 
Engelmayr, Soletti 
et al. 2008) 
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Jockenhoevel et al included a second nutrient chamber and a multi-frame set up to hold 
multiple seeded scaffolds (Jockenhoevel, Zund et al. 2002). An infusionpump removed 
media from the nutrient chamber and a gravity feed replenished it. It was found that 
aortic myofibroblasts seeded into a PGA hydrogel scaffold responded to shear stress by 
producing hydroxyproline, indicating collagen deposition.   
 
The effects of defined tensile strain on native and engineered valve tissues and cells 
have been studied using a variety of stretch bioreactor designs. These bioreactors 
deform the tissue or culture using either a pressure/vacuum or a linear actuator and 
have varying degrees of geometric control. The commercially available Flexcell 
bioreactor deforms flexible membranes that are set into a multi-well plate. A vacuum 
applied to the underside of the well deforms the membrane across a post. The flexible 
membrane setup has been used to condition cell monolayers (Ku, Johnson et al. 2006) 
and has been adapted to condition engineered heart valve tissues (Rubbens, Mol et al. 
2009). A recent bioreactor specifically designed to hold hydrogel based tissues, deforms 
a silicone rubber slab that can hold different mold shapes to control strain direction to 
introduce anisotropy into tissues (Gould, Chin et al. 2012). 
 
 During each cardiac cycle, bending stresses are caused by the reversal of the 
curvature of the leaflets when leaflets open and close in response to pressure gradient 
changes (Deck, Thubrikar et al. 1988; Butcher, Mahler et al. 2011). Dynamic flexure 
bioreactors have enabled study of cell seeded scaffolds for valve engineering and valve 
tissues in bending. The flexure and bending mode of these bioreactors is generally 
driven by a linear actuator. Engelmayr et al. developed multiple bioreactors for testing 
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scaffolds in flexure (Engelmayr, Hildebrand et al. 2003; Engelmayr, Rabkin et al. 2005; 
Engelmayr, Sales et al. 2006; Engelmayr, Soletti et al. 2008). The flex bioreactor 
applies 3 point bending to a scaffold inside a well.   
6.2.2 Whole valve scale bioreactors  
Whole valve scale bioreactors, while not able to target mechanisms of a specific 
stimulus, simulate the entire hemodynamic and mechanical microenvironment on TEHV 
to understand how cells and scaffold materials would interact and remodel towards 
clinically useful valve conduits. Aspects of this 3D environment include (1) leaflet 
stretching and deformation during opening and coaptation; (2) deformation of the valve 
root and pressure induced vessel stretch; (3) non laminar flow in the coronary sinuses 
(Berry, Steen et al. 2010).  They are generally comprised of the following basic 
components: (1) a driving force or pump for fluid movement; (2) a reservoir usually 
containing culture media; (3) a holder or test section containing the heart valve; (4) a 
fluid capacitance to store and release energy every pump cycle; (5) a resistance 
element to help control the overall system pressure, and (6) a means of gas exchange 
(Berry, Steen et al. 2010).  The culture bioreactor must also maintain physiological 
temperature and maintain sterility throughout long term culture. The different designs of 
bioreactors produce different hemodynamics conditions, degrees of control, and 
throughput. There are four main bioreactor types- pneumatic diaphragm/balloon, plate-
piston, pump and splash, as shown in Figure 6.2 and summarized in Table 6.3. 
 
Pneumatic diaphragm or balloon bioreactors use a deformable elastic membrane to 
drive fluid through a flow loop (Figure 6.2A). With this type of design it is possible to  
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(A) Pneumatic diaphragm/balloon (Hildebrand, Wu et al. 2004); (B) plate 
piston (Durst and Grande-Allen 2010; Schleicher, Sammler et al. 2010); (C-D) 
pump driven (Kortsmit, Rutten et al. 2009; Syedain and Tranquillo 2009) and 
(E) splash (Sutherland, Perry et al. 2005; Barzilla, McKenney et al. 2010). 
Figure 6.2-70 Four main bioreactor types.  
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Table 6.3 -6  Whole valve bioreactors 
Operation/ Components Cell/scaffold types 
Hemodynamic/ 
Biomechanical 
conditions 
Mechanistic findings/features of 
study 
Ref. 
Pneumatic Diaphragm 
Diaphragm between an air 
chamber and media chamber 
deforms to pulse media through a 
valve.  
Trileaflet valve construct 
of bio-absorbable 
polymers seeded with 
ovine myofibroblasts and 
endothelial cells 
Systole 10-240 mmHg 
, 0.05 L/min to 2.0 
L/min 
Constructs cultured for 14 days in 
gradually increasing pulsatile flow, 
then implanted into the pulmonary 
position of lambs, were functional up 
to 5 months. At 20 weeks ECM and 
DNA content equal to and greater 
than native, and the mechanical 
strength comparable to native valves.  
(Hoerstrup, 
Sodian et al. 
2000; Hoerstrup, 
Sodian et al. 
2000) 
Air driven diaphragm deforms to 
pulse fluid through valve, and 
system also includes a 
capacitance chamber to control 
transvalvular pressure 
1
st
 study PGA/PLA 
scaffold seeded with 
ovine smooth muscle 
cells, 2
nd
 study 
PGA/PLLA trileaflet valve 
scaffold seeded with bone 
marrow MSCs 
Systole/Diastole 35/20 
mmHg-125/85 mmHg,   
0-6 L/min. Valves 
cultured under 
pulmonary artery 
conditions although 
the bioreactor has a 
wide range of possible 
conditions 
 
3 weeks static and then 3 weeks 
bioreactor culture. Media 
supplemented with bFGF and AA2P 
accelerated collagen collagen 
formation compared to standard 
media.  Dynamic conditioning 
increases collagen production. 
Note: Reduction in GAG content with 
increased culture time.  
Note: Flexibility of scaffold material a 
limitation for replicating deformation 
and motion of native leaflets 
(Hildebrand, Wu 
et al. 2004; 
Ramaswamy, 
Gottlieb et al. 
2010) 
Air driven diaphragm deforms to 
pulse fluid through valve, and 
system also includes a 
capacitance chamber to control 
transvalvular pressure. Universal 
valve holder mounting design 
Decellularized porcine 
scaffolds seeded with 
porcine aortic endothelilal 
cells 
Systole/Diastole 
40/15 mmHg-80/70 
mmHg, 5-23 ml stroke 
volume  
 
17 days of bioreactor culture. Cells 
adhere and form cobblestone 
morphology, but incomplete 
endothelialization, probably due to 
low seeding concentration. Valve 
opening and closing monitored with 
video system.   
(Sierad, 
Simionescu et 
al. 2010) 
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Table 6.3 Continued 
Operation/ Components Cell/scaffold types Hemodynamic/ 
Biomechanical 
conditions 
Mechanistic findings/features of 
study 
Ref. 
Balloon     
Pressure chamber with bladder 
on the outflow side of the valve. 
Negative pressure causes back 
flow on the valve to close it, 
positive pressure to get flow 
through open valve.   
Decellularized porcine 
valves seeded with ovine 
carotid artery endothelial 
cells and myofibroblasts 
Systole/Diastole 
60/40 mmHg-180/120 
mmHg, 25 ml/min- 
3L/min 
Hydrodynamic reseeding of a scaffold 
more effective than static reseeding. 
Hydrodynamic seeded scaffolds had 
more cell mass, collagen and elastin 
content, and strength than static 
controls.  
(Zeltinger, 
Landeen et al. 
2001; Schenke-
Layland, Opitz et 
al. 2003) 
Silicone blub compressed by 
piston  
 TE valve  holder 
 compliance chamber and 
resistance 
 reservoir with aerator 
 mechanical valve 
Checked system for 
biocompatibility using 
endothelial cells. 
Bioreactor materials put 
into media for 2 weeks for 
leaching, and media then 
fed o cells 
Systole/Diastole 
120/80 mmHg-
40/25mmHg,  
1.68L/min-3.44L/min, 
Stroke volume: 35-
76ml 
 
 
The rubber sealing material and 
rubber used for left ventricle was 
cytotoxic.  Ethylene oxide (EtO) vs 
glutaraldehyde (2%) (GA) sterilization 
of all the bioreactor materials: silicone 
tubing, silicone ventricle, rubber 
sealing, Teflon sealing, Plexiglass, 
glue, glued pieces of Plexiglass 
and/or polyvinyl chloride [PVC]), PVC 
tubes, and PVC angles.  
(Dumont, 
Yperman et al. 
2002) 
Plate-Piston 
Plate-Piston Tested with commercial 
bio-prosthetic and 
mechanical valves 
Systole/Diastole 
120/80mmHg 
180/100mmHg, 
∆P: 0-120mmHg. 
Vertical movement 
range associated with 
stroke volume. 
 
Bioreactor evaluated with an aqueous 
xanthan gum solution to give media 
blood- like rheological properties and 
a blood-like salt solution.  Valves 
opening and closing monitored with 
video system.   
(Durst and 
Grande-Allen 
2010; 
Schleicher, 
Sammler et al. 
2010) 
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Table 6.3 Continued 
Operation/ Components Cell/scaffold types Hemodynamic/ 
Biomechanical 
conditions 
Mechanistic findings/features of 
study 
Ref. 
Pump     
Pump Deformation + Flow 
latex tube 
 TEHV mount  
 Flow circuit for stretch 
 Flow circuit or nutrient 
supply 
 reciprocating syringe 
pump 
 peristaltic pump 
Fibrin based valve 
construct seeded with 
human dermal fibroblasts 
 
Cyclic loading of valve 
root. 0-15% Root 
Strain 
Low flow rate 10-
15ml/min 
3 weeks of cyclic stretching with 
incrementally increasing strain 
amplitude. TEHV leaflets after culture 
had circumferential fiber alignment 
and had tensile stiffness and 
anisotropy similar to sheep 
pulmonary valves.  
(Syedain and 
Tranquillo 2009) 
Pump 
Deformation w/Fluid 
Minimal flow/shear  
 
Human saphenous vein 
cells seeded into 
PGA/P4Hb scaffolds 
using fibrin cell carrier.  
Diastole. Applied 
pressure difference 
over leaflets.  
Dynamic trans-
valvular pressure: 0-
80mmHg. Dynamic 
Strain 0-25% 
Low shear stress 
Dynamically loaded leaflets have 
higher UTS, modulus, and tissue 
formation compared  non loaded 
tissue strips after 4 weeks of culture 
Mechanical behavior of loaded 
leaflets non-linear and strips was 
linear. Prestrain induced by the stent 
(3-5%) also affects the mechanical 
and tissue organization. 
(Mol, Driessen 
et al. 2005) 
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Table 6.3 Continued 
Operation/ Components Cell/scaffold types Hemodynamic/ 
Biomechanical 
conditions 
Mechanistic findings/features of 
study 
Ref. 
Pump (continued) 
Developed a proportional integral-
derivative (PID) feedback 
controller to regulate deformation 
in their TEHV bioreactor system. 
Results indicated a good 
correspondence between the 
measured and the prescribed 
deformation values 
Molded valve scaffold of 
PGA coated with P4HB, 
then coated with PCL and 
bonded to a 
polycarbonate cylinder, 
which was seeded with 
human saphenous vein 
endothelial cells using 
fibrin cell carrier. 
Diastole. Applied 
pressure difference 
over leaflets.  Up to 
100 mmHg 
transvalvular 
pressure. Slow media 
circulation 4ml/min. 
12 days culture in low speed media 
circulation then dynamic pressure 
differences applied for 16 days at 1 
Hz.  
With increased culture time the 
leaflets became less stiff, more 
flexible, and less leaky.  
No significant modulus difference 
between loading protocols, but 
anisotropic mechanical properties 
(circumferential vs radial) induced by 
both.  
Study goal to facilitate development 
of an optimal conditioning protocol 
using deformation feedback.  
(Kortsmit, Rutten 
et al. 2009) 
 Capacitance chamber 
 Pulsatile pump 
 Cell seeding inlets 
 Fits into Incubator. Direct 
control of flow rate using 
pulsatile pump. Roller 
pump enabled gas 
exchange in an 
oxygenation chamber  
Decellularized ovine 
pulmonary valves seeded 
with jugular vein 
endothelial cells  
Mean system 
pressure was 
maintained at 
25±4 mmHg, 
0.1 L/min to 2.0 L/min 
Valves were seeded using the 
bioreactor and then implanted into 
lambs for 3 months. Valves were 
completely endothelialzed following 
bioreactor culture.  Found that 
moderate pulsatile flow with 
bioreactor stimulated EC proliferation, 
and high flow damaged endothelium 
and caused loss of cellularity. After 
explant both reseeded valves and 
bare decellularized valves had 
interstitial cells, but a confluent 
monolayer of EC only present on 
recellularized valves.  More 
thrombotic formations on bare 
decellularized valves.  
(Lichtenberg, 
Cebotari et al. 
2006; 
Lichtenberg, 
Tudorache et al. 
2006) 
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Table 6.3 continued 
Operation/ Components Cell/scaffold types Hemodynamic/ 
Biomechanical 
conditions 
Mechanistic findings/features of 
study 
Ref. 
Splash  
As the chamber rotates, the 
culture medium flows 
past the tissue surface, imparting 
normal and shear forces to 
the surface and causing 
deformation of the organ culture. 
 
Porcine mitral valve 
segments including strut 
chordae 
3ml/s Native mitral valves lose 
microstructure and ECM expression 
patterns when cultured under static 
conditions and were better 
maintained in dynamic culture. 
Proliferation of cells throughout the 
leaflet was also effected.  
 
(Barzilla, 
Acevedo et al. 
2010; Barzilla, 
McKenney et al. 
2010) 
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induce leaflet stretching and coaptation and to create non laminar the flow in the valve 
sinuses.  The most elaborate of this type of design models the left side of the heart 
(Hildebrand, Wu et al. 2004; Ramaswamy, Gottlieb et al. 2010; Sierad, Simionescu et 
al. 2010). In this design media is drawn from an ‘atrium’ media reservoir in to a 
‘ventricle’ chamber where air deforms a diaphragm in a ‘ventricle’ chamber which 
pushes media through an aortic valve construct. A pressurized capacitance tank 
following the valve allows for control of transvalvular pressure and fluid recycles to the 
atrium reservoir.  Systole and diastole can be mimicked with this type of design, and it 
enables a high degree of flow and pressure control. One of the major disadvantages of 
a pneumatic diaphragm/balloon design is that a large number of components are 
needed to achieve a high level of control. As these bioreactors become increasingly 
intricate the bioreactor system get larger (Hoerstrup, Sodian et al. 2000; Hoerstrup, 
Sodian et al. 2000; Hildebrand, Wu et al. 2004; Sierad, Simionescu et al. 2010). If the 
system must fit into a culture incubator to regulate temperature and CO2, size becomes 
one of the major limitations to high-throughput culture of multiple valves.  
 
A plate-piston bioreactor physically moves valves through liquid to condition them 
(Figure 6.2B) (Schleicher, Sammler et al. 2010). Multiple valves are mounted in aplate 
that is submerged in liquid. A steel tube that is driven up and down by a piston is 
attached to the plate. By moving the valve back and forth through the liquid it is possible 
to mimic systole and diastole, leaflet stretching and coaptation, and flow eddies in the 
sinuses. The vertical range of movement in the system is coupled to the stroke volume 
for this system.  This design has the benefit of being relatively high throughput  although  
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the multiple valves are not isolated from one another. The piston-plate bioreactor design 
enables a wide range of loading conditions and enable loading of multiple valves 
simultaneously (Schleicher, Sammler et al. 2010). The major disadvantage of the 
system is that the valves are not isolated from one another during culture which means 
it is difficult to test multiple conditions (for example cell type or media composition) and 
contamination would affect the entire set of TEHVs. Additionally the plate-piston 
periodically requires time to reset position which can alter the ‘cardiac’ cycle conditions. 
 
Pump bioreactors like diaphragm bioreactors move fluid through flow loops. For 
convenient sterile culture the syringe pumps and peristaltic pumps have been 
incorporated into these designs. Lichtenberg et al designed a bioreactor specifically for 
seeding TEHV with a pulsatile pump, valve reservoir and holder, and oxygenation 
compliance chamber (Lichtenberg, Cebotari et al. 2006; Lichtenberg, Tudorache et al. 
2006). Cell inlets were incorporated above and below the heart valve.  Several pump 
bioreactor designs mimic both valve leaflet and root deformation with particular 
emphasis on the diastolic phase of the cardiac cycle (Figure 6.2C,D) (Mol, Driessen et 
al. 2005; Kortsmit, Rutten et al. 2009; Syedain and Tranquillo 2009).  Diastolic pressure 
differences can be applied over the leaflets, with minimal shear flow using a bioreactor 
consisting of a valve holding container and a medium container. Using a pump a pulse 
of media of controlled volume and pressure is applied to the outflow side of the leaflets, 
and the valve deformation can be regulated (Kortsmit, Rutten et al. 2009) (Figure 6.2C). 
In another bioreactor design there are two separate flow loops-a stretch circuit for 
applying strain to the valve root wall and leaflets, and a flow circuit for nutrient supply 
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(Figure 6.2D) (Syedain and Tranquillo 2009).  The Syedain design is one of the few that 
specifically attempts to recreate valve root deformation biomechanics. The advantage of 
these pump driven bioreactor designs is that they are very compact compared to other 
bioreactors and multiple systems can fit into an incubator. Pump driven systems have 
been used to replicate specific elements of the cardiac cycle such as blood flow through 
the leaflets during systole (Lichtenberg, Tudorache et al. 2006), diastolic loading 
(Kortsmit, Rutten et al. 2009) and root deformation (Syedain and Tranquillo 2009) and 
several compact designs have been demonstrated.  However, duplicating the full 
cardiac cycle with a pump driven design may involve the same component and 
complexity increase associated with control that effects the diaphragm/balloon 
bioreactors. 
 
The final bioreactor type is a splash bioreactor (Figure 6.2E). A valve segment is 
mounted between two chambers, one of which is filled with media.  As the chamber 
rotates, the culture medium flows past the tissue surface, imparting normal and shear 
forces to the surface and causing deformation of the valve leaflet (Barzilla, McKenney et 
al. 2010). The splash bioreactor has the advantage of having self-contained sterile 
conditioning of individual valves, and can be scaled up to have multiple chambers for 
high-throughput (Barzilla, McKenney et al. 2010). However, the current splash 
bioreactor design is more suited to the mitral valve, and may not be suitable for aortic or 
pulmonary TEHV. It does not allow for control of pressure, flow rate, or stroke volume.     
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6.3 Conclusions 
In vitro bioreactor studies have demonstrated that hemodynamic conditioning affects 
TEHV development and can improve tissue function. However, optimal magnitudes of 
biomechanical conditioning still need to be identified. In vitro conditioning is critically 
important for TEHV strategies that begin with cellularized scaffolds unable to 
immediately function under physiologic levels of cyclic stretch, flexure, and shear stress 
upon implantation (Flanagan, Cornelissen et al. 2007; Flanagan, Sachweh et al. 2009). 
Many of the new materials developed for valve and stem cell culture (Benton, Kern et al. 
2009; Kloxin, Tibbitt et al. 2010; Kloxin, Tibbitt et al. 2010; Pedron, Kasko et al. 2010), if 
fabricated into scaffolds may fall into this category.  As the field of biomaterials expands, 
the need for high throughput in vitro evaluation and conditioning of different materials for 
TEHV is also expanding. 
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CHAPTER 7  
BIOREACTOR FOR PARALLEL DYNAMIC CONDITIONING OF ADULT AND 
PEDIATRIC SIZED 3D PRINTED HYDROGEL HEART VALVES  
 
Portions of this chapter were previously published in Advanced Drug Delivery Reviews 
(Butcher, Mahler et al. 2011) and in the book chapter entitled “Aortic Heart Valve Tissue 
Regeneration” (Duan, Hockaday et al. 2014) in Tissue and Organ Regeneration: 
Advances in Micro and Nanotechnology. 
 
7.1 Summary 
In this study we demonstrate a dynamic conditioning system specifically for the culture 
of 3D bioprinted and ex-vivo native tissue heart valves.  The custom water driven 
diaphragm-type bioreactor was engineered with a conditioning chamber specifically 
designed for ultrasound monitoring of valve root wall and leaflet motion and tissue 
strain. The parameters of the flexible control and water driven flow loop system can be 
scaled or throttled to enable dynamic culture of aortic and pulmonary valves at adult or 
pediatric stroke volume and flow rates. Additionally the system can be scaled for parallel 
conditioning in multiple reactor chambers containing individual valves. Physiological 
systolic and diastolic loading conditions can be achieved or diastolic only loading 
conditions can be induced with the control setup.  This will enable exploration into the 
optimal conditions and loading regimes needed to drive remodeling and tissue 
development in 3D printed hydrogel valves. 3D bioprinted heart valves composed of 
methacrylated gelatin, methacrylated hyaluronic acid, and PEGDA were cultured up to 
14 days under static and dynamic conditions to validate the system and to induce 
remodeling in bioprinted valves.   
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7.2 Introduction 
Heart valves are a particularly challenging target for tissue engineering because the 
engineered tissue must function mechanically the moment it is implanted. The aortic 
and pulmonary valves are situated in two of the most demanding mechanical 
environments in the body (Butcher, Simmons et al. 2008). Tissue engineered heart 
valve strategies depend heavily on  dynamic in vitro conditioning in a bioreactor that 
simulates in vivo   flow conditions prior to implantation to drive cell remodeling and 
matrix deposition to meet these demands (Gandaglia, Bagno et al. 2011). Native heart 
valves develop and function under dynamic conditions. Bioreactors designed to mimic 
the physiological stress and hemodynamics heart valves experience are integral to 
tissue engineering strategies for heart valve regeneration. Numerous studies have 
demonstrated that TEHVs cultured in bioreactors have improved ECM content and 
organization, mechanical properties, and function upon implantation compared to those 
that are statically cultured (Hoerstrup, Sodian et al. 2000; Flanagan, Cornelissen et al. 
2007; Flanagan, Sachweh et al. 2009; Ramaswamy, Gottlieb et al. 2010; Schmidt, 
Dijkman et al. 2010).  The magnitude and distribution of mechanical loading and flow 
changes during the cardiac cycle, and it changes during the course of heart valve 
development (Brewer, Mentzer et al. 1977; Dagum, Green et al. 1999; Aikawa, 
Whittaker et al. 2006).  While upon implantation a TEHV must function at full aortic and 
ventricular pressures and stroke volume, for driving tissue development a more fetal-like 
set of hemodynamic conditions may be needed depending on the starting materials of 
the valve (Aikawa, Whittaker et al. 2006).  Compared to other possible TEHV strategy 
materials,  hydrogels in particular are mechanically weak, and tissue development and 
remodeling activity by the cells is necessary before valves can withstand physiological 
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conditions (Butcher, Mahler et al. 2011; Syedain 2011). The Tranquillo group has 
demonstrated that cell remodeling can be effectively harnessed in a fibrin hydrogel to 
reorganize and deposit more matrix so that the resultant tissue is mechanically robust 
enough to be decellularized and function under pulmonary conditions(Syedain, Bradee 
et al. 2013; Syedain, Meier et al. 2013).  
 
Classical TEHV strategies are limited by their fabrication methods and materials.  For 
autologous biological polymeric valves, tissue contraction of the leaflets resulted in 
valve insufficiency (Flanagan, Sachweh et al. 2009). In contrast, a persistent problem 
for synthetic polymeric fiber TEHV is that the material has been too stiff for the leaflets 
or the leaflets have stiffened over time resulting in stenotic function(Sutherland, Perry et 
al. 2005; Schmidt, Dijkman et al. 2010). Using one material means that the even 
superficial regional mechanical differences present in native tissue, such as compliant 
leaflets and the stiff root, are neglected and the microenvironment could limit 
heterogeneous differentiation of seeded cells and result in undesirable remodeling 
behaviors (Butcher, Mahler et al. 2011). For the field of TEHV to move forward there is 
a need for better mimicry of root and leaflet mechanical function and better control cell-
scaffold interactions/remodeling.  3D printing is of interest as a tool both because it 
enables mechanistic and biological investigation in 3D at multiple scales, such as at the 
cell level (Lee, Moon et al. 2008; Torgersen, Ovsianikov et al. 2012) and the tissue level 
(Chang, Boland et al. 2011; Fedorovich, Alblas et al. 2011)), and because it could 
translate into a means for fabricating living tissue with native heterogeneity at a scale 
suitable for clinical use (Koch, Deiwick et al. 2012; Luangphakdy, Walker et al. 2013).  
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In our previous work and in Chapter 5 we demonstrate the capability of 3D printing to 
create complexly heterogeneous heart valve constructs, but the consequences of this 
heterogeneity must be evaluated.   
 
In this study, we present the characterization of water driven diaphragm-type whole 
valve bioreactor that was designed and built for the pulsatile conditioning of 3D printed 
hydrogel heart valves, inspired by diaphragm-type reactors demonstrated by Hoerstrup  
et al and Sierad et al (Hoerstrup, Sodian et al. 2000; Sierad, Simionescu et al. 2010).  
3D printed hydrogel valves were cultured in the characterized bioreactor conditioning 
system. Human adipose derived mesenchymal stem cells (HADMSC) were combined 
with poly-(ethylene glycol)diacrylate (PEG-DA), methacrylated gelatin (MEGEL), and 
methacrylated hyaluronic acid (MEHA) photo-crosslinkable hydrogel precursors 
(Benton, DeForest et al. 2009; Hutson, Nichol et al. 2011)  to make a solution suitable 
for extrusion 3D printing. PEG-based hydrogels have been used to study heart valve 
interstitial cells response to mechanical properties in both 2D and encapsulate 3D in-
vitro studies (Kloxin, Benton et al. 2010; Durst, Cuchiara et al. 2011). A vast potential for 
mechanical and/or molecular) hydrogels are enzymatically degradable and have been 
used to encapsulate valve interstitial cells (Benton, DeForest et al. 2009), and with the 
addition of PEG-DA the degradation properties are modifiable (Hutson, Nichol et al. 
2011). MEHA has attractive bioactive features and varying the ratios of MEGEL and 
MEHA have previously been demonstrated to modulate resultant hydrogel mechanical 
properties, precursor solution viscosity and 3D printed scaffold fidelity, and cell  
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phenotype within (Duan, Kapetanovic et al. 2014). Bioprinted valves were dynamically 
and statically cultured up to 14 days.  
7.3 Materials and Methods 
7.3.1 Heart Valve Bioreactor Design Overview 
A water driven diaphragm-type whole valve bioreactor was designed and built for the 
pulsatile conditioning of 3D printed hydrogel heart valves.  The design was largely 
based on pneumatic diaphragm-type reactors demonstrated by Hoerstrup  et al and 
Sierad et al (Hoerstrup, Sodian et al. 2000; Sierad, Simionescu et al. 2010).  Sierad et 
al and Hoerstrup et al used an air driven diaphragm pump to move culture medium 
through a tissue engineered heart valve. In this study, a water driven system instead of 
an air driven system was used to enable fast frequency response.  Air driven systems 
have a slight disadvantage compared to piston or post systems due to the 
compressibility of air (Schleicher, Sammler et al. 2010; Gould, Chin et al. 2012). At 
room temperature and at 37°C for the culture incubator, water is effectively 
incompressible. With a fast frequency response a reactor could mimic the faster heart 
rate of the pediatric and fetal cardiac system, so that hemodynamic conditions could be 
selected in the full range of pediatric to adult loading and flow conditions.  In the native 
valve loading and flow conditions change as the valve develops (Dagum, Green et al. 
1999; Aikawa, Whittaker et al. 2006; Kovacs, Berghold et al. 2009; Butcher, Mahler et 
al. 2011).  
 
In our heart valve bioreactor design a pump driven water flow loop is used to circulate 
media in a sterile media loop (Figure 7.1). The media loop is separated from the water  
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Figure 7.1 -71  Over view of the heart valve bioreactor conditioning system which 
uses a pump driven water flow loop to circulate media in a sterile media loop. 
(A) The media loop is separated from the water loop with a silicone diaphragm. 
Water is pumped into the base of the valve conditioning chamber, this 
deflects/deforms the silicone diaphragm in the ‘ventricle’ and pushes media through 
the TEHV into a pressurized aortic chamber, the media circulates back to a reservoir 
of culture media. One way check valves only allow media to flow from the media 
reservoir into the ‘ventricle’ chamber of the conditioning chamber. (B) The water flow 
loop is driven by a pump.  The pump moves water from the reservoir or ‘low’ tank to  
pressurize a capacitance ‘high’ tank. The 3-way solenoid switches between this high 
pressure source and this low pressure sink to provide an oscillating pulse of water to 
the base of the conditioning chamber. This pulse is analogous to one cardiac cycle.  
A shunt is included so that once the system is shut down the tank pressures will 
equilibrate. (C) Signal processing of the pressure transducer information and control 
of the system is enabled by a microcontroller and a timer relay.   A  computer is 
connected to the microcontroller to record pressure data.  
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loop with a silicone diaphragm (7.1A). Water is pumped into the base of the valve 
conditioning chamber; this deflects/deforms the silicone diaphragm in the ‘ventricle’ and 
pushes media through the TEHV into a pressurized aortic chamber. The media 
circulates back to a reservoir of culture media. One way check valves only allow media 
to flow from the media reservoir into the ‘ventricle’ chamber of the conditioning 
chamber. The water flow loop is driven by a pump (7.1B).  The pump moves water from 
the reservoir or ‘low’ tank to pressurize a capacitance ‘high’ tank. The 3-way solenoid 
switches between this high pressure source and this low pressure sink to provide an 
oscillating pulse of water to the base of the conditioning chamber. This pulse is 
analogous to one cardiac cycle.  A shunt is included so that once the system is shut 
down the tank pressures will equilibrate. Signal processing of the pressure transducer 
information and control of the system is enabled by a microcontroller and a timer relay 
(7.1C). A computer is connected to the microcontroller to record pressure data. 
Pressurized gas (CO2/Air) was applied to set the aortic or outflow track pressure to get a 
transvalvular pressure.  
 
7.3.2 Heart valve conditioning chamber and holder for 3D printed hydrogel or ex 
vivo heart valves 
The conditioning chamber and holder assembly is designed so that the heart valve can 
be loaded with pressures that mimic the ventricle, aorta, and the chest cavity. At the 
beginning of the diastolic phase, pressure should be higher on the aortic side of the 
valve leaflets compared to the ventricular side (Figure 7.2A). Under this condition the 
valve leaflets will close. In the human body the circulatory system is pressurized relative 
to the chest cavity, and the root wall experiences stress and deformation based on the 
relative pressure changes between an aorta and the chest cavity (Dagum, Green et al. 
1999). Although it was not monitored in the study presented here, a line for a body 
cavity pressure transducer was included on the side of the bioreactor chamber. Top 
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Figure 7.2 -72 Component diagram of Heart valve conditioning chamber and 
holder for 3D printed hydrogel or ex-vivo heart valves. 
A) Diastolic pressure phase. Top (1) and bottom (2) holder parts are fabricated out of 
the same material as the chamber parts. (2) Silicone rubber band (tightly fit over the 
tube part of the holders and a sleeve of GE Teflon mesh/membrane. (5) PDMS is 
applied to secure it.  (4) The engineered or ex-vivo valve. (6) The silicone rubber 
diaphragm.  (B) Systolic pressure phase. (C) The function and motion of the tissue 
can be observed using an optical viewport (7) and a Teflon ultrasound viewport (8). 
(D) The height of the holder is set using stainless steel shaft collars with set screws. 
(9) The three stainless steel alignment posts. (10) The holders follow a track when 
the valve assembly is loaded into the body of the conditioning chamber and the posts  
were positioned in the holder to not obscure the ultrasound port.  
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 (Figure 7.2A1) and bottom (Figure 7.2A2) holder parts are fabricated out of the same 
material as the chamber parts. They are designed to slide in following a track along the 
reactor wall to fit into the main body of the reactor chamber (Figure 7.2D). The holders 
fit into and can seal with the openings from the ventricle and the aorta when the aortic 
part is bolted to the body of the chamber.  A silicone rubber band (Figure 7.2A3) is cut 
from large silicone tubing and tightly fit over the tube part of the holders and a sleeve of 
GE Teflon mesh/membrane. PDMS is applied to secure it (Figure 7.2A5).  The Teflon 
mesh is used to attach the engineered or ex-vivo valve (Figure 7.2A4) into the holder 
assembly. The valve is secured to the mesh using sutures for native heart valves and 
tissue glue for the 3D printed hydrogel valves. The diaphragm (Figure 7.2A6) of the 
ventricle chamber is made with a 1mm thick sheet of silicone rubber that is tightly bolted 
between the two flanges of the base. During the diastolic phase the diaphragm retracts 
as water is drawn out of the base. During the systolic phase pressure should be higher 
on the ventricular side of the valve leaflets compared to the aortic side. Under this 
condition the valve leaflets will open (Figure 7.2B). During the systolic phase, the 
diaphragm retracts as water is drawn out of the base. On the media side of the 
diaphragm, media is drawn from a reservoir into the ventricle in response to the 
dropping ventricle pressure induced by the diaphragm retraction.  The function and 
motion of the tissue can be observed using an optical viewport (Figure 7.2C7) and a 
Teflon ultrasound viewport (Figure 7.2C8). The height of the holder is set using 
stainless steel shaft collars with set screws  (Figure 7.2D9) and three stainless steel 
alignment posts (Figure 7.2D10). The holders follow a track when the valve assembly is 
loaded into the body of the conditioning chamber and the posts were positioned in the 
holder to not obscure the ultrasound port. 
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7.3.3 Media Flow Loop and Aortic Pressurization  
The conditioning chamber is setup to mimic the systolic and diastolic loading conditions 
of the cardiac cycle.   Pressurized 5%CO2/air is injected into the conditioning chamber 
to pressurize the aortic side of the valve (Airgas, Ithaca) and achieve a transvalvular 
pressure during diastolic loading. This applied aortic side pressure is a set with a 
regulator (Airgas, Ithaca).  Media cycles through the conditioning chamber and the 
TEHV in a flow loop that is driven by and separated from a water loop with a silicone 
diaphragm. During systole water is pumped into the base of the valve conditioning 
chamber, this deflects/deforms the silicone diaphragm in the ‘ventricle’ and pushes 
media through the TEHV into a pressurized aortic chamber (Figure 7.3A). Media 
circulates back to a reservoir of culture media and pressure is periodically vented from 
the reservoir through a pinch valve and sterile filter.  One-way check valves only allow 
media to flow from the media reservoir into the ‘ventricle’ chamber of the conditioning 
chamber.  During the diastolic phase (7.3B), pressure should be higher on the aortic 
side of the valve leaflets compared to the ventricular side. Transducers are connected 
to the ventricle and the aortic chambers to record pressure. During the systolic phase 
the diaphragm retracts as water is drawn out of the base. Media is drawn from the 
reservoir into the ventricular chamber through the one-way check valves.  
 
7.3.4 Two Control Strategies for Pulsatile Conditioning: Timer Relay and Pressure 
Relief   
Two control strategies were investigated for bioreactor conditioning. First a control 
strategy was investigated where the frequency of diastolic loading and system venting is 
pressure independent (Figure 7.4A). Second a control strategy where diastolic loading 
depends on a pressure feedback signal to the microcontroller (Figure 7.4B). In the first 
strategy, all solenoid valves are controlled using a timer relay (Figure 7.4A). A time 
delay repeat cycle relay is used to control the pulse of the switching of the 3-way  
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Figure 7.3 -73  Media flow loop and aortic pressurization diagram. 
 (A) During systole water is pumped into the base of the valve conditioning chamber, 
this deflects/deforms the silicone diaphragm in the ‘ventricle’ and pushes media 
through the TEHV into a pressurized aortic chamber. Media circulates back to a 
reservoir of culture media, and pressure is periodically vented from the reservoir 
through a pinch valve and sterile filter.  One-way check valves only allow media to 
flow from the media reservoir into the ‘ventricle’ chamber of the conditioning 
chamber.  (B) During the systolic phase the diaphragm retracts as water is drawn out 
of the base. Media is drawn from the reservoir into the ventricular chamber through 
the one-way check valves.  
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Figure 7.4 -74 Two strategies for bioreactor system control: pressure independent 
control of diastolic loading or pressure feedback control of diastolic loading. 
(A) Strategy 1. (B)  Strategy 2. 
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solenoid valve and the opening/closing of the pinch valve. The microcontroller signals 
the pump to move water from the ‘low’ tank to pressurize a ‘high’ tank based on signals 
from the pressure transducers.  The 3-way solenoid switches between this high 
pressure source and this low pressure sink to provide an oscillating pulse of water to the 
base of the conditioning chamber. This pulse is analogous to one diastolic and systolic 
cycle. This is one ‘beat’ in terms of heart rate. The timer relay can be connected so that 
power or the energize signal alternates between the 3-way solenoid and the pinch valve 
solenoid. The pinch valve solenoid vents pressure from media reservoir and aorta with 
each beat in this setup. The consequence of this is the frequency of the delivered 
ventricular pulse and frequency of diastolic loading is independent of any pressures in 
the system.  
 
For the first strategy, the functional steps of the system are: (1) the pump fills the water 
capacitance tank or ‘High’ tank with water; (2) the High tank becomes pressurized and 
pressure drops in the water reservoir or ‘Low’ tank; (3) the 3-way solenoid valve 
switches to connect the high tank to the bioreactor base, driving a pulse of fluid into the 
bioreactor base which deforms the silicone diaphragm and pressurizes the ventricle; (4) 
the 3-way solenoid valve switches to connect the low tank to the bioreactor base, and 
water is drawn out of the bioreactor base to the Low tank and the ventricle pressure 
drops. Meanwhile the time delay relay alternately energizes the 3-way solenoid and 
then the pinch valve. Aortic pressure is delivered from a 5%C02/air tank which is set by 
a regulator at the tank. On step three when the 3-way solenoid switches to High tank 
source, the pinch valve closes. On step four when the 3-way Solenoid switches to the 
Low Tank sink the pinch valve opens. It is important to keep in mind when ordering, 
wiring the setup, and programing the microcontroller that the solenoids are sold in either 
an open/energized or open/de-energized assembly. The pinch valve use here is an 
open/energized valve type.  
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As an alternative control strategy, a value can be set in the microcontroller so that the 
pinch valve solenoid opens when pressure in the aortic chamber passes a user defined 
pressure threshold (Figure 7.4B). As in the first strategy, the pump is controlled by the 
microcontroller and the ventricular pulse from the 3-way solenoid is controlled by the 
timer relay. In the alternative setup the signal from the aortic pressure transducer is 
compared to a set pressure, if  Paortic is greater than Pthreshold then pinch valve opens if 
Paorta less than or equal to  Pthreshold then the solenoid remains closed.  
 
7.3.5 Micro-controller for Regulation of Ventricular and Aortic Pressure  
During the development of the bioreactor system and in our initial characterization 
studies, we used two DAQ boards and Simulink/Matlab program in combination with a 
timer relay for the control of the electronics and data acquisition. We found that the DAQ 
boards were very sensitive to electromagnetic interference from the solenoids and the 
system was vulnerable to timeout errors. We believe this was associated with working in 
conjunction with a non-dedicated computer. The electronics control setup was 
converted to a microcontroller (Figure 7.5).The microcontroller was designed using an 
ATmega1284P chip on the prototype board which is used in the Cornell ECE 4760 class 
and programmed with C. The microcontroller was custom fabricated at Cornell at Bruce 
Land’s laboratory in the ECE department.  Four industrial pressure transducers (Dwyer 
Instruments, IN, ordered from Zoro tools) are each connected to a resistor and the 
voltage signal is read by the microcontroller and converted to a pressure measurement. 
The microcontroller reads the signals sent from the pressure transducers using built-in 
Analog-Digital-Convertor and sends out the control signal for the pump and the pinch 
solenoid valve through the junction box.  The junction box energizes the circuit by using 
a relay switch. The microcontroller allows for a more compact system that only needs to 
be connected to  a  computer  to  take  a  data  sample.  The interface for setting the 
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Figure 7.5 -75  Electronics diagram for single conditioning chamber. 
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 pressure and pump and pump conditions is written in Matlab. The user is prompted to 
change the Pdiff setting, the delta setting, the aortic pressure threshold, and the data 
acquisition time. After the data acquisition period the system runs automatically at the 
set parameters. Up to 2 weeks of data can be logged in one acquisition period.  
 
 
7.3.6 Characterizing Water Pump Flow Loop System to Drive Diaphragm in Media 
Loop 
The pump driven water flow loop of the bioreactor system was characterized to 
determine operating volumes and pressures. The pump pressurizes the high tank, 
drawing water from the low tank. The 3-way solenoid controls an alternating pulse of 
high pressure water from the ‘High’ tank and a sink/suction pulse back to the ‘Low’ tank. 
Depending on the pressure on the media side of the membrane there will be volume 
drift when the system equilibrates. Volume offset of the system was measured at a 
neutral (room) pressure by detaching the reactor/diaphragm chamber and connecting a 
graduated column for measuring volume. Deviation/drift in the system as well as the 
periodic oscillation/deflection needed to flex the silicone diaphragm was quantified using 
a video camera and tracking the rise and fall of the volume. Volume was measured with 
increasing pressure difference settings (at a set delta = 2). Pressure difference (Pdiff) 
was the difference between the high tank pressure and the low tank pressure (Pdiff = 
PHigh – PLow ). Volume drift was measured with increasing delta settings (at a set Pdiff 
=150mmHg). Delta describes the sensitivity or anticipation of the pump turning on to 
maintain Pdiff. For these tests the sink time (tsink) and the source time (tsource) were equal 
and set at 1 second. These times tsink and tsource describes switching the connection 
between graduated column from high tank and the low tank and the time for each 
connection. In a connected chamber setup, the sink time is analogous to the diastolic 
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phase of the bioreactor cycle tsink = tdiastolic   and the source time is analogous to the 
ventricular phase of the bioreactor cycle tsource = tdiastolic . 
 
7.3.7 Measurement of Ventricular Stroke Volume for Different Size Conditioning 
Chambers 
To establish dynamic conditioning ranges achievable by the system, stroke volume was 
measured for a miniature and large base reactor design. A graduated column to 
measure volume was connected to the aortic outlet of the conditioning chamber. For 
these tests a 1-mm thick silicone diaphragm, was bolted into the base, the sink and 
source time of delivered water pulse from the pump system was 1 sec (Tsystolic = 
Tsource=1 sec and Tdiastolic=Tsink=1 sec). Also, the effect of applied pressure on the stroke 
volume was tested. 80 mmHg of aortic pressure was applied on the media side of the 
silicone membrane for the large base conditioning chamber. The setup tested had ¼” 
diameter tubing out of the high tank and low tank connected to the 3-way solenoid 
valve.  This test was to determine the delivered stroke volume of the diaphragm so the 
test was run without a heart valve separating the aortic and ventricular chambers and 
the reservoir was disconnected so the check valves at the inlet lines of the ventricle 
remain closed.  
 
7.3.8 Systolic Flow Rate in Heart Valve Bioreactor Calculated from Stroke Volume 
and Cycle Time 
Stroke volume is coupled to the time allowed for source and sink to act through the 3-
way solenoid. The stroke volume is how much volume is moved when the diaphragm 
moves from the retracted position to the inflated position. The time this takes is tsystolic. 
The sink and source time, also known as the diastolic and systolic times are matched 
and when added together equal the cycle time. From the stroke volume data it is 
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possible to calculate an estimated systolic flow rate and then extrapolate the stroke 
volumes for shorter cycle times.  
 
                    
            
 
      
  
 
                                   
                            
 
Using the slope of the stroke volume verses Pdiff trend, the stroke volume at higher 
pressure settings can be calculated. These calculations were also scaled using 
Poiseuille's law to estimate the effect of a larger tubing size (1/2”) for the sink and 
source tube out of the high tank and low tank.  
R=
    
   
 
R= resistance to fluid movement, η=viscosity, Δx=change in distance, and r =radius of 
the tube.   
 
This is treated as a hydraulic circuit where V=IR. The change in pressure is analogous 
to voltage. The volumetric flow rate is analogous to current. Effective resistance in the 
tube is inversely proportional to the fourth power of the radius. Doubling the radius 
reduces the resistance to fluid movement by a factor of 16.  
 
7.3.9 Testing the Holder and Ultrasound Port and Characterizing Bioreactor 
System Pressure with Heart Valves 
Whole porcine aortic and pulmonary valves and whole ovine aortic and pulmonary 
valves were obtained fresh at slaughter from Shirk Meats, Himrod, NY. The aortic 
valves and pulmonary valves were isolated from the heart using very sharp scissors. 
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Blood was rinsed away with cold sterile PBS, making sure to remove blood clots. The 
whole valve (root and leaflets intact) was placed into a container of sterile PBS with 
protease inhibitor.  Protease Inhibitor solution was prepared prior to isolation, with 1 
protease inhibitor cocktail tablet per 50 ml of 1XPBS and sterile filtered (Roche, USA). 
The valves in inhibitor solution were placed into a cooler with ice for transport to the lab. 
At the lab, the valves were trimmed to a desired length of aortic or pulmonary root 
before mounting into the reactor holder. For pressure characterization tests, valves 
were tested within 48 hours of isolation or were frozen and thawed the day of the 
characterization experiment.   
 
7.3.10 Bioreactor System Pressure Characterization 
A range of input parameters were tested to characterize the pressure response of the 
bioreactor system. Porcine and ovine sheep valves were sutured into the mesh of the 
holder assembly and used for the characterization tests.  Pdiff settings in the flow loop 
were tested (10, 25, 50, 75, 100, 150,200, 250, and 300 mmHg) for the miniature and 
large chamber designs. An aortic pressure of 0, 80, or 160 mmHg was applied.  Two 
control setups were tested, the alternating solenoid/timer relay setup and the aortic 
pressure feedback setup.  Data was recorded from four transducers which were 
connected to the high tank, the low tank, the aortic chamber, and the ventricular 
chamber.  The sampling rate was 44 samples per second. At the beginning of each test, 
the capacitance membrane was connected to the flow loop for 10 cycles of the pump. 
The flow loop was then switched from the capacitance membrane to the bioreactor 
chamber base.  
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7.3.11 Optical Imaging of Heart Valves in Bioreactor Chamber 
A VMS-004D - 400x USB Microscope with adjustable focus was used to  capture video 
and still images  through the glass optical port of heart valves being conditioned in the 
reactor (Veho, Dayton Ohio).  
 
7.3.12 Ultrasound Imaging of Heart Valves in Bioreactor Chamber 
The ultrasound port of the bioreactor chamber was tested at the Cornell University 
Veterinary Hospital for animals.  Water soluble ultrasound transmission gel (Aquasonic 
100, Parker Laboratories, Fairfield NJ) was applied to the side port of the reactor and a 
5 MHz probe. The probe could be rotated to obtain different cross-sectional views of the 
valve. The reactor tested in this study had one ultrasound port in the side port position. 
From this position it is possible to use tissue doppler to look at the valve wall and leaflet 
motion.  The chamber is fabricated so that the optical viewport in the aortic chamber 
can be replaced with a Teflon ultrasound port. From this position in the outflow tract of 
the valve it would be possible to obtain velocity information for the flow 
 
7.3.13 Heart Valve and Mesenchymal Cell Culture  
Biocompatibility testing and direct cell printing encapsulation with dynamic culture 
conditions were tested with both primary aortic valve interstitial cells and adipose 
derived mesenchymal stem cells (ADMSC). Valve interstitial cells (VIC) are the main 
cell type that populates valve leaflets (Butcher, Simmons et al. 2008). Primary valve 
cells have been used to study mechanistic and remodeling behavior as well as to 
establish tissue engineering targets (Stephens, Durst et al. 2011; Gould, Chin et al. 
2012; Duan, Hockaday et al. 2013; Gould and Anseth 2013).  Heart valves are non-
sacrificial, and for the purposes of tissue engineering, a heart valve cell source other 
than primary valve cells is needed. A recent study profiled ECM gene expression of 
ADMSC and VICs in response to strain. They found that the two cell types have the 
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capacity to synthesize and remodel the surrounding matrix and the two cell types have 
comparable response to mechanical stimulus (Latif, Sarathchandra et al. 2007; 
Colazzo, Sarathchandra et al. 2011).  ADSC can be differentiated towards osteogenic, 
adipogenic, myogenic, chondrogenic, neurogenic, endothelial, and smooth muscle cell 
lineages (Colazzo, Chester et al. 2010; Wang, Yin et al. 2010). ADMSC have 
demonstrated similar phenotypic  and functional characteristics to bone marrow 
mesenchymal stem cells (BMMSC), which are more established in the literature, but 
ADMSC isolation is less invasive (Bunnell, Flaat et al. 2008) (Colazzo, Chester et al. 
2010).  In addition, adipose tissue is present in infants, children, and adults (Kuzawa 
1998). These characteristics suggest ADMSC are a potentially feasible cell source for 
TEHV that could be applicable to all three age groups.   
 
Porcine aortic valve interstitial cells (PAVIC) were isolated via collagenase digestion as 
previously described (Butcher and Nerem 2004; Butcher, Penrod et al. 2004; Richards, 
El-Hamamsy et al. 2013). PAVIC were cultured with Dulbecco’s Modified Eagle’s 
Medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum 
(FBS; Invitrogen) and 1% penicillin/streptomycin (PS; Invitrogen). Cells were fed every 
2-3 days and were used at passage number 4-8.  
 
Cryopreserved HADMSC were purchased (Cat #:PT-5006, Lot#0F4505) Lonza, 
Walkersville). HADMSC were isolated from a 52 year old female donor and 
cryopreserved December 6, 2010.  Greater than 90% of the cells were positive for 
CD13, CD29, CD44, CD73, CD90, CD105, and CD166. Less than 5% of cells were 
positive for CD14, CD31, and CD45.   (Note: According to the certificate of analysis for 
HADMSC 23 hour doubling time).  HADMSC were thawed and cultured using 
Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (F12:DMEM, Invitrogen) 
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supplemented with 10% FBS, 1% PS. HADMSC were passaged at just sub-confluent 
(~90%) and fed every 3-4 days. Cells were used at passage number 4-8.  
 
PAVIC and HADMSC were expanded and maintained in flasks with DMEM, and 
F12/DMEM media respectively.   
 
7.3.14 Biocompatibility Testing of Media Flow Loop and Conditioning Chamber 
Parts 
In this bioreactor design there are many parts that come in to contact with cell culture 
media and cells. Biocompatibility testing was done to determine what materials to 
fabricate the conditioning chamber out of and what materials, parts, and glues were 
appropriate for the fittings and the holder of the media loop part of the reactor. 
Conditioned media and material-in-well biocompatibility testing of bioreactor materials 
were carried out with PAVIC.  PAVIC are fast dividing and in the Chapter 4 viability tests 
they were the most sensitive cell type to encapsulation conditions.  Cells were 
conditioned with media in 2D culture, imaged with a phase contrast microscope at day  
1 - 7, and then assessed with an MTT assay.  
 
 Conditioned media experiments  
 Media was conditioned in contact with materials to be used in bioreactor valve 
conditioning chamber before it was used to treat cells in 2D culture (Darnell, Sun et al. 
2013). The test was designed so that any leaching or toxins will become more 
concentrated as the test progresses because the conditioned media plus material is 
kept in the incubator throughout the experiment. Conditioned media is decanted from 
the material and media stock. Materials to be tested were cut into 8-10 mm squares, 
washed/scrubbed/rinsed and then sterilized using hydrogen peroxide (VHP® MD140X 
Biodecontamination Unit, Steris Life Sciences, Mentor OH).  Six sterilized material 
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squares and 40 ml of DMEM media were placed in a vented cap vial in the incubator for 
3 days before the media was applied to PAVIC plated into 24-well plates for one week. 
Media was decanted from the condition stock solution and used to feed the 24-well 
plates every other day.  
 
 
Material-in well experiments  
Materials were also cultured with the cells directly. Cell appearance and well coverage 
was assessed. MTT results from these tests were inconsistent because the material in 
the well sometimes mechanically disrupted or scrapes the cells or covered different 
area of the well.  
 
MTT Assay   
3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide; thiazolyl blue (MTT, 
Sigma-Aldrich)  assay was used to measure cell  metabolism of cells in biocompatibility 
and conditioned media experiments (Duan, Wang et al. 2010). MTT is yellow in solution 
and then is converted to a dark blue water insoluble MTT formazan by mitochondrial 
dehydrogenase of living metabolically active cells (Carmichael, DeGraff et al. 1987). 
Cells that are actively proliferating have an increased metabolic activity while cells that 
have been exposed to toxins will have decreased metabolic activity.  MTT assay does 
not distinguish between cytostatic (growth inhibitory) and cytocidal (lethal) effects of a 
treatment. MTT solution was prepared at a concentration of 5 mg MTT powder/ml in 
PBS and sterile filtered before use.  Cell monolayers in 24-well plates were rinsed with 
PBS then each well was filled with1 ml of media. 1/10 media volume of MTT solution 
(0.1 ml) was added to each well and incubated for 2 hours at 37°C.Media MTT solution 
was removed and 500 μl of Dimethyl Sulfoxide (DMSO, Sigma-Aldrich) was added per 
well to dissolve the formazan. 100 μl aliquots of solution were pipetted into a 96-well 
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plate and the absorbance of the solution was analyzed using a multi-detection 
microplate reader (BioTek Synergy HT) at 570 nm.  Three to four wells per condition 
were analyzed.  Results were compared using ANOVA and student’s t-test.  
 
7.3.15 Simplified Interlocking Valve Geometry 
A hydrogel heart valve with a simplified geometry was designed for a first demonstration 
of the bioreactor system with hydrogel valve conditioning. The simplified valve geometry 
was designed in Solidworks. It had two component STL parts that fit together: (1) three 
flat radially symmetric leaflets separated by a slight gap and (2) one tubular root conduit 
with no sinuses.  This geometry had a slightly reinforced hinge point where the leaflet 
meets the root and the gap between the leaflets was slightly larger compared to the flat 
profile valve  in our previous work (Duan, Kapetanovic et al. 2014).  
 
7.3.16 Precursor Solution Preparation for Printing 3D Hydrogel Valves  
The hydrogel valve geometry was printed with 700PEGDA solution for the initial 
handling tests of the 3D printed valves in the bioreactor. MEGEL/MEHA/PEGDA 
precursor solution was then used to encapsulate HADMSC for direct cell printing into 
the valve geometry. The leaflets were printed out of a softer 
MEGEL/MEHA/PEGDA8000 combination and the root was printed in a stiffer 
MEGEL/MEHA/PEGDA8000 combination.   
 
Methacrylation of HA and gelatin and PEGDA Synthesis  
 MEHA (Novozymes, ~1200 kDa) was synthesized by a modification of a previously 
published preparation (Smeds, Pfister-Serres et al. 2001; Brigham, Bick et al. 2009; 
Duan, Hockaday et al. 2013). Briefly, 10 ml methacrylic anhydride (MA, Sigma) was 
reacted with HA aqueous solution at 40 C for 6 hr and the pH of mixture during reaction 
was maintained at 8.5 by adding 5N NaOH. MEGEL was synthesized as previously 
 303 
 
described (Nichol, Koshy et al. 2010; Duan, Hockaday et al. 2013). Brieﬂy, gelatin from 
bovine skin (Sigma) was dissolved at 10% (w/v) into distilled water at 40 C and then 
MA (1:5 v/v to gelatin solution) was added drop by drop under stirred conditions at 40 
C for 1 hour. The obtained MEHA or MEGEL solutions were dialyzed for 3 days and 
lyophilized.  Polyethylene glycol diacrylate molecular weight 3350 was synthesized as 
previously described (PEGDA 3350) (Cruise, Scharp et al. 1998; Guo, Chu et al. 2005).  
Poly(ethylene glycol) (PEG, Sigma) was dissolved in benzene (1.5 mmol of PEG in 150 
ml of benzene) and heated to 45 °C with continuous stirring until completely dissolved. 
The solution was cooled to room temperature and triethylamine was added at eight-fold 
molar concentration (based on PEG diol end groups) to the PEG solution (12 mmol). 
Acryloyl choride (Sigma) at eight-fold molar excess concentration was weighed out then 
diluted using benzene (1:40 acryloyl chloride to benzene) and added drop wise to the 
PEG solution through a drop funnel under an ice bath. The mixture was stirred 
overnight, and then the reaction stopped. The insoluble triethylamine was removed by 
filtration. PEGDA was precipitated from the solution by the addition of petroleum ester 
(Sigma). The PEGDA precipitate was collected using a funnel, re-dissolved in 20 ml of 
benzene, and precipitated again by adding petroleum ester. The precipitation process 
was repeated several times. 
 
After synthesis the MEHA, MEGEL, and PEGDA products were dissolved in distilled 
water and transferred and sealed into dialysis tubing with a molecular weight cut off of 
1000 Da. The polymers were dialyzed against distilled water for 5-7 days in 5 gallon 
containers with frequent water changes. The polymer product was then frozen at -20C 
and then lyophilized.  Lyophilized polymers were stored at -20°C. 
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PEGDA700MW Hydrogel Precursor Solution  
 For hydrogel printing without cells, the precursor solution consisted of 13.7 mM NaCl 
solution, .0%w/v photoinitiator, and 20%w/v PEG-DA 700MW.  Un-modified soluble 
alginate (LF10/60, FMC BioPolymer, Drammen, Norway) was mixed into precursor 
solution, 10%w/v, to temporarily increase viscosity during the printing extrusion process 
(Hockaday, Kang et al. 2012; Kang, Hockaday et al. 2013). 
 
MEGEL/MEHA/PEGDA Sterile Hydrogel Precursor Solution 
Polymer solutions were prepared with 4%w/:10%w/v: 5%w/v MEHA:MEGEL:PEGDA in 
solution for hydrogel printing with encapsulated HADMSC. 8000MW PEGDA was used 
for the leaflets and 3350 MW PEGDA was used for the root.  Polymer precursors were 
weighed out dry and then sterilized for 1 hour using germicidal UV and then transferred 
into sterile 50-ml conical tubes. Photoinitiators 2,2'-Azobis[2-methyl-N-(2-
hydroxyethyl)propionamide] (VA-086, Wako Chemicals)  and 2-hydroxy-1(4-
(hydroxyethox)pheny)-2-methyl-1-propanone (Irgacure 2959, BASF Corporation, 
Newport, DE) were weighed out and dissolved in 70% ethanol  to make stock solutions 
0.015g Irgacure/ml of ethanol solution which was then sterile filtered (Chandler, 
Berglund et al. 2011; Rouillard, Berglund et al. 2011). Stock solutions were stored at 
room temperature and used within 1 week.  Photoinitiator stock solution was added to 
sterilized polymers to give a final concentration of 0.1% w/v Irgacure for the valve root, 
and 0.02%w/v for the valve leaflet. The remaining solution volume was made up by 
F12:DMEM cell culture media.   Polymer precursors, photoinitiator solution, and media 
were combined in conical tube, the tube cap was wrapped with parafilm, and the tube 
placed into water bath at 37°C to dissolve.  
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7.3.17 Encapsulation and 3D Bioprinting of HADMSC into Hydrogel Valves 
To test 3D bioprinted hydrogel valves in the bioreactor conditioning system and to study 
the effects of dynamic culture on remodeling in these constructs, cells were 
encapsulated in precursor solution printed into a heterogeneous simplified valve 
geometry, and crosslinked the high power LED array. Two valves were printed with 
each experiment – one designated for dynamic culture and one designate for static 
culture.  Cells were rinsed with PBS, trypsinized from flasks that were 80 - 95% 
confluent, then the trypsin was inactivated with supplemented media and cells were 
counted. Cells were spun down into a pellet (1000 RPM, 5 min). Cells were suspend in 
a small amount of media and then suspended in warmed 37°C precursor solution so 
that the concentration was 2.5 million cells/ml of precursor solution. Precursor solution 
was prepared in syringes connected by a Luer lock adapter with the stopper/piston 
removed from one side. Cells and precursors were stirred together with a sterile 
spatula.  The syringe piston was reinserted, the solution gently mixed, and the bubbles 
were squeezed out.  One syringe was detached from the Luer adapter and the 
precursor solution was transferred to a printing syringe.  Precursor solution was printed 
and then printed layers were exposed to a high powered LED array (136 mW/cm2 at the 
print surface, Chapter 3) was used to photo-crosslink the hydrogel while material was 
being deposited and for 5 minutes of post-extrusion.  Twenty milliliters of cell culture 
media was applied to submerge, hydrate, and loosen the hydrogel construct and was 
placed in the incubator.  After one hour incubation the media was exchanged for fresh. 
Media was exchanged after 24 hours and then the hydrogel valve designated for 
dynamic culture was installed in the bioreactor for 14 days of stimulation and the static 
culture valve was maintained in the incubator at 37°C, 5% CO2, and was fed every 48 
hours for 14 days.  
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7.3.18 3D Printed Hydrogel Valve Attachment into Bioreactor Holder Assembly 
3D printed hydrogel valves were attached into the bioreactor holder assembly using 
3MTM VetbondTM tissue adhesive to bond the conduit root to the Teflon mesh. The 
Vetbond™ tissue adhesive is a n-butyl cyanoacrylate that polymerizes in seconds after 
contact with tissue and body fluids. The glue was tested for biocompatiblity with both a 
direct material contact and a conditioned media experiment, and the cells were imaged 
with a phase contrast microscope at day 2,4, and 7 days of culture. For the direct glue 
experiment, 1 cm2 square of GE Health Expanded polytetrafluoroethylene (ePTFE) 
membrane was bonded to the surface of the 6-well plate with 50 µl VetBond and PAVIC 
were seeded into the wells. For the conditioned media experiment, three 2 cm2 squares 
of ePTFE membrane with 50 µl of polymerized applied VetBond glue were soaked in 
DMEM media. Media is conditioned for 3 days prior to application to cells for the 
conditioned media experiment. Conditioned media is decanted from the material plus 
media tube every other day. Any leaching or toxins will become more concentrated as 
the test progresses. 
 
7.3.19 Cell viability, collagen, and glycosaminoglycan (GAG) secretion 
Cultured valves were stained with LIVE/DEAD Viability and Cytotoxicity Kit (Invitrogen) 
to determine viability of cells after 7 days and 14 days in culture. Green fluorescent 
Calcein-AM (LIVE) staining indicates intracellular esterase activity and red fluorescent 
ethidium homodimer-1 (DEAD) indicates loss of plasma membrane integrity.  Dye 
working solution was prepared at a concentration of 4 μM DEAD and 2 μM LIVE in PBS 
warmed to 37°C.  Media was aspirated from wells containing gel disks and dye working 
solution was applied directly to gels. Working solution submerged gels were incubated 
for 30 minutes at 37°C. Dye solution was aspirated and gels were rinsed with warmed 
PBS. PBS was aspirated and warmed culture media was added to wells.  LIVE/DEAD 
stained valve portions were imaged using confocal laser scanning microscopy (25X H2O 
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objective, LSM 710, Carl Zeiss). Dimethylmethylene blue (DMMB) assay was performed 
to measure the sulfated GAG production in the hydrogel valves after 7 days and 14 
days culture (Farndale, Buttle et al. 1986; Hui, Cheung et al. 2008).  Pieces of the valve 
constructs were digested with 300 µg/ml papain in 50 mM phosphate buffer (pH 6.5), 
containing 5 mM cysteine and 5 mM EDTA for 16 h at 60 C. GAG concentration was 
calculated by calibrating against a standard curve obtained with shark chondroitin 
sulfate (Sigma). A hydroyproline assay was used to determine if there were the changes 
in collagen content between the static and dynamically cultured valves, as previously 
described (Reddy and Enwemeka 1996; Sinthuvanich, Haines-Butterick et al. 2012).  
 
7.3.20 Statistics 
JMP PRO was used to make statistical comparisons. The Student’s t-test was applied 
to the data sets. Standard error of the mean was calculated and is displayed on graphs. 
Fit least squares regression analysis was done on the stroke volume trends results to 
compare slopes.  
 
7.4 Results 
7.4.1 Characterization of Water Pump Flow Loop System to Drive Diaphragm 
Deflection in Media Loop 
 When first turned on, the water loop system takes a few minutes and several cycles of 
the pump to equilibrate.  Increasing the pressure difference between the high tank and 
low tank (set by the controller) increases the amount of volume drift (Figure 7.6A). The 
periodic deflection of the volume also varies during the cycle of the pump. This is 
related to the oscillation around the pressure difference setting.  The volume deviation 
was 12 ml and 150 ml for a Pdiff pressure setting of 50 mmHg and 250 mmHg 
respectively. The average volume deflection was 6 ml and 13 ml for a Pdiff pressure 
setting of 50 mmHg and 250 mmHg respectively.  Changing the delta setting affected  
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Figure 7.6 -76  Characterizing water pump flow loop system to drive diaphragm in 
media loop. 
(A) Volume drift was plotted against time for different pressure difference settings 
(Pdiff = Hightank – Low tank). (B) Volume drift was plotted against time for different 
delta settings in the controller program. (Delta describe the sensitivity or anticipation 
of the pump turning on  to maintain Pdiff.) (C) Pressure drift affects the water pressure 
in the tubing lines indicated by the yellow arrow and box.  
 
The flexible silicone sheet in the 
base of the conditioning chamber 
will deform until equilibrium is 
reached. With a graduated open 
tube (no resistance) the volume 
change/volume offset for different 
pump control parameters can be 
identified.  
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the pressure deviation inconsistently and did not affect the deflection except at the lower 
pressure setting (Figure 7.6.B). Pressure drift affects the water pressure in the tubing 
lines leading up to the base of the conditioning chamber (Figure 7.2C, indicated by the 
yellow arrow and box). The flexible silicone sheet in the base of the conditioning 
chamber will deform until equilibrium is reached. At higher pressure settings the volume 
deviation could over flex the diaphragm depending on the size of the reactor base 
(Figure 7.7).   
 
Ideally the deflection of the membrane is within the dimensions of the base (Figure 
7.7A). Water from the pump system will deform the silicone diaphragm. It will retract or 
expand as water moves to from higher pressure to lower pressure. This will simulate 
expansion and contraction of the heart ventricle on the media side of the silicone. High 
deviation and/or deflection will over flex the diaphragm where it begins to impact against 
the chamber walls (Figure 7.7B). This will affect the stroke volume of the ventricle 
chamber. Also, if the membrane deforms beyond the base and into the inflow and 
outflow ports, wear and break down of the silicone sheet may occur. This leads to the 
inclusion of an additional capacitance membrane/silicone diaphragm in the water flow 
loop (Figure 7.7C.2). When the pump system (Figure 7.7C.3) is first turned on the 
capacitance membrane expands with the extra deviation volume (Figure 7.7C.2), then 
the flow loop is switched/connected to the bioreactor chamber base when the volume 
has equilibrated (Figure 7.7C.1). Left side is the schematic diagram and right side are 
the images of the actual conditioning chamber with attached pressure transducers, the 
capacitance membrane (pale green), and the tank setup. Two diverting 3-port ball 
valves were used to switch the flow loop from the capacitance membrane to the 
bioreactor chamber base. 
  
 310 
 
 
Figure 7.7 -77  Schematic representation of diaphragm state 
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7.4.2 Ventricular Stroke Volume for Different Size Conditioning Chambers 
The conditioning chamber design became larger as our design progressed, building in 
extra capacity to condition both adult and pediatric heart valves (Figure 7.8A). The 
conditioning chamber design 6 was optimized for minimal media usage.  The working 
volume was 85 ml, not including a media reservoir. Inclusion of an ultrasound port, room 
for a aligned holder frame, and expansion of the base of the reactor increased the 
working volume to 478 ml. The maximum possible stroke volume is set by the 
dimensions of the reactor base.  For the miniature bioreactor this is 37 ml and for the 
large base reactor this is 287 ml. Stroke volume as a function of the pressure difference 
setting in the water pump system followed a similar trend for the miniature base reactor 
(design 6)  and the larger base reactor (design 12) (Figure 7.8B). Applied aortic 
pressure increases the slope of the trend, and stroke volume increases with Pdiff setting 
more sharply with applied pressure. Standard least squares regression (using the full 
factorial macro in JMP) indicates slope is significantly different between the no aortic 
pressure large base stroke volume trend and the applied aortic large reactor base 
stroke volume trend.  
 
7.4.3 Systolic Flow Rate in Heart Valve Bioreactor 
The size of the conditioning chamber base size sets a limit on the stroke volume and 
flow rate.  The bioreactor base and tubing can be scaled for a large range of stroke 
volumes and systolic flow rates through the TEHV. The estimated systolic flow rate and 
stroke volumes for shorter cycle times, at higher pressure settings, and for larger sink 
and source tubing are summarized in Table 7.2.  Shortening the cycle time decreases 
the stroke volume. Systolic flow rate increases with pressure setting for miniature and 
large base reactors, and applied aortic pressure decreases the flow rate and stroke  
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Figure 7.8 -78  Heart valve bioreactor base and chamber design progression and 
stroke volume. 
(A) The conditioning chamber design 6 was optimized for minimal media usage.  The 
working volume was 85 ml, not including a media reservoir. Inclusion of an 
ultrasound port, room for a aligned holder frame , and  expanding the base of the 
reactor increased the working volume to 478 ml. (B) Stroke volume of a small base 
reactor (design 6) was compared to a larger base reactor (design 12). For these tests 
a 1mm thick silicone diaphragm, was bolted into the base, Tsystolic = Tsource=1 sec and 
Tdiastolic=Tsink=1 sec. 
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Pdiff [mmHg] 
250 500 25 
Cycle Time [sec] 
0.25 0.5 1 2 3 4 6 2 2 
Mini  Base Stroke 
Volume [ml] 
2 4 8 17 25 33 N/A 27 7 
Large Base Stroke 
volume [ml] 
2 4 9 17 26 34 51 34 2 
80 mmHg Applied 
Aortic Pressure, 
Large Base Stroke 
Volume [ml] 
2 3 7 14 21 28 42 25 4 
Mini Systolic 
Flow Rate [ml/sec] 
17 27 7 
Large Systolic 
Flow Rate [ml/sec] 
17 34 2 
Large AP 80 
Systolic 
Flow Rate [ml/sec] 
14 25 4 
w/ Double Tube Tank Diameter (1/2”) 
Large Systolic 
Flow Rate [ml/sec] 
273 541 32 
Large AP 80 
Systolic 
Flow Rate [ml/sec] 
222 392 69 
Large Stroke 
Volume [ml] 
34 68 137 273 410 547 820 541 32 
Large AP 80 Stroke 
Volume[ml] 
28 56 111 222 333 445 667 392 69 
Table 7.2 Extrapolated stroke volume and flow rate based on heart valve 
bioreactor base design, delivered pressure, and tank tubing.   
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volume. In the no applied aortic pressure condition, the flow rate increases from 2 
ml/sec to 17 ml/sec for Pdiff at 25 and 250 mmHg respectively. When 80 mmHg aortic 
pressure is applied, the flow rate increases from 2ml/sec to 14 ml/sec for Pdiff at  25 
and 250 mmHg respectively. The effect of a larger tubing size (1/2”) for the sink and 
source tube out of the high tank and low tank had a dramatic effect on flow rates and 
possible stroke volumes. The tubing size works as a throttle in the system. If larger 
systolic flow rate is needed the tank tubing can be increased. In this system setting 
unmatched sink and source times eventually over-inflate or suck down the membrane. 
In the tested setup, the water flow loop is symmetric with the tubing lines.  If an 
asymmetric diastolic and systolic time were desired flow rates in and out of the reactor 
base could be mismatched.   
 
7.4.4 Porcine Valve Sutured into Holder Assembly 
To test the bioreactor system a porcine valve was sutured into the holder assembly and 
loaded into the reactor. The valve was positioned in the holder/mesh so that the leaflets 
and sinus are in the line of sight of the ultrasound port. The base was preassembled 
and the check valves were installed. There were seven main steps to the assembly of 
the holder and insertion into the bioreactor chamber. First, the height of  holder was set 
with the first three shaft collars on the three alignment posts (Figure 7.9A). 2nd the base 
of the heart valve was sutured into the Teflon mesh of the bottom holder, and then the 
aorta/sinotubular junction was sutured into the Teflon mesh of the top holder (7.9B). 3rd, 
the valve needed to be checked for buckling in case the suturing was uneven and re-
sutured if necessary (Figure 7.9C). 4th the holder was fixed onto the alignment posts 
with the remaining three shaft collars using a hex key to tighten the set screws with 
(Figure 7.9D,E). 5th the holder assembly was inserted into the body of the conditioning 
chamber along the guide track (Figure 7.9F). 6th the chamber was filled with enough 
liquid to submerge the valve (PBS for pressure characterization, media for culture tests)  
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Figure 7.9 -79  Testing the  holder setup with a porcine heart valve and system 
pressure characterization. 
To test the bioreactor system a porcine valve was sutured into the holder assembly 
and loaded into the reactor. The assembly steps were: (A) The  height of  holder was 
set with the first three shaft collars on the three alignment posts. (B)  The base of the 
heart valve was sutured into the Teflon mesh of the bottom holder, and then the 
aorta/sinotubular junction was sutured into the Teflon mesh of the top holder. (C) 
The valve was checked for buckling caused by uneven suturing. (D) The holder was 
fixed onto the alignment posts with the remaining three shaft collars by (E) tightening 
the set screws with a hex key. (F) Holder assembly was inserted into the body of the 
conditioning chamber along the guide track. (G) The chamber was filled with enough 
liquid to submerge the valve (PBS for pressure characterization only, media for 
culture tests). (H) The aortic top piece flanges were mated with the body flanges, 
with a silicone gasket in between,  and the bolt/washer/nuts were tightened.  
  flangesilicone gasket in between,  and the bolt/washer/nuts were tightened.  
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(Figure 7.9G). 7th the aortic top piece flanges were mated with the body flanges with a 
silicone gasket in between and the nuts were tightened on the bolts and washers. This 
assembly was connected to the transducer tubing and reservoir, and then to the pump 
apparatus.   
 
7.4.5 Optical and Ultrasound Imaging of Heart Valve in Hard -walled Bioreactor 
Chamber.  
Optical imaging and ultrasound imaging of the valve in the holder setup within the 
bioreactor conditioning chamber was possible (bioreactor chamber design 12/13).  A 
portable USB microscope was used to image the valve through the glass optical port in 
the top of the aortic part of the conditioning chamber (7.10B). This microscope could be  
set up in the incubator  and mounted on a stand. For video and still frame imaging the 
reactor could be lit with a lamp because the bioreactor Steralloy material was 
translucent. By imaging through the glass port the leaflet appearance and movement 
during systole is clearly visible (7.11A). Leaflet coaptation of the porcine valve during 
diastole is visible with the microscope imaging (7.11B).  
 
A 5 MHz ultrasound probe, normally used for transthoracic echocardiograms, was used 
to image the valve through the Teflon port on the side of the reactor chamber (Figure 
7.10B).  The bioreactor conditioning chamber and media flow loop was  fairly portable, 
and could be moved in and out of the incubator and reconnected to the electronics and 
water flow loop as needed. The bioreactor conditioning chamber and flow loop was 
transported to the veterinary hospital for the ultrasound imaging. By imaging through the 
ultrasound  port the leaflet motion during  systole is  visible in the transverse plane or 
short axis (7.11C.1) and in the sagittal plane or long axis (7.11D.1). Tissue and tissue 
movement is clear.  Bubbles were injected and circulated through the valve for contrast. 
to observe liquid movement.   The coaptation of the leaflests is evident in both the short 
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Figure 7.10 -80  Microscope and ultrasound imaging of valve in bioreactor. 
(A) A USB microscope was used to image the valve through the glass optical port in 
the top of the aortic part of the conditioning chamber. (B) A 5 MHz ultrasound probe 
was used to image the valve through the Teflon port through the side of the reactor 
chamber.  
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Figure 7.11 -81  Microscope and ultrasound images of systole and diastole 
(A)By imaging through the glass port leaflet appearance of the porcine valve used for 
validation and movement during systole is clearly visible. (B) Leaflet coaptation of the 
porcine valve during diastole. is visible with the microscope imaging. (C and D) By 
imaging through the ultrasound  port the leaflet motion during  systole is  visible in the 
transverse plane or short axis (C.1) and in the sagittal plane or long axis (D.1). 
Bubbles can be injected and circulated through the valve for contrast.  The 
coaptation of the leaflests is evident  in both the short axis (C.2, C.3) and the long 
axis(D.2, D.3). Diastolic loading of the valve once the leaflets have coapted shows 
deformation of the valve root and leaflets (D.3).  
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axis (7.11C.2, 7.11C.3) and the long axis (7.11D.2, 7.11D.3). Diastolic loading of the 
valve once the leaflets have coapted shows deformation of the valve root and leaflets 
(7.11D.3).  The picture on the ultrasound monitor shows the displayed ‘beam’ from the 
transducer the ultrasound port and structures at the bottom of the images are furthest 
away. The focal zone, where the area of greatest resolution  is, is marked by a small 
carat on the left side of the images .It was possible to adjust this focal  zone to be right 
in the center of the valve, and to section on either side (images were shown here of the 
center section) . The stainless steel posts are acceptably positioned in the reactor  so 
they do not obscure the image. In the short axis view (7.11C) although the three posts 
around the valve are visible to the ultrasound. 
 
7.4.6 Aortic and Ventricular Pressure Ranges of Bioreactor for Changing Flow Loop and 
Applied Pressure Parameters 
Alternating solenoid timer relay control setup  
Pressure traces were recorded for a 10mmHg Pdiff setting with no applied  aortic 
pressure for the high  tank, low tank, ventricle, and aortic chambers for the alternating 
solenoid/timer relay control setup (7.12A).  The sink and source time for the flow loop 
was matched so that tsystolic =tdiastolic which was set to 1 sec. With the alternating solenoid 
control setup the pinch solenoid opens at the same time that the diaphragm expands 
and pushes fluid out of the ventricle. The high and low tank pressures fluctuate as the 
pump turns on and off to maintain the Pdiff. The pump fills the high tank by drawing liquid 
from the low tank, and the rise of the pressure in the high tank is matched by the fall of 
the pressure in the low tank. At the low (10 mmHg) Pdiff  setting the change in the actual 
pressure difference between the high tank and the low tank during the pump cycle 
visibly affects the pressures in the ventricle and aortic chambers. Pressure traces were 
recorded for a 150 mmHg Pdiff setting with no applied  aortic pressure for the high  tank,  
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Figure 7.12 -82  Representative pressure traces of  high tank, low tank, aortic, and 
ventricular chambers in an alternating solenoid control setup. 
(A) Pressure traces were recorded for a 10mmHg Pdiff setting with no applied aortic 
pressure for the high  tank, low tank, ventricle , and aortic chambers.  The sink and 
source time for the flow loop was matched so that tsystolic =tdiastolic which was set to 1 
sec. With the alternating solenoid control setup the the pinch solenoid opens at the 
same time that the diaphragm expands and pushes fluid out of the ventricle. (B) 
Pressure traces were recorded for a 150 mmHg Pdiff setting with no applied  aortic 
pressure for the high  tank, low tank, ventricle , and aortic chambers.  
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low tank, ventricle , and aortic chambers for the alternating solenoid/timer relay control 
setup (7.12B). At the higher (150 mmHg) Pdiff setting an effect of the oscillating pressure 
difference between the high tank and the low tank during the pump cycle is still present   
in the ventricle and aortic pressure traces but it is less pronounced.  When there is no 
applied aortic pressure the aortic pressure follows the rise in ventricle pressure. 
 
Pressure traces were  also plotted showing just the aortic and ventricle pressures  
(7.13) The pressure profile of a  75 mmHg Pdiff setting with no applied  aortic pressure 
(7.13A) and the pressure profile of a 150 mmHg (Pdiff) setting are  similar with the 
ventricle pressure leading the aortic pressure.   When 78 mm Hg pressure is applied to 
the aorta using the pressurized tank of 5% CO2/air the ventricle and aortic pressures 
both shift up for both a 75 mmHg Pdiff condition and a 150 mmHg Pdiff condition (Figure 
7.13B and D respectively). With the alternating solenoid control setup the pinch solenoid 
opens at the same time that the diaphragm expands and pushes fluid out of the 
ventricle. Under a pressurized aortic condition, when the pinch valve opens it vents the 
pressure.  As a result the rise and fall of the aortic and ventricular pressure are more in 
phase. The pressure traces of the applied pressure conditions indicate that the aortic 
pressure remains higher than the ventricular pressure. However, in the viewport it was 
possible to see that the valve is opening and closing with and without applied aortic 
pressure for 75 and 150 mmHg Pdiff settings. There also does not appear to be 
regurgitation of liquid back into the ventricle through the leaflets. This indicates that the 
pressure traces shown by the transducers are offset from the pressures experienced at 
the valve leaflets. For the leaflets to open and fluid to flow through the heart valve, 
pressure on the ventricle side must overcome the pressure on the aortic side.   
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Figure 7.13 -83  Representative pressure traces of aortic and ventricular 
chambers in an alternating solenoid control setup with applied aortic pressure. 
(A) Pressure traces were recorded for a 75 mmHg Pdiff setting with no applied aortic 
pressure for the ventricle and aortic chambers. (B) Pressure traces were recorded for  
a 75 mmHg Pdiff setting with 78 mmHg applied aortic pressure for the ventricle and 
aortic chambers. (C) Pressure traces were recorded for  a 75 mmHg Pdiff setting with 
no applied  aortic pressure for the ventricle and aortic chambers (D) Pressure traces 
were recorded for a 150 mmHg Pdiff setting with no applied  aortic pressure for the 
high  tank, low tank, ventricle , and aortic chambers. With the alternating solenoid 
control setup the the pinch solenoid opens at the same time that the diaphragm 
expands and pushes fluid out of the ventricle. For (A), (B),(C), and (D)the sink and 
source time for the flow loop was matched so that tsystolic =tdiastolic =1 sec. (E) To 
investigate a diastolic loading only condition pressure traces were recorded with the 
flow loop disconnected from the base (connected to the capacitance membrane 
instead) with the regulator for the applied aortic pressure set at 78 mmHg.  
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To investigate a diastolic loading only condition, pressure traces were recorded with the 
flow loop disconnected from the base (connected to the capacitance membrane 
instead) with the regulator for the applied aortic pressure set at 78 mmHg (Figure 
7.13E). In this situation the aortic pressure leads the ventricular pressure. Media does 
move around the valve and which is how the ventricular pressure follows the aortic 
pressure. Water or media can flow around the valve a few ways. The valve is held in a 
Teflon mesh that water (or media) will pass through the mesh at pressures greater than  
38 mmHg. There are small equilibrium holes between the chest cavity and the ventricle 
chamber. For aortic valves, the coronary ostia allow flow from the aorta into the chest 
cavity of the reactor. There could be gaps in the sutures.  
 
Aortic pressure feedback control setup  
 The aortic pressure feedback control setup was tested by setting a threshold for the 
aortic pressure, setting the regulator on the tank for the applied aortic pressure at that 
number, and then  running the system  at the 10-300 mmHg range of  Pdiff settings. The 
pressure traces show that this control strategy (at least at the settings explored) gives a 
more physiological simulation of cardiac conditions (in terms of the Wiggers diagram) 
(Figure 7.14). The pressure traces show that an offset between the aortic pressure and 
the ventricle pressure can be maintained, and that when the ventricle contracts the 
pressure rises to meet the aortic pressure. The logic of the microcontroller is that if 
Pthreshold less than Paortic then the pinch solenoid  valve will energize and open, allowing 
flow through the tubing vent out of the reservoir, and if the Pthreshold is equal to or greater 
than the Paortic, the solenoid will remain closed. It should be noted that the regulator 
pressure  gauges do not have a very fine scale so there is some margin of error for how 
precisely we are able to set the applied aortic pressure at 80 mmHg and 160mmHg.  
When the pressure delivered by the regulator was set at 80 mmHg and  the pressure 
relief threshold in the microcontroller was set to match the applied aortic pressure, a 75  
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Figure 7.14 -84  Representative pressure traces of aortic and ventricular 
chambers in an aortic pressure feedback control setup. 
The pressure relief threshold in the microcontroller was set to match the applied 
aortic pressure. (A) Pressure traces were recorded for the ventricle and aortic 
chambers with a 75 mmHg Pdiff setting in the flow loop with applied  aortic pressure of 
80mmHg. The pinch valve was controlled by the microcontroller and the pressure 
relief threshold was set at 80mmHg. (B)Pressure traces were recorded for the 
ventricle and aortic chambers with a 150 mmHg Pdiff setting, 80mmHg applied aortic 
pressure, and a 80mmHg relief threshold. (C) Pressure traces were recorded for the 
ventricle and aortic chambers with a 150mmHg Pdiff setting, 160 mmHg applied aortic 
pressure, and a 160 mmHg relief threshold. (D) Pressure traces were recorded for 
the ventricle and aortic chambers with a 300mmHg Pdiff setting, 80 mmHg applied 
aortic pressure, and a 80 mmHg relief threshold. (E) Pressure traces were recorded 
for the ventricle and aortic chambers with a 300mmHg Pdiff setting, 160 mmHg 
applied aortic pressure, and a 160 mmHg relief threshold. With the pressure 
feedback control setup the pinch solenoid  opens at the same time that the 
diaphragm expands and pushes fluid out of the ventricle. For all traces shown the 
sink and source time for the flow loop were matched so that tsystolic =tdiastolic =1 sec.  
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mmHg Pdiff setting in the flow loop triggers the pressure relief solenoid to  energize with 
each beat (Figure 7.14A). Pressure traces recorded for the ventricle and aortic 
chambers with a 150 mmHg Pdiff setting, 80 mmHg applied aortic pressure, and a 80 
mmHg relief threshold show that the peak ventricle and aortic pressure for a given beat 
can be increased compared to 7.14A by increasing the Pdff setting and that the pinch 
valve will vent with each beat (Figure 7.14B). Setting the parameters at 150 mmHg Pdiff, 
160 mmHg applied aortic pressure, and a 160 mmHg relief threshold shows that there is 
a delay/recovery phase when the much higher aortic pressure is applied (Figure 7.14C). 
This is also evident for the 300mmHg Pdiff setting tests where 80 mmHg was the applied 
aortic pressure and relief threshold setting(Figure 7.14.D) and 160 mmHg was the 
applied aortic pressure and relief threshold setting (Figure 7.14.E). With the pressure 
feedback control setup, the diaphragm expands and pushes fluid out of the ventricle 
and the aortic pressure rises, triggering the opening of the pinch solenoid.  For all traces 
shown in this set of experiments the sink and source time for the flow loop were 
matched so that tsystolic =tdiastolic =1 sec.  
  
7.4.7 Biocompatibility Testing of Media Flow Loop and Conditioning Chamber 
Parts 
Materials that were biocompatible and could be used in contact with media were 
subsequently chosen for bioreactor assembly and fabrication (Table 7.1).  During the 
design phase of the chamber and holder assembly, possible materials were explored 
with conditioned media experiments and MTT assay. (Figure 7.15, Figure 7.16A, Figure 
7.17A).  For the fabrication of the bioreactor chamber, we found that the Durable Fine 
plastic Ponoko 3D printed material and the Quickparts SLA materials tested were all 
detrimental to PAVIC viability (Figure 7.15, Figure 7.16B).  Once we found that the 
standard commercially 3D printed and SLA parts were not compatible with valve cells, 
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Table 7.1-7 Media loop: Parts in Contact with Cell Culture Media/Bioreactor 
Interior 
list 
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Figure 7.15 -85  Representative images of biocompatiblity well experiments. 
Materials that were tested with conditioned media experiments were: (A) Hapflex 781 
and 781-3, (B) Steralloy 2463, (C) Steralloy 2398, (D) Steralloy 2380, (E) Steralloy 
2871, and (F) Steralloy 2501. (images A-F were taken at day 4 of conditioned media 
treatment for wells seeded at 2.0*104cells/cm2). Conditioned media experiments with 
a sparser cell density were used test materials: (G) Control, (H) GE PTFE Mesh, (I) 
Teflon Mcmaster-Carr for ultrasound port, (J) Ponoko durable fine plastic, (K) 
Quickparts Urethane/Lexan (Note: cells died and peeled off in sheets after 24 hours 
in conditioned media).  (images G-K were taken at day 6 of conditioned media 
treatment for wells seeded at 1.0*104cells/cm2).  Material in well experiment were 
also used to test materials: (L) Control (M) Quickparts Cast Urethane/Lexan, (N) 
Quickparts SLA Acura 50 ABS like, (O) Quickparts SLA Acura 60  Water clear PC 
like, (P) Quickparts SLA Somo's 9420, High res durable PP like, (Q) Quickparts SLA 
Somo's 18420 ,High resolution ABS like, (R) Sylgard PDMS , and (S)Loctitie Epoxy. 
Images L-N were taken 6 days after wells were seeded.  
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Figure 7.16 -86  MTT assay biocompatibility screening of bioreactor materials. 
Cell metabolism of PAVIC treated with conditioned media was assessed for chamber 
and holder materials. (A) During the design phase of the chamber and holder 
assembly, possible materials were explored with conditioned media experiments and 
MTT assay. Wells seeded at 1.0x104cells/cm2 were assayed at day 7 of conditioned 
media treatment. (B) Once we found that the standard commercially 3D printed and 
SLA parts were not compatible with valve cells, specialty resins previously used in 
food and medical equipment for cast parts were explored with conditioned media 
experiments and MTT assay. Wells were seeded  at 2.0x104cells/cm2 . . Statistical 
comparisons were made using Student’s t-test and non matching letters indicate 
significance p<0.05.  Graph error bars indicate standard error of the mean.  
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Figure 7.17-87 Bioreactor chamber fabrication and material selection progression. 
(A.1) Initial testing of chamber design and prototyping  was done with  Ponoko 
fabricated parts made of Durable Fine Plastic. These parts were made with A UV 
cured greenish resin that is printed on an Objet Connex 3D printing machine. The 
Ponoko Durable Fine Plastic was not compatible with valve cells.  Over time it 
absorbed  water, and with repeated clamping of the bolts the flanges eventually 
deform.  A silicone putty was used to pack the gaskets to get a seal for pressurization 
in the early prototypes made with the Durable Fine plastic. (A.2)  Valve holder 
assemblies were initially built out of available materials in lab to refine the Solidworks 
designs prior to fabrication. (B) Quickparts SLA fabricate  parts were used to check 
the design prior to casting multiple bioreactor chambers.  (B.1 and B.2) The PP-like, 
Durable Accura 25 / VisiJet SLFlex SLA parts were water tight and could be 
pressurized for testing. (C) Once the design was refined multiple Steralloy 2463  
chambers were fabricated so that the parallel conditioning system could be setup 
with biocompatible parts.  Quickparts fabricates SLA parts of all the components, 
makes RTV silicone rubber molds, and then casts the parts. (C.1) The final 
bioreactor chamber is translucent so that bubbles and media levels within are visible 
to the outside. (C.2) The holder made of 2643  bonds well to PDMS allowing for the 
attachment of the Teflon mesh.  
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specialty resins previously used in food and medical equipment for cast parts were 
explored with conditioned media experiments and MTT assay (Figure 7.16B).  
 
While we did find that coating the Ponoko plastic with PDMS and curing it in an oven 
overnight improved biocompatibility, the Ponoko parts also experienced significant 
warping over time (Figure 7.17A.1).  Several of the specialty  casting  Steralloy resins 
(Hapco, Hanover MA) were biocompatible with the cells.  Steralloy FDG-2398, Steralloy 
FDG-2380, Steralloy FDG-2501 all had higher MTT results than the control (Figure 
7.16B). From the images it appeared that Steralloy 2380 introduced a particulate or 
some kind of debris into culture. The MTT absorbance was less than control for  
Steralloy 2463 , but the cell morphology was characteristic of healthy PAVIC and there 
was less debris that was seen in 2398 and 2380. Steralloy 2463 was chosen for the 
bioreactor chamber because it was easier for Quickparts to handle. Steralloy 2463 as 
an uncured resin is ~25% less viscous compared to 2398, it is much easier to process, 
and it has a hardness of 80D which is the same as the 2501.  RTV molding as a 
prototyping process is good for fabricating 1 - 100 parts. Once the molds are made, the 
cost of fabricating parts goes down dramatically. Quickparts fabricates SLA  parts of all 
the components, uses the SLA parts as the negative to makes RTV silicone rubber 
molds, gets the needed specialty resin from HAPCO,  and then casts the parts. 
 
Quickparts SLA fabricated parts were used to check the design prior to committing 
resources to casting multiple bioreactor chambers in the biocompatible material. The 
PP-like, Durable Accura 25 / VisiJet SLFlex SLA parts were water tight and could be 
pressurized for testing (7.17B.1 and 6.17B.2). Once the design was refined, multiple 
Steralloy 2463 chambers were fabricated so that the parallel conditioning system could 
be setup with biocompatible parts 7.17C). The final bioreactor chamber is translucent so 
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that bubbles and media levels within are visible to the outside (7.17C.1). The holder 
made of 2643 bonds well to PDMS allowing for the attachment of the Teflon mesh to the 
holder 7.17C.2).  
 
7.4.8 3D Printed Hydrogel Valve Attachment into Biocompatible  Bioreactor 
Holder  
PEGDA700 precursor solutions and MEGEL/MEHA/PEGDA precursor solutions were 
successfully printed into two part STL geometries. UV light applied during the printing 
(Figure 7.18A) and for 5 minutes after the hydrogel was extruded (Figure 7.18B). An ice 
water cooling heat sink keeps the temperature of the LEDs stable so that light intensity 
should be constant during the whole fabrication process (Figure 7.16C). The 3D printed 
hydrogel heart valves in PEGDA700 were sufficiently crosslinked after printing and 5 
minutes additional crosslinking enabled handling and incorporation into the holders 
(Figure 7.19). Tissue glue was used to attach the 3D printed hydrogel valve into the 
Teflon mesh of the holder. Tissue glue compatibility was screened with 2D PAVIC 
culture and showed that cytotoxity of the glue was inconsistent (Figure 7.19A).  Near 
glue and mesh in direct media contact conditions wells either had very few attached 
cells or wells were confluent cells by day 7. PAVIC in wells treated with conditioned 
media from tissue glue bonded to Teflon mesh reached confluence by day 7 (Figure 
7.19 B)  Control wells seeded at the same density as the treatment groups reached 
confluence by day 7 (Figure 7.19C). The 3D printed PEGDA700 valve was successfully 
bonded onto the top holder mesh using tissue glue (Figure 7.19E). The glue was 
injected between the mesh and the conduit wall. Then the bottom holder mesh was 
fitted over the sides of the printed valve. The second set of shaft collars locked the 
holder in place and the assembly was loaded into the bioreactor body. The PEGDA 700   
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Figure 7.18 -88 High power LED printing of hydrogel valves for conditioning. 
(A) A solution of MEGEL/MEHA/PEGDA3350 was printed into a simplified 
interlocking STL hydrogel valve geometry using the Fab@HomeTM extrusion 3D 
printer.  The root was printed with a stiffer hydrogel composition than the leaflets. A 
high powered LED array was mounted on the carriage so that photo-crosslinking 
occurred during printing. (B) An additional 5 minutes of post-print-crosslinking was 
applied with the LEDs centered over the printed valve. (C) An ice water cooling heat 
sink is built into the high powered LED array circuit. The power supply and resistor 
bed as well as the water supply are kept outside of the laminar flow hood.  
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Figure 7.19 -89 3D printed hydrogel valve sealing into bioreactor holder assembly.   
Tissue glue was used to attach the 3D printed hydrogel valve into the teflon mesh of 
the holder. Tissue glue compatibility was screened with 2D PAVIC culture, (A) Near 
glue and mesh in direct media contact conditions wells either had very few attached 
cells or wells were confluent cells by day 7. (B)  PAVIC in wells treated with 
conditioned media from tissue glue bonded to Teflon mesh reached confluence by 
day 7. (C) Control wells seeded at the same density as the treatment groups reached 
confluence by day 7. (D) A simplified valve geometry was 3D printed with a 
PEGDA700 solution with 1% Irgacure. (E) The 3D printed PEGDA700 valve was 1st 
bonded onto the top holder mesh using tissue glue. The glue was injected between 
the mesh and the conduit wall. 2nd the bottom holder mesh was fitted over the sides 
of the printed valve. The second set of shaft collars locked the holder in place and 
the assembly was loaded into the bioreactor body.  (F) The PEGDA 700 Valve was 
tested in the bioreactor setup up to a 250 mmHg Pdiff setting with no applied aortic 
pressure. The leaflet movement for the stiff PEGDA700  leaflets during the systolic 
(F) and diastolic (G) phases of  the conditioning cycle at 250mmHg was slight.    
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Figure 7.20 -90  Dynamic culture of 3D bioprinted heterogeneous hydrogel valves 
printed with encapsulated HADMSC. 
HADMSC were encapsulated into MEGEL/MEHA/PEGDA solutions and printed into 
simplified valve geometries. For each experiment a pair of valves were printed, one 
for dynamic and one for static conditioning for 14 days. (A) The valve root and 
leaflets were printed out of different precursor solutions so that the leaflets are more 
compliant than the root. A static condition bioprinted valve  was stained using 
Live/Dead after 7 days of culture and imaged with a 25X (B) and 10X. (C) confocal 
objective. (D) Snapshots were taken of a dynamically conditioning bioprinted valve 
during systole and diastole directly after it was installed in the reactor and 
conditioning was initiated. Low stroke volume and pressure conditions were used, 
and the conditioning parameters were set at Pdiff= 25mmHg, no applied aortic 
pressure, and tsystolic=tdastolic=1 sec, and an open vent (no aortic threshold). 
(E)Snapshots were taken of the dynamically conditioning bioprinted valve at day 7 of 
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Valve was tested in the bioreactor setup up to a 250 mmHg Pdiff setting with no applied 
aortic pressure. The leaflet movement for the stiff PEGDA700 leaflets during the systolic 
(Figure 7.19F) and diastolic (Figure 7.19G) phases of the conditioning cycle at 250 
mmHg was slight.    
 
7.4.9 Dynamic Conditioning of 3D Bioprinting Hydrogel Valves with Encapsulated 
of HADMSC 
HADMSC encapsulated into MEGEL/MEHA/PEGDA solutions were successfully printed 
into simplified valve geometries. For each experiment, a pair of valves were printed, one 
for dynamic and one for static conditioning for 14 days of culture. The valve root and 
leaflets were printed out of different precursor solutions so that the leaflets are more 
compliant than the root (Figure 7.20A).  A static condition bioprinted valve was stained  
using Live/Dead after 7 days and high viability was present indicating the printing results 
in high viability valves. Snapshots of dynamically conditioning bioprinted valve during 
systole and diastole directly after it was installed in the reactor and conditioning was 
initiated show leaflet movement and flexure (Figure 7.20D). Low stroke volume and 
pressure conditions were used so that conditions would be very gentle, and the 
conditioning parameters were set at Pdiff= 25 mmHg, no applied aortic pressure, and 
tsystolic=tdastolic=1 sec, and an open vent (no aortic threshold). Snapshots taken of the 
dynamically conditioning bioprinted valve at day 7 of culture show clear media and 
leaflet movement and flexure (Figure 7.20D). 
 
7.5 Discussion 
Previous work has shown that 3D printing can be used to fabricate viable mechanically 
and cellularly heterogeneous and hydrogel heart valves (Hockaday, Kang et al. 2012; 
Duan, Hockaday et al. 2013; Duan, Kapetanovic et al. 2014). Critical for the 
advancement of a 3D printed TEHV strategy into animal models and then to clinic is an 
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understanding of 3D print valve remodeling and optimum hemodynamic conditions to 
drive appropriate and necessary tissue development.    In this study we demonstrate a 
dynamic conditioning system specifically for the culture of 3D bioprinted heart valves. 
Mechanically heterogeneous MEHA/MEGEL/PEGDA hydrogel valves were printed with 
encapsulated HADMSC and subjected to dynamic conditioning for up to 14 days to 
validate the system and to induce remodeling in bioprinted valves. Investigators are 
developing an expanding number of encapsulating and tunable  synthetic hydrogel 
material technologies, and have evaluated many of them for valve and mesenchymal 
stem cell culture(Benton, Fairbanks et al. 2009; Benton, Kern et al. 2009; Lin and 
Anseth 2009; Kloxin, Benton et al. 2010; Kloxin, Tibbitt et al. 2010; Kloxin, Tibbitt et al. 
2010; Pedron, Kasko et al. 2010).   The validation our 3D printing and conditioning 
approach using naturally and synthetically derived polymers, indicates that  perhaps 
material technologies that have thus far been confined to  small dimensional 
mechanistic studies could be fabricated into living tissues at a scale suitable for clinical 
use.   These technologies include hydrogels with photo-releasable tethered functional 
groups that allow for control of cell–material interactions (Kloxin, Tibbitt et al. 2010), and 
photo-polymerizable  hydrogels with bound peptide moieties to affect and enhance 
affinity protein binding which would allow for retention and sustained release of growth 
factors from implanted scaffolds (Lin and Anseth 2009). 
 
Ultrasound assessment of valve root wall and leaflet motion and tissue during systolic 
and diastolic loading was enabled by a rigid Teflon ultrasound port or acoustic ‘window’ 
built into the reactor conditioning chamber. The Teflon window can also be moved to the 
top of the aortic chamber so that flow velocity information can be obtained. Other 
studies have used ultrasound to monitor TEHV following implantation into animal 
models (Syedain 2011) and acoustic windows have been built into pulse duplicator 
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systems for Doppler flow mapping studies of prosthetic valves (Giuliatti, Gallo et al. 
2000). Ultrasound echocardiography has been used to assess the performance of 
molded fibrin hydrogel TEHVs(Syedain 2011), in-body TEHV (Nakayama, Takewa et al. 
2014), and nonwoven polymeric fiber scaffold TEHV (Gottlieb, Kunal et al. 2010),  once 
they had been implanted into animal models. These studies have assessed coaptation 
and valve closure and have characterized the flow profile and regurgitation of the valves 
under physiological conditions. Subsequent 3D printed valve studies with our system 
can evaluate flow profiles over time in culture and study the effects of different 
loading/cardiac cycle conditions to assess functional or non-functional remodeling. This 
ultrasound port could also potentially be used for strain mapping of 3D printed heart 
valves. This has previously been done for myocardium and the ventricles (D'Hooge, 
Heimdal et al. 2000; Weidemann, Eyskens et al. 2002; Sutherland, Di Salvo et al. 2004; 
Larsen, Petersen et al. 2006), and it is possible that it could be done for heart valves. 
The conditioning chamber and holder in our system was specifically designed so that 
outflow tract, ventricular, and body cavity pressures surrounding the valve can be 
mimicked. Although it was not monitored in the study presented here, a line for a body 
cavity pressure transducer was included on the side of the bioreactor chamber.  
Quantifying tissue strain could be useful for understanding whole hydrogel valve 
remodeling and in particular for studying the biological implications of valve shape 
(Chapter 3)(Hockaday, Kang et al. 2012), printer-material-specified mechanics (Chapter 
4), complex heterogeneity (Chapter 5), and dynamic conditioning variables. 
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The water driven diaphragm-type bioreactor presented in this study was engineered 
with flexible control parameters and water driven flow loop system. The reactor system 
can be scaled or throttled to enable dynamic culture of aortic and pulmonary valves at 
adult or pediatric stroke volume and flow rates (Figure 7.21). We characterize the 
system for a throttled flow rate and stroke volume output and extrapolate for the higher 
flow setup. We can duplicate the range of 34 week fetal stroke volume to adult stroke 
volume. The size of the conditioning chamber and diaphragm base is actually bigger 
than needed with at least 150 ml extra capacity built in. In human adults ~100 ml is the 
maximum stroke volume of the left ventricle, ~40-70 ml for children  (age 8-16)(Sproul 
and Simpson 1964),  and 0.02 ml-2.7 ml for a fetus(12 weeks to 34 weeks)(Molina, Faro 
et al. 2008) . Additionally the system can be scaled for parallel conditioning in multiple 
reactor chambers containing individual valves (Figure 7.22). Physiological systolic and 
diastolic loading conditions can be achieved or diastolic only loading conditions can be 
induced with two electronics setups that we demonstrate in this study. The alternating 
solenoid control setup enables cyclic diastolic loading, and the pressure relief control 
setup enables a more physiological profile. Cyclic and diastolic loading has been 
demonstrated as a strategy to determine optimal loading conditions and to study tissue 
deformation (Mol, Driessen et al. 2005; Kortsmit, Rutten et al. 2009). In combination 
with the ultrasound port in our bioreactor, these types of deformation studies could 
better determine optimal and precise loading conditions in the reactors needed to drive 
remodeling and tissue development in 3D printed hydrogel valves.  
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Figure 7.21 -91 Heart valve bioreactor conditioning system with a built in flow 
throttle in the pump driven water flow loop. 
To set ranges of stroke volume when circulating media in the sterile media loop a 
throttle switch can be used in the water flow loop.  Two tubes from the high tank and 
two tubes from the low tank are connected with three way diverting valves the outlets 
of which both lead to the 3-way solenoid valve. If a low flow setup is desired the flow 
loop can be throttled and the diverting valves set to connect the smaller, high 
resistance tubes to from the 3-way solenoid ports to the sink and source tanks. 
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7.6 Conclusion 
In this study we demonstrate a dynamic conditioning system specifically for the culture 
of 3D bioprinted and ex-vivo native tissue heart valves.  The custom water driven 
diaphragm-type bioreactor was engineered with a conditioning chamber specifically 
designed for ultrasound monitoring of valve root wall and leaflet motion and tissue 
strain. The parameters of the flexible control and water driven flow loop system can be 
scaled or throttled to enable dynamic culture of aortic and pulmonary valves at adult or 
pediatric stroke volume and flow rates. Additionally the system can be scaled for parallel 
conditioning in multiple reactor chambers containing individual valves. Physiological 
systolic and diastolic loading conditions can be achieved or diastolic only loading 
conditions can be induced with the control setup.  This will enable exploration into the 
optimal conditions and loading regimes needed to drive remodeling and tissue 
development in 3D printed hydrogel valves. 3D bioprinted heart valves composed of 
methacrylated gelatin, methacrylated hyaluronic acid, and PEGDA were cultured up to 
14 days under static and dynamic conditions to validate the system and to induce 
remodeling in bioprinted valves.  
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Figure 7.22 -92  Electronics  diagram for parallel conditioning chambers. 
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CHAPTER 8 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
8.1 One Step Closer to a Viable TEHV 
Heart valve disease is a tremendous national and global burden. Worldwide  80% of all 
cardiovascular disease cases occur in developing countries (Yusuf, Vaz et al. 2004), 
causing more than 19% of deaths,  and causing more deaths than war and malaria 
combined (Ribeiro, Jacobsen et al. 2008).  In Western countries  the population 
primarily suffers from aging related degenerative valve disease, but the vast majority of 
aortic valve disease patients in the developing world are children and young adults 
(Cohen, Malone et al. 2006; Zilla, Brink et al. 2008). Additionally, valve related 
congenital heart defects in the US and worldwide are a serious clinical burden affecting 
1/100 live births. Prosthetic replacement is essentially the only treatment for a critically 
damaged or malformed valve, and current aortic valve replacement options for pediatric 
patients are grimly inadequate. Nearly 20% of children with prosthetic valves die within 
10 years of aortic valve replacement and an additional 40% require repeat surgical 
operations(Alsoufi, Al-Halees et al. 2009) (Karamlou, Jang et al. 2005; Vricella, Williams 
et al. 2005). Tissue engineering has the potential to generate living heart valve 
replacements capable of growth and integration critically needed to treat children with 
valve disease.  
 
Over the last 15 years, researchers have developed and implemented novel synthetic 
polymers as scaffolds for engineered heart valves. Although much progress has been 
made, a persistent problem is the difficulty incorporating native-like heterogeneity and 
controlled remodeling into TEHV. I hope this work using a 3D printing  approach that 
has the capacity to generate complex 3D geometries with extrudable materials and 
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encapsulated cells will help move the field of TEHV forward towards fully functional and 
clinically applicable tissue engineered heart valves.  The fabrication strategy in this work 
demonstrates tools to incorporate heterogeneity directly into engineered tissues and 
suggests a means to evaluate subsequent remodeling through dynamic conditioning 
and ultrasound, μCT and MRI evaluation of the tissue.  
 
8.2 Need for Predictive Swelling, Growth, and Remodeling Models to Guide 3D 
Printing of Complex Geometries  
In Chapter 3, we demonstrated that 3D printing and photo-crosslinking hydrogels can be 
used to rapidly fabricate anatomical scaffolds on a tissue implant scale exhibiting 
mechanical heterogeneity and cytocompatibility.  We used μCT to evaluate adult and 
pediatric sized valve constructs and find that the photo-crosslinking approach enables a 
high degree of geometric control and the hydrogel material swelling does affect scaffold 
fidelity. In this study and in two other subsequent studies from our group,  the  valve 
geometries printed were interlocking STL type files where heterogeneity existed 
between the two parts (the root and the leaflet) but within these parts the material was 
homogeneous (Hockaday, Kang et al. 2012; Duan, Hockaday et al. 2013; Duan, 
Kapetanovic et al. 2014).  In Chapter 5 we described the generation of complex 
heterogeneous valve structures with full control of the interior material distribution based 
on native heterogeneity. We observed in Chapter 5 that hydrogel swelling had to be 
compensated for when assessing fidelity of heterogeneous patterns within printed 
geometries.  Chapter 4 mechanical testing showed that for a polymer precursor mixture 
with a fixed amount of polymer weight to volume ratio that a variation in the 
photoinitiator type, concentration, and light source could more than double the weight 
based swelling ratio.   
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Future work should involve modeling geometric compensation for swelling and 3D 
evaluation of heterogeneous material effect on 3D shape and internal structure. There 
are a growing number of people using the Fab@HomeTM 3D printing platform for 
extrusion printing of hydrogels.  Materials that have been demonstrated with the 
platform for direct cell encapsulation and printing are methcrylated gelatin/methcrylated 
hyaluronic acid (Duan, Kapetanovic et al. 2014), four-armed PEG/hyaluronic 
acid/gelatin derivatives (Skardal, Zhang et al. 2010; Skardal, Zhang et al. 2010), 
alginate (Mannoor, Jiang et al. 2013),  gelatin/alginate (Duan, Hockaday et al. 2013), 
and hydroxyapatite loaded gelatin/alginate (Wust, Godla et al. 2014).  
 
As more materials are investigated and their handling properties are evaluated, the 
applicability of 3D printing to tissue engineering broadens. Each of these materials have 
different swelling and mechanical properties. With the stated goal of engineering 
heterogeneity into living tissues – there is going to be an almost inherent material 
mismatch. In other words engineering mechanical or encapsulating material type 
heterogeneity directly into printed scaffolds will by design mean that the scaffold will 
have anisotropic response to a number of possible conditions. These conditions could 
include surrounding media and mechanical loading.  Additionally hydrogel mechanical 
properties change with remodeling and degradation.  Depending on the hydrogel type, 
mechanisms and rate of degradation, populating cell activity and function (such as 
contractility), this can manifest itself in expansion swelling(Anseth, Metters et al. 2002) 
or tissue contraction (Flanagan, Sachweh et al. 2009). Computational modeling has 
been used to develop a growth and remodeling model for embryonic valve cushion 
response to blood flow induced loading of the tissue(Buskohl, Jenkins et al. 2012).  
Possible future work to better inform 3D printing strategies could include a swelling and 
shape deformation model, a heterogeneous material mechanics finite element analysis 
model, and a growth model for hydrogel TEHV.  
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Adiitional studies could be done with the line printing to incorpoarate bead tracking 
combined with cell tracking. This could be used to differentiate between the effects of 
cell migration from the effects of gel viscosity and mixing and the effects of construct 
swelling. Fluorescent beads or microspheres for tracer studies are commercially 
available. FluoSpheres® are manufactured at different sizes,  with cell culture 
compatibility , and are relatively immune to photobleaching(Johnson 2010).  The bead 
size used would be larger than what cells will ingest/phagoxytos.  Cells and beads 
would be suspended in each precursor solution and the patterns printed into a 
heterogeneous layer.  The layers would be imaged immediately after photocrosslinking 
and 1hour incubation in cultrure media to establish a baseline cell and bead distribution 
and pattern fidelity. The scaffolds would be imaged after 24hrs in culture and over 
several days. The beads and the cells will shift based on changes in the polymer 
scaffold structure. If the cells remodel the matrix or if the matrix degrades causing 
changes in the hydrogel swelling that should be reflected by a shift in the bead and cell 
distribution throughout the hydrogel structure.. Cell migration could be indicated by a 
shift in distribution throughout the hydrogel structure different from the bead distribution.      
 
8.3 Additional Studies to Identify Mechanism of Cell Type Specific Response to 
Photoencapsulation and Characterizing Material Sinking of Initiator Radicals 
 In the Chapter 3 study, the scaffolds were seeded with cells from the outside and in 
general the overall infiltration and integration of cells within the printed material was 
poor, certainly orders of magnitude less than actual tissue. The other critical feature of 
this this type of seeding strategy is there is no control in terms of cell placement 
throughout the hydrogel.  In subsequent studies (Chapter 4, 5, and 7 and our other 
associated studies (Duan, Hockaday et al. 2013; Duan, Kapetanovic et al. 2014)) direct 
cell printing was investigated. Direct cell printing enabled control of cell distribution 
within patterned layers, with high fidelity to the user specified geometry (>80% 
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accuracy). The encapsulated viability of 3D printed cells in photocrosslinked hydrogels 
was tested for more than one cell type relevant to tissue engineering heart valves.   In 
Chapter 4, ranges of cell viability for two primary valve cell types and a mesenchymal 
stem cell type were determined in response to photo-crosslinking variables of light 
intensity, photoinitiator type, and photoinitiator concentration. Contrary to numerous 2D 
cytotoxicity studies, the findings presented in this chapter indicate that in a 
MEGEL:PEGDA3350 hydrogel culture environment and 3D  fabrication setting, Irgacure 
2959 can produce more viable encapsulated cells than VA086 in a higher stiffness 
hydrogel.    
 
Intracellular oxidative stress was not significantly greater in hydrogel conditions of more 
Irgacure 2959 photoinitiator radicals. Normalized oxidative stress ratios suggest that 
increasing VA086 radicals induced higher intracellular oxidative stress. Our findings 
also demonstrate that suppression of intracellular oxidative stress using catalase 
pretreatment does not disrupt hydrogel crosslinking, but it does not rescue cell viability 
from photoinitiator damage. Two recommended future studies following this work 
presented in this thesis are to 1) test for lipid peroxidation and then pursue membrane 
targeted rescue strategies and 2) identify hydrogel material specific differences in ability 
to capture photoinitiator radicals. Phototoinitiator radical induced damage is most likely 
occurring at the outside membrane of cells, and identification for the type of damage 
could lead to damage mitigating strategies.  From the comparison of the results 
presented in Chapter 4 to outside studies, we suspect that different hydrogel materials 
may have different characteristic abilities to act as a sinks for photoinitiator radicals in 
3D photoencapsulation conditions. Under similar photoinitiator concentrations different 
investigators have seen dramatically different results in viability based on the 3D 
material being used to encapsulate the cells.  
 
 369 
 
8.4 Evaluating the Biological Consequences of Complex Heterogeneity in a 
Hemodynamic Environment 
In Chapter 5, a Region Dither Vector (RDV) algorithm that separates intrinsic tissue 
heterogeneity present in medical imaging scans of anatomical tissue into printable 
format files is demonstrated by 3D printing heterogeneous hydrogel scaffolds.  We also 
presented a method to quantify the fidelity of heterogeneous layers, and to quantify the 
degree of cell mixing and blending of different materials within the layer. The biological 
consequence of this 3D printed complex heterogeneity in bioprinted valves was not 
evaluated in this work.  
 
A dynamic conditioning system specifically for the culture of 3D bioprinted heart valves 
was developed for this purpose. The reactor is capable of fetal-like high frequency. The 
bioreactor system was validated in Chapter 7 using simplified geometry 3D bioprinted 
heart valves composed of methacrylated gelatin, methacrylated hyaluronic acid, and 
PEGDA. The valves were cultured up to 14 days under static and dynamic conditions.  
Evaluating the function and remodeling of a complex medical imaging derived 
heterogeneous bioprinted heart valve in a dynamic culture environment would be the 
culmination of all the work presented here. The bioreactor conditioning system has 
optical and acoustic windows for imaging hydrogel valve development and remodeling 
with light microscopy and ultrasound.  Whole valve function under different bioreactor 
loading regimes would be assessed first at different days of culture, and then 
conditioned valves would be assessed for viability, GAG content, collagen content, 
immunohistochemistry, and gene expression.  Ultimately, control of cells within their 
microenvironment is the purpose of utilizing the 3D printing technology in a TEHV 
application, and much more work needs to be done for full understanding of the 
biological effects of fabrication input and output parameters.   
 
 370 
 
8.5 Proposed MRI Study to Evaluate Engineered Valve Heterogeneity Compared 
to Native 
In Chapter 5, the RDV algorithm presented in this study was used to extract tissue 
heterogeneity and anatomic shape information from μCT and MRI images and convert 
those intensity values into a printable format for the scanned 3D tissue geometry.  
However, further study needs to be done to correlate those intensity values with 
biological distributions with the tissue. Towards the goal of investigating the 
consequence of native-tissue-derived complex shape and internal material distribution 
on TEHV remodeling, a pilot study proposal has been accepted by the Cornell Magnetic 
Resonance Imaging Facility (CMRIF). The goal is to use MRI to characterize native and 
engineered heart valve tissue heterogeneity. MRI may be a better choice to assess 
heterogeneous pattern maintenance and remodeling.  Studies have demonstrated that 
MR can be used to detect remodeling and differentiation in engineered tissues and to 
detect differences in modulus between different hydrogels (Feng, Taraban et al. 2011; 
Curtis, Zhang et al. 2012; Kotecha, Klatt et al. 2013).  MR spectroscopy, imaging, and 
elastography could be used to analyze 3D printed hydrogel tissue remodeling and 
pattern maintenance in the entire structure. In the pilot study, MRI scans will be used to 
determine if heterogeneities can be revealed in native valve tissue, if engineered 
hydrogel tissues can be distinguished from each other, and to study 3D printed valve 
remodeling. 
 
8.6 Conclusion 
If subsequent studies build upon the work presented here, these results bring a 3D 
printed hydrogel TEHV strategy one step closer to a living replacement for the treatment 
of pediatric valve disease. This work demonstrates a 3D printing approach that 
generates complex 3D geometry tissue constructs using extrudable materials and 
encapsulated cells based on native valve tissue heterogeneity. As a fabrication strategy 
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3D printing overcomes the limitations associated with classical heart valve tissue 
engineering. The viability experiments and bioreactor validation studies presented in 
this work provide a range of fabrication and conditioning parameters that can be utilized 
for the fabrication and dynamic culture of 3D bioprinted heart valves. Our studies 
indicate that the bioprinted valves can be produced with high viability HADMSC (human 
adipose derived mesenchymal stem cell) for the purposes of a TEHV or with HAVIC and 
HASSMC for the purpose of in vitro testing and study.   
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APPENDIX A 
BIOPRINTER TEAM 
 
The bioprinter project has been a team effort. It is important to a least briefly describe 
which parts people worked on and describe some of the contributions to the progress of 
the 3D valve printing work as a whole. Jonathan Butcher started his laboratory at 
Cornell University in 2007.  The valve bioprinting project was conceived by Dr. Butcher, 
Dr. Hod Lipson, and Dr. Lawrence Bonassar shortly thereafter. When I first joined the 
bioprinter team in fall of 2008, I was mentored by the other 3 students who were 
currently working on the project: Phil Cheung, Nick Colangelo, and Kevin Kang. My role 
and the team dynamics have changed as I have progressed from a trainee to a team 
leader responsible for training and mentoring other students. On the bioprinter team I 
have had privilege of working with 23 talented scientists (Appendix Figure A.1).  The list 
of these scientists follows. 
 
Nicholas Colangelo (2007, 2008, 2009, 2010) – worked on pluronic, UPEA, and PEGDA 
material biocompatibility cell surface seeding experiments, initial encapsulation testing, 
SEM imaging, and hydrogel tensile testing.   
Phillip Y.C Cheng (2008, 2009) – worked on developing protocols for generating 3D 
geometries, exploring and identifying 3D printable materials, 3D printing hydrogel valves 
out of PEGDA, and developing initial heterogeneous dithering code.  
Kevin Heeyong Kang (2008, 2009, 2010, 2011) - worked on investigating alginate 
solubility, optimizing printing techniques for STL printing and vector printing of hydrogel 
materials, refining protocols and code for better shape and gradient information 
extraction from medical image files, application of heterogeneous printing of hydrogels, 
3D printing hydrogel valves, and testing effects of viscosity and shear on cell viability.  
Christopher Caiola (2010) – worked on collagen isolation and investigation into collagen 
printing.  
Dave Filipiak (2009) - worked on development of a prototype design, solidworks 
modeling, and video simulation for a rotating cassette bioreactor.  
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Edward Yip (2009) – worked on development of a prototype design for a rotating 
cassette bioreactor and a clamp holder assembly. 
Jagannath Padmanabhan (2009) – worked on screening a GMA-chitosan material for 
cell encapsulation in hydrogels. 
Jhalak Agarwal (2010,2011) – worked on initial light intensity calculations and light 
meter protocols, testing of photocrosslinking efficiency, and printing optimization.  
Kevin Yeh (2009) – worked on programing the heterogeneous dithering code into a 
format for converting DICOM images into printable material gradients, and assembly of 
the model 2 Fab@HomeTM.   
Kevin Lamott (2009) – worked on development of a pneumatic bioreactor design in 
solidworks with a silicone diaphragm driven ventricle and ball valve aortic return. 
Bin Duan (2010, 2011, 2012, 2013, 2014) – worked on adapting biocompatible hydrogel 
materials for 3D printing, 3D printing valve and blood vessel constructs, synthesizing, 
combining polymers to improve bioactivity of printed constructs, and printed valve 
conditioning validation studies..  Edi Kapetanovic (2011,2012), Anya Laibangyang 
(2012, 2013, 2014), Shoshanna Das (2013,2014), and Charlie Xu (2013, 2014) have 
worked with Duan on these aspects of the project.  
Lauren Lee (2011, 2013) – worked on histological staining and parafilm sectioning of 
hydrogels, compression mechanical testing, and observations of material clogging in 
direct printing of encapsulated cell studies that motivated different handling protocols of 
polymer precursors.  
Scott Newman (2011, 2012) – worked on Solidworks modeling and prototyping during 
reiterative testing and modification of the diaphragm driven bioreactor conditioning 
chamber and TEHV holder assembly.   
Patrick Armstrong (2011) – worked on cell photoencapsulation live/dead studies using 
PAVIC and compression mechanical testing.   
Mohammed Cherkaoui (2011) – worked on a mathematical model to describe the 
bioreactor conditioning chamber and pump system, programming a DAQ 
board/Simulink control system for the reactor, building a pump and capacitance tank 
flow loop to drive the conditioning chamber. 
 Harshal Sawant (2012) – worked on troubleshooting and characterizing the DAQ board 
program and electronics and flow loop, and biocompatibility screening of commercial 
SLA materials and glues and components for the fabrication of the conditioning 
chamber. 
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Figure A.1.93 Bioprinter team 2008-2014. 
 
(A) 2008 team is pictured left to right LA Hockaday, KH Kang, PYC Cheung,  NW 
Colangelo. (B) 2009 team is pictured left to right D Filipiak, NW Colangelo, LA 
Hockaday, KH Kang, E Yip, C Caiola was not present for the team picture. (C) 2010 
team is pictured left to right LA Hockaday, J Agarwal, K Yeh, JT Butcher principle 
investigator, K LaMott, B Duan, and KH Kang. J Padmanahbhan was not present for 
the team picture. (D) 2011 team is pictured. Left to right top row in the picture is the 
Duan family (Bin, Ellie, Angela), J Agarwal, LA Hockaday, KH Kang. Left to right 
bottom row in the picture is E Kapetanovic, S Newman, P Armstrong, L Lee, M 
Cherkaoui. (E) 2013 team is pictured. Left to right top row in the picture is LA 
Hockaday, A Kaldany, L Lee, C Xu, B Duan. Left to right bottom row is S Das, A 
Laibangyang, D Cheung, and K Li. A team picture was not taken for 2012 which 
included Harshal Sawant.  
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Alain Kaldany (2012, 2013, 2014) – worked on troubleshooting the DAQ board program 
and electronics, flow loop and pressure characterization, and biocompatibility screening 
of components in the TEHV holder in the conditioning chamber.   
Kang Li (2013, 2014) – worked on converting the bioreactor electronics control setup 
from a DAQ board assembly to a microcontroller.  
Daniel Cheung (2013, 2014) - worked on Solidworks design modifications to the 
bioreactor chamber, pressure characterization of the conditioning chamber, and printed 
valve conditioning validation studies. 
People on the bioprinter team before I joined the project who should not go 
unacknowledged include Jamie Brennan (2007) who worked on initial tensile testing of 
hydrogels, and Johnson Chiu (2007) and Albert Liang (2007) who worked on assembly 
of the Model 1 Fab@HomeTM printers. 
  
 399 
 
APPENDIX B 
BIOREACTOR PARTS AND ASSEMBLY 
 
B.1 Summary 
Assembly of  the bioreactor heart valve conditioning system 1st requires assembly of the 
water flow loop and assembly of the control system; 2nd requires connection of 
transducers and pump to the control system with the tubes and wires appropriately 
routed for benchtop or incubator testing; 3rd requires assembly and sterilization of the 
bioreactor conditioning chamber and holder; 4th requires installment of a prosthetic, 3D 
bioprinted, or isolated valve into the holder mesh; 5th requires assembly of the 
bioreactor chamber and filling of the media flow loop with culture media or PBS 
depending on the needs of the test; 6th requires the assembled conditioning chamber is 
connected to the control system, applied pressure tank assembly, and water flow loop. I 
recommend assembling the bioreactor conditioning chamber and checking for leaks, 
then partially diassembling for sterilization, and then reassembling the chamber and 
installing valve for the actual test. Leaks can be related to defects and bubbles in the 
silicone sealant bead and rotation of the fitting.  
 
 B.2 Assembly of Bioreactor Pump Driven Water Flow Loop  
Order tanks, tubing, diverting valves, tubing adapters, adapters from VWR, Mcmaster, 
and Grainger Silicone sealant can be obtained at the hardware store. (Refer to the parts 
list, Table B.1) Tools needed for the water flow loop assembly include a drill, a pipe tap, 
adjustable wrench, Allen wrenches, small pliers, and 3 mm Miltex biopsy punches. 
Steps 1 to 5 describe the basic steps for building the water flow loop that drives the 
expansion and contraction of the silicone diaphragm in the base of the bioreactor 
conditioning chamber. 
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Table B.1-8  Parts in Bioreactor 
Parts in Contact with Cell Culture Media/Bioreactor Interior 
Part  Material Manufacturer/
Seller 
Part Number/ID Critical Specifications Sterilization  
Cast 
Conditioning 
Chamber  
Parts 
Quickparts/ 
Hapco 
Steralloy cast 
chamber parts, 
Steralloy 2463 
Quickparts 3D 
Systems, 
Atlanta GA. 
Hapco  
Body_Design 13_no 
twist_fill port supports 
gel time: 20min, hardness 
Shore: 80D, resin viscosity: 
6700cps, Demold time: 6-12 
hours or 2-4 hrs at 50˚C 
H2O2 
Aorta_Design 13_no 
twist 
Base_Design 
13_supports 
Holder Universal 
Bottom_Design 
13_no twist 
Holder Universal 
Top_Design 13_no 
twist 
Mesh 
connecting 
holder to 
valve 
ePTFE 
Membrane 
Laminated to 
Polypropylene 
GE Healthcare 
Bio-Sciences, 
Pitsburg, 
Pennsylvania. 
Dx Assay 
Enabling 
Technologies 
QL230 bonds with tissue glue and 
suturing; biocompatible with 
VIC;  Pore Size: 5.0um;  
Air permeability: 5.5-8.0 cfm 
at 125Pa;  
Water entry Pressure: >0.7 
psi 
H2O2 
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Table B.1 continued. 
Part  Material Manufacturer/
Seller 
Part Number/ID Critical Specifications Sterilization  
Ultrasound 
Port 
1/4" Teflon McMaster-Carr, 
Cleveland, OH 
8545K1 longitudinal speed of sound 
1376  m s–1 compared with 
1540 m s–1 in soft tissue 
H2O2 
Optical Port Heat-Resistant 
Borosilicate 
Glass disc  1-
1/4" Diameter, 
1/4" Thick 
8477K71 glass resists clouding and 
pitting, highly chemical and 
heat resistant, and  low rate 
of thermal expansion 
H2O2 or Autoclave 
(sealed into 
chamber port so 
H202 sterilized) 
Diaphragm extreme 
temperature 
silicone rubber 
sheet 
3788T42  1mm thick H2O2 or Autoclave 
Shaft collars 
for holder 
posts 
Stainless Steel 57485K11 corrosion resistance  H2O2 or Autoclave 
Holder posts Stainless Steel 3180T31 17-4 PH Stainless Steel 
Tight-Tolerance Rod, 2mm 
Diameter 
H2O2 or Autoclave 
(assembled with 
holder H2O2 
sterilization)  
Glue on 
fittings and 
holder 
Polydimethylsil
oxane (PDMS) 
Sylgard 184 
silicone 
elastomer kit 
Dow Corning 3097358-1004 formed at a 
concentration of 20:1 base to 
curing agent, degassed, 
poured applied, and 
solidified at 70°C  overnight 
H2O2 or Autoclave 
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Table B.1 continued. 
Part  Material Manufacturer/
Seller 
Part Number/ID Critical Specifications Sterilization  
Barb to hex 
thread 
fittings 1/8" 
Natural Kynar 
PVDF 
Value Plastics, 
Fort Collins, 
CO.   
S230-J1A   1/4-28 UNF Thread with 
5/16" Hex to 200 Series 
Barb, 1/8" (3.2 mm) ID 
Tubing,  
H202 and 
Autoclave 
  Natural Kynar 
PVDF 
MTLL230-J1A Male Luer Integral Lock Ring 
to 200 Series Barb, 1/8" (3.2 
mm) ID Tubing, Natural 
Kynar PVDF 
H202 and 
Autoclave 
Female luer 
to  hex 
thread 
fittings 1/8" 
Natural Kynar 
PVDF 
18FTLL-J1A  Female Luer Thread Style 
with 7/16" Hex to 1/8-27 NPT 
Thread, Natural Kynar PVDF 
H202 and 
Autoclave 
Check 
valves, 1/8" 
Polycarbonate 
w/Silicone Disc 
VPS5401068N 420 mL/min flow rate at 1M 
head, 30 psi back pressure, 
1/4 13mmHg cracking 
pressure 
H2O2 
Pressure 
Transducers 
Stainless Steel Dwyer 
Instruments 
628-08-GH-P1-E1-S1 Output: 4-20 mA 2-wire, 
Range: 0-30 psig, Power 
Supply: 13-30 VDC, 1/4" 
NPT male thread 
Spray with 70% 
Ethanol and UV 
sterilize 1 hour 
Luer end 
caps 
Plastic Nordson EFD 7012194 end caps H2O2 
Tubing Silicone 
Rubber 
McMaster-Carr, 
Cleveland, OH 
  High-Temperature Silicone 
Rubber Tubing, Soft,, Semi-
Clear White 
Autoclave  (H2O2 
for short open end 
lengths) 
5236K83 1/8" ID, 1/4" OD 
5054K784 9 mm ID, 11 mm OD 
51135K77 1/4" ID, 3/8" OD 
51135K35 3/8" ID, 1/2" OD, 
51135K43 1/2" ID, 3/4" OD, 
51135K51 3/4" ID, 1" OD 
5236K239  1" ID, 1-1/8" OD 
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Table B.1 Continued 
Parts for Applied Aortic Pressure and Relief 
Part  Material Manufacturer
/Seller 
Part Number/ID Critical Specifications Sterilization  
CO2/Air tank   Airgas X02AR95C3000993  Ct 5% Hydrogen Balance 
Argon Size 300 Certified 
Standard-spec CGA 350  
N/A 
CO2/Air tank 
Regulator 
Brass Airgas Y12C144A590  Regulator High Purity 2-
Stage Low-Flow 3000PSI 
Brass, 0-10 Del Range, 
CGA-590  
N/A 
Pinch 
Solenoid 
Valve (DC) 
  McMaster-
Carr, 
Cleveland, 
OH 
5431T132 Pinch-Style Aluminum 
Solenoid Valve for Tubing, 
Normally Closed, for 3/8" 
Tube OD x 1/4" Tube ID, 24 
VDC 
N/A 
Water Flow Loop and Pump Parts 
Nalgene® 
Carboys  
Low-Density 
Polyethylene 
(LDPE) 
VWR, Thermo 
Scientific 
16333-080 10 L (2.6 gal.) 83B cap size, 
handles, serrated tubing 
outlet is molded in one piece 
with bottle for strength and 
leak-resistance. Outlet low 
on bottle for more complete 
drainage. Made for 12.7mm 
(1/2") I.D. tubing  
N/A 
Brass Push-
on Hose 
Fitting 
Brass McMaster-
Carr, 
Cleveland, 
OH 
91465K91 1/4" Hose ID x 1/4" NPTF 
Male Pipe 
N/A 
Female/male 
pipe adapter 
(1/4") 
Brass 50785K27 Medium-Pressure Brass 
Threaded Pipe Fitting, 1/4 
Female x 1/4 Male Pipe 
Size, Adapter, NPT 
N/A 
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Table B.1 continued. 
Part  Material Manufacturer
/Seller 
Part Number/ID Critical Specifications Sterilization  
Diverting ball 
valve (switch 
flow 
between 
throttle and 
high flow) 
PVC 
McMaster-
Carr, 
Cleveland, 
OH 
4757K52 Miniature PVC Ball Valve, 3-
Port, NPT Female x Female 
x Female, 1/4" Pipe Size 
N/A 
Barb/male 
pipe adapter 
for  for 
diverting 
valve 
(throttle) 
Polyethylene  2808K34 Super-Flow Polyethylene 
Barbed Tube Fitting, Straight 
for 1/4" Tube ID x 1/2 Male 
Pipe Size 
H2O2 
Diverting ball 
valve (switch 
flow 
between 
capcitance 
membrane 
and base 
chamber) 
PVC 4757K57 Miniature PVC Ball Valve, 
Diverting, 3-Port, Barb, for 
1/4" Tube ID 
N/A 
Barb/male 
pipe adapter 
1/4" 
Polyethylene  2808K27 Super-Flow Polyethylene 
Barbed Tube Fitting, Straight 
for 1/4" Tube ID x 1/4 Male 
Pipe Size 
  
Button head 
socket cap 
screws 
  98164A434 (but should 
up grade to a harder 
grade) 
Type 316 Stainless Steel 
Button-Head Socket Cap 
Screw 4-40 Thread, 3/4" 
Long 
  
Hex nuts Stainless Steel 91841A005 18-8 Stainless Steel 
Machine Screw Hex Nut 
4-40 Thread Size, 1/4" 
Width, 3/32" Height 
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Table B.1 continued 
Part  Material Manufacturer
/Seller 
Part Number/ID Critical Specifications Sterilization  
Tee 
(connecting 
tank 1/2", 
pump 1/2", 
shunt lines 
1/4") 
Stainless Steel 
McMaster-
Carr, 
Cleveland, 
OH 
  
5670K37 Type 303 Stainless Steel 
Barbed Tube Fitting, 
Reducing Tee for 1/2" x 1/4" 
Tube ID 
  
Elbow 
connector 
Nylon 5463K594 Durable Nylon Tight-Seal 
Barbed Tube Fitting, 90 
Degree Elbow for 1/4" Tube 
ID 
  
Flat washer Stainless Steel  92141A005 18-8 Stainless Steel General 
Purpose Flat Washer, 
Number 4 Screw Size, 5/16" 
OD, .02"-.04" Thick 
  
Tooth 
washer 
Stainless Steel 91757A101 18-8 Stainless STL Internal-
Tooth Lock Washer NO. 4 
Screw Size, .27" OD, .01"-
.02" Thick  
  
Flange ring ABS-Natural, 
Manufactured 
Plastic 
Prototypes 
Quickparts 3D 
Systems, 
Atlanta GA. 
Hapco  
Base Ring_Design 
13_24 bolts 
Tensile strength 6,500 psi, 
flexure strength 10,600psi, 
flexure modulus 331,000psi, 
heat deflection temperature 
190 °F, Vical sofening point 
210 °F 
  
 Biopsy 
punch 
  Integra 
Miltex/VWR 
  3 mm   
Water 
Diaphragm 
Pump 
  Flojet 
Instruments/G
rainger 
 FLOJET Pump Model: 
4300-501/Grainger 
Item # 4YD41  
115 Volts AC 50/60Hz, 1.5 
Amps, Flow 14.4 LPM, 45 
PSI Max 
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Table B.1 continued. 
Part  Material Manufacturer
/Seller 
Part Number/ID Critical Specifications Sterilization  
3-way 
solenoid 
  Parker 
Hannifin 
Corporation/M
cmaster Carr 
Parker:71295SN2ENJ1
NOC111P3/Mcmaster: 
7889K28 
Directional Control 3-Port 
Stainless Steel Solenoid 
Valve, Buna-N Seal, 
Normally Closed, 1/4 NPT 
Female port, 25 PSI, 120 
VAC, valves have wire 
leads, and draw a max. of 
0.42 amps 
N/A 
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B.2.1 Step 1 Drill and tap Nalgene tank walls and caps for adapters, and tap 
outlets for the capacitance membrane base.  
This is to setup the high pressure water source tank and the low pressure water sink 
tank. The tanks have one barbed tubing outlet low on the bottle already – this is for the 
tubing to pump connection Additional outlets on the tank walls (2 per tank) that are 
drilled and then threaded with a pipe tap are for the sink and source tubes. The holes 
should be cut low on the tank walls to install an adapter for ¼” tubing and ½” tubing for 
each tank for a high flow and a throttled flow tube. These holes should be level with 
each other. The caps should be drilled in the center for ¼” adapters and this is to attach 
the pressure transducers.   
 
The capacitance membrane chamber is built using the same cast part as the 
conditioning chamber base. Tap/thread the two outlets so that 1/2” male pipe/barb 
adapters can be installed.  
 
B.2.2 Step 2 Seal adapters with silicone sealant to tanks, pressure transducers, 
and capacitance membrane chamber.  
 Day 1 - Apply a bead of silicon sealant on the threads of the pressure transducer male 
thread connection and screw into the female threads of the male/female pipe adapter 
intended for the tank cap connection. Wrap around Teflon pipe tape around the joint. 
Allow to cure at least overnight.   
 
For each wall flow outlet apply a bead of silicone sealant to a large nylon washer and 
apply a bead of silicone sealant to the male threads of the male/barb adapter. Screw the 
adapter into the appropriate tapped/threaded hole in the wall of the Nalgene tank 
through the washer. If needed apply more silicone sealant (Note: The washer reinforces 
the wall/adapter joint. Without the washer the wall is not thick enough for a good 
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mechanical hold. Consequently any connecting/reconnecting/tension on the tubing can 
loosen the adapter and lead to leaking around the fitting). Allow adapters to cure at least 
overnight.   
 
Manual switch valves will be installed for each flow outlet of the tank. This enables us to 
open and close off flow for each outlet of the tank if the system needs to be moved, 
disassembled, or emptied. It will add resistance to the flow loop.   For each switch valve 
(1/2” between tank and pump, ¼” between the throttle diverting valve and the solenoid 
sink and source connections), seal in a barbed adapter on both ends.  Apply a bead of 
silicone sealant to the threads of the male end of the adapter, screw into the female 
threads of the valve switch (this may require the wrench), and wrap the joints with 
Teflon tape.  
 
For a throttle/high flow assembly seal in 3 barbed adapters into a manual 3-way 
diverting valve. For the adapters all three have ½” male threaded connections pipe 
connections, and then one has a barb are is for ½”ID tubing and two have barbs for ¼” 
ID tubing.  
 
A three way solenoid valve switches the connection between flow from the source tank 
and to the sink tank. The solenoid has female ¼: pipe thread connection ports so male 
pipe/barb tubing adapters need to be sealed in to the assembly to connect it to the flow 
loop. Apply a bead of silicone sealant to the threads of the male end of the adapter, 
screw into the female threads of the valve switch (this may require the wrench), and 
wrap the joints with Teflon tape. 
Seal adapters into the capacitance membrane chamber base ports. Apply silicone 
sealant on the threads of the 1/2” male pipe/barb adapters and screw in to the base 
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ports (may need the wrench but keep in mind that forcing the tap or angling it wrong can 
snap the port). Wrap with Teflon tape and allow curing overnight.  
 
Day 2 - For each tank cap apply a bead of silicone sealant to a large nylon washer and 
apply a bead of silicone sealant to the male threads of the male/female adapter and 
pressure transducer assembly. Screw the male adapter into the tapped/threaded hole in 
the wall of the Nalgene tank through the washer. If needed apply more silicone sealant. 
Allow to cure for 24 hours.  
 
B.2.3 Step 3 Assemble capacitance membrane chamber. 
Cut a disc out of the silicone rubber sheet (1 mm thick) matching the diameter of the 
flange of the cast base part. Flip the base part upside down and place on top of silicone 
rubber sheet disk. Align the edges. Using the 3 mm diameter biopsy punch, form holes 
neat holes in the silicone matching with the 24 bolt holes in the flange.  Sandwich the 
silicone between the base flange and the ABS-like base ring part, line up the holes, and 
then tighten with bolts. For each bolt hole the bolt should insert through a flat washer, 
through the base ring flange, through the silicone diaphragm, through the base part 
flange, thread into a hex nut, then a toothed washer, and a second hex nut. Tighten the 
nut and bolt using a pair of pliers and an Allen wrench. Need strong bolt and nut 
material to keep from stripping the caps of the bolts.  
 
B.2.4 Step 4: Assemble the water flow loop. 
Cut silicone rubber tubing tubing to connect the components of the flow loop together 
(Refer to Table B.2 for suggested tubing lengths). Cut the tubing so that the system is 
symmetric. Attach the tubing to the barb ends of the adapters.   Changing the lengths of 
the tubing may change the resistance in the flow loop which could change which may 
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affect the stroke volume and flow rate (so the characterization should be checked for 
the different setups). Tighten zipties on the tubing and the 1/2” barb adapters.   
 
B.2.5 Build electronics control setup.  
A list of the Bioreactor electronics and signal processing parts is provided in Table B.3. 
During the development of the bioreactor system and in initial characterization studies, 
we used two DAQ boards and Simulink/Matlab program (See Cherkaoui Masters of 
Engineering Project Report 2012 and Sawant Masters of Engineering Project Report 
2013) in combination with a timer relay for the control of the electronics and data 
acquisition. We found that the DAQ boards were very sensitive to electromagnetic 
interference from the solenoids and the system was vulnerable to timeout errors. We 
believe this was associated with working in conjunction with a non-dedicated computer. 
The electronics control setup was converted to a microcontroller. The microcontroller 
was designed using an ATmega1284P chip on the prototype board which is used in the 
Cornell ECE 4760 class and programmed with C (See Li Masters of Engineering Project  
Report). The microcontroller was custom fabricated at Cornell at Bruce Land’s 
laboratory in the ECE department. Four industrial pressure transducers (Dwyer 
Instruments, IN, ordered from Zoro tools) are each connected to a resistor and the 
voltage signal is read by the microcontroller and converted to a pressure measurement. 
The microcontroller reads the signals sent from the pressure transducers using built-in 
Analog-Digital-Convertor and sends out the control signal for the pump and the pinch 
solenoid valve through the junction box.  The junction box energizes the circuit by using 
a relay switch. The microcontroller allows for a more compact system that only needs to 
be connected to a computer  to  take  a  data  sample.  The interface for setting the 
pressure and pump and pump conditions is written in Matlab. The user is prompted to 
change the Pdiff setting, the delta setting, the aortic pressure threshold, and the data  
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Table B.2-9  Tubing Cheat Sheet  for Water Flow Loop 
Connection Tubing Size Tubing Length 
High tank to switch valve adapter barb 1/2"  40cm 
Switch valve to tee     
Tee to pump barb 1/2"  10cm 
Switch valve to pump barb, Inlet 1/2"  10cm 
Low tank to switch valve adapter barb 1/2"  40cm 
Switch valve to tee 1/2"  10cm 
Tee to pump barb 1/2"  10cm 
Switch valve to pump barb, Outlet 1/2"  10cm 
Reducing tee to shunt elbow 1/4" 15cm 
Shunt  1/4" 46 cm 
Single Flow Setting Setup 
High tank to switch valve adapter for source 
line 
1/4" 60 cm 
Low tank to switch valve adapter for sink line  1/4" 60 cm 
Source line from switch valve to 3-way 
solenoid  
1/4" 60cm 
Sink line from switch valve to 3-way solenoid  1/4" 60cm 
Throttle/Highflow Setup 
Throttle line high tank to 3-way diverting 
valve  
1/4" 60 cm 
High flow line high tank to 3-way diverting 
valve  
1/2" 60 cm 
Source line from diverting valve to 3-way 
solenoid  
1/4" 60cm 
Throttle line low tank to 3-way diverting valve  1/4" 60cm 
High flow line low tank to 3-way diverting 
valve  
1/2" 60cm 
Sink line from diverting valve to 3-way 
solenoid  
1/4" 60cm 
Single Conditioning Chamber setup 
3-way solenoid to 1/4" tee 1/4" ~80cm (initial bench testing), 
~275 cm to route into the 
incubator 
tee to three way diverting valve (two) 1/4" 15 cm 
diverting valve to capacitance membrane 
(two) 
1/4" 45cm 
diverting valve to chamber base  (two) 1/4" 45 cm 
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 Table B.3 -10 Bioreactor Electronics and Signal Processing Parts Not in Contact 
with Media or Water 
Microcontroller 
Part Manufacturer/Seller Part Number/ID Critical Specifications 
ATmega 
1284P chip 
Bruce Land Laboratory 
Prototype 
Board 
330 Ohm 
protective 
resistor 
USB cable 
Junction Box 
Wall switch Grainger 6X063 LEVITON Wall Switch,1-
Pole,Toggle,Brown 
Receptacle 6A702 LEVITON Receptacle,20A,125V,5-
20R,2P,3W,1PH 
Box 6XC61 RACO Box, Plastic 2 Gang 
Wall plate 1LXT1 HUBBELL WIRING DEVICE-
KELLEMS Wall 
Plate,2Gang,Nylon,Ivory 
Solid State 
Relay 
6C900 OMRON Relay, Solid State 
Extension 
cord 
5XFP9 NO BRAND NAME ASSIGNED 
Extension 
Cord,6ft,16/3,13A,SJT,Black 
Connector Wires and Timer Relay 
250 Ohm 
reciever load 
resistance 
Digikey WHA250FECT-
ND 
RES 250 OHM 1/2W 1% AXIAL 
3M 
Breadboard 
Digikey     
Powersupply 
for 
transducers 
Radioshack/Enercell   AC/DC Adapter  
13-30V DC, 1A  
Plug-in 
Timer Relay 
Repeat 
Cycle 
McMaster 
Carr/Macromatic 
7630K12 Plug-in Timer Relay, Repeat Cycle, 
120V AC/DC Control, .1 to 10 
Seconds 
Relay 
Socket 
McMaster Carr 7122K11 8-Pin Circular, 2.6" High x 1.5" Wide 
x 1.1" Deep 
Inline fuse to 
protect 
pump 
Radioshack   Inline fuse 2A 250A 
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Table B.3 continued 
Part Manufacturer/Seller Part Number/ID Critical Specifications 
Power 
supply for 
pinch valve 
Digikey 2 Power Supply 
AC/DC (LED 
Drivers), 
disconnected 
HighLED 
printing driver to 
use on heart 
valve bioreactor 
but need to 
rebuild LED 
circuit and 2nd 
electronics 
setup  
  
Terminal 
block for 
easier 
connections 
in incubator 
(pinch 
solenoid) 
7527K44   300 VAC/VDC Terminal Block 3 
Circuits, 3/8" Center-to-Center, 20 
Amps  
cover for 
terminal 
block 
7527K827   Cover for 3/8" Center-to-Center, 3 
Circuit 300 VAC/VDC Terminal 
Block 
cover for 
terminal 
block 
7527K828   Cover for 3/8" Center-to-Center, 4 
Circuit 300 VAC/VDC Terminal 
Block  
Terminal 
block for 
easier 
connections 
in incubator 
(tranducers) 
7527K44    300 VAC/VDC Terminal Block 4 
Circuits, 3/8" Center-to-Center, 20 
Amps 
Easy 
connect 
male wires 
7548K462   Terminals Connected to Wire Male 
Quick-Disconnect on One End, 24" 
L, 14 AWG, Black  
Easy 
connect 
female wires 
7548K362   Terminals Connected to Wire Fem 
Quick-Disconnect on One End, 24" 
L, 14 AWG, Black 
Connector 
for pinch 
solenoid 
valve 
4985K15    Solenoid Valve Connector DIN Type 
A Fem Plug, 2 Pole, 250V AC/DC, 
1/2" NPT Thrd 
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Table B.3 continued. 
Part Manufacturer/Seller Part Number/ID Critical Specifications 
Shielded 
cables to 
route into 
incubator 
  6452T26   Cable-Tray-Rated Control Cable 
Shielded, Includes Three 14-Gauge 
Wires, 10 ft. Length  
Shielded 
cables to 
route into 
incubator 
6452T27   Cable-Tray-Rated Control Cable 
Shielded, Includes Four 14-Gauge 
Wires, 10 ft. Length  
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acquisition time. After the data acquisition period the system runs automatically at the 
set parameters. Up to 2 weeks of data can be logged in one acquisition period. 
Wire the electronics according to the diagram in Figure B.1 for a single conditioning 
chamber with an aortic feedback control setup and according to the diagram in Figure 
7.22 for a parallel conditioning chamber with an aortic feedback control setup. The 
parallel setup shown in 7.22 assumes that the valves and therefore the conditions in 
each chamber will be similar because only one aortic and ventricle transducer is shown. 
It would be better for quantification for each chamber to have a set of aortic and 
ventricular transducers. Wire the electronics according to the diagram in Figure B.2 for a 
single conditioning chamber with a time delay repeat cycle  relay setup used to control 
the pulse of the switching of the 3-way solenoid valve and the opening/closing of the 
pinch valve. 
 
B.3 Partial assembly of bioreactor conditioning chamber and holder assembly 
and sterilization of media flow loop parts.  
 
B.3.1 Step 1 Drill and tap the cast conditioning chamber base part outlets, aortic 
part outlet, body part outlets, and media reservoir.  
Tap and thread the cast conditioning chamber base part. Tap/thread the two outlets so 
that 1/2” male pipe/barb adapters can be installed. 
 
Tap and thread the cast conditioning chamber body part. Tap/thread the 3 outlets on the 
‘ventricle’ wall so that 1/8” thread/luer adapters can be installed. Tap/thread the single 
outlet on the side wall of the body part so that 1/8” thread/luer adapters can be installed. 
Tap and thread the cast conditioning chamber aorta part. Tap/thread the single outlet so 
that 1/4” male pipe/barb adapter can be installed. 
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Figure B.1 -94Bioreactor electronics setup for pressure feedback control of 
diastolic loading.  
In this control strategy, a value can be set in the microcontroller so that the pinch 
valve solenoid opens when pressure in the aortic chamber passes a user defined 
pressure threshold. This allows for pressure feedback control of diastolic loading of 
the TEHV. The pump is controlled by the microcontroller and the ventricular pulse 
from the 3-way solenoid is controlled by the timer relay.  
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Figure B.2 -95Electronics setup for bioreactor system control: pressure 
independent control of diastolic loading. 
A time delay repeat cycle relay is used to control the pulse of the switching of the 3-
way solenoid valve and the opening/closing of the pinch valve. The microcontroller 
signals the pump to move water from the ‘low’ tank to pressurize a ‘high’ tank based 
on signals from the pressure transducers. The timer relay is connected so that power 
or the energize signal alternates between the 3-way solenoid and the 2-way solenoid. 
The pinch valve solenoid which vents pressure after the aorta vents with each beat in 
this setup. The consequence of this is the frequency of the delivered ventricular pulse 
and diastolic loading is independent of any pressures in the system.  
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Tap media reservoir container so that 1/4” male pipe/barb adapters, and 1/8” luer to hex 
thread fittings can be installed. 
 
Cut out and sand down a Teflon disk for the ultrasound port. Make sure it fits tightly into 
the side inset port.  
 
B.3.2 Step 2 Seal adapters into ports of bioreactor chamber and reservoir parts.  
Day 1 -  Apply PDMS on the threads of 1/4” male pipe/barb adapters and screw in to 
the base ports (may need the wrench but keep in mind that forcing the tap or angling it 
wrong can snap the port). Allow curing overnight in the oven (60C) and then wrap with 
Teflon tape.    
 
Seal the 1/8”hex thread adapters into the body ports. (This may require the wrench but 
keep in mind that forcing or or angling it wrong can snap the port). Fittings were 
clamped for additional mechanical hold as per Figure B.3.  PDMS is applied to the 
threads, the threads and fitting are screwed in to the port, additional PDMS is applied 
around the fitting, a short length of silicone tubing is slid over the hex and the protruding 
port of the cast part. The silicone rubber is Zip-tied (clamped tightly) over the cast port 
and over the hex part of the fitting. This is to keep fitting from rotating with vibration due 
to the cyclic pulse through the system. Allow curing overnight in the oven (60C) and 
then wrap with Teflon tape. 
 
Apply PDMS on the threads of a 1/4” male pipe/barb adapters and screw in to the aorta 
part outlet ports. Allow curing overnight in the oven (60C) and then wrap with Teflon 
tape. 
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Figure B.3-96 Fittings were clamped for additional mechanical hold in addition to 
PDMS sealing of luer fittings.   
PDMS is applied to the threads, the threads and fitting are screwed in to the port,, 
additional PDMS is applied around the fitting, a short length of silicone tubing is slid 
over the hex and the protruding port of the cast part. The silicone rubber is Zip-tied 
(campled tightly) over the cast port and over the hex part of the fitting. This is to keep 
fitting from rotating with vibration due to the cyclic pulse through the system 
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Apply PDMS in a bead in the inset/shelf of the ultrasound port on the body of the 
bioreactor and in the inset/shelf of the optical port on the aorta part. Insert the Teflon 
disk in the side view port and the glass disk in the top view port. Allow curing overnight 
in the oven (60C).  
 
Apply PDMS on the threads of 1/8”, 1/4” male pipe/barb adapters and screw in to the 
reservoir parts. Allow curing overnight in the oven (60C) and then wrap with Teflon tape. 
Using silicone rubber tubing pieces, telescope and size the holders to match the size of 
the valve. Cut two pieces of Teflon mesh to fit into top and bottom holder assembly. For 
the mesh at the maximum diameter apply PDMS on the edges of feflon mesh and 
around the cylindrical protrusion of the holder part then clamp the mesh into place using 
a rubber band cut from the silicone rubber tubing. Apply additional PDMS to seal it into 
place. Allow curing overnight in the oven (60C).  
 
Day 2 - Cut 3 posts posts for the holder using a hack saw and then wash and rinse 
vigorously. Apply PDMS to the post peg-holes in the bottom holder part, and insert 
posts. Allow curing overnight in the oven (60C). 
 
B.3.3 Step 3 Assemble conditioning chamber base. 
Cut a disc out of the silicone rubber sheet (1mm thick) matching the diameter of the 
flange of the cast base part. Flip the base part upside down and place on top of silicone 
rubber sheet disk. Align the edges. Using the 3 mm diameter biopsy punch, form holes 
neat holes in the silicone matching with the 24 bolt holes in the flange. Cut a gasket ring 
for the aortic/body flanges. Flip the body part upside down and place on top of silicone 
rubber sheet. Align the edges. Using the 3 mm diameter biopsy punch, form neat holes 
in the silicone matching with the bolt holes in the flanges. 
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Wash and rinse all the chamber parts. Assemble the base prior to sterilization. 
Sandwich the silicone between the base flange and the body chamber part, line up the 
holes, and then tighten with bolts. For each bolt hole the bolt should insert through a flat 
washer, through the body flange, through the silicone diaphragm, through the base part 
flange, thread into a hex nut, then a toothed washer, and a second hex nut. Tighten the 
nut and bolt using a pair of pliers and an Allen wrench. Need strong bolt and nut 
material to keep from stripping the caps of the bolts.  
 
B.3.4 Step 4 - Sterilization of bioreactor conditioning chamber, reservoir, and 
tubing.  
Cast parts must be sterilized using hydrogen peroxide sterilization at the Vet school 
instead of an autoclave. H2O2 does not have the same penetration as ethylene oxide, 
and the parts need to be prepared for sterilization with short distances in mind. Also the 
parts must be completely dry for the sterilization. After washing and rinsing parts 
thoroughly, use pressurized air to dry and then put in the oven to dry all the way before 
packaging the parts up in Tyvek sleeves for sterilization. The check valves and cap 
ends are sterilized with H2O2 loose in a sleeve.  
 
Autoclave the tubing and adapter parts (when not sealed into the chamber parts). Also 
autoclave pliers, Allen wrenches, tweezers, spatulas, and gloves for assembly.   
For the pressure transducers, sterilize before connecting into the sterile flow loop setup. 
The tubing is removed from each transducer (and autoclaved). The transducer is 
sprayed with 70% ethanol and then swabbed down. The transducer is oriented in the 
biosafety cabinate with the tubing adapter pointed up. The transducer is then exposed 
to the germicidal UV light for a least 1 hour.  
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B.4 Installment of a valve into the holder mesh and media flow loop and chamber 
assembly.  
All the sterilized tubing and check valves and reservoir connections are attached before 
handling the valve.  
 
Chapter 7 and Figure 7.9 describe the loading of the valves into the chamber assembly   
Working in the biosafety cabinet a prosthetic, 3D bioprinted, or an isolated valve can be 
loaded into the holder mesh. The chamber is then partially filled with media. The aortic 
part is then bolted into place (with the silicone rubber gasket in place). The bioreactor 
chamber and media flow loop is filled with culture media or PBS depending on the 
needs of the test. Connect the sterilized pressure transducers to the reactor in the hood. 
  
B.5 Transfer the conditioning chamber setup to the large incubator and connect 
to electronics and applied aortic pressure line.  
The incubator needs to be scrubbed down with Alconox, sprayed down with 70% 
ethanol, and allowed to dry the day before the test. The week of and the morning of the 
experiment, turn on the incubator to make sure that it reaches and holds at temperature 
(37C). Once the valve is loaded and the conditioning chamber is fully assembled the 
system can be moved to the incubator. Note the only opening should be through a 
sterile filter leading to the aortic pressure inlet connection, and a sterile filter at the end 
of the pinch valve line for the vent. Connect the pressure transducers to the terminal 
blocks in the incubator connected to the microcontroller, connect the applied pressure 
tank assembly to the aorta of the conditioning chamber, and insert the vent tubing into 
pinch valve, and connect the water flow loop to the base of the reactor. Note: Running 
into the incubator through a side port are 4 lines – the aortic pressure line, the 
transducer line, the sink/source line of the water flow loop, and the pinch solenoid line.   
 423 
 
Once the reactor is connected, initialize the microcontroller. Observe the valve and 
check the system for leaks. Open the valve on the applied aortic pressure. Check for 
leaks. Close the incubator door and then oven the valve to the CO2 on the incubator 
tanks.  
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APPENDIX C 
HIGH POWER LED ARRAY AND HEAT SINK ASSEMBLY 
 
The high powered LED array was built to enable higher intensity exposure during 
extrusion printing. The first version rapidly over heated (Figure C.1), and as a result I 
built a water cooled heat sink (Figure C.2) to keep the LEDs cool. The heat sink was 
built to fit on the syringe carriage with the high powered LED array. Copper tubing was 
soldered to a copper plate and liquid heat sinking compound was layered together 
(Figure C.3). High powered LED array intensities were estimated for different 
resistances (Figure C.4). 
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Figure C.1 -97 First version of high powered LED array was built with small heat 
sinks and rapidly overheated. 
(A) Small gauge wires soldered to a PCB board, and anchored in a bread board. (B) 
After 1-2 minutes the LEDs run at 70% current the LEDS will begin to melt loose from 
their solder connections (C) LED before soldering. (D and E) Solder has shifted on 
the wires when the LED heats up.  
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 Figure C.2 -98 High powered LED schematic. 
(A) LED array mounts on the syringe carriage with 3M dual lock fasteners.  (B) Cross 
section diagram of the heat sink array assembly.  
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Figure C.3 -99 Water cooling loop and copper heat sink.   
(A) Solder large copper wires (to maximize heat sinking by wires) to LEDs (B) Route 
wires so can be held in pin connectors (C) Copper tubing align using copper wire and 
silicone tubing. Remove silicone tubing and use pipe solder to fill gaps between 
copper tubing and heat sink plate. (D) Attach silicone tubing and tees to route water 
through copper tubing lay a bead of copper filled (Ultra copper) silicone sealant and a 
bead of arctic silver thermal compound on heatsink plate side. (E) Press the 
wire/copper plate/LED circuit into the sealent/thermal compound (tape down to hold 
in contact overnight for curing). (F) Wrap/encase in electrical tape so the live wires 
will not be exposed power supply is a 2 Amp LED Driver and parallel resistor. 
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Figure C.4 -100 High powered LED array intensity calculation estimates for different 
resistances.  
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APPENDIX D 
 
 
 Figure D.1. Family Tree Cheat  Sheet for (A) Hockaday (B) Pottenger, and 
(C)Takahashi..  
 
